Document:

EX-10.1

 Exhibit 10.1 

EXECUTION VERSION 
  

 
  

INVESTOR RIGHTS AGREEMENT 
 Dated
as of March 1, 2016 
 by and between 

AVON PRODUCTS, INC. 
 and 

CLEVELAND APPLE INVESTOR L.P. 
  

 
  

                    TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
		 	ARTICLE I	  			
			
		 	Definitions	  			
			
	 SECTION 1.01.
	 	Definitions	  	 	1	 
			
		 	ARTICLE II	  			
			
		 	Corporate Governance	  			
			
	SECTION 2.01.	 	Actions at the Closing	  	 	14	 
	SECTION 2.02.	 	Committee Composition	  	 	15	 
	SECTION 2.03.	 	Investor Directors; Chairman	  	 	16	 
	SECTION 2.04.	 	Independent Director Designees.	  	 	18	 
	SECTION 2.05.	 	Step-Downs of Investor Board Rights.	  	 	19	 
	SECTION 2.06.	 	Director Qualifications	  	 	20	 
	SECTION 2.07.	 	Voting; Quorum	  	 	21	 
	SECTION 2.08.	 	Investor Consent	  	 	22	 
	SECTION 2.09.	 	Certificate of Incorporation; Bylaws	  	 	25	  
	SECTION 2.10.	 	Interested Transactions	  	 	25	 
	SECTION 2.11.	 	Corporate Opportunities	  	 	25	 
	SECTION 2.12.	 	Board Obligations	  	 	25	 
			
		 	ARTICLE III	  			
			
		 	Registration Rights	  			
			
	SECTION 3.01.	 	Registration	  	 	26	  
	SECTION 3.02.	 	Piggyback Registration	  	 	28	 
	SECTION 3.03.	 	Registration Procedures	  	 	30	 
	SECTION 3.04.	 	Suspension	  	 	36	  
	SECTION 3.05.	 	Expenses of Registration	  	 	36	 
	SECTION 3.06.	 	Information by Holders	  	 	36	 
	SECTION 3.07.	 	Rule 144 Reporting	  	 	38	  
	SECTION 3.08.	 	Holdback Agreement	  	 	38	 
	SECTION 3.09.	 	Indemnification	  	 	38	 
	SECTION 3.10.	 	Termination of Registration Rights	  	 	41	 
			
		 	ARTICLE IV	  			
			
		 	 Limitations on Purchases of

Equity Securities and Other Actions
	  			
			
	SECTION 4.01.	 	Limitations on Purchases of Equity Securities and Other Actions	  	 	42	  
	SECTION 4.02.	 	Third-Party Standstills	  	 	44	 

  
 i 

					
		 	ARTICLE V	  	
			
		 	Limitations on Transfers	  	
			
	 SECTION 5.01.
	 	Limitation on Transfer of Series C Preferred Stock	  	44
	 SECTION 5.02.
	 	Permitted Transfers	  	46
	 SECTION 5.03.
	 	Legend	  	46
			
		 	ARTICLE VI	  	
			
		 	Participation	  	
			
	 SECTION 6.01.
	 	Participation	  	47
			
		 	ARTICLE VII	  	
			
		 	Additional Agreements	  	
			
	 SECTION 7.01.
	 	Information and Access	  	50
	 SECTION 7.02.
	 	Confidentiality	  	52
	 SECTION 7.03.
	 	Section 16 Matters	  	52
	 SECTION 7.04.
	 	Rights Plan	  	53
	 SECTION 7.05.
	 	Financing Cooperation	  	53
		 	ARTICLE VIII	  	
			
		 	Miscellaneous	  	
			
	 SECTION 8.01.
	 	Notices	  	53
	 SECTION 8.02.
	 	Amendments; Waivers	  	55
	 SECTION 8.03.
	 	Counterparts and Facsimile	  	55
	 SECTION 8.04.
	 	Governing Law; Specific Enforcement; Submission to Jurisdiction; Waiver of Jury Trial	  	55
	 SECTION 8.05.
	 	Interpretation	  	56
	 SECTION 8.06.
	 	Severability	  	57
	 SECTION 8.07.
	 	No Third-Party Beneficiaries	  	57
	 SECTION 8.08.
	 	Assignment	  	58
	 SECTION 8.09.
	 	Termination	  	58
	 SECTION 8.10.
	 	Entire Agreement, etc.	  	58

  
 ii 

 INVESTOR RIGHTS AGREEMENT, dated as of March 1, 2016 (this
“Agreement”), between Avon Products, Inc., a New York corporation (the “Company”), and Cleveland Apple Investor L.P. (f/k/a Cleveland Apple Investor LLC), a Delaware limited partnership (the
“Investor”). 
 WHEREAS, the Company and the Investor are parties to an Investment Agreement dated as of December 17,
2015 (the “Investment Agreement”), pursuant to which on the date hereof the Company issued, sold and delivered to the Investor, and the Investor purchased and acquired from the Company, pursuant to the terms and subject to the
conditions set forth therein, an aggregate of 435,000 shares of the Company’s Series C Convertible Preferred Stock, par value $1.00 per share (the “Series C Preferred Stock”), having the designation, powers, preferences and
rights, and the qualifications, limitations and restrictions, as specified in the Certificate of Amendment of the Company’s Certificate of Incorporation filed with the Department of State of the State of New York on February 26, 2016, providing
for the designation of the Series C Preferred Stock (the “Series C Certificate of Amendment”); 
 WHEREAS, on or prior to
the date hereof the Company has discontinued its regular quarterly dividend; and 
 WHEREAS, the Company and the Investor desire to
establish in this Agreement certain terms and conditions concerning the rights of and restrictions on the Investor with respect to the Investor Parties’ ownership of the Series C Preferred Stock and other capital stock of the Company, and it is
a condition of the closing of the transactions contemplated by the Investment Agreement that the Company and the Investor execute and deliver this Agreement. 

NOW, THEREFORE, in consideration of the mutual covenants and agreements contained in this Agreement, the receipt and sufficiency of which are
hereby acknowledged, the parties to this Agreement hereby agree as follows: 
 ARTICLE I 

Definitions 
 SECTION
1.01. Definitions. (a) As used in this Agreement (including the recitals hereto), the following terms shall have the following meanings: 

“5% Entity” means any Person that, immediately after giving effect to a proposed Transfer, to the transferor’s knowledge
(after reasonable inquiry), would beneficially own, on an as converted basis, greater than 5% of the then outstanding Common Stock, on an as converted basis. In determining the transferor’s knowledge for purposes of this definition, the Company
agrees that the transferor will have reasonably inquired in the event that the transferor obtains a written representation from the proposed transferee that, following the proposed Transfer, such Person will not beneficially own, on an as converted
basis, greater than 5% of the then outstanding 

 
Common Stock, on an as converted basis; provided, that, for the avoidance of doubt, the transferor will have no affirmative obligation to seek or receive such a written representation.

 “10% Entity” means any Person that, immediately after giving effect to a proposed Transfer, to the Investor’s
knowledge (after reasonable inquiry), would beneficially own, on an as converted basis, greater than 10% of the then outstanding Common Stock, on an as converted basis. In determining the Investor’s knowledge for purposes of this definition,
the Company agrees that the Investor will have reasonably inquired in the event that the Investor obtains a written representation from the proposed transferee that, following the proposed Transfer, such Person will not beneficially own, on an as
converted basis, greater than 10% of the then outstanding Common Stock, on an as converted basis; provided, that, for the avoidance of doubt, the Investor will have no affirmative obligation to seek or receive such a written representation.

 “25.0% Beneficial Ownership Requirement” means that the Investor Parties continue to beneficially own at all times
shares of Series C Preferred Stock and/or shares of Common Stock that represent, in the aggregate and on an as converted basis, at least 25.0% of the number of shares of Common Stock beneficially owned by the Investor Parties, on an as converted
basis, as of the Closing. 
 “50.0% Beneficial Ownership Requirement” means that the Investor Parties continue to
beneficially own at all times shares of Series C Preferred Stock and/or shares of Common Stock that represent, in the aggregate and on an as converted basis, at least 50.0% of the number of shares of Common Stock beneficially owned by the Investor
Parties, on an as converted basis, as of the Closing. 
 “75.0% Beneficial Ownership Requirement” means that the Investor
Parties continue to beneficially own at all times shares of Series C Preferred Stock and/or shares of Common Stock that represent, in the aggregate and on an as converted basis, at least 75.0% of the number of shares of Common Stock beneficially
owned by the Investor Parties, on an as converted basis, as of the Closing. 
 “Activist” means, as of any date of
determination, a Person (other than an Investor Party) that has, directly or indirectly through its Affiliates, whether individually or as a member of a “group” (as defined in Section 13(d)(3) of the Exchange Act), within the two-year
period immediately preceding such date of determination, and in each case with respect to the Company or any of its equity securities (a) made, engaged in or has been a participant in any “solicitation” of “proxies”, as such
terms are used in the proxy rules of the SEC promulgated under Section 14 of the Exchange Act, in order to (i) vote, or knowingly influence any Person with respect to the voting of, any equity securities of the Company, including in
connection with a proposed change of control or other extraordinary corporate transaction not approved (at the time of the first such proposal) by the board of directors of the Company, (ii) call or seek to call a meeting of the stockholders of
the Company not approved (at the time of the first such action) by the board of directors of the Company, (iii) initiated any stockholder proposal for action by stockholders of the Company initially publicly opposed by the board of directors of
the 

  
 2 

 

 
Company or (iv) sought election to, or to place a representative on, the board of directors of the Company, or sought the removal of a director from the board of directors of the Company, in
each case which election or removal was not recommended or approved (at the time such election or removal is first sought) by the board of directors of the Company, (b) otherwise publicly acted, alone or in concert with others, to seek to
control or influence the management or board of directors of the Company (provided, that this clause (b) is not intended to include the activities of any officer or member of the board of directors of the Company, taken in his or her capacity
as an officer or director of the Company), or (c) publicly disclosed any intention, plan or arrangement to do any of the foregoing. 

“Adverse Disclosure” means public disclosure of material non-public information that, in the good faith judgment of the
Company (after consultation with legal counsel): (a) would be required to be made in any registration statement filed with the SEC by the Company so that such registration statement would not be materially misleading; (b) would not be
required to be made at such time but for the filing, effectiveness or continued use of such registration statement; and (c) the Company has a bona fide business purpose for not disclosing publicly. 

“Affiliate” means, with respect to any specified Person, any other Person directly or indirectly controlling or controlled
by, or under direct or indirect common control with, such specified Person; provided that the following Persons shall not be deemed to be Affiliates of the Investor or any of its Affiliates: (a) the Company and its Subsidiaries and
(b) any portfolio company in which the Investor or any of its Affiliates has an investment (whether debt or equity) or any of such portfolio companies’ controlled Affiliates, so long as, in the case of this clause (b), such Person shall
not have been acting on behalf of or at the direction of the Investor or any of its Affiliates or received any Confidential Information from or on behalf of the Investor (it being acknowledged and agreed that an employee of the Investor or its
Affiliates that is a director or officer of such portfolio company or its controlled Affiliates shall not be deemed to have received Confidential Information solely by reason of such individual serving on the board or similar governing body of such
portfolio company). For the purposes of this definition, “control”, when used with respect to any specified Person, means the power to direct the management and policies of such Person, directly or indirectly, whether through the
ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing. 

  
 3 

 

 “Applicable Total Leverage Ratio” means, for any Test Period ending on the last
day of a fiscal quarter of the Company set forth below, the applicable Total Leverage Ratio for such fiscal quarter set forth in the grid below: 
  

			
	 Fiscal Quarter Ended
	  	Applicable Total Leverage Ratio
	September 30, 2015	  	5.50 to 1.00
	December 31, 2015	  	5.95 to 1.00
	March 31, 2016	  	5.40 to 1.00
	June 30, 2016 and thereafter	  	5.00 to 1.00

 “Bankruptcy” means, with respect to any Person, the occurrence of any of the following:
(a) the making of an assignment for the benefit of creditors, (b) the filing by such Person of a voluntary petition in bankruptcy, (c) the adjudication of such Person as bankrupt or insolvent or the entry against such Person of an
order for relief in any bankruptcy or insolvency proceeding, (d) the filing by such Person of a petition or answer seeking for such Person any reorganization, arrangement, composition, readjustment, liquidation, dissolution or similar relief
under any Law, (e) the filing by such Person of an answer or other proceeding admitting or failing to contest the material allegations of a petition filed against such Person in any proceeding of this nature, (f) such Person seeks,
consents to or acquiesces in the appointment of a trustee, receiver or liquidator of the Person or of all or any substantial part of such Person’s properties, or (g) 120 days after the commencement of any proceeding against such Person
seeking reorganization, arrangement, composition, readjustment, liquidation, dissolution or similar relief under any Law, if such proceeding has not been dismissed or, if within 90 days after the appointment without such Person’s consent or
acquiescence of a trustee, receiver or liquidator of such Person or of all or any substantial part of such Person’s properties, the appointment is not vacated or stayed, or within 90 days after the expiration of any such stay, the appointment
is not vacated. 
 Any Person shall be deemed to “beneficially own”, to have “beneficial ownership” of, or
to be “beneficially owning” any securities (which securities shall also be deemed “beneficially owned” by such Person) that such Person is deemed to “beneficially own” within the meaning of
Rules 13d-3 and 13d-5 under the Exchange Act as in effect on the date hereof; provided that any Person shall be deemed to beneficially own any securities that such Person has the right to acquire, whether or not such right is exercisable
immediately, within 60 days or within another period of time (including assuming conversion of all Series C Preferred Stock, if any, owned by such Person into shares of Common Stock). 

“Board” means the Board of Directors of the Company. 

“Business Day” means any weekday that is not a day on which banking institutions in New York, New York are authorized or
required by law, regulation or executive order to be closed. 
 “Bylaws” means the Bylaws of the Company as of the Signing
Date, as the same shall be amended, modified or supplemented between the Signing Date and Closing in accordance with the Investment Agreement, and as may be amended, modified or supplemented from and after the Closing in compliance with this
Agreement. 

  
 4 

 

 “Capital Stock” means any and all shares, interests, rights to purchase,
warrants, options, participations or other equivalents of or interests in (however designated) stock issued by the Company. 

“Certificate of Incorporation” means the Restated Certificate of Incorporation of the Company, as amended by the Series C
Certificate of Amendment and the Series D Certificate of Amendment, in each case, as may be further amended from time to time in compliance with this Agreement and the Investment Agreement. 

“Chairman” means the Chairman of the Board. 

“Change of Control Exchange” has the meaning set forth in the Series C Certificate of Amendment. 

“Closing” means the closing of the Purchase. 

“Closing Date” means the date on which the Closing occurs. 

“Committee Qualification Requirements” means the requirements for service on a given Board committee generally applicable to
all of the members of such committee (and not, for the avoidance of doubt, requirements applicable to a director fulfilling a particular function) as set forth in (a) any applicable Law, (b) the NYSE Listed Company Manual, (c) the
Company’s Corporate Governance Guidelines and (d) such committee’s charter, in the case of clause (c) and (d), as publicly disclosed and as in effect prior to the Signing Date, as the same shall be amended, modified or
supplemented between the Signing Date and Closing in accordance with the Investment Agreement, and as may be amended, modified or supplemented from and after the Closing in compliance with this Agreement. 

“Common Stock” means the common stock, par value $0.25 per share, of the Company and any Capital Stock issued in exchange for
or as a result of the conversion of such Common Stock. 
 “Corporate Governance Guidelines” means the corporate governance
guidelines of the Company applicable to all members of the Board or of such Board committee, as applicable, as publicly disclosed and as in effect prior to the Signing Date, as the same shall be amended, modified or supplemented between the Signing
Date and Closing in accordance with the Investment Agreement, and as may be amended, modified or supplemented from and after the Closing in accordance with this Agreement. 

“Debt” has the meaning set forth in the Revolving Credit Agreement. 

“Delegation of Authority Policy” means the Company’s delegation of authority policy in the form agreed by the Company
and the Investor in accordance with the Investment Agreement, and as may be amended, modified or supplemented from and after the Closing in accordance with this Agreement. 

“Director” means a member of the Board. 

  
 5 

 

 “Director Qualification Standards” means (a) any requirements generally
applicable to all of the Directors (and not, for the avoidance of doubt, requirements applicable to a director fulfilling a particular function) regarding service as a Director of the Company under applicable Law or the rules and regulations of the
NYSE and (b) any additional qualification standards generally applicable to all Directors (and not, for the avoidance of doubt, requirements applicable to a director fulfilling a particular function) established by the Board for eligibility of
individuals to serve as Directors as in effect and publicly disclosed prior to the Signing Date, as the same may be amended, modified or supplemented between the Signing Date and Closing in accordance with the Investment Agreement, and amended,
modified or supplemented from and after the Closing in accordance with this Agreement. 
 “Equity Security” means
(a) any Common Stock, Preferred Stock or other Voting Stock, (b) any securities of the Company convertible into or exchangeable for Common Stock, Preferred Stock or other Voting Stock or (c) any options, rights or warrants (or any
similar securities) issued by the Company to acquire Common Stock, Preferred Stock or other Voting Stock. 
 “Exchange Act”
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. 
 “Fall-Away of
Investor Board Rights” means the first day on which the 25.0% Beneficial Ownership Requirement is not satisfied. 
 “Funded
Debt” means all indebtedness for borrowed money of the Company or any Restricted Subsidiary (as defined in the Revolving Credit Agreement) that appears on the consolidated balance sheet of the Company in accordance with GAAP and that
matures more than one year from the date of its incurrence or matures within one year from such date and is renewable or extendable, at the option of such Person, to a date more than one year from such date or arises under a revolving credit or
similar agreement that obligates the lender or lenders thereunder to extend credit during a period of more than one year from such date, including all amounts of Funded Debt required to be paid or prepaid within one year from the date of its
creation. 
 “Governmental Entity” means any federal, state, provincial, local or foreign governmental, administrative or
regulatory (including any stock exchange) authority, agency, court, instrumentality, binding arbitration body, commission or other entity or self-regulatory organization. 

“Hedging Transaction” means any transaction, agreement or arrangement (or series of transactions, agreements or arrangements)
involving a security linked to any of the Company’s Equity Securities or any security that would be deemed to be a “derivative security” (as defined in Rule 16a-1(c) under the Exchange Act) with respect to any of the Company’s
Equity Securities or any transaction (even if not a security) which would (were it a security) be considered such a derivative security, or that hedges or transfers, directly or indirectly, some or all of the economic risk of ownership of any of the
Company’s Equity Securities, including any forward contract, equity swap, put or 

  
 6 

 

 
call, put or call equivalent position, collar, non-recourse loan, sale of exchangeable security or similar transaction or is otherwise based on the value of any of the Company’s Equity
Securities. 
 “Independent Director” means a Director who would be considered an “independent director” were he
or she to serve on the Board, under (a) NYSE Rule 303A.02 in effect at the time such Person is elected to the Board as such rule may be amended, supplemented or replaced from time to time (whether by final rule or otherwise), (b) the
Company’s Corporate Governance Guidelines and (c) any other applicable Law, rule or regulation mandating the independence of one or more members of the Board, excluding, in each case, requirements that relate to “independence”
only for members of a particular Board committee or directors fulfilling a particular function. In no event will any Person be deemed an Independent Director who is, or at any time during the previous three years was, a director, officer or employee
of the Company or its Subsidiaries. For the avoidance of doubt, a Person elected as an Independent Director shall not cease to be an Independent Director if during the term of his or her directorship such Person ceases to satisfy the requirements
set forth in the first sentence of this definition of “Independent Director.” 
 “Independent Director Designee”
means an individual qualified to serve as an Independent Director that (a) was identified and agreed to in writing by the Company and the Investor prior to the date hereof pursuant to Section 5.16 of the Investment Agreement (an
“Initial Independent Director Designee”) to be elected to the Board pursuant to Section 2.01(b) or (b) was jointly identified by the Other Directors and the Investor Directors to be elected to the Board pursuant to
Section 2.04(a). For the avoidance of doubt, the Initial Independent Director Designees shall be considered Independent Director Designees for all purposes of this Agreement. 

“Independent Acting Director” means a member of the Board who was elected to the Board pursuant to
Section 2.01(b) or 2.04(a) as an Independent Director Designee. 
 “Investor Director Designee” means an
individual designated in writing by the Investor to be elected to the Board pursuant to Section 2.01(b) or 2.03, as applicable. For the avoidance of doubt, the Initial Investor Director Designees shall be considered Investor
Director Designees for all purposes of this Agreement. 
 “Investor Directors” means a member of the Board who was elected
to the Board pursuant to Section 2.01(b) or 2.03 as an Investor Director Designee. 
 “Independent Sales
Representatives” means an independent contractor who directly or indirectly purchases products or services from the Company or any of its Subsidiaries at a discount from the retail price pursuant to the Company’s or any of its
Subsidiaries’ direct sales programs and policies. 

  
 7 

 

 “Investor Party” or “Investor Parties”, as applicable, means
the Investor and each Affiliate of the Investor to whom shares of Series C Preferred Stock or Common Stock are transferred pursuant to and in accordance with Section 5.02. 

“Judgment” means any judgment, writ, stipulation, award, injunction, determination, order or decree of any Governmental
Entity. 
 “Junior Stock” means the Common Stock and any other class or series of Capital Stock now existing or authorized
after the date hereof other than (i) the Series C Preferred Stock and the Series D Preferred Stock, (ii) any class or series of Parity Stock and (iii) any class or series of Senior Stock. “Junior Stock” shall include
any rights, options or warrants exercisable or exchangeable for or convertible into Junior Stock. 
 “Laws” means all
federal, national, state, or local statutes, laws (including common laws), ordinances, rules, requirements, directives or regulations of any Governmental Entity, together with any decision or approval of, or determination by, or any interpretation
or administration of any of the foregoing by, any Governmental Entity. 
 “LLC Agreement” means the Amended and Restated
Limited Liability Company Agreement, dated as of the date hereof by and among Avon Capital Corporation, Avon Products, Inc., Cleveland NA Investor LLC and New Avon, as may be amended and restated from time to time. 

“Material Company Breach” means (a) (i) the Company breaches Section 2.01, 2.02, 2.03,
2.04 or 2.08 hereof, (ii) the Company fails to declare and pay in full all unpaid dividends when due as required by Section 4 of the Series C Certificate of Amendment or Section 4 of the Series D Certificate of
Amendment, (iii) the Company fails to effect any conversion as required by Section 6 of the Series C Certificate of Amendment or redemption as required by Section 9 of the Series D Certificate of Amendment, (iv) the Company fails
to effect any Change of Control Exchange as required by Section 8 of the Series C Certificate of Amendment or any Change of Control Repurchase as required by Section 8 of the Series D Certificate of Amendment, (v) the Company breaches
its obligations under Section 10, 11 or 12 of the Series C Certificate of Amendment or (vi) the Company breaches Section 11 or 12 of the Series D Certificate of Amendment and (b) the Company fails to cure any such breach, in the
event such breach is curable, within fifteen (15) Business Days following written notice thereof from the Investor. 
 “Maximum
Percentage” means the greater of (a) 19.98% plus any additional percentage ownership as a result of any Equity Securities issued pursuant to the Series C Certificate of Amendment or
the Series D Certificate of Amendment and (b) the highest percentage of the outstanding Common Stock, on an as converted basis, beneficially 

  
 8 

 

 
owned by any Person (other than the Investor or any of its Affiliates), on an as converted basis, at any time after the date hereof other than as a result of a transaction or a series of related
transactions that were recommended against by the Board (it being understood and agreed that the Maximum Percentage shall not decrease if such Person subsequently reduces its ownership percentage). 

“National Securities Exchange” means the NYSE or the NASDAQ Stock Market. 

“New Avon” means New Avon LLC (f/k/a C-A NA LLC), a Delaware limited liability company. 

“Nominating Committee” means the Nominating and Corporate Governance Committee of the Board or any successor committee
thereto. 
 “North America Investment Agreement” means the Separation and Investment Agreement by and among the Company,
New Avon and Cleveland NA Investor LLC, dated as of December 17, 2015. 
 “NYSE” means the New York Stock Exchange and
its successors. 
 “Other Director” means a Director that is not elected (or designated for nomination) solely by holders
of Series C Preferred Stock. For the avoidance of doubt, Independent Director Designees (and Independent Acting Directors) shall be considered Other Directors for all purposes of this Agreement. 

“Parity Stock” means any class or series of Capital Stock authorized after the date hereof that expressly ranks on a parity
basis with the Series C Preferred Stock as to dividend rights, rights of redemption and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company. “Parity
Stock” shall include the Series D Preferred Stock and any rights, options or warrants exercisable or exchangeable for or convertible into Parity Stock. 

“Person” means any individual, estate, corporation, partnership, limited liability company, joint venture, association,
joint-stock company, trust, unincorporated organization, Governmental Entity or other entity. 
 “Pro Forma Basis” has the
meaning set forth in the Revolving Credit Agreement. 
 “Purchase” means the purchase of Series C Preferred Stock by the
Investor pursuant to the Investment Agreement. 
 “Qualifying Approved Tender Offer” means a tender offer or exchange offer
that has been at any time recommended by, or approved by, the Board. 
 “Qualifying Non-Approved Tender Offer” means a
tender offer or exchange offer that (a) has not been recommended or has been recommended against by the Board, (b) includes a majority minimum tender or approval condition, and, as of the tender date, all of the conditions to closing of
which (including the majority minimum tender or approval condition) have been satisfied or (other than with respect to the 

  
 9 

 
majority minimum tender or approval condition) waived and (c) is expiring on the tender date (provided, that if such tender or exchange offer is subsequently extended, such offer
shall cease to be a “Qualifying Non-Approved Tender Offer” until subsequently complying with the terms hereof). 

“register”, “registered” and “registration” shall refer to a registration effected by
preparing and filing a registration statement with the SEC in compliance with the Securities Act, and the declaration or ordering of effectiveness of such registration statement by the SEC or the automatic effectiveness of such registration
statement, as applicable. 
 “Registrable Securities” means all shares of Series C Preferred Stock, Series D Preferred
Stock and all shares of Common Stock issued to the Investor or any other Investor Party (x) upon the conversion of the Series C Preferred Stock, (y) as dividends on the Series C Preferred Stock or Series D Preferred Stock or (z) in
connection with the exercise of the Investor Parties’ rights under Section 6.01; provided, however, that such securities shall cease to be Registrable Securities when (a) a registration statement relating to such
securities shall have been declared effective by the SEC and such securities shall have been disposed of by an Investor Party pursuant to such registration statement, (b) such securities have been disposed of by an Investor Party pursuant to
Rule 144 promulgated under the Securities Act, (c) in the case of Series C Preferred Stock, such securities have been converted into Common Stock in accordance with their terms and are no longer outstanding or (d) in the case of
Series D Preferred Stock, such securities have been validly redeemed in accordance with their terms and are no longer outstanding. 

“Registration Expenses” means (a) all expenses incurred by the Company in complying with Section 3.01 or
3.02, including all registration, qualification, listing and filing fees, expenses incurred by the Company in connection with any roadshow related to such registration and offering, auditor fees, printing expenses, escrow fees, and fees and
disbursements of counsel for the Company, blue sky fees and expenses; (b) reasonable, documented out-of-pocket fees and expenses of one outside legal counsel to the Investor and all Holders retained in connection with registrations contemplated
hereby; and (c) reasonable, documented out-of-pocket fees and expenses for any local counsel necessary to effect a registration contemplated hereby, if applicable; provided, however, that Registration Expenses shall not be deemed
to include any Selling Expenses. 
 “Related Investment Funds” means (a) any current or potential private equity
funds, parallel investment funds, co-investment funds, successor investment funds and other investment vehicles and managed accounts under direct or indirect common management, governance or control and other similar investment management
relationships with, the Investor or its Affiliates and (b) any current or potential limited partners or members of each Person described in clause (a). 

  
 10 

 “Representatives” means, with respect to any Person, the directors, officers,
employees, investment bankers, financial advisors, attorneys, accountants, consultants or other advisors, agents or representatives of such Person or any of its Affiliates; provided that, the Representatives of the Company and its
Subsidiaries shall not include the Independent Sales Representatives. 
 “Revolving Credit Agreement” means the Revolving
Credit Agreement, dated as of June 5, 2015, among Avon Products, Inc., Avon International Operations, Inc., the banks and other lenders party thereto and Citibank, N.A., as administrative agent and collateral agent, as in effect as of the
Signing Date. 
 “Rights Plan” means any stockholder rights agreement or plan, or other “poison pill” agreement
or plan, in each case, relating to the Company or with respect to any Equity Securities or debt securities of the Company or any of its Subsidiaries or relating to or affecting the Company’s stockholders. 

“Rule 144” means Rule 144 promulgated under the Securities Act and any successor provision. 

“Rule 462(e)” means Rule 462(e) promulgated under the Securities Act and any successor provision. 

“SEC” means the U.S. Securities and Exchange Commission. 

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. 

“Selling Expenses” means (a) all underwriting discounts, selling commissions and stock transfer taxes applicable to the
securities registered by any Investor Party holding Registrable Securities and (b) the fees and expenses of any counsel to such Investor Parties (other than such fees and expenses expressly included in Registration Expenses). 

“Senior Stock” means any class or series of Capital Stock authorized after the date hereof that expressly ranks senior to the
Series C Preferred Stock and has preference or priority over the Series C Preferred Stock as to dividend rights, rights of redemption or rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up
of the affairs of the Company. “Senior Stock” shall include any rights, options or warrants exercisable or exchangeable for or convertible into Senior Stock. 

“Series D Certificate of Amendment” means the Certificate of Amendment of the Company’s Certificate of Incorporation,
filed with the Department of State of the State of New York on February 26, 2016, providing for the issuance of Series D Preferred Stock. 

“Series D Preferred Stock” means the series of Preferred Stock, par value $1.00 per share, having the powers, preferences and
rights, and the qualifications, limitations and restrictions, as specified in the Series D Certificate of Amendment. 

  
 11 

 “Shelf Registration” means a Resale Shelf Registration or a Subsequent Shelf
Registration, as applicable. 
 “Signing Date” means December 17, 2015. 

“Specified Actions” means any of the actions set forth on Exhibit A. 

“Specified Agreement” means an agreement entered into with a Person that is the beneficial owner of 5% or more of the then
issued and outstanding Voting Stock in connection with an equity investment in the Company by such Person or its Affiliates, in each case other than an agreement entered into with an Activist. 

“Standstill Period” means the period from and after the date the Initial Investor Directors are appointed to the Board until
the earlier of (a) the Fall-Away of Investor Rights has occurred and (b) (x) the first date on which the 50% Beneficial Ownership Requirement is not satisfied (but the Fall-Away of Investor Board Rights has not occurred) and
(y) no Investor Director is serving on the Board and the Investor has irrevocably waived its rights under Sections 2.01, 2.02, 2.03, 2.04 and 2.08 and under Section 12(c) of the Series C Certificate of
Amendment; provided that the Standstill Period shall immediately terminate and expire (and the restrictions of Section 4.01 shall cease to apply and shall be of no further force and effect) at such time as (a) the Company
enters into a definitive written agreement to consummate a merger, consolidation, business combination, tender or exchange offer, recapitalization, reorganization or sale transaction pursuant to which 50% or more of the issued and outstanding Voting
Stock and securities convertible into or exchangeable for Voting Stock would be converted into, or the holders of 50% or more of the issued and outstanding Voting Stock and securities convertible into or exchangeable for Voting Stock would receive a
distribution of, cash, securities or other property of a third party Person or Persons, or which would result in 50% or more of the Company’s consolidated assets (based on the fair market value thereof) being sold to or owned by any Person or
Persons (in each case, other than any holding company of which the stockholders of the Company immediately prior to the transaction own 50% or more of the outstanding securities having the right to vote generally in any election of directors of such
holding company immediately following the consummation of the transaction), (b) any Person or “group” (within the meaning of Section 13(d)(3) of the Exchange Act) becomes the beneficial owner of 50% or more of the issued and
outstanding Voting Stock or securities convertible into or exchangeable for Voting Stock (other than any holding company of which the stockholders of the Company immediately prior to the transaction own 50% or more of the outstanding securities
having the right to vote generally in any election of directors of such holding company immediately following the consummation of the transaction), (c) any Qualifying Approved Tender Offer (other than a Company self-tender offer) is commenced
that, if consummated, would result in a Person or “group” (within the meaning of Section 13(d)(3) of the Exchange Act) becoming the beneficial owner of 50% or more of the issued and outstanding Voting Stock or securities convertible
into or exchangeable for Voting Stock, (d) a Bankruptcy, liquidation, dissolution or winding up of the Company is voluntarily initiated or any proceeding for Bankruptcy, insolvency, receivership or similar action with respect to the Company is
commenced or (e) a Material Company Breach has occurred. 

  
 12 

 “Subsidiary” means, with respect to any Person, another Person, an amount of the
voting securities, other voting rights or voting partnership interests of which is sufficient to elect at least a majority of its board of directors or other governing body (or, if there are no such voting interests, more than 50% of the equity
interests of which) is owned directly or indirectly by such first Person. 
 “Test Period” has the meaning set forth in the
Revolving Credit Agreement. 
 “Total Leverage Ratio” has the meaning set forth in the Revolving Credit Agreement. 

“Transaction Documents” has the meaning set forth in the Investment Agreement. 

“Underwriter” means a securities dealer who purchases any Registrable Securities as a principal in connection with a
distribution of such Registrable Securities and not as part of such dealer’s market-making activities. 
 “Voting
Stock” means the Common Stock, the Series C Preferred Stock and any other Capital Stock of the Company having the right to vote generally in any election of Directors. 

(b) In addition to the terms defined in Section 1.01(a), the following terms have the meanings assigned thereto in the Sections
set forth below: 
  

			
	 Term
	  	 Section

	 2016 Annual Meeting
	  	2.01(b)
	 Action
	  	8.04(c)
	 Agreement
	  	Preamble
	 Company
	  	Preamble
	 Company Indemnified Parties
	  	3.09(a)
	 Confidential Information
	  	7.02
	 Director Designee
	  	2.06
	 Effectiveness Period
	  	3.01(b)
	 Excluded Issuance
	  	6.01(a)
	 Extraordinary Transaction
	  	4.01(c)
	 FINRA
	  	3.03(a)(xv)
	 Holder Indemnified Parties
	  	3.09(b)
	 Holders
	  	3.01(a)

  
 13 

			
	 Term
	  	 Section

	 Indemnified Party
	  	3.09(c)
	 Indemnifying Party
	  	3.09(c)
	 Independent Director Designees
	  	2.04(a)
	 Initial Investor Director Designees
	  	2.01(b)(ii)
	 Interruption Period
	  	3.03(b)
	 Investment Agreement
	  	Recitals
	 Investor
	  	Preamble
	 Investor Related Parties
	  	2.10
	 Investor Transactions
	  	2.11
	 Lead Independent Director
	  	2.03(b)
	 Losses
	  	3.09(a)
	 Offering Persons
	  	3.03(a)(xiv)
	 Permitted Lien
	  	5.01(a)
	 Piggyback Notice
	  	3.02(a)
	 Piggyback Registration Statement
	  	3.02(b)
	 Piggyback Request
	  	3.02(b)
	 Proposed Securities
	  	6.01(b)(i)
	 Resale Shelf Registration Statement
	  	3.01(a)
	 Restricted Period
	  	5.01(a)
	 Series C Certificate of Amendment
	  	Recitals
	 Series C Preferred Stock
	  	Recitals
	 Shelf Offering
	  	3.01(g)
	 Subsequent Holder Notice
	  	3.01(e)
	 Subsequent Shelf Registration
	  	3.01(c)
	 Take-Down Notice
	  	3.01(g)
	 Transfer
	  	5.01(a)
	 Underwritten Offering
	  	3.01(f)(i)
	 Underwritten Offering Notice
	  	3.01(f)(i)

 ARTICLE II 

Corporate Governance 

SECTION 2.01. Actions at the Closing. The Company and the Board shall take all necessary action to cause, effective as of the Closing:

 (a) the size of the Board to be decreased to 11 members; 

(b) the Board to be comprised solely of: 

(i) six Directors that served on the Board immediately prior to the Closing; 

(ii) Chan W. Galbato, Steven F. Mayer and Michael F. Sanford (such individuals, the “Initial Investor Director
Designees”); 

  
 14 

 (iii) two Independent Director Designees; provided that if two Independent
Director Designees have not been jointly identified and agreed to by the Company and the Investor prior to the Closing, such seat (in the case one Independent Director Designee shall have been so identified and agreed to) or seats (in the case no
Independent Director Designees shall have been so identified and agreed to) shall remain vacant until such Independent Director Designee or Independent Director Designees, as applicable, have been elected pursuant to, and in accordance with,
Section 2.04(a); 
 each such Director in this clause (b) to serve a term that expires at the 2016 annual meeting of the
Company’s stockholders (the “2016 Annual Meeting”) and until his or her successor is duly elected and qualified or his or her earlier death, disability or resignation; 

(c) the committees of the Board to be comprised solely as follows: 

(i) The Audit Committee shall have no more than 4 members; 

(ii) The Compensation and Management Development Committee shall have no more than 4 members; 

(iii) The Nominating Committee shall have no more than 4 members; and 

(iv) The Finance Committee shall have no more than 4 members. 

SECTION 2.02. Committee Composition. 

(a) Unless and until there has occurred a Fall-Away of Investor Board Rights, the Investor Parties shall have the right to identify one
Investor Director to serve on each committee of the Board and to remove and/or replace such Person, and the Company shall cause the Board to promptly designate each applicable Investor Director to serve as a member of such committees as the Investor
Parties shall identify and remove and/or replace any Investor Director as a member of any committee as identified by the Investor Parties; provided that such designation shall in each case be subject to such Investor Director meeting the
applicable Committee Qualification Requirements. Other than as required by the rules and regulations of the SEC, the NYSE Listed Company Manual, the Company’s corporate governance guidelines applicable to all of the members of such committee or
such committee’s charter, no Investor Director chosen by the Investor and designated to a Board committee pursuant to this Section 2.02 shall be removed from his or her position on such committee without the consent of the Investor.
The Company shall cause the Board to promptly after the date hereof (and in any event prior to the earlier of (x) the first meeting of any committee of the Board after the date hereof and (y) the close of business on the tenth (10th) day after the
date hereof) nominate, subject to the terms of this Section 2.02(a) and Section 2.02(b), the Initial Investor Director Designees to the committees designated in accordance with this Section 2.02(a). 

  
 15 

 (b) If at any time none of the Investor Directors meet the Committee Qualification Requirements
with respect to the Audit Committee, the Investor shall have the right to select one of the Other Directors, and the Board shall take all necessary action to appoint such Other Director (subject to such Other Director’s agreement to serve and
such Other Director meeting the Committee Qualification Requirements), to serve on such committee in place of an Investor Director and, at the Investor’s election, an Investor Director to serve as an observer on such committee. Such observer
shall have all the rights of the other members of such committee (including the right to receive notice of such meetings and all materials provided to the Directors serving on such committee) other than the right to vote. 

SECTION 2.03. Investor Directors; Chairman 

(a) Unless and until there has occurred a Fall-Away of Investor Board Rights, (i) for so long as shares of Series C Preferred Stock remain
outstanding, the Investor Parties shall be entitled to appoint and elect one or more Directors to serve on the Board pursuant to Section 12(c) of the Series C Certificate of Amendment or (ii) if no shares of Series C Preferred Stock remain
outstanding, the Investor Parties shall have the right, but not the obligation, (A) for so long as the 75.0% Beneficial Ownership Requirement is satisfied, to designate for nomination up to three (3) nominees to serve as Investor Director
Designees, (B) for so long as the 75.0% Beneficial Ownership Requirement is not satisfied and the 50.0% Beneficial Ownership Requirement is satisfied, to designate for nomination up to two (2) nominees to serves as Investor Director
Designees and (C) for so long as the 50.0% Beneficial Ownership Requirement is not satisfied and the 25.0% Beneficial Ownership Requirement is satisfied, to designate for nomination up to one nominee to serve as the Investor Director Designee,
subject in each case to such Person’s satisfaction of the Director Qualification Standards. Thereafter, in the event that the Investor Director Designee is nominated pursuant to clause (ii) above, the Company shall (A) include the
Investor Director Designee in its slate of nominees for election to the Board at each annual or special meeting of the stockholders of the Company at which directors are to be elected and at which the seat held by the Investor Director Designee is
subject to election and (B) recommend that the Company’s stockholders vote in favor of the election of the Investor Director Designee at each annual meeting of the Company’s stockholders and shall otherwise support such Independent
Director Designees in a manner no less rigorous and favorable than the manner in which the Company supports its other nominees. The Company and the Board shall take all necessary actions to ensure that, at all times when an Investor Director
Designee is eligible to be appointed or nominated, there are sufficient vacancies on the Board to permit such designation. For the avoidance of doubt, the Investor shall not be required to comply with the advance notice provisions generally
applicable to the nomination of Directors by the Company so long as the Investor provides reasonable advance notice to the Company of the Director Designees prior to the mailing of the proxy statement by the Company (provided, that the
Company shall provide reasonable advance notice to the Investor of the expected mailing date). 

  
 16 

 (b) For so long as the 50.0% Beneficial Ownership Requirement is satisfied, the Investor shall
have the right to select a Director to serve as the Chairman and the Company and the Board shall take all necessary action to elect such Director as the Chairman. The Chairman shall have such rights, powers and authority as are set forth in the
Certificate of Incorporation, the Bylaws and the Corporate Governance Guidelines, and the right to (i) receive regular reports from the Company’s Chief Executive Officer, (ii) coordinate periodic Board input and review of
management’s strategic plans for the Company, (iii) assist and advise the Company’s Chief Executive Officer in connection with corporate strategy and personnel and organizational matters, (iv) lead the Board’s review of a
succession plan, (v) assist and advise the Company’s Chief Executive Officer in the development and monitoring of budgets, operations and similar plans and (vi) have a reasonable opportunity to review and comment on the agenda of any
special meeting of the Board not called by the Chairman. For such time as the Chairman has been chosen by the Investor in accordance with the terms of the first sentence of this Section 2.03(b), one of the other Directors shall be appointed by the
Board as the Lead Independent Director (the “Lead Independent Director”). The Lead Independent Director shall have the right to (i) preside at all meetings of the Board at which the Chairman is not present, (ii) have a
reasonable opportunity to review and comment on Board meeting agendas other than the agenda for any special meeting of the Board called by the Chairman, (iii) serve as a liaison between the Chairman and the Other Directors (provided that, in no
event shall the Chairman be restricted from communicating directly with any Other Director), and (iv) have the authority to call special meetings of the Board and set the agenda for any such meetings. 

(c) Without the prior written consent of the Investor, until such time as the Fall-Away of the Investor Board Rights has occurred, the Board
shall not remove any Investor Director from his or her directorship (subject to Section 2.05). The Investor shall have the right to remove any Investor Director at any time. 

(d) If any Investor Director ceases to serve on the Board for any reason (other than pursuant to Section 2.05) during his or her
term (until such time as the Fall-Away of Investor Board Rights has occurred), the vacancy created thereby shall be filled, and the Company shall cause the Board to fill such vacancy, with a new Investor Director Designee and appoint such Investor
Director to all committees on which the prior Director served, subject to satisfaction of the applicable Committee Qualification Requirements. 

(e) Until such time as the Fall-Away of Investor Board Rights has occurred, upon the written request of the Investor, the Board shall cause
the Company to call a special meeting of the holders of Series C Preferred Stock for the purpose of electing one or more Investor Directors at such time and location as the Investor may reasonably request (subject to applicable Law). The Company and
the Board agree that, for so long as the Investor Parties hold any shares of Series C Preferred Stock, all annual meetings of the holders of Series C Preferred Stock (and any record date applicable thereto) will be at the same time and location as
the annual meetings of the holders of Common Stock. 

  
 17 

 (f) For the avoidance of doubt, the Investor Directors shall be entitled (i) to the same
retainer, equity compensation and other fees or compensation, including travel and expense reimbursement, paid to the non-executive Directors for his or her service as a Director, including any service on any committee of the Board and (ii) to
indemnification rights no less favorable than those provided to any other non-employee Directors (including entering into an indemnification agreement that is no less favorable than that provided to any other non-employee director in the event that
the Company enters into any such agreement with another non-employee director) and in any event no less favorable than as in effect as of the Signing Date, and the Company shall maintain in full force and effect directors’ and officers’
liability insurance. Each Investor Director shall be covered as an insured director, in such a manner as to provide each Investor Director in his or her capacity as a Director with rights and benefits under all directors’ and officers’
insurance policies no less favorable than those provided to any other non-employee Directors. The Company acknowledges and agrees that the Company is the indemnitor of first resort with respect to any Investor Related Party who is an officer,
director or other fiduciary of the Company and its Subsidiaries (i.e., its obligations to such Person are primary and any obligation of any other Persons to which such Investor Director or its Affiliates may have rights to advancement of expenses or
to indemnification for the same expenses or liabilities incurred by such Investor Related Party are secondary). 
 (g) Notwithstanding
anything to the contrary in the Bylaws, (i) notice of the time and place of any meeting of a committee of the Board on which an Investor Director serves as a member or observer shall be provided to each member of such committee at least 24 hours
prior to such meeting unless such Investor Director consents to a shorter notice period therefor and (ii) until such time as the Fall-Away of Investor Board Rights has occurred, the Investor Directors shall be provided with notice of the time and
place of any special meeting of the Board (whether called by the Lead Independent Director or otherwise, but other than a meeting called by an Investor-appointed Chairman) at least 24 hours prior to such meeting unless a majority of the Investor
Directors otherwise consent. 
 (h) The Company and the Board shall take all necessary action to promptly waive the obligations for any
Investor Director to comply with the “Director Stock Ownership Guideline” (as set forth in the Corporate Governance Guidelines), and the Company acknowledges and agrees that such obligations for the Initial Investor Director Designees have
been irrevocably waived as of the date hereof. 
 SECTION 2.04. Independent Director Designees. 

(a) If less than two Independent Director Designees shall have been jointly identified and agreed to in writing by the Company and the Investor
and elected to the Board on the date hereof, the Other Directors and the Investor Directors agree to, as promptly as practicable following the Closing, jointly identify one (if only one Independent Director Designee was elected to the Board as of
the Closing) or two (if no Independent Director Designees were elected to the Board as of the Closing) Independent Director Designees for election to the Board. Promptly following the identification of such Independent Director Designee(s), the
Board will elect such Independent Director Designee(s) to the Board to fill the vacancy or vacancies then existing, in each case for a term that expires at the 2016 Annual Meeting and until their successors are duly elected and qualified. Following
his or her election, other than as required by applicable Law or the Certificate of Incorporation, no Independent Director Designee shall be removed from the Board unless the removal of such Independent Director Designee has been approved by a
majority of the Investor Director Designees. If any Independent Director Designee ceases to serve on the Board for any reason during his or her term (until such time as the Fall-Away of Investor Board Rights has occurred), the vacancy created
thereby shall be filled, and the Company shall cause the Board to fill such vacancy, with a new Independent Director Designee jointly identified by the Other Directors and the Investor Directors. 

(b) The Company agrees to include the Initial Independent Director Designees (and/or, if less than two Independent Director Designees have
been jointly identified and agreed to by the Company and the Investor prior to the Closing, the then-serving Independent Director Designee(s)) or any other Initial Independent Director 

  
 18 

 
Designee(s) jointly identified by the Other Directors and the Investor Directors on the slate of nominees recommended by the Board in the Company’s proxy statement and on its proxy card
relating to the 2016 Annual Meeting. Unless and until there has occurred a Fall-Away of Investor Board Rights, from and after the 2016 Annual Meeting the Other Directors and the Investor Directors shall jointly identify two Independent Director
Designees to be included on the slate of nominees recommended by the Board in the Company’s proxy statement and on its proxy card for each subsequent annual meeting of the Company’s stockholders (which may or may not be the same Persons as
the Initial Independent Director Designees or any replacements thereof). Unless and until there has occurred a Fall-Away of Investor Board Rights, the Company shall recommend that the Company’s stockholders vote in favor of each Independent
Director Designee at each annual meeting of the Company’s stockholders and shall otherwise support such Independent Director Designees in a manner no less rigorous and favorable than the manner in which the Company supports its other nominees.

 SECTION 2.05. Step-Downs of Investor Board Rights. 

(a) If at any time the 75.0% Beneficial Ownership Requirement is not satisfied (but the 50.0% Beneficial Ownership Requirement is satisfied),
then, at the written request of a majority of the Other Directors to the Investor, one of the Investor Directors, as specified by the Investor (or, if the Investor fails to do so within five Business Days of such requirement not being satisfied, as
specified by a majority of the Other Directors), shall immediately resign, and the Investor Parties shall cause such Investor Director immediately to resign, from the Board effective as of the receipt of such notice. For the avoidance of doubt,
notwithstanding that a majority of the Other Directors do not request the removal of an Investor Director in accordance with this Section 2.05(a), from and after such time as the 75.0% Beneficial Ownership Requirement is no longer
satisfied, the Investor Parties shall only have the right to elect to the Board the applicable number of Directors set forth in Section 2.03(a) and Section 12(c) of the Series C Certificate of Amendment. 

(b) If at any time the 50.0% Beneficial Ownership Requirement is not satisfied (but the Fall-Away of Investor Board Rights has not occurred),
then, at the written request of a majority of the Other Directors to the Investor, one of the Investor Directors, as specified by the Investor (or, if the Investor fails to do so within five Business Days of such requirement not being satisfied, a
majority of the Other Directors), shall immediately resign, and the Investor Parties shall cause such Investor Director immediately to resign, from the Board effective as of the receipt of such notice; provided that the Investor Director
specified by the Investor for resignation in accordance with this Section 2.05(b) shall in no event be the same Investor Director as was specified by the Investor for resignation in accordance with Section 2.05(a), if such
Investor Director was required to resign at such time. For the avoidance of doubt, notwithstanding that a majority of the Other Directors do not request the removal of an Investor Director in accordance with this Section 2.05(b), from
and after such time as the 50.0% Beneficial Ownership Requirement is no longer satisfied, the Investor Parties shall only have the right to elect to the Board the applicable number of Directors set forth in Section 2.03(a) and
Section 12(c) of the Series C Certificate of Amendment. 

  
 19 

 (c) Following the occurrence of the Fall-Away of Investor Board Rights, (i) at the written
request of a majority of the Other Directors to the Investor, any or all of the Investor Directors then serving on the Board shall immediately resign, and the Investor Parties shall cause all of such Investor Directors immediately to resign, from
the Board effective as of the receipt of such notice, and (ii) the Investor Parties shall no longer have any rights with respect to Investor Directors or Independent Directors, including under Sections 2.01, 2.03, 2.04 and
2.05 or under Section 12(c) of the Series C Certificate of Amendment. 
 SECTION 2.06. Director Qualifications.
Notwithstanding anything to the contrary in this Agreement or the Series C Certificate of Amendment, the Investor agrees that, prior to and as a condition to the election to the Board of any Investor Director Designee or any Independent Director
Designee (and, in the case of any Independent Director Designee, as a condition to the Board’s obligation to elect or nominate such Independent Director Designee for election as a Director) (any such Investor Director Designee or Independent
Director Designee, a “Director Designee”), (x) such Director Designee shall have satisfied the Director Qualification Standards (and the Company acknowledges and agrees that the Initial Investor Director Designees and Initial
Independent Director Designees (to the extent identified as of the date hereof) have satisfied such requirements as of the date hereof and the Board has determined that based on the information supplied by such individuals as of the date hereof each
of the Initial Investor Director Designees is an “independent director” under NYSE Rule 303A.02 and the Corporate Governance Guidelines as of the date hereof; provided that (1) no Director Designee shall be eligible to serve on
the Board if he or she has been involved in any of the events enumerated under Item 2(d) or (e) of Schedule 13D under the Exchange Act or Item 401(f) of Regulation S-K under the Securities Act (to the extent material to his or her
ability or integrity to serve as a Director) or is subject to any Judgment prohibiting service as a director of any public company and (2) if any Director Designee shall fail to satisfy the Director Qualification Standards or the requirements
of the preceding clause (1), the Investor agrees that such Director Designee shall not be nominated or elected to the Board, and the Person having the right to nominate or elect such Director Designee in accordance with this
Section 2.06 and the Series C Certificate of Amendment shall have the right to designate a replacement therefor (which replacement Director Designee shall be subject to the requirements of this Section 2.06), (y) each
Director Designee shall (and the Investor shall cause each Investor Director Designee to) make himself or herself reasonably available for an interview and to consent to such customary reference and background checks as the Nominating Committee may
reasonably request to determine such Director Designee’s eligibility to serve as a Director and compliance with the Director Qualification Standards and (z) each Director Designee must provide to the Company: 

(a) all information reasonably requested by the Company that is required to be or is customarily disclosed for Directors, candidates for
Directors and their respective Affiliates and Representatives in a proxy statement or other filings in accordance with applicable Law, any stock exchange rules or listing standards or the Certificate of Incorporation or Bylaws or Corporate
Governance Guidelines, in each case, relating to such Director Designee’s nomination or election, as applicable, as a Director; 
 (b)
all information reasonably requested by the Company in connection with assessing eligibility under the Director Qualification Standards and the Committee Qualification Requirements, to the extent applicable, in each case, relating to such Director
Designee’s nomination or election, as applicable, as a Director; 

  
 20 

 (c) an undertaking in writing by such Director Designee in the form provided by all Directors and
by candidates for Directors, including any such undertakings, representations and agreements that are required under the Certificate of Incorporation, Bylaws or Corporate Governance Guidelines; and 

(d) an undertaking in writing by each Investor Director Designee, to recuse himself or herself, if requested by the Board or committee, from
any deliberations or discussion of the Board or any committee thereof regarding (i) negotiations or good faith disputes between the Company and the Investor or New Avon or any of its Subsidiaries to the extent regarding the exercise of the
Company’s rights under Section 10.3(a) of the North America LLC Agreement, (ii) any litigation or good faith dispute between the Company and the Investor or New Avon or any Affiliate of New Avon under the Investment Agreement or North
American Investment Agreement or (iii) any matter adverse to the Company related to the Transaction Documents or the Transactions (in each case, as defined in the North American Investment Agreement). 

SECTION 2.07. Voting; Quorum. Until the first to occur of (i) the Fall-Away of the Investor Board Rights, (ii) (x) the
first date on which the 50% Beneficial Ownership Requirement is not satisfied (but the Fall-Away of Investor Board Rights has not occurred) and (y) no Investor Director is serving on the Board and the Investor has irrevocably waived its rights
under Sections 2.01, 2.02, 2.03, 2.04 and 2.08 and under Section 12(c) of the Series C Certificate of Amendment or (iii) a Material Company Breach: 

(a) at each meeting of the stockholders of the Company and at every postponement or adjournment thereof, the Investor Parties shall take all
reasonable actions such that all of the shares of Series C Preferred Stock and Common Stock beneficially owned, directly or indirectly, by the Investor Parties and entitled to vote at such meeting of stockholders are voted: 

(i) in favor of each Director nominated and recommended by the Board for election at any such meeting; 

(ii) in favor of the Company’s “say-on-pay” proposal and any proposal by the Company relating to equity
compensation that has been approved by the Compensation and Management Development Committee of the Board; and 
 (iii) in
favor of the Company’s proposal for ratification of the appointment of the Company’s independent registered public accounting firm. 

(b) Except as set forth in Section 2.07(a), no Investor Party shall be under any obligation to vote in the same manner as
recommended by the Board or in any other manner, other than in its sole discretion. 

  
 21 

 (c) In connection with any proposal submitted for the approval of the Company’s stockholders
which is the subject of Section 2.07(a) (including at any annual or special meeting or in connection with any other action), each Investor Party, on its own behalf, shall cause all of the shares of Voting Stock beneficially owned by such
Investor Party to be present or represented by proxy at all such meetings of the Company’s stockholders (including at any adjournments or postponements thereof) for purposes of establishing a quorum and voting in accordance with
Section 2.07(a). 
 SECTION 2.08. Investor Consent. 

(a) As long as the Investor Parties continue to beneficially own any shares of Series C Preferred Stock issued to the Investor on the Closing
Date and, following such time as the Investor Parties no longer own any shares of Series C Preferred Stock, and in the case of clause (iii), for so long as the Investor Parties continue to hold any Common Shares issued upon conversion of such shares
of Series C Preferred Stock, without the prior written consent of the Investor, the Company shall not take (and the Board shall not authorize the Company to take) any of the following actions: 

(i) authorize or issue any Parity Stock or Senior Stock, or amend or alter the Certificate of Incorporation to authorize or
create, or increase the number of authorized or issued shares of, or any securities convertible into shares of, or reclassify any security into, any Parity Stock (including any increase in the number of authorized or issued shares of Series C
Preferred Stock) or Senior Stock; provided that the consent of the Investor will not be required for (A) the authorization or creation of, or the increase in the number of authorized or issued shares of, or any securities convertible into
shares of, or the reclassification of any security (other than Series C Preferred Stock) into, any Junior Stock or (B) the authorization and issuance of Series D Preferred Stock in accordance with this Agreement and the Series C Certificate of
Amendment; 
 (ii) amend, modify or supplement any provision of the Certificate of Incorporation or Bylaws in a manner that
alters or changes the rights, preferences or privileges of the holders of Series C Preferred Shares (including by reducing the Liquidation Preference Amount (as defined in the Series C Certificate of Amendment)) or otherwise has an adverse effect
on, the holders of Series C Preferred Stock; 
 (iii) voluntarily de-list the Common Stock from the NYSE or any other
National Securities Exchange upon which the Common Stock may subsequently be listed; or 
 (iv) voluntarily cause the Common
Stock to be de-registered under the Exchange Act. 
 (b) Until the Fall-Away of Investor Board Rights, without the prior written consent of
the Investor, the Company shall not take (and the Board shall not authorize the Company to take) any of the following actions: 

(i) increase the size of the Board to more than a total of 11 Director seats; 

  
 22 

 (ii) amend or modify the rights, power or authority of the Chairman or Lead
Independent Director in a manner that adversely affects in any material respect the rights of the Investor Parties set forth in this Agreement (other than as required by a change in applicable Law or the rules and regulations of the NYSE after the
Signing Date); 
 (iii) classify the Board; 

(iv) allow or authorize the Board or any committee thereof to take action by written consent other than unanimously; 

(v) increase the size of any Board committee to more than the number set forth in Section 2.01(c), as may be
increased in accordance with this Agreement; 
 (vi) create any new Board committee with more than 4 members; 

(vii) enter into any transaction that would be required to be disclosed by the Company pursuant to Item 404 of Regulation
S-K promulgated under the Exchange Act) (whether or not such Item is applicable to the Company and whether or not in the current fiscal year or in any future fiscal year) that does not comply with the policies set forth in the Company’s Audit
Committee charter or any similar successor policy thereto; 
 (viii) amend or alter the Director Qualification Standards, the
Company’s Corporate Governance Guidelines, the policies set forth in any of the Company’s committee charters (including the Audit Committee charter) or any similar successor policies thereto, provisions of the Company’s Code of
Conduct applicable to Directors, the insider trading policy applicable to Directors and any other Company rules, policies, guidelines, indemnification and exculpation applicable to Directors, Board committees, or the Chairman, including in the
Certificate of Incorporation or the Bylaws, in each case, in a manner that adversely affects in any material respect the rights of the Investor Parties set forth in this Agreement or the Series C Certificate of Amendment (including by diminishing
the rights, power or authority of the Chairman, or increasing the rights, power or authority of the Lead Independent Director, in each case beyond the rights, power and authority contemplated by Section 2.03(b)) or has a
disproportionately adverse effect on the eligibility for office of the then sitting or proposed Investor Directors relative to other then sitting Directors (in each case, other than as required by a change in applicable Law or the rules and
regulations of the NYSE after the Signing Date); 
 (ix) amend or alter the Delegation of Authority Policy; or 

(x) take any action to voluntarily effect or initiate a Bankruptcy, liquidation, dissolution or winding up of the Company. 

  
 23 

 (c) Until such time as the Investor Parties shall fail to satisfy the 50.0% Beneficial Ownership
Requirement, without the prior written consent of the Investor, the Company shall not take (and the Board shall not authorize the Company to take) any of the following actions: 

(i) establish a record date for, declare, set aside for payment or make payment in respect of, any dividend or other
distribution upon any shares of capital stock of the Company (other than the payment of any dividends on the Series C Preferred Stock or the Series D Preferred Stock); provided that at any time following the establishment of a new regular
quarterly dividend (subject to receipt of the Investor’s consent), no further consent of the Investor shall be required for any regular quarterly cash dividends from and after the date of the adoption of such new dividend policy to the extent
such quarterly cash dividends have a declaration, record and payment date consistent with such new dividend practice; or 

(ii) create, incur, issue or assume any Debt, in a single transaction or a series of related transactions, in excess of the
greater of (A) (x) existing Funded Debt outstanding as of the date hereof (without giving effect to the transactions contemplated by this Agreement or the North America Investment Agreement) plus (y) $500,000,000, and (B) any
Debt if, after giving effect to the creation, incurrence, issuance or assumption thereof on a Pro Forma Basis, the Total Leverage Ratio as of the last day of the Test Period ended immediately preceding the incurrence of such Debt is not greater than
the Applicable Total Leverage Ratio. 
 (d) Notwithstanding anything to the contrary in this Section 2.08, (i) the Company
may take (and the Board may authorize the Company to take) any of the actions set forth in Section 2.08(a)(iii), (iv), Sections 2.08(b)(i), (v) and (vii) and Section 2.08(c)(i), in each
case for the purpose of effecting (and effective upon or following the consummation of) any merger or other business combination transaction of the Company, the sale of all or substantially all of the assets of the Company and its Subsidiaries or
any other change of control transaction of the Company, in each case that has been recommended by a majority of the Board and (ii) for purposes of the Investor’s consent right pursuant to Section 2.08(c)(ii), in connection with
the exercise by the Company or any of its Subsidiaries of the Company’s rights under Section 10.3(a) of the LLC Agreement, the reference to “Applicable Total Leverage Ratio” in Section 2.08(c)(ii) shall be replaced by
“6.00 to 1.00.” 
 SECTION 2.09. Certificate of Incorporation; Bylaws ; Other Governance Authorities. The Company and the
Board shall take or cause to be taken all lawful action necessary to ensure at all times that the Certificate of Incorporation, Bylaws, committee charters, Corporate Governance Guidelines, Delegation of Authority Policy, Director Qualification
Standards and all Company rules, policies and guidelines applicable to Directors are consistent in all but de minimis respects with the provisions of this Agreement. 

  
 24 

 SECTION 2.10. Interested Transactions. The approval by a majority of the Other Directors
shall be required (in addition to any other Board or stockholder approval required by applicable Law) for the Company or any of its Subsidiaries to enter into or effect, or agree to enter into or effect, any material contract or transaction between
or involving the Company or any of its Subsidiaries, on the one hand, and the Investor, any of its Affiliates and any of their respective directors, officers, employees and consultants, including any Investor Directors (collectively, the
“Investor Related Parties”), on the other hand, the terms of which are not governed by (a) any agreement to which the Company or any of its Subsidiaries is a party as of the date hereof, (b) a provision of the Certificate
of Incorporation or Bylaws or (c) compensation, indemnification, equity award or other ordinary course agreement with Investor Directors. 

SECTION 2.11. Corporate Opportunities. Notwithstanding anything contained herein or in any other “Transaction Document” (as
defined in the North American Investment Agreement), the Investor, any Investor Related Parties, may freely offer to any other Person or effect on behalf of itself or any other Person any other investment or business opportunity or prospective
economic advantage (which may include investments or activities relating to competitors of the Company), including those competitive with the business of the Company, or other transactions in which the Company, its subsidiaries, any Director or any
other stockholder may have an interest or expectancy, including as a result of any fiduciary duties applicable to such Person (“Investor Transactions”), in each case without any prior Company, Board or stockholder notification or
approval; provided, that if the Company or an Investor Related Party, to the Investor’s knowledge, is considering the same Investor Transaction, the Investor will promptly notify the Company of such Investor Related Party’s interest
in such Investor Transaction and cause each Director that is an Investor Related Party to recuse, if requested by the Board, himself or herself from all Board discussions and activities relating to such Investor Transaction. 

SECTION 2.12. Board Obligations. Any breach by the Board of its obligations under this Article II shall be deemed a breach by
the Company of its obligations hereunder. 
 ARTICLE III 

Registration Rights 

SECTION 3.01. Registration. (a) Resale Shelf Registration Statement. Subject to the other applicable provisions of this
Agreement, the Company shall use its commercially reasonable efforts to prepare and file within 90 days after the date hereof a registration statement covering the sale or distribution from time to time by any Investor Party holding Registrable
Securities (the “Holders”), on a delayed or continuous basis pursuant to Rule 415 of the Securities Act, of all of the Registrable Securities on Form S-3 (except if the Company is not then eligible to register for resale the
Registrable Securities on Form S-3, then such registration shall be on another appropriate form and shall provide for the registration of such Registrable Securities for resale by the Holders in accordance with any reasonable method of distribution
elected by the Investor) (the “Resale Shelf Registration Statement”) and shall use its commercially reasonable efforts 

  
 25 

 
to cause such Resale Shelf Registration Statement to be declared effective by the SEC as promptly as is reasonably practicable after the filing thereof (it being agreed that the Resale Shelf
Registration Statement shall be an automatic shelf registration statement that shall become effective upon filing with the SEC pursuant to Rule 462(e) if Rule 462(e) is available to the Company). 

(b) Effectiveness Period. Once declared effective, the Company shall, subject to the other applicable provisions of this Agreement, use
its commercially reasonable efforts to cause the Resale Shelf Registration Statement to be continuously effective and usable until such time as there are no longer any Registrable Securities (the “Effectiveness Period”). 

(c) Subsequent Shelf Registration. If any Shelf Registration ceases to be effective under the Securities Act for any reason at any time
during the Effectiveness Period, the Company shall use its commercially reasonable efforts to as promptly as is reasonably practicable cause such Shelf Registration to again become effective under the Securities Act (including obtaining the prompt
withdrawal of any order suspending the effectiveness of such Shelf Registration), and shall use its commercially reasonable efforts to as promptly as is reasonably practicable amend such Shelf Registration in a manner reasonably expected to result
in the withdrawal of any order suspending the effectiveness of such Shelf Registration or file an additional registration statement (a “Subsequent Shelf Registration”) for an offering to be made on a delayed or continuous basis
pursuant to Rule 415 of the Securities Act registering the resale from time to time by the Holders thereof of all securities that are Registrable Securities as of the time of such filing. If a Subsequent Shelf Registration is filed, the Company
shall use its commercially reasonable efforts to (i) cause such Subsequent Shelf Registration to become effective under the Securities Act as promptly as is reasonably practicable after the filing thereof (it being agreed that the Subsequent
Shelf Registration shall be an automatic shelf registration statement that shall become effective upon filing with the SEC pursuant to Rule 462(e) if Rule 462(e) is available to the Company) and (ii) keep such Subsequent Shelf Registration
continuously effective and usable until the end of the Effectiveness Period. Any such Subsequent Shelf Registration shall be a registration statement on Form S-3 to the extent that the Company is eligible to use such form. Otherwise, such Subsequent
Shelf Registration shall be on another appropriate form and shall provide for the registration of such Registrable Securities for resale by the Holders in accordance with any reasonable method of distribution elected by the Investor. 

(d) Supplements and Amendments. The Company shall supplement and amend any Shelf Registration if required by the Securities Act or the
rules, regulations or instructions applicable to the registration form used by the Company for such Shelf Registration. 
 (e) Subsequent
Holder Notice. If a Person entitled to the benefits of this Agreement becomes a Holder of Registrable Securities after a Shelf Registration becomes effective under the Securities Act, the Company shall, as promptly as is reasonably
practicable following delivery of written notice to the Company of such Person becoming a Holder and requesting for its name to be included as a selling securityholder in the prospectus related to the Shelf Registration (a “Subsequent Holder
Notice”): 
 (i) if required and permitted by applicable Law, file with the SEC a supplement to the related
prospectus or a post-effective amendment to the Shelf Registration so that such Holder is named as a selling securityholder in the Shelf Registration and the related prospectus in such a manner as to permit such Holder to deliver a prospectus to
purchasers of the Registrable Securities in accordance with applicable Law; provided, however, that the Company shall not be required to file more than one post-effective amendment or a supplement to the related prospectus for such
purpose in any 30-day period; 

  
 26 

 (ii) if, pursuant to clause (i) above, the Company shall have filed a
post-effective amendment to the Shelf Registration that is not automatically effective, use its commercially reasonable efforts to cause such post-effective amendment to become effective under the Securities Act as promptly as is reasonably
practicable; and 
 (iii) notify such Holder as promptly as is reasonably practicable after the effectiveness under the
Securities Act of any post-effective amendment filed pursuant to clause (i) above. 
 (f) Underwritten Offering. 

(i) Subject to any applicable restrictions on transfer in this Agreement or otherwise, the Investor may, after the Resale Shelf Registration
Statement becomes effective, deliver a written notice to the Company (the “Underwritten Offering Notice”) specifying that the sale of some or all of the Registrable Securities subject to the Shelf Registration, is intended to be
conducted through an underwritten offering (the “Underwritten Offering”); provided, however, that the Holders of Registrable Securities may not, without the Company’s prior written consent, (x) launch more
than three Underwritten Offerings at the request of the Holders within any three-hundred sixty-five (365) day period, (y) launch an Underwritten Offering the anticipated gross proceeds of which shall be less than $50,000,000 (unless the
Holders are proposing to sell all of their remaining Registrable Securities) or (z) launch any underwritten offering within the period commencing fourteen (14) days prior to and ending two (2) days following the Company’s
scheduled earnings release date for any fiscal quarter or year. 
 (ii) In the event of an Underwritten Offering, the Investor shall select
the managing Underwriter or Underwriters to administer the Underwritten Offering; provided that the choice of such managing underwriter(s) shall be subject to the consent of the Company, which is not to be unreasonably withheld, conditioned or
delayed, and the Company, the Investor and the Holders of Registrable Securities participating in the Underwritten Offering will enter into and perform its obligations under an underwriting agreement in customary form with the managing Underwriter
or Underwriters selected for such offering. 

  
 27 

 (iii) The Company will not include in any Underwritten Offering pursuant to this
Section 3.01(f) any securities that are not Registrable Securities without the prior written consent of the Investor. If the managing Underwriter or Underwriters advise the Company and the Investor in writing that in its or their good
faith opinion the number of Registrable Securities (and, if permitted hereunder, other securities requested to be included in such offering) exceeds the number of securities which can be sold in such offering in light of market conditions or is such
so as to adversely affect the success of such offering, the Company will include in such offering only such number of securities that can be sold without adversely affecting the marketability of the offering, which securities will be so included in
the following order of priority: (A) first, the Registrable Securities of the Holders that have requested to participate in such Underwritten Offering, allocated pro rata among such Holders on the basis of the percentage of the
Registrable Securities requested to be included in such offering by such Holders, and (B) second, any other securities of the Company that have been requested to be so included. 

(g) Take-Down Notice. Subject to the other applicable provisions of this Agreement, at any time that any Shelf Registration is
effective, if the Investor delivers a notice to the Company (a “Take-Down Notice”) stating that it intends to effect a sale or distribution of all or part of its Registrable Securities included by it on any Shelf Registration (a
“Shelf Offering”) and stating the number of the Registrable Securities to be included in such Shelf Offering, then the Company shall amend, subject to the other applicable provisions of this Agreement, or supplement the Shelf
Registration as may be necessary in order to enable such Registrable Securities to be sold and distributed pursuant to the Shelf Offering. 

SECTION 3.02. Piggyback Registration. (a) Notice of Registration. If at any time or from time to time the Company proposes
to file a registration statement under the Securities Act with respect to, or otherwise commence a public, offering of its Common Stock or securities convertible into, or exchangeable or exercisable for, Common Stock, whether or not for sale for its
own account (other than any registration statement filed (i) on Form S-4, Form S-8 or any substitute or successor forms or (ii) filed to effectuate an exchange offer or any employee benefit or dividend reinvestment plan), the Company will
promptly give to the Investor written notice of such filing or commencement, which notice shall be given, to the extent reasonably practicable, no later than five (5) Business Days prior to the filing date or commencement date (the
“Piggyback Notice”) to the Investor on behalf of the Holders of Registrable Securities. 
 (b) Right to Participate.
The Piggyback Notice shall offer such Holders the opportunity to include (or cause to be included) in such registration statement and offering the number of shares of Registrable Securities as the Investor on behalf of any such Holder may request
(each, a “Piggyback Registration Statement”). Subject to Section 3.02(c), the Company shall include in each Piggyback Registration Statement all Registrable Securities with respect to which the Company has received written
requests for inclusion therein (each, a “Piggyback Request”) within five (5) Business Days after the date of the Piggyback Notice but in any event not later than one (1) Business Day

  
 28 

 
prior to the filing date of a Piggyback Registration Statement. Such notice shall state the intended method of disposition of the Registrable Securities by such Holder. If a Holder decides not to
include all of its Registrable Securities in any registration statement thereafter filed by the Company, such Holder shall nevertheless continue to have the right to include any Registrable Securities in any subsequent registration statement or
registration statements as may be filed by the Company with respect to offerings of its securities, all upon the terms and conditions set forth herein. The Company shall not be required to maintain the effectiveness of a Piggyback Registration
Statement beyond the earlier of (x) 180 days after the effective date thereof and (y) consummation of the distribution by the Holders of the Registrable Securities included in such registration statement. 

(c) Underwriting. The right of any Holder to registration pursuant to Section 3.01(f) or this Section 3.02 shall be
conditioned upon such Holder’s participation in such underwriting and the inclusion of Registrable Securities in the underwriting to the extent provided therein. If any of the securities to be registered pursuant to the registration giving rise
to the rights under this Section 3.02 are to be sold in an underwritten offering, the Company shall use commercially reasonable efforts to cause the managing Underwriter or Underwriters of a proposed underwritten offering to permit
Holders of Registrable Securities who have timely submitted a Piggyback Request in connection with such offering to include in such offering all Registrable Securities included in each Holder’s Piggyback Request on the same terms and subject to
the same conditions as any other shares of capital stock, if any, of the Company included in the offering. Each Holder proposing to distribute its securities through a Piggyback Registration Statement shall (together with the Company and the other
holders distributing their securities through such underwriting) enter into an underwriting agreement with the managing Underwriter or Underwriters selected for such underwriting by the Company or by the stockholders of the Company who have the
right to select the Underwriters (such underwriting agreement to be in the form negotiated by the Company or such stockholders, as the case may be). Notwithstanding any other provision of this Section 3.02, if the managing Underwriter or
Underwriters of a proposed underwritten offering with respect to which Holders have exercised their piggyback registration rights advise the Board that in its or their good faith opinion the number of Registrable Securities requested to be included
in the offering thereby and all other securities proposed to be sold in the offering exceeds the number which can be sold in such underwritten offering in light of market conditions, the Registrable Securities and such other securities to be
included in such underwritten offering shall be allocated, (i) first, (A) in the event such offering was initiated by the Company, up to the total number of securities that the Company has requested to be included in such registration for
its own account and (B) in the event such offering was initiated by holders of securities (including the Investor or the Investor Parties, as applicable) who have exercised their demand registration rights, up to the total number of securities
that such holders of such securities have requested to be included in such offering, allocated pro rata among such holders on the basis of the percentage of the Registrable Securities requested to be included in such offering by such holders,
(ii) second, the Registrable Securities of the Investor and the Investor Parties that it has or they have requested to participate in such underwritten offering, allocated pro rata among such Holders on the basis of the

  
 29 

 
percentage of the Registrable Securities requested to be included in such offering by such Holders; (iii) third, the Registrable Securities of the Holders, other than the Investor and the
Investor Parties, that have requested to participate in such underwritten offering, allocated pro rata among such Holders on the basis of the percentage of the Registrable Securities requested to be included in such offering by such Holders; and
(iv) fourth, any other securities of the Company that have been requested to be included in such offering. If any Holder disapproves of the terms of any such underwriting, such Holder may elect to withdraw therefrom by written notice to the
Company and the managing Underwriter or Underwriters, provided that such election is made prior to the earlier of (a) the effectiveness of the registration statement and (b) the time at which the offering price or the
underwriter’s discount is determined with the managing Underwriter or Underwriters. Any securities excluded or withdrawn from such underwriting (i) may be substituted by securities held by the Holders to be included in such registration;
or (ii) in the event the Holders elect not to substitute any shares, may be substituted by securities held by the Company to be included in such registration; or (iii) in the event that the Holders and the Company elect not to substitute
any shares, shall be withdrawn from such registration. 
 (d) Right to Terminate Registration. The Company or the holders of
securities who have caused Registrable Securities to be included in a registration statement pursuant to Section 3.01 or 3.02 to be filed as contemplated by this Section 3.02, as the case may be, shall have the right to have any
registration initiated by it or them, as applicable, under this Section 3.02 terminated or withdrawn prior to the effectiveness thereof, whether or not any Holder has elected to include securities in such registration. 

SECTION 3.03. Registration Procedures. (a) Subject to the other applicable provisions of this Agreement, in the case of each
registration of Registrable Securities effected by the Company pursuant to Section 3.01, the Company will: 
 (i)
prepare and promptly file with the SEC a registration statement with respect to such securities and use commercially reasonable efforts to cause such registration statement to become and remain effective for the period of the distribution
contemplated thereby in accordance with the applicable provisions of this Agreement; 
 (ii) prepare and file with the SEC
such amendments (including post-effective amendments) and supplements to such registration statement and the prospectus used in connection with such registration statement as (i) reasonably requested by any Holder (to the extent such request
related to information relating to such Holder) or (ii) may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such registration statement in accordance with the
Investor’s intended method of distribution set forth in such registration statement and as may be necessary to keep the registration statement continuously effective for the period set forth in this Agreement; 

  
 30 

 (iii) respond promptly to any comments received from the SEC and request
acceleration of effectiveness promptly after it learns that the SEC will not review the registration statement or after it has satisfied comments received from the SEC; 

(iv) furnish, (i) to the Investor’s legal counsel, copies of the registration statement and the prospectus included
therein (including each preliminary prospectus), in each case including all exhibits thereto, proposed to be filed and provide such legal counsel a reasonable opportunity to review and comment on such registration statement and (ii) to the
Investor and the Underwriters, such other documents as it may reasonably request in order to facilitate the disposition of Registrable Securities owned by it; 

(v) if requested by the managing Underwriter or Underwriters, if any, or the Investor, promptly include in any prospectus
supplement or post-effective amendment such information as the managing Underwriter or Underwriters, if any, or the Investor may reasonably request in order to permit the intended method of distribution of such securities and make all required
filings of such prospectus supplement or post- effective amendment as soon as reasonably practicable after the Company has received such request; provided, however, that the Company shall not be required to take any actions under this
Section 3.03(a)(iv) that are not, in the opinion of counsel for the Company, in compliance with applicable law; 
 (vi)
in the event that the Registrable Securities are being offered in an Underwritten Offering, furnish to the Investor and to the Underwriters of the securities being registered such reasonable number of copies of the registration statement,
preliminary prospectus and final prospectus as the Investor or such Underwriters may reasonably request in order to facilitate the public offering or other disposition of such securities; 

(vii) as promptly as reasonably practicable, use commercially reasonable efforts to notify the Investor at any time when
(i) a prospectus relating thereto is required to be delivered under the Securities Act or of the Company’s discovery of the occurrence of any event as a result of which the prospectus included in such registration statement, as then in
effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading or incomplete in the light of the circumstances then existing, and,
subject to Section 3.04, at the request of the Investor, prepare as promptly as is reasonably practicable and furnish to the Investor a reasonable number of copies of a supplement to or an amendment of such prospectus as may be necessary
so that, as thereafter delivered to the purchaser of such securities, such prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein
not misleading or incomplete in the light of the circumstances then existing, (ii) any request by the SEC or any other regulatory body or other body having jurisdiction has been made for any 

  
 31 

 
amendment of or supplement to any registration statement or other document relating to such offering, or (iii) if for any other reason it shall be necessary to amend or supplement such
registration statement or prospectus in order to comply with the Securities Act; 
 (viii) use reasonable best efforts to
register and qualify (or exempt from such registration or qualification) the securities covered by such registration statement under such other securities or “blue sky” laws of such jurisdictions within the United States as shall be
reasonably requested in writing by the Investor; provided, however, that the Company shall not be required in connection therewith or as a condition thereto to (A) qualify to do business in any jurisdictions where it would not
otherwise be required to qualify but for this subsection or (B) file a general consent to service of process in any such states or jurisdictions; 

(ix) in the event that the Registrable Securities are being offered in an underwritten public offering, enter into an
underwriting agreement, in usual and customary form and otherwise in accordance with the applicable provisions of this Agreement (including using commercially reasonable efforts to include (i) indemnification and contribution provisions
substantially to the effect and to the extent provided in Section 3.08 and (ii) agreements as to the provision of the opinions of counsel and accountants’ letters to the effect and to the extent provided in
Section 3.03(a)(xii); 
 (x) in connection with an Underwritten Offering, the Company shall cause its officers to
use their commercially reasonable efforts to support the marketing of the Registrable Securities covered by such offering (including participation in “road shows” or other similar marketing efforts); 

(xi) use commercially reasonable efforts to furnish, on the date that such Registrable Securities are delivered to the
Underwriters for sale (if such securities are being sold through Underwriters) or, solely in the case of clause (A), (D) and (E), the pricing or closing date of the applicable offering or sale (in the case of an offering with the assistance of
a broker, placement agent or other agent of the Holder): (A) an opinion, dated as of such date, of the counsel representing the Company for the purposes of such registration, in form and substance as is customarily given to the managing
Underwriter or Underwriters in an underwritten public offering, addressed to the Underwriter or Underwriters (in the case of an underwritten offering) or, if requested, in form and substance as is customarily given to the broker, placement agent or
other agent of the Holders assisting in the sale of the Registrable Securities addressed to such broker, placement agent or other agent, if any, (B) a “negative assurances letter”, dated such date of the legal counsel representing the
Company for the purposes of such registration, in form and substance as is customarily given to underwriters in an underwritten public offering; (C) a “cold comfort” and “bring-down” letter, dated as of such date, from the
independent certified public accountants of the Company, in form and substance as is customarily given by independent certified 

  
 32 

 
public accountants to Underwriters in an underwritten public offering, addressed to the Underwriters, (D) customary certificates executed by authorized officers of the Company as may be
requested by any Holder or any underwriter of such Registrable Securities, and (E) make available to the appropriate representatives of the underwriters, if any, and any Holder access to such information and personnel as is reasonable and
customary to enable such parties to establish a due diligence defense under the Securities Act; 
 (xii) (a) in the
event that the Registrable Securities covered by such registration statement are shares of Common Stock or shares of capital stock of the Company in a series that are otherwise listed on a securities exchange, use commercially reasonable efforts to
list the Registrable Securities covered by such registration statement with any securities exchange on which the Common Stock or such other shares of capital stock are then listed and (b) in the event that the Registrable Securities covered by
such registration statement are shares of Common Stock and the Common Stock is not currently listed on a National Securities Exchange, to use commercially reasonable efforts to take actions within the control of the Company to list such Registrable
Securities on a National Securities Exchange; 
 (xiii) provide a transfer agent and registrar for all such Registrable
Securities and, if requested by Underwriter(s) or the Holder, a CUSIP/ISIN number for all such Registrable Securities, in each case not later than the effective date of such registration statement; 

(xiv) in connection with a customary due diligence review, make available for inspection by the Investor, any underwriter
participating in any such disposition of Registrable Securities, if any, and any counsel or accountants retained by the Investor or underwriter (collectively, the “Offering Persons”), at the offices where normally kept, all
financial and other records, pertinent corporate documents and properties of the Company and its subsidiaries, and cause the officers, directors and employees of the Company and its subsidiaries to supply all information and participate in customary
due diligence sessions in each case reasonably requested by any such representative, underwriter, counsel or accountant in connection with such Registration Statement; provided, however, that any information that is not generally publicly available
at the time of delivery of such information shall be kept confidential by such Offering Persons unless (i) disclosure of such information is required by court or administrative order or in connection with an audit or examination by, or a
blanket document request from, a regulatory or self-regulatory authority, bank examiner or auditor, (ii) disclosure of such information, in the reasonable judgment of the Offering Persons, is required by law or applicable legal process
(including in connection with the offer and sale of securities pursuant to the rules and regulations of the SEC), (iii) such information is or becomes generally available to the public other than as a result of a non-permitted disclosure or
failure to safeguard by such Offering Persons in violation of this Agreement or (iv) such information (A) was known to such Offering Persons (prior to its disclosure by the Company) from a source other

  
 33 

 
than the Company when such source, to the knowledge of the Offering Persons, was not bound by any contractual, legal or fiduciary obligation of confidentiality to the Company with respect to such
information, (B) becomes available to the Offering Persons from a source other than the Company when such source, to the knowledge of the Offering Persons, is not bound by any contractual, legal or fiduciary obligation of confidentiality to the
Company with respect to such information or (C) was developed independently by the Offering Persons or their respective representatives without the use of, or reliance on, information provided by the Company. In the case of a proposed
disclosure pursuant to (i) or (ii) above, such Person shall be required to give the Company written notice of the proposed disclosure prior to such disclosure (except in the case of (ii) above when a proposed disclosure was or is to
be made in connection with a registration statement or prospectus under this Agreement and except in the case of clause (i) above when a proposed disclosure is in connection with a routine audit or examination by, or a blanket document request
from, a regulatory or self-regulatory authority, bank examiner or auditor); 
 (xv) cooperate with the Investor and each
Underwriter or agent participating in the disposition of Registrable Securities and their respective counsel in connection with any filings required to be made with the Financial Industry Regulatory Authority (“FINRA”), including
the use of commercially reasonable efforts to obtain FINRA’s pre-clearance or pre-approval of the registration statement and applicable prospectus upon filing with the SEC; 

(xvi) use its reasonable best efforts to obtain as promptly as reasonably practicable the withdrawal of, any stop order with
respect to the applicable registration statement or other order suspending the use of any preliminary or final prospectus; 

(xvii) promptly incorporate in a prospectus supplement or post-effective amendment to
the applicable registration statement such information as the managing Underwriter or Underwriters, if any, and the Holder, as applicable, relating to the plan of distribution with respect to such Registrable Securities; and make all required
filings of such prospectus supplement or post-effective amendment as promptly as reasonably practicable after being notified of the matters to be incorporated in such prospectus supplement or post-effective amendment; 
 (xviii) as promptly as is reasonably practicable notify the
Investor (A) when the prospectus or any prospectus supplement or post-effective amendment has been filed and, with respect to such registration statement or any post-effective amendment, when the same has become effective, (B) of any
request by the SEC for amendments or supplements to such registration statement or to amend or to supplement such prospectus or for additional information, (C) of the issuance by the SEC of any stop order suspending the effectiveness of such
registration statement or the initiation of any proceedings for such purpose, (D) if at any time the Company has reason to believe that the representations and warranties of the 

  
 34 

 
Company contained in any agreement contemplated by Section 3.03(a)(viii) above relating to any applicable offering cease to be true and correct or (v) of the receipt by the Company of
any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any proceeding for such purpose; and 

(xix) use its commercially reasonable efforts to take such other steps that are customarily taken by issuers necessary to
effect the registration and sale of the Registrable Securities contemplated hereby. 
 (b) The Investor agrees that, upon receipt of any
notice from the Company of the happening of any event of the kind described in Section 3.03(a)(vii), 3.03(a)(ix)(B) or 3.03(a)(ix)(C), the Investor shall discontinue, and shall cause each Holder to discontinue, disposition
of any Registrable Securities covered by such registration statement or the related prospectus until receipt of the copies of the supplemented or amended prospectus, which supplement or amendment shall, subject to the other applicable provisions of
this Agreement, be prepared and furnished as soon as reasonably practicable, or until the Investor is advised in writing by the Company that the use of the applicable prospectus may be resumed, and has received copies of any amended or supplemented
prospectus or any additional or supplemental filings which are incorporated, or deemed to be incorporated, by reference in such prospectus (such period during which disposition is discontinued being an “Interruption Period”) and, if
requested by the Company, the Investor shall use commercially reasonable efforts to return, and cause the Holders to return, to the Company all copies then in its or their possession, of the prospectus covering such Registrable Securities at the
time of receipt of such request. As soon as practicable after the Company has determined that the use of the applicable prospectus may be resumed, the Company will notify the Investor thereof. In the event the Company invokes an Interruption Period
hereunder and in the reasonable discretion of the Company the need for the Company to continue the Interruption Period ceases for any reason, the Company shall, as soon as reasonably practicable, provide written notice to the Investor that such
Interruption Period is no longer applicable. 
 SECTION 3.04. Suspension. (a) The Company shall be entitled on one
(1) occasion in any six (6) month period, for a period of time not to exceed sixty (60) days in the aggregate in any six (6) month period and seventy-five (75) days in any twelve (12) month period to (x) defer any
registration of Registrable Securities and shall have the right not to file and not to cause the effectiveness of any registration covering any Registrable Securities, (y) suspend the use of any prospectus and registration statement covering
any Registrable Securities and (z) require the Holders of Registrable Securities to suspend any offerings or sales of Registrable Securities pursuant to a registration statement, if the Company delivers to the Investor a certificate signed by
an executive officer certifying that such registration and offering would (i) require the Company to make an Adverse Disclosure or (ii) materially interfere with any bona fide material financing, acquisition, disposition or other similar
transaction involving the Company or any of its subsidiaries then under consideration. Such certificate shall contain a statement of the reasons for such suspension and an approximation of the anticipated length of such suspension. The Investor
shall keep the information contained in such certificate confidential subject to the same terms set forth in Section 3.02(a)(xv). 

  
 35 

 (b) If the Company defers any registration of Registrable Securities in response to an
Underwritten Offering Notice or requires the Investor or the Holders to suspend any Underwritten Offering, the Investor shall be entitled to withdraw such Underwritten Offering Notice and if it does so, such request shall not be treated for any
purpose as the delivery of an Underwritten Offering Notice pursuant to Section 3.01(f). 
 (c) In the event that the Company
shall exercise its right to delay or suspend the filing or effectiveness of a registration hereunder, the applicable time period during which the registration statement is to remain effective shall be extended by a period of time equal to the
duration of the total aggregated period of suspension. 
 SECTION 3.05. Expenses of Registration. All Registration Expenses incurred
in connection with any registration pursuant to Sections 3.01 and 3.02 shall be borne by the Company. All Selling Expenses relating to securities registered on behalf of the Holders shall be borne by the Holders of the Registrable
Securities included in any such registration. 
 SECTION 3.06. Information by Holders. (a) The Holder or Holders of Registrable
Securities included in any registration shall, and the Investor shall cause such Holder or Holders to, furnish to the Company such information regarding such Holder or Holders and their Affiliates, the Registrable Securities held by them and the
distribution proposed by such Holder or Holders and their Affiliates as the Company or its Representatives may reasonably request and as shall be required in connection with any registration, qualification or compliance referred to in this
Agreement. It is understood and agreed that the obligations of the Company under Sections 3.01 and 3.02 are conditioned on the timely provisions of the foregoing information by such Holder or Holders and, without limitation of the
foregoing, will be conditioned on compliance by such Holder or Holders with the following: 
 (i) such Holder or Holders
will, and will cause their respective Affiliates to, cooperate with the Company in connection with the preparation of the applicable registration statement and prospectus and, for so long as the Company is obligated to keep such registration
statement effective, such Holder or Holders will and will cause their respective Affiliates to, provide to the Company, in writing and in a timely manner, for use in such registration statement (and expressly identified in writing as such), all
information regarding themselves and their respective Affiliates and such other information as may be required by applicable Laws to enable the Company to prepare or amend such registration statement, any related prospectus and any other documents
related to such offering covering the applicable Registrable Securities owned by such Holder or Holders and to maintain the currency and effectiveness thereof; 

(ii) during such time as such Holder or Holders and their respective Affiliates may be engaged in a distribution of the
Registrable Securities, such 

  
 36 

 
Holder or Holders will, and they will cause their Affiliates to, comply with all Laws applicable to such distribution, including Regulation M promulgated under the Exchange Act, and, to the
extent required by such Laws, will, and will cause their Affiliates to, among other things (A) not engage in any stabilization activity in connection with the securities of the Company in contravention of such Laws, (B) distribute the
Registrable Securities acquired by them solely in the manner described in the applicable registration statement and (C) if required by applicable Law, cause to be furnished to each agent or broker-dealer to or through whom such Registrable
Securities may be offered, or to the offeree if an offer is made directly by such Holder or Holders or their respective Affiliates, such copies of the applicable prospectus (as amended and supplemented to such date) and documents incorporated by
reference therein as may be required by such agent, broker-dealer or offeree; 
 (iii) such Holder or Holders shall, and they
shall cause their respective Affiliates to, (A) permit the Company and its Representatives to examine such documents and records and will supply in a timely manner any information as they may be reasonably requested to provide in connection
with the offering or other distribution of Registrable Securities by such Holder or Holders and (B) execute, deliver and perform under any agreements and instruments reasonably requested by the Company or its Representatives to effectuate such
registered offering, including opinions of counsel and questionnaires; and 
 (iv) on receipt of any notice from the Company
of the occurrence of any of the events specified in Section 3.03(a)(vii), 3.03(a)(ix)(B) or 3.03(a)(ix)(C) or that otherwise requires the suspension by such Holder or Holders and their respective Affiliates of the offering,
sale or distribution of any of the Registrable Securities owned by such Holder or Holders, such Holders shall, and they shall cause their respective Affiliates to, cease offering, selling or distributing the Registrable Securities owned by such
Holder or Holders until the offering. Sale and distribution of the Registrable Securities owned by such Holder or Holders may recommence in accordance with the terms hereof and applicable Law. 

SECTION 3.07. Rule 144 Reporting. With a view to making available the benefits of Rule 144 to the Holders, the Company agrees that, for
so long as a Holder owns Registrable Securities, the Company will use its commercially reasonable efforts to: 
 (a) make and keep public
information available, as those terms are understood and defined in Rule 144, at all times after the date of this Agreement; 
 (b) file
with the SEC in a timely manner all reports and other documents required of the Company under the Exchange Act; and 
 (c) so long as a
Holder owns any Registrable Securities, furnish to the Holder upon written request a written statement by the Company as to its compliance with the reporting requirements of the Exchange Act. 

  
 37 

 SECTION 3.08. Holdback Agreement. If during the Effectiveness Period, the Company shall
file a registration statement (other than in connection with the registration of securities issuable pursuant to an employee stock option, stock purchase or similar plan or pursuant to a merger, exchange offer or a transaction of the type specified
in Rule 145(a) under the Securities Act) with respect to an underwritten public offering of Common Stock or securities convertible into, or exchangeable or exercisable for, such securities or otherwise informs the Investor that it intends to conduct
such an offering utilizing an effective registration statement or pursuant to an underwritten Rule 144A and/or Regulation S offering and provides the Investor and each Holder the opportunity to participate in such offering in accordance with and to
the extent required by Section 3.02, the Investor and each Holder shall, if requested by the managing Underwriter or Underwriters, enter into a customary “lock-up” agreement relating to the sale, offering or distribution of
Registrable Securities, in the form reasonably requested by the managing Underwriter or Underwriters, covering the period commencing on the date of the prospectus pursuant to which such offering may be made and continuing until 60 days from the date
of such prospectus or such shorter period as may be agreed by the managing Underwriter or Underwriters. 
 SECTION 3.09.
Indemnification. (a) Indemnification by Company. To the extent permitted by applicable Law, the Company will, with respect to any Registrable Securities covered by a registration statement or prospectus, or as to which
registration or qualification or compliance under applicable “blue sky” laws has been effected pursuant to this Agreement, indemnify and hold harmless each Holder, each Holder’s current and former officers, directors, partners,
members, managers, stockholders, accountants, attorneys, agents and employees, and each Person controlling such Holder within the meaning of Section 15 of the Securities Act and such Holder’s current and former officers, directors,
partners, members, managers, stockholders, accountants, attorneys, agents and employees, and each Underwriter thereof, if any, and each Person who controls any such Underwriter within the meaning of Section 15 of the Securities Act
(collectively, the “Company Indemnified Parties”), from and against any and all expenses, claims, losses, damages, costs (including costs of preparation and reasonable attorney’s fees and any legal or other fees or expenses
actually incurred by such party in connection with any investigation or proceeding), judgments, fines, penalties, charges, amounts paid in settlement and other liabilities, joint or several (or actions in respect thereof) (collectively,
“Losses”), to the extent arising out of or based on any untrue statement (or alleged untrue statement) of a material fact contained in any registration statement, prospectus, preliminary prospectus, offering circular, “issuer
free writing prospectus” (as such term is defined in Rule 433 under the Securities Act) or other document, in each case related to such registration statement, or any amendment or supplement thereto, or based on any omission (or alleged
omission) to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading, or any violation by the Company of the Securities Act, the
Exchange Act, any state securities law or any rules or regulations thereunder applicable to the Company and (without limiting the preceding portions of this Section 3.08) the Company will reimburse each of the Company Indemnified Parties for
any reasonable and documented out-of-pocket legal expenses and any other reasonable and documented out-of-pocket expenses actually 

  
 38 

 
incurred in connection with investigating, defending or, subject to the last sentence of this Section 3.09, settling any such Losses or action, as such expenses are incurred; provided
that the Company’s indemnification obligations shall not apply to amounts paid in settlement of any Losses or action if such settlement is effected without the prior written consent of the Company (which consent shall not be unreasonably
withheld or delayed), nor shall the Company be liable to a Holder in any such case for any such Losses or action to the extent that it arises out of or is based upon a violation or alleged violation of any state or federal Law (including any claim
arising out of or based on any untrue statement or alleged untrue statement or omission or alleged omission in the registration statement or prospectus) which occurs in reliance upon and in conformity with written information regarding such Holder
furnished to the Company by such Holder or its authorized representatives expressly for use in connection with such registration by or on behalf of any Holder. 

(b) Indemnification by Holders. To the extent permitted by applicable Law, each Holder will, if Registrable Securities held by such
Holder are included in the securities as to which registration or qualification or compliance under applicable “blue sky” laws is being effected, indemnify, severally and not jointly with any other Holders of Registrable Securities, the
Company, each of its Representatives, each Person who controls the Company or such Underwriter within the meaning of Section 15 of the Securities Act (collectively, the “Holder Indemnified Parties”), against all Losses (or
actions in respect thereof) to the extent arising out of or based on any untrue statement (or alleged untrue statement) of a material fact contained in any registration statement, prospectus, preliminary prospectus, offering circular or other
document, in each case related to such registration statement, or any amendment or supplement thereto, or based on any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances in which they were made, not misleading, and will reimburse each of the Holder Indemnified Parties for any reasonable and documented out-of-pocket legal expenses and any other reasonable and documented
out-of-pocket expenses actually incurred in connection with investigating, defending or, subject to the last sentence of this Section 3.08, settling any such Losses or action, as such expenses are incurred, in each case to the extent, but only
to the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made in such registration statement, prospectus, offering circular or other document in reliance upon and in conformity with written
information furnished to the Company by such Holder or its authorized representatives and stated to be specifically for use therein; provided, however, that in no event shall any indemnity under this Section 3.09(b)
payable by the Investor and any Holder exceed an amount equal to the net proceeds received by each Holder in respect of the Registrable Securities sold pursuant to the registration statement. The indemnity agreement contained in this
Section 3.09(b) shall not apply to amounts paid in settlement of any loss, claim, damage, liability or action if such settlement is effected without the prior written consent of the applicable Holder (which consent shall not be
unreasonably withheld or delayed). 
 (c) Notification. If any Person shall be entitled to indemnification under this
Section 3.08 (each, an “Indemnified Party”), such Indemnified Party shall give prompt notice to the party required to provide indemnification (each, an “Indemnifying 

  
 39 

 
Party”) of any claim or of the commencement of any proceeding as to which indemnity is sought. The Indemnifying Party shall have the right, exercisable by giving written notice to the
Indemnified Party as promptly as reasonably practicable after the receipt of written notice from such Indemnified Party of such claim or proceeding, to assume, at the Indemnifying Party’s expense, the defense of any such claim or litigation,
with counsel reasonably satisfactory to the Indemnified Party and, after notice from the Indemnifying Party to such Indemnified Party of its election to assume the defense thereof, the Indemnifying Party will not (so long as it shall continue to
have the right to defend, contest, litigate and settle the matter in question in accordance with this Section 3.09(c)) be liable to such Indemnified Party hereunder for any legal expenses and other expenses subsequently incurred by such
Indemnified Party in connection with the defense thereof; provided, however, that an Indemnified Party shall have the right to employ separate counsel in any such claim or litigation, but the fees and expenses of such counsel shall be
at the expense of such Indemnified Party unless the Indemnifying Party shall have failed within a reasonable period of time to assume such defense and the Indemnified Party is or would reasonably be expected to be materially prejudiced by such
delay. The failure of any Indemnified Party to give notice as provided herein shall relieve an Indemnifying Party of its obligations under this Section 3.08 only to the extent that the failure to give such notice is materially
prejudicial or harmful to such Indemnifying Party’s ability to defend such action. No Indemnifying Party, in the defense of any such claim or litigation, shall, except with the prior written consent of each Indemnified Party (which consent
shall not be unreasonably withheld or delayed), consent to entry of any judgment or enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party of a release from
all liability in respect to such claim or litigation. The indemnity agreements contained in this Section 3.08 shall not apply to amounts paid in settlement of any claim, loss, damage, liability or action if such settlement is effected
without the prior written consent of the Indemnifying Party, which consent shall not be unreasonably withheld or delayed. The indemnification set forth in this Section 3.08 shall be in addition to any other indemnification rights or
agreements that an Indemnified Party may have. An Indemnifying Party who is not entitled to, or elects not to, assume the defense of a claim will not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified by
such Indemnifying Party with respect to such claim, unless in the reasonable judgment of any Indemnified Party a conflict of interest may exist between such Indemnified Party and any other Indemnified Parties with respect to such claim. 

(d) Contribution. If the indemnification provided for in this Section 3.08 is held by a court of competent jurisdiction to
be unavailable to an Indemnified Party, other than pursuant to its terms, with respect to any Losses or action referred to therein, then, subject to the limitations contained in this Section 3.08, the Indemnifying Party, in lieu of
indemnifying such Indemnified Party hereunder, shall contribute to the amount paid or payable by such Indemnified Party as a result of such Losses or action in such proportion as is appropriate to reflect the relative fault of the Indemnifying
Party, on the one hand, and the Indemnified Party, on the other, in connection with the actions, statements or omissions that resulted in such Losses or action, as well as any other relevant equitable considerations. The relative fault of the
Indemnifying Party, on the one hand, and the Indemnified Party, on the other hand, shall be determined by reference 

  
 40 

 
to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, has been made
(or omitted) by, or relates to information supplied by such Indemnifying Party or such Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent any such action, statement or
omission. The Company and the Holders agree that it would not be just and equitable if contribution pursuant to this Section 3.09(d) was determined solely upon pro rata allocation or by any other method of allocation which does not take
account of the equitable considerations referred to in the immediately preceding sentence of this Section 3.09(d). Notwithstanding the foregoing, the amount the Investor and any Holder will be obligated to contribute pursuant to this
Section 3.09(d) will be limited to an amount equal to the net proceeds received by the Investor and each Holder (in the aggregate) in respect of the Registrable Securities sold pursuant to the registration statement which gives rise
to such obligation to contribute. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent
misrepresentation. 
 SECTION 3.10. Termination of Registration Rights. The rights of any particular Holder to cause the Company to
register securities under Article III shall terminate with respect to such Holder upon the date upon which such Holder no longer holds any Registrable Securities. The registration rights contained in this Article III shall terminate on
the date on which all shares of Common Stock issuable (or actually issued) to any of the Investor Parties upon conversion of the Series C Preferred Stock cease to be Registrable Securities. 

ARTICLE IV 
 Limitations on
Purchases of 
 Equity Securities and Other Actions 

SECTION 4.01. Limitations on Purchases of Equity Securities and Other Actions. At all times during the Standstill Period, without the
prior approval of a majority of the Other Directors, or as otherwise expressly permitted by this Agreement (including Article VI), each Investor Party shall not, directly or indirectly, and shall cause its Affiliates and Representatives
acting on its and its respective Affiliates’ behalf not to: 
 (a) acquire, offer to acquire, agree to acquire or make a
public proposal to acquire, by purchase or otherwise, any Equity Securities of the Company or any of its Subsidiaries, any securities convertible into or exchangeable for any Equity Securities of the Company, or any right to vote or to direct the
voting of any Equity Securities of the Company, in each case, such that the Investor Parties would, after giving effect to such transaction, beneficially own, on an as converted basis, more than the Maximum Percentage of the then outstanding Common
Stock, on an as converted basis; provided that the restrictions in this clause (a) shall not apply to (i) purchases or acquisitions permitted by Section 5.02(d), (ii) acquisitions of Equity Securities of the
Company issued in connection with stock dividends, stock splits, recapitalizations or similar transactions 

  
 41 

 
(including any Equity Securities issued as a dividend, coupon or other distribution on shares of Series C Preferred Stock) and (iii) issuances by the Company of Equity Securities of the
Company or options, warrants or other rights to acquire Equity Securities of the Company (or the exercise thereof) to any Director, as compensation for his or her membership on the Board; provided, further, that the Investor Parties
shall not be deemed to violate this clause (a) (and shall not be required to Transfer any Equity Securities) as a result of any acquisition of Equity Securities by the Company (or similar transaction) which, by reducing the number of
shares of Common Stock then outstanding, on an as converted basis, increases the proportionate number of shares of Common Stock beneficially owned, on an as converted basis, by the Investor Parties to the Maximum Percentage or more of the then
outstanding Common Stock, on an as converted basis; 
 (b) other than solely with respect to class votes of the holders of
Series C Preferred Stock, make, knowingly encourage or participate in any “solicitation” of “proxies”, as such terms are used in the proxy rules of the SEC promulgated under Section 14 of the Exchange Act, in order to
(i) vote, or seek to advise or influence any Person with respect to the voting of, any Voting Stock of the Company (other than, in each case, in a manner that is not inconsistent with the Board’s recommendation in connection with such
matter), (ii) call or seek to call a meeting of the Company’s stockholders or initiate any stockholder proposal for action by the Company’s stockholders or (iii) seek election to, or to place a Representative on, the Board or
seek the removal of any Director from the Board (other than, in each case, any Investor Director or Independent Acting Director in accordance with this Agreement); 

(c) effect, publicly offer or publicly propose or make any public announcement with respect to, or solicit or submit a proposal
(public or otherwise) for, any merger, consolidation, business combination, tender or exchange offer, recapitalization, reorganization, purchase or license of all or a material portion of the assets, properties or Equity Securities of or other
similar extraordinary transaction involving the Company or any of its Subsidiaries or any of their respective securities (any such transaction, an “Extraordinary Transaction”) or enter into any discussions, negotiations,
arrangements, understandings or agreements (whether written or oral) with any other Person regarding any of the foregoing; 

(d) enter into any discussions, negotiations, arrangements or understandings with any Person (including security holders of the
Company, but excluding, for the avoidance of doubt, the Investor and its Affiliates) or form, join or in any way participate in a “group” (as defined in Section 13(d)(3) of the Exchange Act) with respect to any Voting Stock (other
than a “group” (as defined in Section 13(d)(3) of the Exchange Act) composed of the Investor Parties) or otherwise in connection with any of the actions prohibited by this Section 4.01; 

  
 42 

 (e) make any public disclosure, public proposal or public statement of inquiry or
publicly disclose any intention, plan or arrangement inconsistent with the agreements contained in this Section 4.01; 

(f) advise, assist, knowingly encourage or direct any Person to do or take, or to advise, assist, knowingly encourage or direct
any other Person to do or take, any of the actions prohibited by this Section 4.01 or knowingly act as a financing source for or otherwise invest in any Person in connection with such Person taking any of the actions prohibited by this
Section 4.01; provided, that, this Section 4.01(g) shall not restrict the Investor or its Affiliates from purchasing already outstanding debt or debt securities of any Person; 

(g) take any action that would, in effect, require the Company to make a public announcement regarding the possibility of a
transaction or any of the events described in this Section 4.01; 
 (h) contest the validity of this
Section 4.01 or make, initiate, take or participate in any Action or proposal to amend, waive, terminate or seek a release of the restrictions contained herein (whether by legal action or otherwise); or 

(i) request the Company, directly or indirectly, to amend or waive any provisions of this Section 4.01; 

provided, however that, notwithstanding anything to the contrary in this Section 4.01, (i) the Investor and its Affiliates may
at any time (A) initiate and engage in private discussions with, and submit non-public, confidential proposals to, the Board (or any committee or other designee thereof) regarding any Extraordinary Transaction, so long as such proposals do not
require public disclosure and the making of such proposal would not reasonably be expected to require the Company to make a public announcement of its receipt, (B) make a confidential request to the Company seeking an amendment or waiver of
this Section 4.01, which a majority of the Other Directors may accept or reject in their sole discretion, so long as the making of such request would not reasonably be expected to require the Company to make a public announcement of its
receipt and (C) engage in discussions or negotiations regarding, enter into, consummate or take any other action in furtherance of any transaction with any Person related to a recapitalization, reorganization or restructuring of any Debt of the
Company or its Subsidiaries, including with respect to the conversion of any debt securities of the Company or its Subsidiaries held by the Investor or its Affiliates into Equity Securities and (ii) for the avoidance of doubt,
(A) (x) the consummation of the transactions contemplated by the North America Investment Agreement and (y) the Investor’s exercise of its rights or the performance of its obligations under any other “Transaction
Document” (as defined in the North American Investment Agreement) shall not be deemed violations of this Section 4.01 and (B) nothing in this Section 4.01 shall limit (x) any Investor Party’s ability to
vote (subject to Section 2.07), Transfer (subject to Section 5.01) or otherwise exercise rights under its Common Stock or Series C Preferred Stock or (y) the ability of any Investor Director to vote or otherwise exercise
its fiduciary duties as a member of the Board. Nothing in this Section 4.01 shall restrict the Investor from designating any Investor Designee or 

  
 43 

 
Independent Director Designee in accordance with this Agreement or taking any action to cause such Investor Designee or Independent Director Designee to be appointed to the Board (or any
committee thereof) or the actions of any Investor Director in his or her capacity as Chairman or similar office or position), including in respect of such Director’s participation in Board and Board committee meetings and votes on and
discussions regarding matters at such meetings, and influencing officers, employees, agents, management or other Directors in his or her capacity as such, and otherwise exercising such Investor Director’s fiduciary duties. 

SECTION 4.02. Third-Party Standstills. In the event that the Company enters into any Specified Agreement that contains standstill
provisions on terms (other than terms regarding the length of such standstill restrictions) that are more favorable in any material respect to such Person than the provisions set forth in this Article IV are to the Investor Parties, then this
Article IV shall automatically be amended to provide for such more favorable terms. The Company shall promptly notify the Investor of the entry into such Specified Agreement. 

ARTICLE V 
 Limitations on
Transfers 
 SECTION 5.01. Limitation on Transfer of Series C Preferred Stock and Series D Preferred Stock. (a) Except as
otherwise permitted by this Agreement, including Section 5.02, the Investor Parties shall not, from and after the date hereof until the earliest of (i) the date that is 24 months following the date hereof, (ii) the date of the
consummation of a Mandatory Conversion (as defined in the Series C Certificate of Amendment) in accordance with the Series C Certificate of Amendment and (iii) the date a Bankruptcy, liquidation, dissolution or winding up of the Company is
voluntarily initiated or any proceeding for Bankruptcy, insolvency, receivership or similar action with respect to the Company is commenced (such period, the “Restricted Period”), directly or indirectly, sell, transfer, pledge,
place a lien on, assign, loan or otherwise dispose of, including by way of any Hedging Transaction (each, a “Transfer”), any portion of or interest in any shares of Series C Preferred Stock or Series D Preferred Stock acquired
pursuant to the Purchase (including any Common Stock issued upon conversion of such shares of Series C Preferred Stock or redemption of Series D Preferred Stock) without the prior written consent of the Company (which consent may be given or
withheld or made subject to such conditions as are determined by the Company in its sole discretion); provided, that, a “Transfer” will not include the granting of a pledge, lien or other security interest over Equity Securities in
connection with any bona fide financing arrangements (including any bona fide margin loan transaction) entered into with a nationally recognized bank or broker-dealer, or the ability of such a bank or broker-dealer to foreclose on and Transfer such
Company Securities and any foreclosure or Transfer by such a bank or broker-dealer, as long as such bank or broker-dealer agrees with the relevant Investor Party (with the Company as an express third party beneficiary of such agreement) that
following such foreclosure it shall not directly or indirectly Transfer (other than pursuant to a broadly distributed public offering or a sale effected through a broker dealer) such foreclosed Equity Securities to a 5% Entity without the
Company’s consent (each, a “Permitted Lien”), or the enforcement of any rights related thereto. 

  
 44 

 (b) The Investor Parties shall not, at any time (whether prior to or after the expiration
of the Restricted Period), directly or indirectly Transfer any Series C Preferred Stock, Series D Preferred Stock or Common Stock issued upon conversion of the Series C Preferred Stock or redemption of the Series D Preferred Stock to a 10% Entity
without the Company’s consent; provided, that this Section 5.01(b) shall not restrict any Transfer into the public market pursuant to a bona-fide, broadly distributed underwritten public offering or broker sale made pursuant
to Article III. 
 (c) Any purported Transfer that is not in accordance with the terms and conditions of this Article V
shall be, to the fullest extent permitted by Law, null and void ab initio, and, in addition to other rights and remedies at law and in equity, the Company shall be entitled to injunctive relief enjoining the prohibited action. 

(d) Notwithstanding anything to the contrary in this Section 5.01, the obligations of the Investor Parties under this
Section 5.01 shall terminate and be of no further force and effect upon the first to occur of (A) a Material Company Breach, (B) the occurrence of an “Event of Default” as defined in clauses (a), (b) (but only
with respect to negative covenants), (f), (i) or (j) of Section 8.01 of the Revolving Credit Agreement or (C) upon the Board taking any of the Specified Actions without the approval of a majority of the Investor Directors. 

SECTION 5.02. Permitted Transfers. Notwithstanding anything to the contrary in Section 5.01, the Investor Parties may
Transfer all or any portion of or any interest in any shares of Series C Preferred Stock, Series D Preferred Stock or any shares of Common Stock issued upon conversion of such shares of Series C Preferred Stock or redemption of Series D Preferred
Stock as follows: 
 (a) to the Company or its Subsidiaries; 

(b) pursuant to a Qualifying Approved Tender Offer initiated and commenced by any Person(s); 

(c) pursuant to a Qualifying Non-Approved Tender Offer initiated and commenced by any Person(s) (other than the Investor or any of its
Affiliates); 
 (d) to any Affiliate of the Investor, and such permitted transferees may further Transfer all or any portion of or any
interest in any shares of Series C Preferred Stock, Series D Preferred Stock or any shares of Common Stock issued upon conversion of such shares of Series C Preferred Stock or redemption of Series D Preferred Stock (or any dividends received
thereon) to any other Affiliate; provided, however, that no such Transfer shall be permitted pursuant to this clause (d) unless and until any such permitted transferee agrees in writing for the benefit of the Company (in such
customary form and substance reasonably satisfactory to the Company) to be bound by the terms of this Agreement, unless such transferee is already bound by this Agreement; and 

  
 45 

 (e) pursuant to any Extraordinary Transaction of the Company or similar business combination
transaction that has been recommended or approved by a majority of the Board. 
 SECTION 5.03. Legend. (a) The Company may place
appropriate and customary legends on the shares of Series C Preferred Stock, the shares of Series D Preferred Stock or the shares of Common Stock issued upon conversion of shares of Series C Preferred Stock or redemption of shares of Series D
Preferred Stock held by any of the Investor Parties setting forth the restrictions referred to in this Article V and any restrictions appropriate for compliance with U.S. federal securities Laws. The Investor Parties agree with the
Company that, other than to take into account any changes in applicable securities Laws, each share of Series C Preferred Stock held by the Investor on the Closing Date shall be marked with a legend substantially in the form set forth below: 

THESE SECURITIES AND THE SECURITIES ISSUABLE UPON THE EXCHANGE THEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. THE SECURITIES MAY NOT BE OFFERED, SOLD, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF EXCEPT (1) PURSUANT TO AN EXEMPTION FROM REGISTRATION
UNDER THE SECURITIES ACT OR (2) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT RELATING TO SUCH SECURITIES UNDER THE SECURITIES ACT, IN EACH CASE IN ACCORDANCE WITH ALL APPLICABLE STATE SECURITIES LAWS AND THE SECURITIES LAWS OF OTHER
JURISDICTIONS. 
 THESE SECURITIES ARE SUBJECT TO TRANSFER AND OTHER RESTRICTIONS SET FORTH IN THE INVESTOR RIGHTS AGREEMENT DATED MARCH 1,
2016 BETWEEN AVON PRODUCTS, INC. AND CLEVELAND APPLE INVESTOR L.P., AS AMENDED FROM TIME TO TIME, COPIES OF WHICH ARE ON FILE WITH THE SECRETARY OF THE ISSUER. 

(b) Upon request of the applicable Investor Party, upon receipt by the Company of an opinion of counsel reasonably satisfactory to the Company
to the effect that such legend is no longer required under the Securities Act and applicable state securities laws, the Company shall promptly cause the first paragraph of the legend to be removed from any certificate for any Series C Preferred
Stock, Common Stock or Series D Preferred Stock to be Transferred in accordance with the terms of this Agreement and the second paragraph of the legend shall be removed upon the expiration of such transfer and other restrictions set forth in this
Agreement (and, for the avoidance of doubt, immediately prior to any termination of this Agreement). 

  
 46 

 ARTICLE VI 

Participation 
 SECTION
6.01. Participation. (a) For the purposes of this Section 6.01, “Excluded Issuance” shall mean (i) the issuance of shares of any Equity Securities (including upon exercise of options) to directors,
officers, employees, consultants or other agents of the Company as approved by the Board in connection with their employment or performance of services, (ii) the issuance of shares of Equity Securities in connection with any “business
combination” (as defined in the rules and regulations promulgated by the SEC) or otherwise in connection with bona fide acquisitions of securities or substantially all of the assets of another Person, business unit, division or business, in
each case, to the sellers in such transaction as consideration thereof, (iii) the issuance of any securities pursuant to the conversion, exercise or exchange of Series C Preferred Stock issued to the Investor or Series D Preferred Stock,
(v) the issuance of any securities as payment of a dividend pursuant to the Series C Certificate of Amendment or the Series D Certificate of Amendment, (vi) the issuance of any shares of a Subsidiary of the Company to the Company or a
wholly owned Subsidiary of the Company or (vii) the issuance of any securities exercisable for, exchangeable for or convertible into Common Stock, if the conversion or exercise price is at least as great as the fair market value of the Common
Stock, pursuant to a bona fide, broadly distributed underwritten public offering. 
 (b) Until the occurrence of the Fall-Away of Investor
Board Rights, if the Company proposes to issue Equity Securities of any kind, other than in an Excluded Issuance, then the Company shall: 

(i) give written notice to the Investor Parties (no less than seven (7) Business Days prior to the closing of such
issuance or, if the Company reasonably expects such issuance to be completed in less than seven (7) Business Days, such shorter period (which shall not be less than (3) Business Days, and which shall be as long as commercially
practicable), setting forth in reasonable detail (A) the designation and all of the material terms and provisions of the securities proposed to be issued (the “Proposed Securities”), including, to the extent applicable, the
voting powers, preferences and relative participating, optional or other special rights, and the qualifications, limitations or restrictions thereof and interest rate and maturity, (B) the price and other terms of the proposed sale of such
securities and (C) the amount of such securities proposed to be issued; provided, that following the delivery of such notice, the Company shall deliver to the Investor Parties any such information the Investor Parties may reasonably
request in order to evaluate the proposed issuance, except that, in connection with a public offering, the Company shall not be required to deliver any information that has not been or will not be provided or otherwise made available to the proposed
purchasers of the Proposed Securities; and 
 (ii) offer to issue and sell to the Investor Parties, on such terms as the
Proposed Securities are issued and upon full payment by the Investor Parties, a portion of the Proposed Securities equal to a percentage determined by dividing 

  
 47 

 
(A) the number of shares of Common Stock beneficially owned, on an as converted basis, by the Investor Parties, by (B) the total number of shares of Common Stock outstanding immediately
prior to the issuance of the Proposed Securities, on an as-converted basis; provided that if an issuance of Proposed Securities would result in an adjustment to the holders of Series C Preferred Stock pursuant to Section 10 of the Series
C Certificate of Amendment, those shares of Series C Preferred Stock held by an Investor Party that will receive the benefit of such adjustment shall be excluded from the foregoing sub-clause (A) (subject to actually receiving the benefit of
such adjustment); provided, further, that, subject to compliance with the terms and conditions set forth in Section 6.01(f), the Company shall not be required to offer to issue or sell to the Investor Parties (or to any of them)
the portion of the Proposed Securities that would require the Company to obtain stockholder approval in respect of the issuance of any Proposed Securities under the listing rules of the NYSE or any other securities exchange or any other applicable
Law (to the extent not obtained pursuant to Section 6.01(f)). 
 (c) The Investor will have the option, on behalf of the
applicable Investor Parties, exercisable by written notice to the Company, to accept the Company’s offer and commit to purchase any or all of the Equity Securities offered to be sold by the Company to the Investor Parties, which notice must be
given within seven (7) Business Days after receipt of such notice from the Company (or such shorter period if the notice by the Company was sent in accordance with the preceding paragraph less than seven (7) Business Days prior to the
proposed issuance date, and in no event less than two (2) Business Days) (the failure of the Investors to respond within such time period shall be deemed a waiver of the Investor Parties’ rights under this Section 6.01 with
respect to the applicable issuance of Equity Securities). If the Company offers two or more securities in units to the other participants in the offering, the Investor Parties must purchase such units as a whole and will not be given the opportunity
to purchase only one of the securities making up such unit. The closing of the exercise of such subscription right shall take place simultaneously with the closing of the sale of the Proposed Securities giving rise to such subscription right;
provided, however, that the closing of any purchase by any such Investor Party may be extended beyond the closing of the sale of the Proposed Securities giving rise to such preemptive right to the extent necessary to (i) obtain
required approvals from any Governmental Entity or (ii) permit the Investor Parties to receive proceeds from calling capital pursuant to commitments made by its (or its Affiliated investment funds’) limited partners. Upon the expiration of
the offering period described above, the Company will be free to sell such Proposed Securities that the Investor Parties have not elected to purchase during the 90 days following such expiration on terms and conditions no more favorable to the
purchasers thereof than those offered to the Investor Parties in the notice delivered in accordance with Section 6.01(b). Any Proposed Securities offered or sold by the Company after such 90-day period must be reoffered to issue or sell
to the Investor Parties pursuant to this Section 6.01; provided that, subject to compliance with the terms and conditions set forth in Section 6.01(f), the Company shall not be required to reoffer to the Investor
Parties (or to any of them) a number of the Proposed Securities that would require the Company to obtain stockholder approval in respect of the issuance of any Proposed Securities under the listing rules of the NYSE or any other securities exchange
or any applicable Law (to the extent not obtained pursuant to Section 6.01(f)). 

  
 48 

 (d) The election by the Investor on behalf of any Investor Party not to exercise its subscription
rights under this Section 6.01 in any one instance shall not affect their right as to any subsequent proposed issuance. 
 (e)
In the case of an issuance subject to this Section 6.01 for consideration in whole or in part other than cash, including securities acquired in exchange therefor (other than securities by their terms so exchangeable), the consideration
other than cash shall be deemed to be the fair market value thereof as reasonably determined in good faith by the Board. 
 (f) In the event
that the Company is not required to offer or reoffer to the Investor Parties any Proposed Securities because such issuance would require the Company to obtain stockholder approval in respect of the issuance of any Proposed Securities under the
listing rules of the NYSE or any other securities exchange or any other applicable Law, the Company shall provide written notice of such proposed issuance to the Investor Parties pursuant to Section 6.01(b)(i) (which notice shall include
a description of the Proposed Securities (including the number thereof) that would require stockholder approval in respect of the issuance thereof), and the Company shall, upon the Investor Parties’ reasonable request delivered to the Company
in writing within no later than seven (7) Business Days following its receipt of the written notice of such issuance to the Investor Parties pursuant to Section 6.01(b)(i), at the Investor Parties’ election: 

(i) waive the restrictions set forth in Section 4.01 solely to the extent necessary to permit any Investor Party to
acquire such number of Equity Securities (including Common Stock) equivalent to its Participation Portion of the Proposed Securities such Investor Party would have been entitled to purchase had it been entitled to acquire such Proposed Securities
pursuant to Section 6.01(b) (provided, that such request by Investor Parties shall not be deemed to be a violation of Section 4.01(i)); 

(ii) consider and discuss in good faith modifications proposed by the Investor Parties to the terms and conditions of such
portion of the Proposed Securities which would otherwise be issued to the Investor Parties such that the Company would not be required to obtain stockholder approval in respect of the issuance of such Proposed Securities as so modified; and/or 

(iii) solely to the extent that stockholder approval is required in connection with the issuance of Equity Securities to
Persons other than Investor Parties, take such actions as may be reasonably necessary to seek stockholder approval in respect of the issuance of any Proposed Securities to the Investor Parties. 

  
 49 

 ARTICLE VII 

Additional Agreements 

SECTION 7.01. Information and Access. Following the Closing until the Investor Parties no longer hold at least 10.0% of the number of
shares of Common Stock beneficially owned by the Investor Parties, on an as converted basis, as of the Closing, the Company agrees to provide the Investor Parties with the following: 

(a) within 90 days after the end of each fiscal year of the Company, (i) an audited, consolidated balance sheet of the Company and its
Subsidiaries as of the end of such fiscal year and (ii) audited, consolidated statements of income, comprehensive income, cash flows and changes in shareholders’ equity of the Company and its Subsidiaries for such fiscal year;
provided that this requirement shall be deemed to have been satisfied if on or prior to such date the Company files its annual report on Form 10-K for the applicable fiscal year with the SEC; 

(b) within 45 days after the end of each of the first three quarters of each fiscal year of the Company, (i) an unaudited, consolidated
balance sheet of the Company and its Subsidiaries as of the end of such fiscal quarter and (ii) consolidated statements of income, comprehensive income and cash flows of the Company and its Subsidiaries for such fiscal quarter; provided
that this requirement shall be deemed to have been satisfied if on or prior to such date the Company files its quarterly report on Form 10-Q for the applicable fiscal quarter with the SEC; 

(c) reasonable access, to the extent reasonably requested by the Investor Parties, to the offices and the properties of the Company and its
Subsidiaries, including its and their books and records, all upon reasonable notice and at such reasonable times and as often as the Investor Parties may reasonably request; provided that any access pursuant to this
Section 7.01(c) shall be conducted in a manner as not to interfere unreasonably with the conduct of the business of the Company and its Subsidiaries; 

(d) prior to the end of each fiscal year, a budget and business plan for the Company for the succeeding fiscal year, including
(i) projected monthly statements of income for each of the Company’s top geographies and (ii) projected consolidated quarterly balance sheets and statements of cash flows for the Company and its Subsidiaries; 

(e) to the extent available to the Company at the applicable time, following the end of each month, monthly summary consolidated financial
reports for the Company and its Subsidiaries; 
 (f) for so long as the 25.0% Beneficial Ownership Requirement is satisfied, the Company
shall afford the Investor an opportunity to receive and discuss with senior management of the Company on a regular basis (it being the expectation that such discussions will occur on no more than a monthly basis), during normal business hours and
without unduly interfering with the operation of the business, monthly reports regarding financial, operating, strategic and such other matters relating to the 

  
 50 

 
management of the Company as may be mutually acceptable to management and the Company in good faith. At the request of the Company, such monthly calls will be open to all Directors who wish to
attend; and 
 (g) copies of all material, substantive materials provided to the Board at substantially the same time as provided to the
Directors of the Company; 
 provided that, the Company shall not be obligated to provide such access or materials to the Investor Parties to the
extent the Company determines, in its reasonable judgment, that doing so would (A) violate or materially prejudice the rights of its customers, (B) result in the disclosure of trade secrets or competitively sensitive information to third
parties, (C) materially violate any applicable Law, Judgment or contract or obligation of confidentiality owing to a third party, (D) jeopardize the protection of an attorney-client privilege, attorney work product protection or other
similar legal privilege, (E) be materially adverse to the interests of the Company or any of its Subsidiaries in any pending or threatened Action or (F) expose the Company to risk of liability for disclosure of personal information;
provided, that, in each case, the Company shall use commercially reasonable efforts to provide the maximum access such that clauses (A) through (F) do not apply. In addition, notwithstanding anything to the contrary contained
herein, neither the Company nor any of its Subsidiaries will be required to provide any information or materials that relate to, contain or reflect any analyses, studies, notes, memoranda and other information related to or prepared in connection
with the Investment Agreement, the North America Investment Agreement, the other Transaction Documents or any of the transactions contemplated thereby or any matters relating thereto or any transactions with or matters relating to the Investor or
any of its Affiliates. Notwithstanding anything to the contrary in this Section 7.01, the Investor Parties shall have the right to waive its right to receive information and/or access under this Section 7.01 for such period
of time as such Investor Party may specify and, upon receipt of written notice of such waiver, the Company agrees to no longer provide the Investor Party with information and/or access for the duration of the period so specified. 

SECTION 7.02. Confidentiality. Each Investor shall, and shall cause its Affiliates and Representatives to, keep confidential any
information (including oral, written and electronic information) concerning the Company, its Subsidiaries or its Affiliates that may be furnished to the Investor Parties or their respective Affiliates or Representatives by or on behalf of the
Company or any of its Representatives pursuant to this Agreement (collectively referred to as the “Confidential Information”), provided that the Confidential Information shall not include information that (a) was or
becomes available to the public other than as a result of a disclosure by the Investor Parties or any of their respective Affiliates or Representatives in violation of this Section 7.02, (b) was or becomes available to the Investor
Parties or any of their respective Affiliates or Representatives from a source other than the Company or its Representatives, provided that such source is believed by the Investor Parties not to be disclosing such information in violation of
an obligation of confidentiality (whether by agreement or otherwise) to the Company or any of its Affiliates, (c) at the time of disclosure is already in the possession of the Investor Parties or any of their respective Affiliates or
Representatives, provided that such information is believed by the Investor Parties not to be subject to an obligation 

  
 51 

 
of confidentiality (whether by agreement or otherwise) to the Company, or (d) was independently developed by the Investor Parties or any of their respective Affiliates or Representatives
without use of any Confidential Information. Each of the Investor Parties agrees, on behalf of itself and its Affiliates and Representatives, that Confidential Information may be disclosed solely (i) to the Related Investment Funds, the
Investor Party’s Affiliates and their respective Representatives on a need-to-know basis or (ii) in the event that the Investor Party, any of its Affiliates, the Related Investment Funds or any of its or their respective Representatives
are requested or required by applicable Law, Judgment or by a Governmental Entity (including by deposition, interrogatory, request for documents, subpoena, civil investigative demand, summons or similar process) to disclose any Confidential
Information, in each of which instances, to the extent permissible by applicable Law and reasonably practicable, such Investor Party, its Affiliates, the Related Investment Funds and their respective Representatives, as the case may be, shall
provide notice to the Company sufficiently in advance of any such disclosure so that the Company shall have a reasonable opportunity to timely seek to limit, condition or quash such disclosure; and, provided, that, with respect to any
Related Investment Fund receiving Confidential Information hereunder (i) such Related Investment Fund will agree (with the Company as an express third party beneficiary of such agreement) to be bound by the terms of this
Section 7.02 as though it were a party hereto and (ii) the Investor will remain liable for any breaches by the Related Investment Funds of this Section 7.02. 

SECTION 7.03. Section 16 Matters. If the Company becomes a party to a consolidation, merger or other similar transaction that may
result in the Investor, its Affiliates and/or the Investor Directors being deemed to have made a disposition of Equity Securities of the Company or derivatives thereof for purposes of Section 16 of the Exchange Act, and if any of the Investor
Directors is serving on the Board at such time or has served on the Board during the preceding six months (i) the Board will pre-approve such disposition of Equity Securities or derivatives thereof for the express purpose of exempting the
Investor’s, its Affiliates’ and the Investor Directors’ interests (to the extent the Investor or its Affiliates may be deemed to be “directors by deputization”) in such transaction from Section 16(b) of the Exchange Act
pursuant to Rule 16b-3 thereunder and (ii) if the transaction involves (A) a merger or consolidation to which the Company is a party and Capital Stock is, in whole or in part, converted into or exchanged for equity securities of a
different issuer, (B) a potential acquisition by the Investor, the Investor’s Affiliates, and/or the Investor Directors of equity securities of such other issuer or derivatives thereof and (C) an Affiliate or other designee of the
Investor or its Affiliates will serve on the board of directors (or its equivalent) of such other issuer, then if the Company requires that the other issuer pre-approve any acquisition of equity securities or derivatives thereof for the express
purpose of exempting the interests of any director or officer of the Company or any of its Subsidiaries in such transactions from Section 16(b) of the Exchange Act pursuant to Rule 16b- 3 thereunder, the Company shall require that such other
issuer pre-approve any such acquisitions of equity securities or derivatives thereof for the express purpose of exempting the interests of the Investor’s, its Affiliates’ and the Investor Directors’ (for the Investor and/or its
Affiliates, to the extent such persons may be deemed to be “directors by deputization” of such other issuer) in such transactions from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder. 

  
 52 

 SECTION 7.04. Rights Plan. Unless and until there has occurred a Fall-Away of Investor
Board Rights, the Company shall not enter into, adopt or implement any Rights Plan that is applicable to the Investor Parties unless the Company has excluded the Investor Parties from the definition of “acquiring person” (or such similar
term) as such term is defined in such Rights Plan to allow for acquisitions up to the Maximum Percentage. 
 SECTION 7.05. Financing
Cooperation. The Company shall use its commercially reasonable efforts to, and shall use commercially reasonable efforts to cause its Subsidiaries to, cooperate with any reasonable requests by the Investor Parties in connection with any bona
fide loan or credit arrangement entered into with a nationally recognized bank or broker-dealer secured in whole or in part with a pledge of Equity Securities, including cooperating with Investor Parties to satisfy the reasonable and customary
requirements of secured lenders in connection with such loan or credit arrangement, such as agreeing to an issuer acknowledgement in customary form (and reasonably acceptable to the Company) which includes an acknowledgement that such lender will be
permitted to hold such pledged Equity Securities (other than the Series C Preferred Stock and the Series D Preferred Stock) in unrestricted, book-entry form without any legend, subject to such lender agreeing comply with all applicable securities
Laws and the requirements for incurring a Permitted Lien under Section 5.01(a). 
 ARTICLE VIII 

Miscellaneous 
 SECTION
8.01. Notices. All notices, requests, permissions, waivers or other communications required or permitted to be given under this Agreement shall be in writing and shall be delivered by hand or sent by facsimile or email or sent, postage
prepaid, by registered, certified or express mail or overnight courier service and shall be deemed given when so delivered by hand, by facsimile (which is confirmed, such confirmation not to be unreasonably withheld, conditioned or delayed), by
email (which is confirmed, such confirmation not to be unreasonably withheld, conditioned or delayed) or if mailed, three days after mailing (one Business Day in the case of express mail or overnight courier service marked for overnight delivery) to
the parties at the following addresses or facsimiles or emails (or at such other address or facsimile or email for a party as shall be specified by like notice): 

(a) If to the Company: 
 Avon
Products, Inc. 
 777 Third Avenue 

New York, NY 10017-1307 

Attention:         General Counsel 

Email:               Jeff.benjamin@avon.com 

  
 53 

 with a copy to (which copy alone shall not constitute notice): 

Cravath, Swaine & Moore LLP 

Worldwide Plaza 
 825 Eighth
Avenue 
 New York, NY 10019 

Attention:         Scott A. Barshay, Esq. 

 Jonathan L. Davis, Esq. 

Facsimile:         (212) 474-3700 

Email:               sbarshay@cravath.com 

 jdavis@cravath.com 
 (b)
If to the Investor: 
 Cleveland Apple Investor L.P., c/o 

Cerberus Capital Management, L.P. 

875 Third Avenue 
 10th Floor 
 New York, NY 10022 

Attention: General Counsel 

with a copy to (which copy alone shall not constitute notice): 

Kirkland & Ellis LLP 

601 Lexington Avenue 
 New York,
NY 10022 
 Attention:         Douglas Ryder, Esq. 

 Richard Aftanas, Esq. 

Facsimile:         (212) 446-4900 

Email:               Douglas.Ryder@kirkland.com 

 Richard.Aftanas@kirkland.com 

SECTION 8.02. Amendments; Waivers. This Agreement may be amended or waived if, and only if, such amendment or waiver is in writing and
signed by the party against whom such amendment or waiver shall be enforced. The failure of any party hereto to exercise any right, power or remedy provided under this Agreement or otherwise available in respect hereof at law or in equity, or to
insist upon compliance by any other party hereto with its obligations hereunder, shall not constitute a waiver by such party of its right to exercise any such other right, power or remedy or to demand such compliance. 

SECTION 8.03. Counterparts and Facsimile. This Agreement may be executed in two or more identical counterparts (including by facsimile
or electronic transmission), each of which shall be an original, with the same effect as if the signatures 

  
 54 

 
thereto and hereto were upon the same instrument, and shall become effective when one or more counterparts have been signed by each of the parties hereto and delivered (by facsimile, electronic
transmission or otherwise) to the other parties. 
 SECTION 8.04. Governing Law; Specific Enforcement; Submission to Jurisdiction; Waiver
of Jury Trial. (a) This Agreement shall be governed by and construed in accordance with the internal laws of the State of New York applicable to agreements made and to be performed entirely within such state, without regard to the conflicts
of law principles of such state. 
 (b) The parties hereto acknowledge and agree that irreparable damage would occur in the event that any
of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties hereto shall be entitled to an injunction or injunctions, specific performance or
other equitable relief to prevent breaches or threatened breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in the courts described in Section 8.04(c), without proof of damages or otherwise
(in each case, subject to the terms and conditions of this Section 8.04) (and each party hereto acknowledges and agrees that any party seeking an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically
the terms and provisions of this Agreement in accordance with this Section 8.04 shall not be required to provide any bond or other security in connection with any such order or injunction), this being in addition to any other remedy to
which they are entitled at law or in equity. The parties hereto agree not to assert that a remedy of specific enforcement is unenforceable, invalid, contrary to Law or inequitable for any reason, or that a remedy of monetary damages would provide an
adequate remedy or that the parties otherwise have an adequate remedy at law. 
 (c) Each of the parties hereto irrevocably and
unconditionally submits to the exclusive jurisdiction of the Supreme Court of the State of New York, New York County, and the United States District Court for the Southern District of New York, for the purposes of any demand, action, suit,
countersuit, arbitration, inquiry, proceeding or investigation by or before any Governmental Entity or any arbitration or mediation tribunal (“Action”) or other proceeding arising out of this Agreement and the rights and obligations
arising hereunder, and irrevocably and unconditionally waives any objection to the laying of venue of any such Action or proceeding in any such court, and further irrevocably and unconditionally waives and agrees not to plead or claim in any such
court that any such Action or proceeding has been brought in an inconvenient forum. Each party hereto agrees that service of any process, summons, notice or document by registered mail to such party’s respective address set forth in
Section 8.01 shall be effective service of process for any such Action or proceeding. 
 (d) EACH PARTY HERETO HEREBY WAIVES, TO
THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY ACTION, CLAIM OR OTHER PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT. EACH PARTY HERETO
(i) CERTIFIES 

  
 55 

 
THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, CLAIM OR OTHER PROCEEDING, SEEK TO ENFORCE THE
FOREGOING WAIVER, (ii) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVER, (iii) IT MAKES SUCH WAIVER VOLUNTARILY AND (iv) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT
BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 8.04(d). 
 SECTION 8.05. Interpretation.
(a) When a reference is made in this Agreement to an Article or Section, such reference shall be to an Article or Section of this Agreement unless otherwise indicated. The table of contents and headings contained in this Agreement are for
reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. The word “will” shall be construed to have the same meaning as the word “shall”. Whenever the words “include”,
“includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation”. The words “hereof”, “herein” and “hereunder” and words of
similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. The words “date hereof” shall refer to the date of this Agreement. The word “or” shall not
be exclusive. The word “extent” in the phrase “to the extent” shall mean the degree to which a subject or other thing extends, and shall not simply mean “if”. All references to “$” mean the lawful currency of
the United States of America. The definitions contained in this Agreement are applicable to the singular as well as the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such term, and references to the
masculine, feminine or neuter gender shall include other gender. Except as specifically stated herein, any agreement, instrument or statute defined or referred to herein or in any agreement or instrument that is referred to herein means such
agreement, instrument or statute as from time to time amended, modified or supplemented, including (in the case of agreements or instruments) by waiver or consent and (in the case of statutes) by succession of comparable successor statutes and
references to all attachments thereto and instruments incorporated therein. Except as otherwise specified herein, references to a Person are also to its successors and permitted assigns. Each of the parties hereto has participated in the drafting
and negotiation of this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement must be construed as if it is drafted by all the parties and no presumption or burden of proof shall arise favoring or disfavoring any
party by virtue of authorship of any of the provisions of this Agreement. 
 (b) For purposes of determining beneficial ownership, the
Investor Parties may rely on the Company’s most recent publicly available Quarterly Report on Form 10-Q or Annual Report on Form 10-K to determine the number of issued and outstanding Equity Securities of the Company at any given time and any
Person’s beneficial ownership percentage, unless the Company provides written notice to the Investor with an updated number of Equity Securities of the Company then issued and outstanding. 

  
 56 

 (c) In the event that the Common Stock is listed on a National Securities Exchange other than the
NYSE, all references herein to NYSE rules shall be deemed to be to the most comparable rule applicable to such other National Securities Exchange and all references to NYSE shall be deemed to be such other National Securities Exchange, in each case,
mutatis mutandis. In the event that the Common Stock is listed on both the NYSE and any other securities exchange, the Company and the Investor shall cooperate to make any amendments to this Agreement reasonably requested by the other party;
provided, that in no event shall the Investor be required to accept any changes that would result from any shares Capital Stock beneficially owned by any Investor Party being listed on any exchange other than a National Securities Exchange. 

SECTION 8.06. Severability. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced because
of any Law or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner
adverse in any material respect to any party hereto. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to
effect the original intent of the parties as closely as possible so as to effect the original intent of the parties as closely as possible to the fullest extent permitted by applicable Law. 

SECTION 8.07. No Third-Party Beneficiaries. Except as expressly set forth in Section 3.08, this Agreement is for the sole
benefit of the parties hereto and their permitted assigns and nothing expressed or referred to in this Agreement will be construed to give any Person, other than the parties to this Agreement and such permitted assigns, any legal or equitable right,
remedy or claim under or with respect to this Agreement or any provision of this Agreement, whether as third party beneficiary or otherwise. 

SECTION 8.08. Assignment. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned, in whole
or in part, by any party hereto (whether by operation of Law or otherwise) without the prior written consent of the other party; provided that notwithstanding the foregoing, (a) the Company shall be permitted to assign this Agreement and
its rights, interests and obligations hereunder without the prior written consent of any other party hereto to the successor or surviving entity in any merger, business combination or other transaction involving a change of control of the Company
and (b) this Section 8.08 shall not prohibit any Transfer permitted under Section 5.02; provided, further, that in the event of any such assignment pursuant to clause (b), the Investor will remain liable
for all of its obligations under this Agreement. 
 SECTION 8.09. Termination. 

(a) Automatic Termination. Other than the termination provisions applicable to particular Sections of this Agreement that are
specifically provided elsewhere in this Agreement, this Agreement shall terminate, subject to Section 8.09(b), (i) upon the mutual written agreement of the Company and the Investor and (ii) at such time when the Investor
Parties no longer beneficially own shares of Capital Stock. 

  
 57 

 (b) Survival. In the event that this Agreement shall terminate, all provisions of this
Agreement shall terminate and shall be void, except Section 7.02 and Articles I and VIII and shall survive any such termination indefinitely. The termination of this Agreement shall not relieve any party from any
liability for any breach by a party of this Agreement. 
 SECTION 8.10. Entire Agreement, etc. This Agreement (including the Exhibits
hereto), together with the Series C Certificate of Amendment, the Series D Certificate of Amendment and the Investment Agreement, constitutes the entire agreement, and supersedes all other prior agreements, understandings, representations and
warranties, both written and oral, between the parties, with respect to the subject matter hereof; provided, that nothing herein shall limit, restrict, prevent or supersede the other Transaction Documents (as defined in the North American
Investment Agreement), or serve as a consent or waiver thereunder. 
 [Remainder of page intentionally left blank] 

  
 58 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first
above written. 
  

			
	AVON PRODUCTS, INC.,
		
	By	 	 /s/ James S. Scully

	Name:	 	James S. Scully
	Title:	 	Executive Vice President Chief Operating Officer & Chief Financial Officer
	
	CLEVELAND APPLE INVESTOR L.P.,
		
	By:	 	Avon GP, LLC, its general partner
		
	By	 	 /s/ Seth Plattus

	Name:	 	Seth Plattus
	Title:	 	Senior Managing DirectorEX-10.2

 Exhibit 10.2 

EXECUTION VERSION 
  

 
 INTELLECTUAL PROPERTY LICENSE
AGREEMENT 
 among 
 AVON
PRODUCTS, INC., 
 AVON INTERNATIONAL OPERATIONS, INC. 

AVON NA IP LLC 
 and 

NEW AVON LLC 
 Dated as of
March 1, 2016 
  
  

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
	ARTICLE I	  
	
	Definitions	  
	 SECTION 1.01.
	 	Definitions	  	 	1	  
	
	ARTICLE II	  
	
	License Grants; Sublicensing; Non-Assertion; Ownership	  
			
	 SECTION 2.01.
	 	Licenses to Avon NA	  	 	9	  
	 SECTION 2.02.
	 	Licenses to Avon International	  	 	12	  
	 SECTION 2.03.
	 	Sublicensing and Licensing	  	 	13	  
	 SECTION 2.04.
	 	Sales Outside North America or International Region	  	 	14	  
	 SECTION 2.05.
	 	Third-Party IP Rights	  	 	15	  
	 SECTION 2.06.
	 	Ownership	  	 	15	  
	 SECTION 2.07.
	 	Non-Assertion	  	 	15	  
	 SECTION 2.08.
	 	Separately Licensed IP	  	 	16	  
	 SECTION 2.09.
	 	Delivery	  	 	18	  
	
	ARTICLE III	  
	
	Trademark Use and Quality Standards	  
			
	 SECTION 3.01.
	 	Quality Standards	  	 	18	  
	 SECTION 3.02.
	 	Samples	  	 	20	  
	 SECTION 3.03.
	 	Trademark Use Guidelines	  	 	21	  
	 SECTION 3.04.
	 	Non-Degradation	  	 	22	  
	
	ARTICLE IV	  
	
	Royalties; Minor Improvements; Audit Rights	  
			
	 SECTION 4.01.
	 	Information on New Products	  	 	23	  
	 SECTION 4.02.
	 	Request to Make New License Rights Effective	  	 	23	  
	 SECTION 4.03.
	 	Royalties	  	 	24	  
	 SECTION 4.04.
	 	Minor Improvements	  	 	25	  
	 SECTION 4.05.
	 	Taxes	  	 	25	  
	 SECTION 4.06.
	 	Late Payments	  	 	25	  
	 SECTION 4.07.
	 	Non-Payment	  	 	25	  
	 SECTION 4.08.
	 	Audit Rights	  	 	26	  

							
	
	ARTICLE V	  
	
	Reserved Rights	  
			
	 SECTION 5.01.
	 	Avon International Retained Rights	  	 	27	  
	 SECTION 5.02.
	 	Avon NA Retained Rights	  	 	27	  
	 SECTION 5.03.
	 	Pre-Existing Licenses	  	 	27	  
	 SECTION 5.04.
	 	Rights Reserved	  	 	28	  
	
	ARTICLE VI	  
	
	Additional Covenants	  
			
	 SECTION 6.01.
	 	Restricted Business	  	 	28	  
	
	ARTICLE VII	  
	
	Prosecution, Maintenance and Enforcement	  
	 SECTION 7.01.
	 	Cooperation	  	 	28	  
	 SECTION 7.02.
	 	Filing and Maintenance of Registered IP Rights	  	 	28	  
	 SECTION 7.03.
	 	Enforcement	  	 	31	  
	 SECTION 7.04.
	 	Social Media Cooperation	  	 	33	  
	
	ARTICLE VIII	  
	
	Confidentiality	  
			
	 SECTION 8.01.
	 	Confidentiality	  	 	33	  
	 SECTION 8.02.
	 	Disclosure	  	 	33	  
	 SECTION 8.03.
	 	Legal Orders	  	 	34	  
	 SECTION 8.04.
	 	Exclusions	  	 	34	  
	 SECTION 8.05.
	 	Formulas	  	 	34	  
	
	ARTICLE IX	  
	
	Warranties and Indemnities	  
			
	 SECTION 9.01.
	 	Warranties	  	 	35	  
	 SECTION 9.02.
	 	Indemnity by Avon NA	  	 	36	  
	 SECTION 9.03.
	 	Indemnity by Avon International	  	 	37	  
	 SECTION 9.04.
	 	Indemnification Procedures	  	 	37	  
	 SECTION 9.05.
	 	Disclaimer	  	 	38	  

							
	ARTICLE X	  
	
	Term	  
			
	 SECTION 10.01.
	 	Term	  	 	39	  
	ARTICLE XI	  
	
	General Provisions	  
			
	 SECTION 11.01.
	 	Further Assurances	  	 	39	  
	 SECTION 11.02.
	 	Security Interests	  	 	39	  
	 SECTION 11.03.
	 	Force Majeure	  	 	39	  
	 SECTION 11.04.
	 	Severability	  	 	40	  
	 SECTION 11.05.
	 	Notices	  	 	40	  
	 SECTION 11.06.
	 	Entire Agreement	  	 	41	  
	 SECTION 11.07.
	 	Governing Law; Specific Enforcement; Submission to Jurisdiction; Waiver of Jury Trial	  	 	41	  
	 SECTION 11.08.
	 	Amendments; Waivers	  	 	42	  
	 SECTION 11.09.
	 	Assignment; Successors and Assigns	  	 	42	  
	 SECTION 11.10.
	 	Rights in Bankruptcy	  	 	43	  
	 SECTION 11.11.
	 	Migration	  	 	44	  
	 SECTION 11.12.
	 	Interpretation	  	 	44	  
	 SECTION 11.13.
	 	Counterparts and Facsimile	  	 	45	  
	 SECTION 11.14.
	 	Independent Contractors	  	 	45	  
	 SECTION 11.15.
	 	No Third-Party Beneficiaries	  	 	45	  
	 SECTION 11.16.
	 	Costs and Expenses	  	 	45	  
	 SECTION 11.17.
	 	Parent Guaranty	  	 	46	  
			
	 Schedules
	 		  			
			
	 Schedule A
	 	Existing North America Trademarks	  			
	 Schedule B
	 	Existing North America Domain Names	  			
	 Schedule C
	 	Existing North America Patents	  			
	 Schedule D
	 	Existing North America Copyrights	  			
	 Schedule E
	 	Restricted Business	  			
	 Schedule F
	 	Restricted Persons	  			
	 Schedule G
	 	Section 2.05 Third-Party IP Rights	  			
	 Schedule H
	 	Section 5.03 Pre-Existing Licenses	  			
	 Schedule I
	 	Trademark Use Guidelines	  			
	 Schedule J
	 	Specified Quality Brands	  			
	 Schedule K
	 	Licensed IP Quality Standards	  			

 Index of Defined Terms 
  

			
	 Term
	  	 Section

	Affiliate	  	Section 1.01(a)
	Agreement	  	Section 1.01(b)
	AIO	  	Preamble
	Applicable Law	  	Section 1.01(c)
	Assignable Asset	  	Section 11.09
	Assigning Party	  	Section 11.09(a)
	Auditor	  	Section 4.08(b)
	Avon Brand Logo	  	Section 1.01(d)
	Avon Canada	  	Section 1.01(e)
	Avon Corporate Logo	  	Section 1.01(f)
	Avon Domain	  	Section 1.01(g)
	Avon International	  	Section 1.01(h)
	Avon International Business	  	Section 1.01(i)
	Avon International Covered Product	  	Section 1.01(j)
	Avon International Indemnified Claims	  	Section 9.02
	Avon International Indemnified Parties	  	Section 9.02
	Avon International New Envoy Images	  	Section 2.08(b)
	Avon NA	  	Preamble
	Avon NA Business	  	Section 1.01(k)
	Avon NA Covered Product	  	Section 1.01(l)
	Avon NA Indemnified Claims	  	Section 9.03
	Avon NA Indemnified Parties	  	Section 9.03
	Avon NA New Envoy Images	  	Section 2.08(b)
	Avon Products	  	Preamble
	Bankruptcy Code	  	Section 11.10(a)
	Beauty Products	  	Section 1.01(m)
	Business Day	  	Section 1.01(n)
	Catalox Database	  	Section 1.01(o)
	Catalox License	  	Section 2.08(a)
	Claims	  	Section 1.01(p)
	Cleveland NA	  	Recitals
	Closing	  	Section 1.01(q)
	Confidential Information	  	Section 1.01(r)
	Control	  	Section 1.01(s)
	Controlled	  	Section 1.01(s)
	Controlling	  	Section 1.01(s)
	Copyrights	  	Section 1.01(vv)(i)
	Corporate Identity	  	Section 1.01(t)
	Disclosing Party	  	Section 1.01(r)
	Domain Names	  	Section 1.01(u)

			
	 Term
	  	 Section

	Effective Date	  	Preamble
	Electing Party	  	Section 7.02(b)(iv)
	Enforcing Party	  	Section 7.03(d)(i)
	Envoy Database	  	Section 1.01(u)
	Envoy NA Image License	  	Section 2.08(b)
	Excluded Costs	  	Section 1.01(w)
	Existing Envoy Images	  	Section 2.08(b)
	Existing Non-North America IP	  	Section 1.01(x)
	Existing North America IP	  	Section 1.01(y)
	Existing North America Product	  	Section 1.01(z)
	Fashion & Home Products	  	Section 1.01(aa)
	Filing Party	  	Section 11.10(a)
	Formula-Related Information	  	Section 8.05
	Formulas	  	Section 1.01(vv)(iii)
	Governmental Entity	  	Section 1.01(bb)
	Guaranteed Obligations	  	Section 11.17
	Guaranteed Party	  	Section 11.17
	Have Made	  	Section 1.01(cc)
	Indemnified Claim	  	Section 9.04(a)
	Indemnified Party	  	Section 9.04(a)
	Indemnifying Party	  	Section 9.04(a)
	Independent Sales Representative	  	Section 1.01(ee)
	International Licensees	  	Section 2.03(e)
	International Region	  	Section 1.01(ff)
	IP Rights	  	Section 1.01(dd)
	IPCO	  	Preamble
	Judgment	  	Section 1.01(gg)
	Legal Order	  	Section 8.03
	Licensed IP Quality Standards	  	Section 1.01(hh)
	Licensed IP Rights	  	Section 1.01(ii)
	Licensee	  	Section 1.01(jj)
	Licensor	  	Section 1.01(kk)
	Liens	  	Section 1.01(ll)
	LLC Agreement	  	Section 1.01(mm)
	Losses	  	Section 1.01(nn)
	Minor Improvements	  	Section 4.04
	NA Licensed IP Rights	  	Section 1.01(ii)
	New International IP	  	Section 1.01(oo)
	New International Products	  	Section 1.01(qq)
	New North America IP	  	Section 1.01(pp)
	New North America Products	  	Section 1.01(rr)
	Non-Filing Party	  	Section 11.10(a)
	North America Business	  	Section 1.01(ss)
	North America Products	  	Section 1.01(tt)

			
	 Term
	  	 Section

	North America Region	  	Section 1.01(uu)
	Other IP Rights	  	Section 1.01(vv)
	Owned or Controlled	  	Section 1.01(ww)
	Parties	  	Preamble
	Party	  	Preamble
	Patents	  	Section 1.01(vv)(ii)
	Person	  	Section 1.01(xx)
	Personnel	  	Section 1.01(yy)
	Pipeline Product	  	Section 1.01(zz)
	Pre-Existing Licenses	  	Section 5.03
	Protected Entity	  	Section 1.01(aaa)
	Quality Compliance Conflict	  	Section 3.01(c)(i)
	Quality Objection Notice	  	Section 3.02(a)
	Quality Review Materials	  	Section 1.01(bbb)
	R&D License	  	Section 1.01(ccc)
	Receiving Party	  	Section 1.01(q)
	Recipients	  	Section 8.02
	Registered Existing North America IP	  	Section 1.01(ddd)
	Registered New International IP	  	Section 1.01(eee)
	Registered New North America IP	  	Section 1.01(fff)
	Request Date	  	Section 4.02(a)
	Restricted Business	  	Section 1.01(ggg)
	Restricted Persons	  	Section 1.01(hhh)
	Royalty Fee	  	Section 4.03(c)
	Royalty Paying Party	  	Section 4.03(c)
	Royalty Receiving Party	  	Section 4.03(c)
	Samples	  	Section 3.02(a)
	Separately Licensed IP	  	Section 1.01(iii)
	Separation and Investment Agreement	  	Recitals
	Specified Quality Brands	  	Section 1.01(jjj)
	Subcontractor	  	Section 1.01(kkk)
	Subsidiary	  	Section 1.01(lll)
	Term	  	Section 10.01
	Trade Secrets	  	Section 1.01(vv)(iv)
	Trademark Extensions	  	Section 1.01(nnn)
	Trademarks	  	Section 1.01(mmm)
	Transaction Documents	  	Section 1.01(ooo)
	Transferred Subsidiaries	  	Section 1.01(ppp)
	Transition Services Agreement	  	Section 1.01(qqq)
	Unused Technology	  	Section 2.07
	Unused Trademarks	  	Section 2.07

 INTELLECTUAL PROPERTY LICENSE AGREEMENT dated as of March 1, 2016 (the
“Effective Date”) among AVON PRODUCTS, INC., a New York corporation (“Avon Products”), AVON INTERNATIONAL OPERATIONS, INC., a Delaware corporation (“AIO”), AVON NA IP LLC, a Delaware limited
liability company (“IPCO”) and NEW AVON LLC (f/k/a C-A NA LLC), a Delaware limited liability company (“Avon NA”). Avon International and Avon NA are each hereinafter referred to as a “Party”, and,
collectively, as the “Parties”. 
 RECITALS 

WHEREAS, Avon Products and its Subsidiaries have been engaged in the North America Business (as defined below), and are the owners of certain
IP Rights (as defined below) related thereto; 
 WHEREAS, Avon Products, Avon NA and Cleveland NA Investor LLC (“Cleveland
NA”) have entered into a Separation and Investment Agreement dated as of December 17, 2015 (the “Separation and Investment Agreement”), pursuant to which Avon Products agreed to transfer its North America Business to
Avon NA and to sell to Cleveland NA a majority interest in Avon NA, in each case in accordance with the terms set forth therein; 
 WHEREAS,
Avon NA wishes to obtain from Avon International, and Avon International wishes to grant to Avon NA, a license to use certain IP Rights, effective as of the Effective Date, upon the terms set forth in this Agreement; and 

WHEREAS, Avon International and Avon NA further each wish to obtain from one another, and grant to one another, royalty-bearing licenses to
certain IP Rights developed by each of them after the Effective Date in the conduct of their respective businesses, upon the terms set forth in this Agreement; 

NOW, THEREFORE, in consideration of the representations, warranties, covenants and agreements contained in this Agreement set forth herein,
the Parties hereto, intending to be legally bound, hereby agree as follows: 
 ARTICLE I 

Definitions 
 SECTION
1.01. Definitions. For purposes of this Agreement, the following terms shall have the following meanings: 
 (a)
“Affiliate” of any Person means another Person that directly or indirectly, through one or more intermediaries, Controls, is Controlled by, or is under common Control with, such first Person; provided that, after the
Effective Date, none of Avon Products or its Subsidiaries shall be deemed to be Affiliates of Avon NA. 

 (b) “Agreement” means this Intellectual Property License Agreement, including
its recitals and schedules. 
 (c) “Applicable Law” means (i) with respect to Avon NA and its Subsidiaries, any
statute, law, ordinance, regulation, rule, code or other binding requirement of law of the applicable Governmental Entity in the North America Region, and (ii) with respect to Avon International and its Subsidiaries, any statute, law,
ordinance, regulation, rule, code or other binding requirement of law of the applicable Governmental Entity in the International Region. 

(d) “Avon Brand Logo” means the trademark described in the Licensed Trademark Use Guidelines as the new Avon Brand logo. 

(e) “Avon Canada” means Avon Canada Inc., and any other Subsidiary of Avon NA organized under the laws of Canada but excluding
any such Subsidiary upon written notice from Avon NA to Avon International that such entity is to be excluded. 
 (f) “Avon Corporate
Logo” means the trademark described in the Licensed Trademark Use Guidelines as the new Avon Corporate logo. 
 (g) “Avon
Domain” means the Internet domain name avon.com. 
 (h) “Avon International” means any of Avon Products, AIO and
IPCO or any combination thereof, as the intent of the Agreement or the context may require. 
 (i) “Avon International
Business” means the business of researching, developing, producing, manufacturing, packaging, labelling, sourcing, licensing, maintaining, marketing, promotion, advertisement, lease, sale, and other distribution of any products or services
solely to, directly or indirectly, consumers in the International Region conducted by Avon International and its Affiliates from or after the Effective Date (including the sale of New International Products). 

(j) “Avon International Covered Product” means a product based upon and using in a material respect any New North America IP.

 (k) “Avon NA Business” means the business of researching, developing, producing, manufacturing, packaging, labelling,
sourcing, licensing, maintaining, marketing, promotion, advertisement, lease, sale, and other distribution of any products or services solely to, directly or indirectly, consumers through any channel in the North America Region conducted by Avon NA
and its Affiliates from or after the Effective Date (including the North America Business and the sale of New North America Products). 
 (l)
“Avon NA Covered Product” means a product based upon and using in a material respect any New International IP. 

  
 2 

 (m) “Beauty Products” means skincare, personal care, fragrance, haircare and
color (cosmetics) products, in each case including all components, ingredients, related tools and implements thereof and tools and accessories for use in connection therewith. 

(n) “Business Day” means any weekday that is not a day on which banking institutions in New York, New York are authorized or
required by law, regulation or executive order to be closed. 
 (o) “Catalox Database” means a creative electronic catalogue
publishing system containing images related to brochures and branding for the North America Business. 
 (p) “Claims” means
any and all claims, counterclaims, allegations, and demands made in writing and any causes of action, suits, proceedings or investigations. 

(q) “Closing” means the closing of the subscription and sale of the Class A Units of Avon NA pursuant to the Separation
and Investment Agreement. 
 (r) “Confidential Information” means, subject to Article VIII, any and all confidential
information and material (including the terms of this Agreement) disclosed by a Party (“Disclosing Party”) to the other Party (“Receiving Party”), whether in writing, or in oral, graphic, electronic or any other
form, that is designated, marked or otherwise identified by the Disclosing Party in writing as confidential or proprietary. Confidential Information excludes any and all information material that (a) is at the Effective Date, or at any time
thereafter becomes, publicly known or known within the applicable industry other than by the Receiving Party’s or a Recipient’s breach of this Agreement or other wrongful act, (b) was already known to the Receiving Party without
restriction on use or disclosure prior to the receipt of such information directly or indirectly from or on behalf of the Disclosing Party, (c) was or is independently developed or acquired by the Receiving Party without reference to or use of
any Confidential Information except to the extent retained in the memory of an individual of the Receiving Party, (d) was received by the Receiving Party from a third Person who was not, at the time, under any obligation to the Disclosing Party
or any other Person to maintain the confidentiality of such information, or (e) constitutes Formulas and Formula-Related Information, the protection of confidentiality of which is the subject of Section 8.05 (for the avoidance of doubt,
Formulas and Formula-Related Information are of a highly confidential nature and no interpretation to the contrary is intended based on their exclusion from the definition of Confidential Information). 

(s) “Control”, when used with respect to any specified Person, means the power to direct the management and policies of such
Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise. The terms “Controlling” and “Controlled” have meanings correlative to the foregoing except that, for the
avoidance of doubt, the term “Controlled” as used as part of the term “Owned and Controlled” shall have a meaning correlative thereto as set forth in Section 1.01(ww). 

(t) “Corporate Identity” means, collectively, letterhead, business cards, corporate signs, stationery, packaging slips,
invoices, product datasheets, product labels, or any other materials that would normally identify a company or imply a corporate identity. 

  
 3 

 (u) “Domain Names” means Internet domain names. 

(v) “Envoy Database” means a creative electronic catalogue publishing system containing images related to global branding
(including branding for the International Business and for the Avon NA Business). 
 (w) “Excluded Costs” means the
following items to the extent permitted by generally accepted accounting principles: (i) value added or any other similar transaction taxes to be accrued on sales invoices, (ii) sales discounts and all kinds of rebates, (iii) any
orders or parts thereof which are subsequently returned to the obligated Party (or an Affiliate, agent or sublicensee thereof, as appropriate) and refunded to the customer or wholesaler, and (iv) charges for late payment collected from
customers, registration charges and other service charges. 
 (x) “Existing Non-North America IP” means all IP Rights Owned
or Controlled by Avon International or its Subsidiaries on or prior to the Effective Date, excluding Existing North America IP. 
 (y)
“Existing North America IP” means all IP Rights Owned or Controlled by Avon International or its Subsidiaries and used in the conduct of the North America Business on or prior to the Effective Date (including the Trademarks
identified on Schedule A, the Domain Names identified on Schedule B, the Patents identified on Schedule C and the Copyrights identified on Schedule D, and with respect to any Patents, including those identified on Schedule C, all reissues,
divisionals, terminal disclaimers, corrected patents, continuations, continuations-in-part, reexaminations, supplemental examinations, inter partes reviews, post-grant oppositions, and renewals, substitutions and extensions of such Patents and all
Patents claiming priority thereto or serving as a basis for priority thereof) but excluding (i) Separately Licensed IP and (ii) any IP Rights solely related to Pipeline Products. 

(z) “Existing North America Product” means any product or service sold by Avon International or its Subsidiaries in the North
America Business prior to the Effective Date. 
 (aa) “Fashion & Home Products” means fashion jewelry, watches,
apparel, footwear, accessories, gift and decorative products, housewares, entertainment and leisure products, children’s products and health, wellness and nutritional products, in each case including all components, ingredients, and implements
thereof. 
 (bb) “Governmental Entity” means any governmental or regulatory (including any stock exchange) authorities,
agencies, courts, instrumentalities, binding arbitration bodies, commissions or other entities, whether federal, state, local or foreign, or applicable self-regulatory organizations. 

(cc) “Have Made” means the right of a Party to subcontract the manufacture of products to a third party manufacturer for use
or resale by, or for the benefit of, the Party to a third party other than such third party manufacturer or any of its Affiliates. 
 (dd)
“IP Rights” means, collectively, Trademarks, Domain Names and Other IP Rights. 

  
 4 

 (ee) “Independent Sales Representative” means an independent contractor who
directly or indirectly purchases products or services from Avon International or Avon NA, or any of their respective Subsidiaries, at a discount from the retail price pursuant to the direct sales programs and policies thereof. 

(ff) “International Region” means all countries and other jurisdictions of the world other than the North America Region. For
the avoidance of doubt, the International Region shall not include Guam, Saipan, St. Thomas, St. Croix, St. Maarten, St. Lucia, St. Vincent, Tortola, Anguilla or Grenada. 

(gg) “Judgment” means any judgment, writ, stipulation, award, injunction, determination, order or decree of any Governmental
Entity. 
 (hh) “Licensed IP Quality Standards” means the quality standards: (i) that are existing as of the Effective
Date and that are disclosed on Schedule K or in substantially the same form, nature and length as those quality standards disclosed in Schedule K (including, for the avoidance of doubt, any amendments thereto as contemplated by Section 3.01(b)
and Section 3.01(c) of this Agreement); (ii) with respect to New International IP, established by Avon International and provided to Avon NA in writing in connection with any New International Products, and in any case, no less protective
than the standards used in the Avon NA Business for like products; and (iii) with respect to New North America IP, the standards used in the Avon International Business for like products, unless Avon NA establishes and provides to Avon
International quality standards for any particular New North America Product(s), in which case such Avon NA-provided quality standards shall be used for such New North America Product(s), provided that such quality standards shall, on a
product-by-product basis, be substantially similar in form, nature and length to the quality standards provided to Avon NA by Avon International prior to the Effective Date. 

(ii) “Licensed IP Rights” means (i) with respect to Avon NA and its Subsidiaries, any and all IP Rights licensed to Avon
NA and its Subsidiaries in Sections 2.01, 4.04 and 7.02 (the “NA Licensed IP Rights”), and (ii) with respect to Avon International and its Subsidiaries, any and all IP Rights licensed to Avon International and its Subsidiaries
in Sections 2.02, 4.04 and 7.02. 
 (jj) “Licensee” means (i) Avon NA and its Subsidiaries, with respect to the
licenses granted to Avon NA in Sections 2.01, 4.04 and 7.02, and (ii) Avon International and its Subsidiaries, with respect to the licenses granted to Avon International in Sections 2.02, 4.04 and 7.02. 

(kk) “Licensor” means (i) Avon International, with respect to the licenses granted to Avon NA Sections 2.01, 4.04 and
7.02, and (ii) Avon NA, with respect to the licenses granted to Avon International in Sections 2.02, 4.04 and 7.02. 
 (ll)
“Liens” means any pledge, lien, charge, mortgage, encumbrance or security interest of any kind or nature. 

  
 5 

 (mm) “LLC Agreement” means the amended and restated limited liability company
agreement of Avon NA dated as of December 17, 2015, as amended, supplemented or otherwise modified from time to time. 
 (nn)
“Losses” means any claim, loss, liability, tax, interest, charge, damage, cost or expense (including reasonable fees and expenses of counsel and other costs of defense, investigation and collection), diminution in value, settlement
payments, awards, judgments, fines, penalties, assessments, deficiencies, or obligations and any value added or similar tax in respect of any aforementioned fees. 

(oo) “New International IP” means all IP Rights Owned or Controlled by Avon International or its Subsidiaries in and to any
New International Products, other than any such IP Rights licensed to Avon NA under an R&D License and excluding Trademark Extensions. 

(pp) “New North America IP” means all IP Rights Owned or Controlled by Avon NA or its Subsidiaries in and to any New North
America Products. 
 (qq) “New International Products” means any products or services developed by or for Avon International
or its Subsidiaries for sale to consumers in the International Region on or after the Effective Date (for the avoidance of doubt, including all Pipeline Products, but excluding all Existing North America Products and New North America Products).

 (rr) “New North America Products” means any products or services developed by or for Avon NA or its Subsidiaries for sale
to consumers in the North America Region on or after the Effective Date (for the avoidance of doubt, excluding all Existing North America Products and New International Products). 

(ss) “North America Business” means the business conducted by Avon International and its Subsidiaries (including Avon NA and
the Transferred Subsidiaries) of the research, development, production, manufacture, packaging, labelling, sourcing, marketing, licensing, distribution, sale and maintenance of North America Products, whether through Avon International’s direct
selling model or through e-commerce platforms or decentralized branches, satellite stores and independent retail operations or any other channel, and any support activities relating thereto; provided, however, that the North America
Business (i) excludes any development, manufacturing, packaging and sale of Beauty Products and Fashion & Home Products exclusively targeted for distribution in any geographic region other than the North America Region, and any support
activities relating thereto, but (ii) includes any development, manufacturing, packaging, distribution or supply of North America Products outside of the North America Region for ultimate marketing and sale in the North America Region, and any
support activities relating thereto. 
 (tt) “North America Products” means any Beauty Products, Fashion & Home
Products, and other products and services (including all components, ingredients, and implements thereof) sold or intended for sale to consumers in the North America Region. 

  
 6 

 (uu) “North America Region” means the United States of America, Canada, the
Commonwealth of Puerto Rico, Guam, Saipan, St. Thomas, St. Croix, St. Maarten, St. Lucia, St. Vincent, Tortola, Anguilla and Grenada. 
 (vv)
“Other IP Rights” means all intellectual property and similar proprietary rights, other than Trademarks and Domain Names, in any and all countries, including the following: 

(i) copyrights, applications and registrations therefor and renewals, extensions, restorations and reversions thereof
(“Copyrights”); 
 (ii) patents (including all reissues, divisionals, terminal disclaimers, corrected
patents, continuations, continuations-in-part, reexaminations, supplemental examinations, inter partes reviews, post-grant oppositions, and renewals, substitutions and extensions thereof and all patents claiming priority thereto or serving as a
basis for priority thereof), utility models, industrial designs, and inventions, and all applications and registrations therefor and all inventions, invention disclosures, and discoveries described in any such applications and registrations
(“Patents”); 
 (iii) specifications, compositions and combinations of ingredients, methods of use,
processing requirements, and methods of manufacturing a product (“Formulas”); 
 (iv) trade secrets,
know-how and other proprietary or confidential information (including information relating to Formulas, technical data, software, processes, methods, ideas, discoveries, designs and improvements) (“Trade Secrets”); and 

(v) rights of publicity. 

(ww) “Owned or Controlled” means, with respect to a Party’s entitlement to license IP Rights hereunder, the possession by
that Party of rights sufficient to grant the specified rights in the IP Rights (without incurring liability to or a duty to provide consideration to any third Person). 

(xx) “Person” means any individual, corporation, partnership, limited liability company, joint venture, association,
joint-stock company, trust, unincorporated organization or Governmental Entity or other entity. 
 (yy) “Personnel” means,
as to any Person, its and its Affiliates’ officers, directors, employees, attorneys, accountants, advisors, agents and subcontractors. 

(zz) “Pipeline Product” means any product under development by Avon International or its Subsidiaries for which development
and commercialization efforts necessary to prepare such product for sale to consumers in the North America Region or International Region has not been completed as of the Effective Date. 

(aaa) “Protected Entity” means any distributor, reseller, Subcontractor or Independent Sales Representative of Avon NA or any
of its Subsidiaries solely with respect to such Person’s activities in connection with products or services incorporating any NA Licensed IP Rights under this Agreement. 

  
 7 

 (bbb) “Quality Review Materials” means, with respect to any product, package,
label, specification or commercial material containing any product claim, any and all (i) information and materials regarding the evaluation of such product, package, label, specification or material, including any reports, studies, analysis,
tests, comparisons, evaluations, and measurements, (ii) protocols, specifications, and methodologies used to perform any of the foregoing, (iii) results, observations and notes with respect to any of the foregoing, and (iv) drafts of
any of the foregoing. 
 (ccc) “R&D License” means any license of IP Rights granted by Avon International to Avon NA
pursuant to the Research and Development Agreement. 
 (ddd) “Registered Existing North America IP” means any registrations
or applications for registration of any Existing North America IP or Trademark Extension. 
 (eee) “Registered New International
IP” means any registrations and applications for registration of any New International IP related to a New International Product for which Avon NA’s license has become effective as provided in Section 4.02. 

(fff) “Registered New North America IP” means any registrations and applications for registration of any New North America IP
related to a New North America Product for which Avon International’s license has become effective as provided in Section 4.02. 

(ggg) “Restricted Business” means the categories set forth on Schedule E. 

(hhh) “Restricted Persons” means the Persons set forth on Schedule F, any of their respective Affiliates (except Licensee) or
any successor to any of the foregoing (except Licensee). 
 (iii) “Separately Licensed IP” means any and all IP Rights in
images contained in the Catalox Database and the Envoy Database, including any and all publicity rights related thereto. 
 (jjj)
“Specified Quality Brands” means the brands listed on Schedule J of this Agreement. 
 (kkk)
“Subcontractor” means an independent third party whom a Party contracts to perform, on behalf of such Party, one or more of the Party’s obligations or rights under this Agreement. 

(lll) “Subsidiary” means, with respect to any Person, any other Person Controlled by the first Person. For the avoidance of
doubt, from and after the Closing, (i) each of the Transferred Subsidiaries shall be deemed to be Subsidiaries of Avon NA and (ii) none of Avon NA or the Transferred Subsidiaries shall be deemed to be Subsidiaries of Avon International.

  
 8 

 (mmm)“Trademarks” means all trademarks, service marks, trade names, rights in
trade dress, corporate names, certification marks, collective marks, and other source identifiers or indicia of origin, and all applications, registrations and renewals therefor, together with the goodwill associated with any of the foregoing. 

(nnn) “Trademark Extensions” means any Trademark that is derived from or is confusingly similar to a Trademark included in the
Existing North America IP. 
 (ooo) “Transaction Documents” has the meaning set forth in the Separation and Investment
Agreement. 
 (ppp) “Transferred Subsidiaries” means, together, Avon Canada and CFC Blocker. 

(qqq) “Transition Services Agreement” has the meaning set forth in the Separation and Investment Agreement. 

ARTICLE II 
 License Grants;
Sublicensing; Non-Assertion; Ownership 
 SECTION 2.01. Licenses to Avon NA. 

(a) Trademarks. Avon International hereby grants on behalf of itself and its Subsidiaries to Avon NA and its Subsidiaries (except for
Avon Canada) the perpetual, irrevocable, transferable (subject to Section 11.09), sublicensable (subject to Section 2.03): 

(i) sole and exclusive (subject only to the rights expressly retained by Avon International under Section 5.01),
royalty-free, fully paid-up right and license under all Trademarks included in the Existing North America IP and under all Trademark Extensions to use, reproduce and display such Trademarks and Trademark Extensions solely in the North America Region
(except with respect to the rights granted to Avon NA under Section 2.01(a)(i)(b)) to conduct the Avon NA Business, including, for the avoidance of doubt, the right to: (a) incorporate such Trademarks and Trademark Extensions in the
business name and Corporate Identity of Avon NA and (b) use, reproduce and display any such Trademark or Trademark Extension in the International Region to conduct the Avon NA Business, solely to the extent such use in the International Region
is incidental to a use, or a natural extension thereof, that (X) is directed to the North America Region and is usual and customary in the conduct of the Avon NA Business and (Y) could not reasonably be prevented by Avon NA or any of its
Subsidiaries without severely limiting such use described in Section 2.01(a)(i)(b)(X); and 

  
 9 

 (ii) non-exclusive, royalty-bearing, right and license under any Trademarks
included in the New International IP, effective as of the applicable Request Date, to use, reproduce and display such Trademarks solely in the North America Region to conduct the Avon NA Business including, for the avoidance of doubt, the right to:
(a) incorporate such Trademarks and Trademark Extensions in the business name and Corporate Identity of Avon NA and (b) use, reproduce and display any such Trademark or Trademark Extension in the International Region to conduct the Avon NA
Business, solely to the extent such use in the International Region is incidental to a use, or a natural extension thereof, that (X) is directed to the North America Region and is usual and customary in the conduct of the Avon NA Business and
(Y) could not reasonably be prevented by Avon NA or any of its Subsidiaries without severely limiting such use described in Section 2.01(a)(i)(b)(X). 

(b) Domain Names. Avon International hereby grants on behalf of itself and its Subsidiaries to Avon NA and its Subsidiaries (except for
Avon Canada) a perpetual, irrevocable, exclusive (subject to the rights expressly retained by Avon International under Section 2.01(b)(ii) and Section 5.01), transferable (subject to Section 11.09), sublicensable (subject to
Section 2.03), royalty-free, fully paid-up license to use: 
 (i) the Domain Names included in the Existing North
America IP, other than the Avon Domain, solely in connection with the conduct of the Avon NA Business (including by hosting and operating servers or sites accessible under such Domain Names for such purposes), and solely with respect to websites
targeted to consumers in the North America Region and through which products are shipped only to consumers with a shipping address in the North America Region. For the avoidance of doubt, nothing set forth in this Agreement shall limit Avon
NA’s right to register or use any Domain Names, in connection with the Avon NA Business or otherwise, that do not incorporate and are not confusingly similar to Trademarks or Domain Names included in the Licensed IP Rights. Upon the reasonable
request of Avon NA, (A) to the extent that Avon NA identifies any Domain Name that incorporates or is confusingly similar to Trademarks or Domain Names included in the Licensed IP Rights that is available for registration, then Avon
International shall, at Avon NA’s sole expense, register such Domain Name, and the same shall be licensed to Avon NA on the terms set forth above, provided that registration of such Domain Name would not reasonably be expected to violate the IP
Rights of any third Person; and (B) to the extent any Domain Name is registered to Avon International and not used or planned to be used in the Avon International Business, and does not include any country-specific or product-specific
identifier only pertaining to the Avon International Business, such Domain Name shall be licensed on the terms set forth above. 

(ii) the Avon Domain solely in connection with the conduct of the Avon NA Business (including by hosting and operating servers
or sites accessible under the Avon Domain for such purposes), and solely with respect to websites targeted to consumers in the North America Region and through which products are shipped only to consumers with a shipping address in the North America
Region. The license granted to Avon NA pursuant to Section 1.02(b)(ii) shall be exclusive to Avon NA solely to the extent that the use of the Avon Domain is targeted only to consumers in the North America Region. Avon NA hereby agrees that it
will not use any country domain suffix or prefix in connection with the Avon Domain (e.g. “uk.avon.com” or “avon.com.uk”), except for 

  
 10 

 the country domain suffixes or prefixes corresponding to jurisdictions in the North America
Region. Avon International hereby agrees that it will not use any country domain suffix or prefix corresponding to jurisdictions in the North America Region in connection with the Avon Domain (e.g. “us.avon.com” or
“avon.com.us”). Notwithstanding anything to the contrary in this Agreement, Avon International shall retain all of its right, title and interest in and to the Avon Domain that is not expressly granted to Avon NA by this
Section 1.02(b)(ii). For the avoidance of doubt, but subject to the provision of email services using email addresses not ending in “avon.com” after the end of email services under the Transition Services Agreement, Avon International
will retain worldwide exclusive rights to use the Avon Domain in email addresses, including sole and exclusive ownership thereof and all rights therein related to the conduct of the International Business. 

(c) Other IP Rights. Avon International hereby grants on behalf of itself and its Subsidiaries to Avon NA and its Subsidiaries (except
for Avon Canada) the perpetual, irrevocable, transferable (subject to Section 11.09), sublicensable (subject to Section 2.03): 

(i) sole and exclusive (subject only to the rights expressly retained by Avon International under Section 5.01),
royalty-free, fully paid-up right and license under all Other IP Rights included in the Existing North America IP to conduct the Avon NA Business, including, for the avoidance of doubt, the rights: 

(a) to make, Have Made, use, import, offer for sale, lease, sell or otherwise exploit or transfer or dispose of any products or services solely
in the North America Region under any Patents or Trade Secrets included in the Existing North America IP, and to practice solely in the North America Region any method claimed in any such Patents in connection with the foregoing, 

(b) under any Patents or Trade Secrets included in the Existing North America IP, to make, Have Made, and import any products or services
outside the North America Region solely for sale to consumers in the North America Region, and to practice in the International Region any method claimed in any such Patents solely in connection with the foregoing, and 

(c) to use, distribute, reproduce, modify, display, perform, prepare derivative works based on, or otherwise exploit any Copyrights included in
the Existing North America IP solely in the North America Region to conduct the Avon NA Business; 
 (ii) non-exclusive,
royalty-bearing (as provided in Article IV) license under all Other IP Rights included in the New International IP, effective as of the applicable Request Date, to conduct the Avon NA Business, including, for the avoidance of doubt, the rights 

(a) to make, Have Made, use, import, offer for sale, lease, sell or otherwise transfer or dispose of any products solely in the North America
Region under any Patents or Trade Secrets included in the New International IP, and to practice solely in the North America Region any method claimed in any such Patents in connection with the foregoing, 

  
 11 

 (b) under any Patents or Trade Secrets included in the New International IP, to make and Have
Made any products outside the North America Region solely for sale to consumers in the North America Region, and to practice in the International Region any method claimed in any such Patents solely in connection with the foregoing, and 

(c) to use, reproduce, modify, display, perform, prepare derivative works based on or otherwise exploit any Copyrights included in the New
International IP solely in the North America Region to conduct the Avon NA Business. 
 (d) Exclusivity. The exclusive rights and
licenses identified in Section 2.01 (except for those granted in Section 2.01(b)) are exclusive to Avon NA and its Subsidiaries, including to the exclusion of Avon International and its Subsidiaries (subject only to the rights expressly
retained by Avon International under Section 5.01). 
 SECTION 2.02. Licenses to Avon International. 

(a) Trademarks. Avon NA hereby grants on behalf of itself and its Subsidiaries to Avon International and its Subsidiaries a perpetual,
irrevocable, non-exclusive, transferable (subject to Section 11.09), sublicensable (subject to Section 2.03), royalty-bearing (as provided in Article IV) license under all Trademarks included in the New North America IP, effective as of
the applicable Request Date, to use, reproduce and display such Trademarks solely in the International Region to conduct the Avon International Business. 

(b) Other IP Rights. Avon NA hereby grants on behalf of itself and its Subsidiaries to Avon International and its Subsidiaries a
perpetual, irrevocable, non-exclusive, transferable (subject to Section 11.09), sublicensable (subject to Section 2.03), royalty-bearing (as provided in Article IV) license under all Other IP Rights included in the New North America IP,
effective as of the applicable Request Date, to conduct the Avon International Business, including, for the avoidance of doubt, the rights (i) to make, Have Made, use, import, offer for sale, lease, sell or otherwise transfer or dispose of any
products and services solely in the International Region under any Patents or Trade Secrets included in the New North America IP, and to practice solely in the International Region any method claimed in any such Patents in connection with the
foregoing, (ii) under any Patents or Trade Secrets included in the New North America IP to make and Have Made any products in the North America Region solely for sale to consumers in the International Region, and to practice in the North
America Region any method claimed in any such Patents solely in connection with the foregoing, and (iii) to use, reproduce, modify, display, perform, prepare derivative works based on or otherwise exploit any Copyrights included in the New
North America IP solely in the International Region to conduct the Avon International Business. 

  
 12 

 SECTION 2.03. Sublicensing and Licensing. 

(a) Subject to this Section 2.03, each Licensee may grant sublicenses under the Licensed IP Rights to its Affiliates or to third parties;
provided that, prior to the Restricted List Lock-Up Expiration Date (as defined in the LLC Agreement), Licensee may not grant any such sublicense to any Restricted Person. Any sublicense to a Subsidiary shall automatically terminate if the
sublicensee ceases to be a Subsidiary of Licensee. 
 (b) Each Licensee’s right to grant sublicenses provided in Section 2.03(a)
with respect to Trademarks and Formulas shall require the following for sublicenses to all Persons, including Subsidiaries and Subcontractors to which Avon NA has granted an express sublicense of IP Rights: (i) Licensee shall provide on a
reasonable basis, no less frequently than once per semi-annual period, a summary report of the sublicensing activity that has become newly effective in the previous six (6) months (including, at minimum, the effective date and term of each
sublicense, the identity of all sublicensees thereto, and the Licensed IP subject thereof); (ii) Licensee shall be responsible for compliance by such sublicensee with the terms and conditions of this Agreement to the same extent as
Licensee’s own compliance; (iii) the sublicensee shall not be a Person that Licensee knows, or has reason to believe, intends to export, sell, offer for sale, lease or otherwise transfer or dispose of Licensee’s products
(incorporating Licensed IP Rights) outside the North America Region or International Region, as applicable; (iv) with respect to sublicenses granted by Avon NA, the sublicensee shall not be permitted to exercise any Licensed IP Rights in a
manner that would benefit a Restricted Person in a manner that would, if the same action were taken by Avon NA, constitute a breach of this Agreement; and (v) Licensee shall promptly notify Licensor of any material breach by the sublicensee of
the terms related to the Licensed IP Rights of its sublicense of which Licensee becomes aware, and Licensee and Licensor shall cooperate, at Licensee’s expense, in causing the sublicensee to remedy such material breach as appropriate. 

(c) Each Licensee’s right to grant sublicenses provided in Section 2.03(a) with respect to Trademarks and Formulas shall require, in
addition to the requirements described in Section 2.03(b), the following for sublicenses to Persons that are not Subsidiaries and are not solely Subcontractors: (i) Licensee shall provide advance written notice to Licensor of the identity
of the intended sublicensee; (ii) such sublicensee shall agree in writing that it is subject to the terms of this Agreement applicable to the rights sublicensed to such sublicensee; (iii) Licensee shall include a provision in any agreement
with any distributor, representative, or reseller expressly prohibiting such distributor, representative, or reseller from selling, offering for sale, leasing or otherwise transferring or disposing of any product of Licensee (incorporating Licensed
IP Rights) outside of the North America Region or International Region, as applicable; (iv) such sublicense shall be subordinate to the terms and conditions of this Agreement; and (v) such sublicense shall require sublicensee to keep
records and submit reports to Licensor of the same type and at the same time as required by Section 4.03, to the extent applicable. 

(d) Notwithstanding anything in this Agreement to the contrary, no action taken by Licensor against Licensee shall prejudice such
Licensor’s rights against any sublicensee. Notwithstanding any sublicense, each Licensee shall remain liable for the fulfillment of all obligations under this Agreement and for any acts and omissions of any sublicensee at any tier to the same
extent as it would in the absence of such sublicense. 

  
 13 

 (e) Avon International shall require the following for its future or renewing non-Subsidiary
licensees and their sublicensees of Trademarks included in the Existing Non-North America IP and Trademark Extensions (excluding Avon NA) throughout the world (“International Licensees”): (i) Avon International shall use good
faith efforts to provide advance written notice to Avon NA of the identity of each intended International Licensee; (ii) Avon International shall be responsible for compliance by such International Licensee with the provisions of
Section 3.01(a) to the same extent as Avon International’s own compliance therewith; (iii) Avon International shall expressly exclude from any license of Existing Non-North America IP to such International Licensee the use of Existing
Non-North America IP in products or services sold, offered for sale, leased or otherwise transferred or disposed of in the North America Region; and (iv) Avon International shall include a provision in any agreement with any distributor,
representative, or reseller expressly prohibiting such distributor, representative, or reseller from selling, offering for sale, leasing or otherwise transferring or disposing of any product or services in the North America Region. Notwithstanding
any license, Avon International shall remain liable for the fulfillment of all its obligations under this Agreement as it would in the absence of such license. 

SECTION 2.04. Sales Outside North America or International Region. 

(a) Avon NA shall use reasonable efforts to monitor, detect and prevent (i) any direct or indirect export, sale, offer for sale, lease or
other transfer or disposition of any product of Avon NA outside of the North America Region (including any substantial distribution of such products by any Independent Sales Representative of Avon NA to family members or other personal acquaintances
residing outside of the North America Region), and (ii) recruitment by any Independent Sales Representative of Avon NA of any Independent Sales Representative located outside of the North America Region. In the event Avon NA or any of its
permitted sublicensees discovers any actual or suspected occurrence of any of the activities described in clauses (i) and (ii) herein, Avon NA agrees to promptly notify Avon International in writing and cooperate with Avon International in
taking all reasonable measures necessary to prevent and address any such occurrence that has, or is suspected to have, taken place. 
 (b)
Upon request from Avon NA or upon Avon International discovering any actual or suspected occurrence of any of the activities listed in (i) or (ii) below, Avon International agrees to cooperate with Avon NA in taking all reasonable measures
necessary to prevent and address any of the following occurrences that have or are suspected to have taken place: (i) any direct or indirect export, sale, offer for sale, lease or other transfer or disposition of any product or service of Avon
International or International Licensees in the North America Region (including any substantial distribution of such products by any Independent Sales Representative of Avon International to family members or other personal acquaintances residing
outside of the International Region), and (ii) recruitment by any Independent Sales Representative of Avon International of any Independent Sales Representative located in the North America Region. 

(c) Notwithstanding anything to the contrary in this Agreement, on-selling by Independent Sales Representatives from the North America Region
to the International Region, or from the International Region to the North America Region, shall be considered unlicensed activity under this Agreement, to the extent such on-selling is not an accepted business practice 

  
 14 

 of Avon International as of the Closing or within the six-month period immediately prior to Closing. The Parties
hereby agree that the sole remedy available to a Party adversely affected by any occurrence of on-selling described in the immediately preceding sentence shall be a direct claim against the Independent Sales Representative. For the avoidance of
doubt, nothing in this Section 2.04(c) shall be interpreted to limit the scope of the each Party’s obligations under Section 2.04(a) and Section 2.04(b), as applicable. 

SECTION 2.05. Third-Party IP Rights. With respect to any IP Rights that would be included in the Licensed IP Rights licensed to either
Licensee under this Agreement but for the fact that Licensor cannot grant the requisite rights to Licensee thereunder without incurring liability to or a duty to provide consideration to a third Person: (i) a true and complete list of all such
material IP Rights included in the Existing North America IP (other than rights expressly retained by Avon International under Section 5.01) are disclosed in Schedule G to this Agreement, provided that, with respect to rights in software,
inclusion of such material rights in Schedule G is limited to Avon International’s knowledge thereof; and (ii) Licensor and Licensee shall cooperate with one another and use reasonable best efforts in attempting to obtain any consent or
approval required from such third Person for such IP Rights to be included in the Licensed IP Rights (which in the case of Licensor shall include the obligation to pay applicable third parties (at Licensor’s expense) any non-material amounts
that are reasonably necessary to be paid in order to obtain such consent); provided that Licensor receives the prior consent of Licensee (not to be unreasonably withheld, conditioned or delayed) prior to making any such payment),
provided further that granting a license to such IP Rights under the Transition Services Agreement shall satisfy the requirements of this Section 2.05(ii). If such third Person’s consent or approval is obtained, then the
subject IP Rights shall be deemed included in the Licensed IP Rights granted to Licensee under the relevant provisions of this Agreement or under the relevant provisions of the Transition Services Agreement, in each case, as applicable, from the
date of such consent or approval (subject to any terms and conditions applicable to such IP Rights under any agreements with such third Person disclosed to Licensee). 

SECTION 2.06. Ownership. As between the Parties, all right, title and interest in and to the Existing North America IP, Trademark
Extensions and New International IP are and shall remain the exclusive property of Avon International and its Subsidiaries, and all right, title and interest in and to the New North America IP are and shall remain the exclusive property of Avon NA
and its Subsidiaries, in each case subject only to the licenses expressly set forth in this Agreement. Except for the rights and licenses expressly set forth in this Agreement, this Agreement does not, by implication, estoppel or otherwise, grant
(i) to Avon NA or any other person any right, title or interest in or to any IP Rights of Avon International, or (ii) to Avon International or any other person any right, title or interest in or to any IP Rights of Avon NA. 

SECTION 2.07. Non-Assertion. Avon International and its Subsidiaries shall not assert against Avon NA or any of its Subsidiaries or any
Protected Entity any claims of infringement, misappropriation or dilution: (a) of any Trade Secrets, Formulas or Patents Owned or Controlled by Avon International or its Subsidiaries not used in the conduct of the North America Business on or
prior to the Effective Date (the “Unused Technology”) arising out of the use of Unused Technology by Avon NA, any of its Subsidiaries or any Protected Entity in the 

  
 15 

 North America Region, in connection with the conduct of the North America Business; or (b) Trademarks owned
by Avon International or its Subsidiaries not used in the conduct of the North America Business on or prior to the Effective Date (the “Unused Trademarks”); in the International Region solely to the extent required for
manufacturing, packaging, labeling or exporting to the North America Region products manufactured in the International Region, or Unused Technology in connection with the research, development, manufacture and export of North America Products for
ultimate marketing and sale in the North America Region. For the avoidance of doubt, the non-assertion described herein shall not apply with respect to the marketing, selling or other distribution to consumers of any product or service in the
International Region. The Parties acknowledge and agree that the covenant in this Section 2.07 made by Avon International and its Subsidiaries in this Agreement attaches in rem to, and runs with, the Unused Technology and Unused
Trademarks, and any subsequent purchaser of any of the Unused Technology or Unused Trademarks shall remain subject to such covenant. If Avon International or any of its Subsidiaries assigns, transfers, or conveys any of the Unused Technology or
Unused Trademarks to any Person after the Effective Date, Avon International or its applicable Subsidiary shall use good faith efforts to include a clause in the corresponding assignment agreement with such Person that such Person is acquiring the
applicable Unused Technology or Unused Trademarks subject to the covenant. 
 SECTION 2.08. Separately Licensed IP 

(a) Avon International hereby grants on behalf of itself and its Subsidiaries to Avon NA and its Subsidiaries the perpetual, irrevocable,
transferable, exclusive, sublicensable, (in each case subject to any restrictions in accordance with the terms of any existing agreements between or among Avon International or its Subsidiaries and any third Person), royalty-free, fully paid-up
license to use in the North America Region, solely for the conduct of the Avon NA Business, all of the IP Rights Owned or Controlled by Avon International or its Subsidiaries in or to any image stored in the Catalox Database, solely to the extent
Avon International or its applicable Subsidiary can license such Intellectual Property Rights to Avon NA without incurring liability to or a duty to provide consideration to any third Person (the “Catalox License”). Promptly upon
Closing, Avon International shall deliver to Avon NA a true and complete copy of the Catalox Database including all images stored in the Catalox Database. 

(b) Avon International hereby grants a perpetual, irrevocable, transferable, exclusive, sublicensable (in each case subject to any restrictions
in accordance with the terms of any existing agreements between or among Avon International or its Subsidiaries and any third Person), royalty-free, fully paid-up license to use in the North America Region, solely for the conduct of the Avon NA
Business, all of the IP Rights Owned or Controlled by Avon International or its Subsidiaries in each of the images stored in the Envoy Database as of the Effective Date (the “Existing Envoy Images”) and uploaded to the Envoy
Database by Avon International after the Effective Date and marked as available to Avon NA (the “Avon International New Envoy Images”), provided that Avon NA shall not use any of the Existing Envoy Images or Avon
International New Envoy Images in a manner inconsistent with the metadata in the Envoy Database for each such image (the “Envoy NA Image License”). 

  
 16 

 (c) Avon NA shall indemnify and hold harmless the Avon International Indemnified Parties (as
defined in Section 9.02), and defend such Avon International Indemnified Parties, from and against all Losses arising out of or resulting from any Claim by any third Person against such Avon International Indemnified Parties related to (i) Avon
NA’s use of any Existing Envoy Image or Avon International New Envoy Image, except where such Losses are the direct result of Avon International providing inaccurate Envoy Database metadata with respect to the usage rights to such
Existing Envoy Image or Avon International New Envoy Image, (ii) Avon International’s use of any image uploaded to the Envoy Database by Avon NA after the Effective Date and marked as available to Avon International (the “Avon NA
New Envoy Images”), solely to the extent such Losses are the direct result of Avon NA providing inaccurate Envoy Database metadata with respect to the usage rights to such Avon NA New Envoy Image, and (iii) Avon NA’s use of
software or other IP Rights (excluding IP Rights in Existing Envoy Images or Avon International New Envoy Images) in connection with the use of the Envoy Database. Notwithstanding anything to the contrary in clauses (i) or (ii) of this
Section 2.08(c), to the extent the inaccurate Envoy Database metadata referenced therein is apparent on its face to be so inaccurate as to provide reasonable notice to an observer of its inaccuracy, the existence of such metadata in the Envoy
Database shall expressly not be deemed as either Party “providing inaccurate Envoy Database metadata” solely as such phrase appears in clauses (i) or (ii) of this Section 2.08(c). 

(d) Avon International shall indemnify and hold harmless the Avon NA Indemnified Parties (as defined in Section 9.03), and defend such Avon NA
Indemnified Parties, from and against all Losses arising out of or resulting from any Claim by any third Person against such Avon NA Indemnified Parties related to (i) Avon International’s use of any Avon NA New Envoy Image, except
where such Losses are the direct result of Avon NA providing inaccurate Envoy Database metadata with respect to the usage rights to such Avon NA New Envoy Image, and (ii) Avon NA’s use of any Existing Envoy Image or Avon International New
Envoy Image, solely to the extent such Losses are the direct result of Avon International providing inaccurate Envoy Database metadata with respect to the usage rights to such Existing Envoy Image or Avon International New Envoy Image.
Notwithstanding anything to the contrary in clauses (i) or (ii) of this Section 2.08(d), to the extent the inaccurate Envoy Database metadata referenced therein is apparent on its face to be so inaccurate as to provide reasonable notice to
an observer of its inaccuracy, the existence of such metadata in the Envoy Database shall be expressly not be deemed as either Party “providing inaccurate Envoy Database metadata” solely as such phrase appears in clauses (i) or
(ii) of this Section 2.08(d). 
 (e) Notwithstanding anything to the contrary in this Agreement, Avon International and its Subsidiaries
(i) shall not be required by this Agreement to renew or secure any rights in the North America Region to any images stored in or uploaded to the Envoy Database, whether existing now or in the future, and (ii) hereby expressly disclaim any
representations or warranties as to Avon NA’s ability to exploit (including the rights to reproduce, distribute, modify, display, perform, license or otherwise use) any IP Right granted to Avon NA pursuant to the Catalox License or the Envoy NA
Image License or any other IP Right in any image stored in the Catalox Database or Envoy Database. 

  
 17 

 SECTION 2.09. Delivery. Avon International shall deliver to Avon NA, (a)(i) on the
Effective Date, to the extent not in the possession of Avon NA upon Closing and not accessible to and usable by Avon NA, in an electronic format reasonably acceptable to Avon NA, a copy of each Formula used by the North America Business at any point
from 2011 through the Effective Date, all Formula-Related Information reasonably associated with such Formulas, and all other regulatory, claims, and testing data reasonably related to such Formulas, (a)(ii) after the Effective Date, and to the
extent reasonably accessible to Avon International, upon reasonably timed requests of Avon NA, in an electronic format reasonably acceptable to Avon NA, a copy of each Formula used by the North America Business at any point from 2005 through 2010,
all Formula-Related Information reasonably associated with such Formulas, and all other regulatory, claims, and testing data reasonably related to such Formulas, and to the extent not reasonably accessible, to Avon International, Avon International
and Avon NA will use good faith efforts to achieve a work-around reasonably acceptable to both Parties, including by allowing Avon NA to insert personnel or a designee at Avon International to collect such information, and (a)(iii) after the
Effective Date, upon reasonably timed requests of Avon NA and to the extent within Avon International’s reasonable possession, custody or control, in a format reasonably acceptable to Avon NA or the closest available format in which Avon
International has stored such Formula-Related Information, a copy of each Formula used by the North America Business before 2005, all Formula-Related Information reasonably associated with such Formulas, and all other regulatory, claims, and testing
data reasonably related to such Formulas; and (b) on the Effective Date, a full copy of the source code, object code, and any associated documentation (including developer notes) of any software included in the Licensed IP Rights or otherwise
necessary to access or use the Formulas, in each case solely to the extent such source code, object code, or associated documentation (i) is necessary to access or use the Formulas and is available to Avon International (or would be available
to Avon International upon using commercially reasonable efforts to obtain it) or (ii) is available to Avon International and can be delivered to Avon NA without requiring Avon International to incur liability to or a duty to provide
consideration to any third Person. 
 ARTICLE III 

Trademark Use and Quality Standards 

SECTION 3.01. Quality Standards. 

(a) Each Licensee and all permitted sublicensees shall only use a Trademark (or a Trademark Extension derivative thereof or confusingly similar
thereto) included in the Licensed IP Rights in connection with products or services that (i) are developed, produced, manufactured, packaged, labeled, sourced, marketed, licensed, distributed, sold and maintained in material compliance with
established Applicable Law, (ii) if marketed under any of the Specified Quality Brands, meet or exceed the Licensed IP Quality Standards for the product(s) or service(s) associated with such Trademark and (iii) if marketed under any other
Trademark included in the Licensed IP, are materially consistent with the active ingredients and chemical composition identified in the Licensed IP Quality Standards for the product(s) or service(s) associated with such Trademark but not with regard
to color or fragrance except where a change in color or fragrance would have a significant and adverse effect on the product’s marketability or on such Trademark. 

  
 18 

 (b) Licensor may amend the Licensed IP Quality Standards from time to time in its reasonable
discretion based solely on: (i) the need to comply with Applicable Law, (ii) a good faith concern about an environmental, health or safety risk, or (iii) good faith determination that amended standards will significantly improve the
competitiveness of the applicable products or services, by providing reasonable advance written notice to Licensee; provided that (x) such Licensed IP Quality Standards and any amendments thereto shall be consistent with and no more onerous
than the quality standards applicable to Licensor or any of its Affiliates with respect to its and their own use of the corresponding Trademarks in the North America Region or International Region, as applicable, (y) Licensor provides to
Licensee reasonable assistance and reasonably detailed information as required to effect a reformulation of the applicable product to which the amended Licensed IP Quality Standards relate, and (z) solely if Licensor amends the Licensed IP
Quality Standards as permitted under 3.01(b)(iii), Licensee may, at its sole option, comply with the Licensed IP Quality Standards as amended or with the Licensed IP Quality Standards without such amendments. 

(c) Licensee may amend the Licensed IP Quality Standards: 

(i) in the event that Licensee’s compliance with Section 3.01(a)(i) or Licensee’s reasonable need to address
concerns relating to an environmental, health or safety risk (irrespective of whether an enacted or pending Applicable Law addresses such risk) would necessarily result in non-compliance with the Licensed IP Quality Standards described in
Section 3.01(a)(ii) or Section 3.01(a)(iii) (such event, a “Quality Compliance Conflict”), solely to the extent necessary to resolve the Quality Compliance Conflict, provided that Licensee shall promptly provide
written notice of such amendment to Licensor; 
 (ii) in the event that, with respect to a given product sold under any of
the Specified Quality Brands, Licensee reasonably demonstrates to Licensor Licensee’s ability to manufacture or have manufactured a product that is substantially equivalent in visual appearance, texture and fragrance to the product sold under
such Trademark and is in material compliance with established Applicable Law, provided that Licensee provides advance written notice of such change to Licensor. 

(d) Without limiting any obligation under the R&D License, (i) each Party shall promptly notify the other Party of any actual, pending
or reasonably foreseeable changes in Applicable Law in the North America Region, or potential environmental, health or safety risks, of which it becomes aware that relate to the production, manufacture, packaging, labelling, sourcing, marketing,
licensing, distribution, sale or maintenance of products or services using any of the Formulas included in the Licensed IP Rights; and (ii) the Parties shall reasonably cooperate and coordinate with respect to identifying and mitigating any
legal exposure or potential business interruption relating to such changes or such risks. 

  
 19 

 SECTION 3.02. Samples. 

(a) Upon Licensor’s reasonable request, Licensee shall submit to Licensor, at no cost or expense to Licensor, samples of any products,
packages, labels, specifications or commercial materials containing any product claim used by Licensee or its permitted sublicensees, that (i) use, reproduce or display the Trademarks or Trademark Extensions included in the Licensed IP Rights and
(ii) have not been manufactured by or for Licensor or its Affiliates (including Avon Products or its Subsidiaries prior to the Effective Date) or previously provided in substantially identical form or design (“Samples”). If Licensor
reasonably determines that any Sample (A) does not materially comply with established Applicable Law, (B) does not, to the extent corresponding to a product or service marketed under a Specified Quality Brand, comply with the Licensed IP Quality
Standards applicable to such Sample or (C) is not, if marketed under any other Trademark included in the Existing North America IP, generally consistent with the active ingredients, chemical compositions and, solely where a change in color and
fragrance would have a significant and adverse effect on the products marketability, color and fragrance identified in the Licensed IP Quality Standards for the product(s) or service(s) associated with such Trademark, Licensor shall promptly provide
written notice of such non-compliance to Licensee, including a reasonably detailed explanation of Licensor’s objections with respect to the relevant Sample, all Quality Review Materials regarding the Sample used to determine non-compliance with
the Licensed IP Quality Standards or Applicable Law and any proposed changes or modifications that Licensor would suggest be made for Licensee or its designee to achieve compliance or material compliance, as applicable, with the Licensed IP Quality
Standards or Applicable Law (such notice and related information, a “Quality Objection Notice”). Any such Quality Objection Notice shall be delivered to Licensee no later than ten (10) Business Days from Licensor’s receipt of
the Samples, provided that if Licensor becomes aware that it will require additional time to complete such evaluation, Licensor may request (no later than five (5) Business Days subsequent to receipt of such Samples) a reasonable extension of time
to complete such evaluation, which, solely to the extent Licensor has taken all commercially reasonable measures toward completing its evaluation of the Samples, Licensee shall not unreasonably deny. If Licensor fails to provide a Quality Objection
Notice within ten (10) Business Days from Licensor’s receipt of the Samples (or such later time as approved by Licensee), Licensee shall be deemed to have complied with the applicable Licensed IP Quality Standards or Applicable Law with respect
to such Samples, subject to any determination of non-compliance by a Governmental Entity of competent jurisdiction or a change to Applicable Law that reasonably would result in such Sample not being in compliance therewith. Upon receipt of a Quality
Objection Notice, Licensee shall use reasonable efforts to implement corrective measures to cure the material non-compliance therein and Licensee may at its election resubmit such corrected Sample, except as otherwise agreed by the Parties in
accordance with Section 3.02(c). Notwithstanding anything to the contrary in this Article III, in the event Licensee is not in compliance with any Licensed IP Quality Standards applicable to a product or service, and Licensee ceases to use,
reproduce or display a Trademark or Trademark Extension included in the Licensed IP Rights in connection with the products, packages, labels, specifications and commercial materials containing any product claim corresponding to such product, then
Licensee shall not be deemed in breach of any provision herein directly related to non-compliance with Licensed IP Quality Standards. 

  
 20 

 (b) Upon determination by a Governmental Entity of competent jurisdiction that, with regard to
the development, production, manufacture, packaging, labeling, sourcing, marketing, licensing, distribution, sale and maintenance of a product or service in connection with a Trademark or Trademark Extension included in the Licensed IP Rights,
(i) Licensee is not in material compliance with established Applicable Law or (ii) in the event such Trademark directly corresponds to a Specified Quality Brand, Licensee is not in compliance with the Licensed IP Quality Standards
applicable to such product or service (except to the extent such non-compliance is caused by Avon International or its Subsidiaries), then in each case Licensee agrees to, and agrees to cause its permitted sublicensees to, promptly cease using,
reproducing and displaying the applicable Trademarks or Trademark Extensions in connection with the products, packages, labels, specifications and commercial materials containing any product claim corresponding to the applicable noncompliant Sample,
until such time as a revised Sample thereof has been reasonably approved by Licensor as compliant with the Licensed IP Quality Standards or Applicable Law (or determined by a Governmental Entity of competent jurisdiction to be in compliance with
Applicable Law, if earlier). For the purposes of this Section 3.02(b), the Parties recognize and hereby agree that any non-compliance by Licensee as described in clauses (i) or (ii) herein shall be deemed to give rise to a presumption
of irreparable harm to Licensor. 
 (c) If Licensee reasonably does not agree that any Sample does not comply with the Licensed IP Quality
Standards applicable to such Sample or with Applicable Law, or Licensor reasonably does not agree that, within ten (10) Business Days after Licensor’s receipt of the corrected Sample from Licensee, Licensee’s corrective measures have
cured any such non-compliance, Licensee or Licensor, as applicable, may escalate the issue to be resolved between executives of Licensor and Licensee of suitable authority. If the executives of Licensee and Licensor do not resolve the issue within
twenty (20) Business Days after such escalation, each Party retains all other rights and remedies available to it under this Agreement. 

SECTION 3.03. Trademark Use Guidelines. 

(a) Each of Avon International and Avon NA shall (and each shall ensure that its permitted sublicensees shall) use, reproduce and display the
Avon Corporate Logo and the Avon Brand Logo in material compliance with the Licensed Trademark Use Guidelines set forth on Schedule I. Upon receiving written notice from Licensor that any use by Licensee (or its permitted sublicensee) of a Trademark
included in the Licensed IP Rights is not in material compliance with the Trademark Use Guidelines and a reasonably detailed explanation of the material non-compliance, Licensee shall use reasonable efforts to promptly implement corrective measures
to cure the material non-compliance identified therein. 
 (b) In the event Licensor amends the Licensed Trademark Use Guidelines, Avon NA
shall (and shall ensure that its permitted sublicensees shall) either use, reproduce and display the Avon Corporate Logo and the Avon Brand Logo in material compliance (i) solely with the amended Licensed Trademark Use Guidelines or
(ii) solely with Licensed Trademark Use Guidelines set forth on Schedule I. 
 (c) Avon International agrees to consider in good faith
requests by Avon NA to modify or replace the Avon Corporate Logo or the Avon Brand Logo, provided that Avon International shall not be required to consider more than one proposal in any six (6) month period, and provided further
that any such request can be approved or denied by Avon International in its sole discretion. 

  
 21 

 SECTION 3.04. Non-Degradation. 

(a) Each Licensee agrees that in connection with all uses by Licensee or permitted sublicensees of the Trademarks or Trademark Extensions
included in the Licensed IP Rights, and all products and services offered in connection therewith, Licensee and any permitted sublicensee: (i) shall not make any statements that are misleading as to the quality of the products or services, or
that cause confusion with the business or identity of a Person (provided that the use by Licensee and its permitted sublicensees of the Trademarks or Trademark Extensions included in the Licensed IP Rights within the scope of the licenses granted
pursuant to this Agreement shall not be deemed to cause confusion as to the business or identity of any Person), (ii) shall be in compliance with all Judgments, (iii) shall not enter into any agreement that conflicts with, results in any
breach of, or constitutes a default under, the terms and conditions of this Agreement, (iv) shall not do, omit to do, or permit to be done, any act that will invalidate any registration of any Trademark, Trademark Extension or other associated
IP Rights included in the Licensed IP Rights, (v) shall not do any act that will cause substantial damage to a Specified Quality Brand, provided (A) any Licensee or sublicensee shall not be deemed to have caused substantial damage
to a Specified Quality Brand by exercising its rights under this Agreement, (B) the occurrence of an ordinary adverse event in the conduct of the Licensee’s or sublicensee’s business or an act outside the reasonable control of
Licensee or sublicensee cannot be the basis for an allegation of substantial damage under this Section 3.04, (C) upon learning of any act that will cause substantial damage to a Specified Quality Brand, Licensor shall promptly give notice
to the Licensee or sublicensee, (D) such Licensee or sublicensee shall have a reasonable period of time to remedy such act before Licensor seeks to enforce any rights under this Agreement in connection with the act that violates
Section 3.04 but without limiting Licensor’s rights to enforce under this Agreement should that same violate another section of this Agreement, and (E) the burden to prove substantial damage to a Specified Quality Brand under this
Section 3.04 is on the Licensor and must be met by clear and convincing evidence, (vi) shall not file applications to register any Trademarks or design patent registrations that consist in whole or in part of, or are confusingly similar
to, the Trademarks or Trademark Extensions included in the Licensed IP Rights, or assist any Person in doing the same, and (vii) shall not contest, challenge, or otherwise take any action adverse to Licensor’s ownership of or rights in and
to the Trademarks or Trademark Extensions included in the Licensed IP Rights, or assist any Person in doing the same. 
 (b) In the event
that Avon NA notifies Avon International that an International Licensee, with respect to any Trademark included in the Existing Non-North America IP, has engaged in conduct that would result in a breach of Section 3.04(a) were such conduct engaged
in by Avon International with respect to any Trademark included in the International IP Rights, Avon International agrees to cooperate with Avon NA in taking commercially reasonable measures necessary to prevent and address such conduct. 

  
 22 

 (c) Each Licensee shall perform periodic inspections, at reasonable intervals, for products and
services offered and/or performed by any permitted sublicensee licensed under any Trademarks or Other IP Rights included in the Licensed IP Rights to ensure compliance with this Article III, provided, however, that such periodic inspections
will not be required for (i) any product that has been manufactured at its present manufacturing facility or (ii) any service that has been made commercially available, in each case of (i) and (ii) for at least three
(3) consecutive months. 
 (d) Each Licensee agrees that any and all goodwill that accrues based on any and all uses of Trademarks or
Trademark Extensions included in the Licensed IP Rights, or by operation of law or otherwise, shall accrue solely for the benefit of Licensor, and Licensee shall be deemed and hereby irrevocably assigns such goodwill to Licensor without any further
action by either Party. For the avoidance of doubt, “goodwill” as used in this Section 3.04(d) does not include lists of customers or Independent Sales Representatives or related data. 

(e) Conduct of the Business. Notwithstanding anything to the contrary in this Agreement, and except to the extent prohibited by
Applicable Law, Avon NA may continue any past business practice of the North America Business without liability or recourse under this Agreement. 

ARTICLE IV 
 Royalties; Minor
Improvements; Audit Rights 
 SECTION 4.01. Information on New Products. After the Effective Date, to the extent either Party is
interested in obtaining a license to a commercially available New International Product or New North America Product, as applicable, the other Party shall use commercially reasonable efforts to provide (subject the confidentiality obligations set
forth in Article VIII) any information reasonably requested by the requesting Party in respect thereof to enable the requesting Party to evaluate whether to request a license under Section 4.02 (to the extent such information is in the
providing Party’s possession and can be disclosed without incurring liability to any third Person or violating any Applicable Law or Judgment). 

SECTION 4.02. Request to Make New License Rights Effective. 

(a) If either Party, after obtaining information regarding any New International Product or New North America Product pursuant to
Section 4.01, wishes to make effective its rights in respect thereof under the licenses granted in Sections 2.01 or 2.02, as applicable, it shall make such request in writing to the other Party, and such licenses shall be effective upon the
date the other Party receives such request. From the date such request is received by the Licensor as to a particular New International Product or New North America Product (a “Request Date”), the notifying Party shall be entitled
to exercise its rights under Section 2.01 or 2.02 with respect to the New International IP or New North America IP related to such product, as applicable, and shall be obligated to pay royalties for use of the same as provided in
Section 4.03; provided, however, that all rights, entitlements and obligations of the Parties, solely to the extent related to the making of or compliance with any request pursuant to Section 4.01, Section 4.02(a),
Section 4.02(b) or Section 4.04 shall immediately terminate upon a change of control of either Party. 

  
 23 

 (b) Within a commercially reasonable time following the Request Date, the other Party shall
provide to the notifying Party the material information in its possession (to the extent such information can be disclosed without incurring liability to any third Person or violating any Applicable Law or Judgment) reasonably pertaining to the New
International Product or New North America Product as applicable, including formulation, branding and packaging information. 
 (c) Without
limiting Section 3.01(d), the other Party will have no obligation to undertake any research, development or any other effort in support of the notifying Party to commercialize, reformulate or otherwise use the New International or New North
America IP licensed pursuant to this Section 4.02. 
 SECTION 4.03. Royalties. 

(a) In consideration of the rights and licenses granted by Avon International to Avon NA under Sections 2.01(a)(ii) and 2.01(c)(ii), Avon NA
shall pay to Avon Products, a royalty of four per cent (4%) of the invoiced price of the total sales realized by Avon NA (or an Affiliate, agent or sublicensee thereof, as appropriate) of each Avon NA Covered Product sold on or after the
associated Request Date, less Excluded Costs. 
 (b) In consideration of the rights and licenses granted by Avon NA to Avon International
under Section 2.02, Avon International shall pay to Avon NA a royalty of four per cent (4%) of the invoiced price of the total sales realized by Avon International (or an Affiliate, agent or sublicensee thereof, as appropriate) of each
Avon International Covered Product sold on or after the associated Request Date, less Excluded Costs. 
 (c) The royalties owed under
Section 4.03(a) and 4.03(b) (each a “Royalty Fee”) shall be paid within sixty (60) days after the end of each quarter of the calendar year, and each Party shall submit a royalty report to the other Party which sets forth
the details of the calculation of the Royalty Fee owed by such Party (the “Royalty Paying Party”) for such quarter, together with a payment to the other Party (the “Royalty Receiving Party”) for the Royalty Fee due
with respect to such quarter, to be paid in U.S. dollars (or, if necessitated by legal or tax concerns, other reasonable currency) in immediately available funds to the bank account of the Royalty Receiving Party designated by the Royalty Receiving
Party in writing. For purposes of determining the Royalty Fee due and payable in U.S. dollars (or other reasonable currency), the exchange rate shall be determined at the date on which the Royalty Fee is remitted by the Royalty Paying Party. 

(d) If any products on which royalties are due under this Section 4.03 are subsequently returned to a Royalty Paying Party (or an
Affiliate, agent or sublicensee thereof, as appropriate) and refunded after the Royalty Fee payment in respect of such sales has been made to the Royalty Receiving Party, the relevant proportion of the Royalty Fee will be deducted from the next
Royalty Fee due to the Royalty Receiving Party, and the details of the same will be provided by the Royalty Paying Party in its next royalty report. 

  
 24 

 SECTION 4.04. Minor Improvements. For the avoidance of doubt, notwithstanding anything in
this Agreement to the contrary, neither Avon NA nor Avon International shall be obligated to pay a royalty with respect to any modifications or improvements based on, using or derived from any Other IP Rights included in the Existing North America
IP, except for such modifications or improvements that result in a material alteration of an Existing North America Product or a Formula associated therewith (such as the replacement of the principal active ingredient(s) that are material for
product functionality and marketing claims, or a noticeable alteration of product appearance and fragrance) (such modifications and improvements on which no royalties are owed, “Minor Improvements”). Avon NA hereby grants on behalf
of itself and its Subsidiaries to Avon International a license to all such Minor Improvements of Avon NA and its Subsidiaries on the same terms and conditions applicable to the license grant to Avon International in Section 2.02 (other than the
obligation to pay royalties), and Avon International hereby grants on behalf of itself and its Subsidiaries to Avon NA a license to all such Minor Improvements of Avon International and its Subsidiaries on the same terms and conditions applicable to
the license grants to Avon NA in Sections 2.01(a)(ii) and 2.01(c)(ii) (other than the obligation to pay royalties). 
 SECTION 4.05.
Taxes. The consideration and payment set forth in Section 4.03 shall be paid without deduction of any taxes levied against such consideration and payment imposed by any applicable tax authority; provided, however, that each
Party is responsible for its own income taxes, corporate taxes and applicable franchise taxes. The Parties further acknowledge and agree that no withholding tax obligation should apply with respect to the payments to be made to either Party
hereunder, provided that each Party cooperates with the other Party in providing and completing in a timely manner, in a form acceptable to the applicable tax authorities, all forms that must be filed with such tax authorities in order to avoid
withholding obligations. 
 SECTION 4.06. Late Payments. In the event payments due under this Agreement are not received by a Royalty
Receiving Party by the due date, the Royalty Paying Party shall pay to Royalty Receiving Party interest on the overdue payment from the date such payment was due to the date of actual payment at a rate of 1.5% per month, or if lower, the
maximum amount permitted under Applicable Law. 
 SECTION 4.07. Non-Payment. If a Royalty Paying Party commits any breach or default
with respect to its royalty obligations under Section 4.03 and fails to remedy such breach or default (including payment of all accrued interest on late payments) within six (6) months after written notice thereof by the Royalty Receiving
Party, the royalty rate and late payment interest rate applicable to the Royalty Paying Party under this Article IV shall immediately increase to eight per cent (8%) and three per cent (3%) respectively, for the duration of the period
until the Royalty Paying Party fully remedies its breach or default. If the Royalty Paying Party does not remedy such breach or default within one (1) year after written notice thereof by the Royalty Receiving Party, the Royalty Paying Party
and its permitted sublicensees shall be prohibited from using, reproducing, and displaying the applicable Trademarks or any associated Other IP Rights licensed to the Royalty Paying Party under the New International IP or New North America IP, as
appropriate, and such licenses granted hereunder to the Royalty Paying Party to use, reproduce or display such Trademarks or associated Other IP Rights shall be suspended until the Royalty Paying Party fully remedies its breach or default. 

  
 25 

 SECTION 4.08. Audit Rights. 

(a) Each Party shall, during the Term and for so long thereafter as any royalties under this Agreement have been incurred but are unpaid, keep
and maintain books and records in accordance with its standard accounting procedures to verify the applicable Royalty Fees owed during the Term as may be reasonably required to confirm the royalties payable under this Agreement. 

(b) Each Party shall have the right during such period, on ten (10) Business Days advance written notice and not more than once in any
twelve (12) month period, to have an independent accounting firm that is mutually selected by both Parties (the “Auditor”) examine such books and records of the Royalty Paying Party during such Party’s normal business
hours solely to verify the accuracy of the royalty reports and the amount of royalties made by the Royalty Paying Party hereunder after any period covered by the previous audit. The Auditor may not be paid on a contingency or other basis related to
the outcome of the audit, and shall execute a confidentiality agreement with the Royalty Paying Party in a form reasonably acceptable to the Royalty Paying Party that prohibits the Auditor from disclosing or using information obtained in connection
with the audit (other than the disclosure to the Royalty Receiving Party of the amount of any underpayment or overpayment). Any such audit shall be conducted during the normal business hours of the Royalty Paying Party, in such a manner as not to
interfere with the normal business activities of the Royalty Paying Party, and shall be at the Royalty Receiving Party’s expense; provided, however, if such audit reveals an underpayment of more than ten percent (10%) during the audited
period, the Royalty Paying Party shall pay all reasonable costs of the audit. Prompt adjustment shall be made to correct for any underpayment, or overpayment revealed by any such audit. 

(c) Upon reasonable belief that the other Party has breached any term or condition of this Agreement, each Party shall further have the right
to audit the other Party’s implementation and use of the IP Rights licensed to such other Party under this Agreement to ensure the audited Party’s compliance with the terms and conditions of this Agreement (except for compliance with
royalty payment obligations, audit rights with respect to which are set forth in 4.08(a)-(b)). Such audits shall be scheduled at the request of the auditing Party in consultation with the audited Party (but no more than once per year by each Party).
Any such audit shall be conducted during the normal business hours of audited Party, in such a manner as not to interfere with the normal business activities of audited Party, and shall be at the auditing Party’s expense. Upon the auditing
Party’s reasonable request, the audited Party shall cooperate with the auditing Party to perform such audits of the audited Party or its permitted sublicensees, and enforce the auditing Party’s and any permitted sublicensees’
obligations under this Agreement and any sublicenses granted hereunder. In the event that, upon completion of any audit pursuant to this Section 4.08(c), the audited Party is found not to have breached any term or condition of this Agreement,
the auditing Party shall not be permitted to exercise the audit rights provided in this Section 4.08(c) for a period of two (2) years following completion of such audit. 

  
 26 

 ARTICLE V 

Reserved Rights 
 SECTION
5.01. Avon International Retained Rights. With respect to the licenses granted in Section 2.01, Avon NA acknowledges that Avon International and its Subsidiaries retain a non-exclusive, perpetual, fully paid-up, royalty-free,
sublicensable right to use any Existing North America IP, any Trademark Extensions and New International IP in the North America Region: (a) in connection with the business name and Corporate Identity of Avon International and its Subsidiaries,
(b) in connection with the development and manufacturing of products solely for sale to consumers in the International Region, (c) through written license agreements subject to Avon NA’s prior written consent, which shall not be
unreasonably withheld, to enable and support the activities of the Avon Products Foundation, Inc. (including pursuant to the Sponsorship Agreement between Avon International and Avon Breast Cancer Crusade, dated September 11, 2015), including
“Avon 39” Walk and the manufacturing and sale of “Avon 39” Walk-associated non-beauty “cause” merchandise, sublicenses in connection with corporate sponsorships and partnerships (including co-venture arrangements) and
charitable partnerships (including with educational and health organizations), in each case under clause (c), consistent with the Avon Products Foundation, Inc.’s stated charitable purpose as in effect at the Closing, solely to the extent all
such activities are conducted exclusively on a non-profit basis for the exclusive benefit of the Avon Products Foundation, Inc., solely consistent with past practice prior to Closing and upon Avon NA’s prior written consent to any use of a
materially different nature from any use in the three (3) year period prior to the Effective Date, which consent shall not be unreasonably withheld, provided that Avon NA shall not be obligated to take or permit any action that would
substantially expand the scope of the retained right described in Section 5.01(c) or extend such rights to third Persons that, in Avon NA’s reasonable judgment, would adversely affect the Avon NA Business. 

SECTION 5.02. Avon NA Retained Rights. With respect to the licenses granted in Section 2.02, Avon International acknowledges that
Avon NA and its Subsidiaries retain a non-exclusive, perpetual, fully paid-up, royalty-free, sublicensable right to use any New North America IP in the International Region in connection with the business name and Corporate Identity of Avon NA and
its Subsidiaries and the development and manufacturing of products solely for sale to consumers in the North America Region. 
 SECTION
5.03. Pre-Existing Licenses. The licenses granted by Avon International and Avon NA in Sections 2.01 and 2.02, respectively, are subject to any pre-existing licenses, settlement agreements, coexistence agreements, covenants not to sue and
arrangements having a substantially similar effect to a coexistence agreement or covenant not to sue granted to third parties under such IP Rights prior to the Effective Date or Request Date, as applicable (the “Pre-Existing
Licenses”). A true and complete list of each of the material Pre-Existing Licenses is listed on Schedule H. Without the prior written consent of Avon NA, Avon International shall not amend or renew any agreement relating to any such
pre-existing rights and licenses in the North America Region in a fashion that would materially impair Avon NA’s rights under the licenses granted to Avon NA pursuant to Section 2.01. 

  
 27 

 SECTION 5.04. Rights Reserved. Except for the rights and licenses explicitly granted by
each Licensor under this Agreement, this Agreement does not grant to Licensee or any other Person any right, title or interest in or to any IP Rights of Licensor, by implication, estoppel or otherwise. All rights, titles and interests not
specifically and expressly granted by each Licensor hereunder are hereby reserved. 
 ARTICLE VI 

Additional Covenants 

SECTION 6.01. Restricted Business. Notwithstanding anything in this Agreement to the contrary, while this Agreement remains in effect,
neither Avon NA, Avon International, nor their respective Subsidiaries shall conduct or operate any Restricted Business without the other Party’s prior written consent. 

ARTICLE VII 
 Prosecution,
Maintenance and Enforcement 
 SECTION 7.01. Cooperation. Licensee agrees to reasonably cooperate with Licensor’s
preparation and filing of any applications, renewals or other documentation necessary or useful to protect Licensor’s ownership of the Licensed IP Rights (at Licensor’s expense, unless expressly provided otherwise in this Article VII).
Each Party agrees to promptly notify in writing the other Party (including the relevant details known to the notifying Party) of any (i) discovered or suspected infringement or misappropriation by any Person of any of the IP Rights licensed
under this Agreement in the North America Region (or, solely with respect to Avon NA, such infringement or misappropriation in the International Region of which Avon NA becomes aware) or (ii) actual or threatened challenge by any Person
concerning the validity, registration or ownership any of the Licensed IP Rights. 
 SECTION 7.02. Filing and Maintenance of Registered
IP Rights. 
 (a) Existing North America IP. 

(i) Except as expressly set forth below, each of Avon Products, AIO and IPCO shall have the sole and exclusive right and option
to determine whether to file, prosecute or maintain the Registered Existing North America IP owned by each of Avon Products, AIO and IPCO, respectively. Subject to Section 7.02(c), Avon NA agrees to reimburse Avon International for fifty
percent (50%) of all direct, out-of pocket costs and expenses (including reasonable attorneys’ fees) related to the filing, prosecution or maintenance of any Registered Existing North America IP filed with a Governmental Entity in the
North America Region. Avon NA shall have the right to request either Avon Products or IPCO to file any reasonable applications for: (A) registration of unregistered Existing North America IP with the appropriate Governmental Entity in the North
America Region, and (B) any Trademarks including Trademark Extensions in the North America Region necessary to provide Trademark protection for brand extensions to the Licensed IP that are proposed by Avon NA, which requests each of Avon
Products and IPCO shall use its respective commercially reasonable efforts to accomplish. 

  
 28 

 (ii) Avon International shall provide to Avon NA reasonable notice of any
material developments with respect to the filing, prosecution or maintenance of any Registered Existing North America IP filed with a Governmental Entity in the North America Region, and Avon NA shall have the right to provide recommendations in
respect thereof to Avon International for consideration (in Avon International’s sole discretion). 
 (iii) Avon
International shall further use good faith efforts to provide reasonable advance notice of any decision to not prosecute or maintain, or to abandon or allow to lapse, any item of Registered Existing North America IP filed with a Governmental Entity
in the North America Region, and Avon NA may elect by providing written notification within fifteen (15) Business Days thereof to prosecute or otherwise maintain such item of Registered Existing North America IP at Avon NA’s sole expense.
Upon Avon NA making such election and agreeing to pay any costs for such item of Registered Existing North America IP, (A) Avon International shall promptly thereafter transfer to Avon NA the control of the prosecution and maintenance of such
item of Registered Existing North America IP, and assign all right, title and interest thereto to Avon NA, (B) Avon International shall cooperate with Avon NA, at Avon NA’s sole cost and expense, in executing any documents or taking any
other actions reasonably necessary to perfect such assignment, and (C) Avon NA shall grant and hereby grants to Avon International a license to any item of Registered Existing North America IP assigned to Avon NA under this
Section 7.02(a)(iii) on the same terms and conditions applicable to the license grant to Avon International in Section 2.02 (other than the obligation to pay royalties). 

(iv) Avon International shall pay all direct, out-of pocket costs and expenses (including reasonable attorneys’ fees)
related to the filing, prosecution or maintenance of any Registered Existing North America IP filed with a Governmental Entity in the North America Region, which costs and expenses are due prior to the Effective Date including all renewal documents,
declarations of use, affidavits of use, and annuities. Avon International shall obtain and record with the relevant Governmental Entity in the North America Region inventor assignment agreements, intellectual property assignment agreements, and
other agreements and documentation necessary for one of Avon Products, AIO, or IPCO to be recorded as the owner of record with the relevant Governmental Entity for each item of Registered Existing North America IP as of the Effective Date. Avon NA
shall have no obligation to reimburse Avon International for any costs or expenses associated with Avon International’s obligations under this Section 7.02(a)(iv). 

(b) New International IP and New North America IP. 

(i) Except as expressly set forth below, Avon International and Avon NA shall each have the sole and exclusive right and
option, as applicable, to determine whether to file, prosecute or maintain any registrations or applications for registration of any New International IP or New North America IP, respectively, at their own expense. 

  
 29 

 (ii) Subject to Section 7.02(c), Avon NA agrees to reimburse Avon
International for fifty percent (50%) of all direct, out-of-pocket costs and expenses (including reasonable attorneys’ fees) related to the filing, prosecution or maintenance of all Registered New International IP filed with a Governmental
Entity in the North America Region, no later than sixty (60) days after request by Avon International for reimbursement. Avon NA shall have the right to request Avon International to file any reasonable applications for registration of
unregistered New International IP (for which Avon NA’s license has become effective as provided in Section 4.02) with any appropriate Governmental Entity in the North America Region, which request Avon International shall use its
commercially reasonable efforts to accomplish, and, in which case, Avon NA agrees to reimburse Avon International for all costs and expenses (including reasonable attorneys’ fees) related to such filing, prosecution or maintenance. 

(iii) Subject to Section 7.02(c), Avon International agrees to reimburse Avon NA for fifty percent (50%) of all
direct, out-of-pocket costs and expenses (including reasonable attorneys’ fees) related to the filing, prosecution or maintenance of all Registered New North America IP filed with a Governmental Entity in the International Region, no later than
sixty (60) days after request by Avon NA for reimbursement. Avon International shall have the right to request Avon NA to file any reasonable applications for registration of unregistered New North America IP (for which Avon
International’s license has become effective as provided in Section 4.02) with any appropriate Governmental Entity in the International Region, which request Avon NA shall use its commercially reasonable efforts to accomplish, and, in
which case, Avon International agrees to reimburse Avon NA for all costs and expenses (including reasonable attorneys’ fees) related to such filing, prosecution or maintenance. 

(iv) Avon International and Avon NA shall each provide reasonable advance notice to the other of any decision to abandon or
allow to lapse any item of Registered New International IP filed with a Governmental Entity in the North America Region or Registered New North America IP filed with a Governmental Entity in the International Region, respectively, and the Party
receiving such notice (the “Electing Party”) may elect by providing written notification within fifteen (15) Business Days thereof to prosecute or otherwise maintain such item of Registered New International IP or Registered
New North America IP at its own sole expense. Upon the Electing Party making such election and agreeing to pay any costs for such item of Registered New International IP or Registered New North America IP, (A) the other Party shall promptly
thereafter transfer to the Electing Party the control of the prosecution and maintenance of such item of Registered New International IP or Registered New North America IP, and assign all right, title and interest thereto to the Electing Party,
(B) the other Party shall cooperate with the Electing Party, at the Electing Party’s sole cost and expense, in executing any documents and taking any other actions reasonably necessary to perfect such assignment, and (C) the Electing
Party shall grant and hereby grants to the other Party a license to any item of Registered New International IP or Registered New North America IP assigned 

  
 30 

 to the Electing Party under this Section 7.02(b)(iv) on the same terms and conditions applicable
to the license grant to the assigning Party in Sections 2.01(a)(ii) and 2.01(c)(ii) (with respect to Avon NA) or Section 2.02 (with respect to Avon International) (in each case, other than the obligation to pay royalties). 

(c) Notwithstanding anything to the contrary in this Article VII, in no event shall Avon NA be required to reimburse Avon International for
more than $350,000 in a single calendar year (but, starting on the third anniversary of the Closing, adjusted each calendar year in accordance with the Consumer Price Index) for direct, out-of-pocket costs and expenses (including reasonable
attorneys’ fees) incurred by Avon International in such year that are related to the filing, prosecution or maintenance of any Licensed IP Rights filed with any Governmental Entity, provided that such costs and expenses arising out of
any request for registration of Licensed IP Rights made by Avon NA shall not be counted toward the $350,000 threshold described herein. 

SECTION 7.03. Enforcement. 

(a) Existing North America IP. Avon NA shall have the first right, but not the obligation, to take enforcement action against any third
Person in respect of any infringement, misappropriation or other unlawful use of any Existing North America IP or any Trademark Extension, at Avon NA’s sole expense and for Avon NA’s sole benefit, to the extent such infringement,
misappropriation or unlawful use is primarily to the North America Region (with Avon International having step-in rights as provided in Section 7.03(c)); provided that Avon NA shall notify and reasonably cooperate with Avon International
with respect to the assertion of Claims related to IP Rights against any Restricted Person. Avon International shall have the first right, but not the obligation, to take enforcement action against any third Person in respect of any infringement,
misappropriation, or other unlawful use of any Existing North America IP or any Trademark Extension, at Avon International’s sole expense and for Avon International’s sole benefit, to the extent such infringement, misappropriation or
unlawful use is not primarily related to the North America Region (with Avon NA having step-in rights as provided in Section 7.03(c), provided that Avon NA shall reasonably cooperate with Avon International with respect to the assertion
of Claims related to IP Rights against any Restricted Person), provided that Avon International shall notify and reasonably cooperate with Avon NA with respect to the assertion of Claims related to IP Rights against any Restricted Person.

 (b) New International IP and New North America IP. 

(i) Avon NA shall have the first right, but not the obligation, to take enforcement action against any third Person in respect
of any infringement, misappropriation or other unlawful use of any New International IP, at Avon NA’s sole expense and for Avon NA’s sole benefit, to the extent Avon NA’s license to such New International IP has become effective as
provided in Section 4.02 and to the extent such infringement, misappropriation or unlawful use is primarily limited to the North America Region (with Avon International having step-in rights as provided in Section 7.03(c), provided
that Avon NA shall reasonably cooperate with Avon International with respect to the assertion of Claims related to IP Rights against any Restricted Person). Avon 

  
 31 

 International shall have the first right, but not the obligation, to take enforcement action
against any third Person in respect of any infringement, misappropriation, or other unlawful use of any New International IP, at Avon International’s sole expense and for Avon International’s sole benefit, to the extent such infringement,
misappropriation or unlawful use is not primarily related to the North America Region (with Avon NA having step-in rights as provided in Section 7.03(c) solely to the extent Avon NA’s license to such New International IP has become
effective as provided in Section 4.02, provided that Avon NA shall reasonably cooperate with Avon International with respect to the assertion of Claims related to IP Rights against any Restricted Person). Avon International shall have
the sole right, but not the obligation, to take enforcement action against any third Person in respect of any infringement, misappropriation, or other unlawful use of any New International IP, at Avon International’s sole expense and for Avon
International’s sole benefit, to the extent such infringement, misappropriation or unlawful use is solely limited to the International Region. 

(ii) Avon International shall have the first right, but not the obligation, to take enforcement action against any third Person
in respect of any infringement, misappropriation or other unlawful use of any New North America IP, at Avon International’s sole expense and for Avon International’s sole benefit, to the extent Avon International’s license to such New
North America IP has become effective as provided in Section 4.02 and such infringement, misappropriation, or unlawful use is solely limited to the International Region (with Avon NA having step-in rights as provided in Section 7.03(c)).
Avon NA shall have the sole right, but not the obligation, to take enforcement action against any third Person in respect of any infringement, misappropriation, or other unlawful use of any New North America IP, at Avon NA’s sole expense and
for Avon NA’s sole benefit, to the extent such infringement, misappropriation or unlawful use is solely limited to the North America Region. 

(c) Step-in Rights. If, upon receiving notice of infringement or misappropriation of Existing North America IP or Trademark Extensions
in accordance with Section 7.03(a) or upon receiving notice of infringement or misappropriation of New International IP or New North America IP in accordance with Section 7.03(b), the Party with the first right to take enforcement action
under Section 7.03(a) or under Section 7.03(b) does not provide notice to the other Party within a reasonable time that it intends to exercise its right to take enforcement action, and within such reasonable time take such action, then the
other Party may then take enforcement action in its own name and at its sole expense in respect of such infringement or misappropriation. 

(d) Cooperation and Assistance. 

(i) The other Party shall reasonably cooperate with and provide assistance to the Party taking any enforcement action in
accordance with this Section 7.03 (an “Enforcing Party”), at the Enforcing Party’s expense (including reimbursement for reasonable attorneys’ fees), which shall include being joined as a necessary or indispensable
party to any proceeding. The Enforcing Party will be solely responsible for the costs of such enforcement action and will retain all recoveries and awards in 

  
 32 

 connection therewith, provided that the Enforcing Party shall not settle any such
enforcement action in a manner that adversely affects the rights of the other Party under the IP Rights licensed to it under this Agreement or otherwise without such other Party’s prior written consent (which consent shall not be unreasonably
withheld or delayed). 
 (ii) Except as otherwise provided in Sections 9.02, 9.03, and 9.04, below, each Party shall
reasonably cooperate with and provide assistance to the other Party in respect of any proceedings or Claims brought or threatened against any Licensed IP Rights owned by such other Party, at such other Party’s sole expense (except with respect
to any Registered Existing North America IP filed with a Governmental Entity in the North America Region, in respect of which all costs and expenses shall be borne by Avon NA). 

SECTION 7.04. Social Media Cooperation. The Parties shall work together and reasonably cooperate with one another in efforts to prevent
or mitigate any damage to the Avon brand and the Parties’ respective businesses on social media platforms. 
 ARTICLE VIII 

Confidentiality 
 SECTION
8.01. Confidentiality. Each Party acknowledges that in connection with this Agreement it may gain access to Confidential Information of the other Party. Each Receiving Party shall, in perpetuity: (i) not use the Confidential Information
other than as necessary to exercise its rights and perform its obligations under this Agreement or, subject to its non-disclosure obligation, to operate its respective business, and (ii) maintain the Confidential Information in strict
confidence and, subject to Section 8.02, not disclose the Confidential Information without the Disclosing Party’s prior written consent, provided, however, that the Receiving Party may disclose the Confidential Information as permitted in
this Article VIII. 
 SECTION 8.02. Disclosure. The Receiving Party may disclose the Confidential Information to any of its
Subsidiaries, shareholders, Personnel, representatives and finance providers, and to permitted sublicensees (collectively, “Recipients”) to the extent that disclosure is necessary for the purposes of this Agreement or in connection
with a contemplated or actual merger, business combination or other change of control transaction permitted under the LLC Agreement, provided that the Receiving Party ensures that any such Recipient is informed in writing of the
confidentiality requirements under this Agreement (which notification shall include a copy of the terms of this Article VIII) and further that such Recipient is itself bound by a written nondisclosure agreement that is at least as restrictive as the
one set forth in this Article VIII; provided, further that a Receiving Party (i) in the case of disclosure to any sublicensee, shall not disclose to such sublicensee any Confidential Information relating to (A) any financial
terms of this Agreement found in Article IV or (B) the list of Restricted Persons, and (ii) in the case of disclosure to any Recipient that is not a sublicensee, shall redact such Confidential Information from any disclosure to such
Recipient unless strictly necessary for the purposes of this Agreement or financing or selling its business. The Receiving Party shall be 

  
 33 

 responsible for ensuring each Recipient’s compliance with, and shall be liable for any breach by a Recipient
of, this Article VIII. Each Recipient shall be required by the Receiving Party to use reasonable care, at least as protective as the efforts it uses for its own confidential information, to safeguard the Confidential Information from use or
disclosure other than as permitted hereby. 
 SECTION 8.03. Legal Orders. Any disclosure by the Receiving Party or a Recipient of any
Confidential Information pursuant to Applicable Law or a valid order issued by a court or Governmental Entity of competent jurisdiction (a “Legal Order”) shall be subject to the terms of this Section 8.03. Prior to making any
such disclosure, the Receiving Party or Recipient shall provide the Disclosing Party with (a) prompt written notice of such requirement so that the Disclosing Party may seek a protective order or other remedy, and (b) reasonable assistance
in opposing such disclosure or seeking a protective order or other limitations on disclosure. If, after providing such notice and assistance as required herein, the Receiving Party or Recipient remains subject to a Legal Order to disclose any
Confidential Information, the Receiving Party or Recipient (or its representatives or other Persons to whom such Legal Order is directed) shall disclose no more than that portion of the Confidential Information which such Legal Order specifically
requires the Receiving Party or Recipient to disclose, and upon the Disclosing Party’s request shall use commercially reasonable efforts to obtain assurances from the applicable court or Governmental Entity that such Confidential Information
will be afforded confidential treatment. 
 SECTION 8.04. Exclusions. For the avoidance of doubt, this Article VIII is not intended
to restrict in any respect either Party’s use of its own Confidential Information (including, with respect to Avon International, any Confidential Information relating to the North America Business in existence prior to the Effective Date,
other than Confidential Information transferred to Avon NA pursuant to the Separation and Investment Agreement.) 
 SECTION 8.05.
Formulas. The Parties hereby acknowledge and agree that the Formulas licensed under this Agreement and all non-public information, material, documentation and data contained in or used in connection with manufacturing, processing or testing
such Formulas (collectively, “Formula-Related Information”) are of a highly confidential nature and each Party shall, and shall ensure that its sublicensees shall, take all reasonably necessary steps to protect the confidentiality
of and maintain the Formulas licensed to such Party under this Agreement and the Formula-Related Information, including (a) binding such Party’s (and its permitted sublicensees’) Personnel, contractors, partners and other Persons
having access to the Formula-Related Information through such Party with confidentiality obligations, (b) requiring such Party’s (and its permitted sublicensees’) Personnel, contractors, partners and other Persons having access to the
Formula-Related Information through such Party to comply with such confidentiality obligations, (c) restricting access to the Formula-Related Information to those Persons that are bound by confidentiality obligations, and (d) implementing
reasonably sufficient physical, technological and other security measures to maintain the secrecy of the Formula-Related Information. 

  
 34 

 ARTICLE IX 

Warranties and Indemnities 

SECTION 9.01. Warranties. 

(a) Mutual Warranties. Each Party hereby represents and warrants to the other Party that (i) such first Party has the requisite
authority and power, and has taken all requisite actions, to execute and perform this Agreement, (ii) this Agreement constitutes a legal, valid and binding obligation of such first Party, enforceable against such Party in accordance with its
terms. and (iii) this Agreement does not conflict in any material respect with any agreement or rights of any Person. 
 (b) Avon
International Warranties. Avon International hereby represents and warrants to Avon NA that: 
 (i) Schedules A, B, C and
D contain a true and complete list as of the Effective Date (specifying the jurisdiction, the owner(s) thereof, and the registration or application number if applicable) of all Registered Existing North America IP, provided that with respect to
Copyrights included in the Registered Existing North America IP, inclusion of such Copyrights on Schedule D is limited to Avon International’s knowledge thereof upon review of the U.S. Copyright Office’s electronic records available over
the Internet; 
 (ii) As of the Closing Date, Avon International owns all right, title and interest in and to, or has a valid
right to license pursuant to an agreement disclosed, to the extent such agreement is material, on Schedule A, B, C or D, the NA Licensed IP Rights, without any Liens (other than Liens or title defects that are not material in amount or do not
materially detract from the value of or materially impair Avon NA’s use of the NA Licensed IP Rights affected by such Lien or title defect) and solely with regard to any material registered NA Licensed IP Rights owned by Avon International,
such ownership is sole and exclusive to Avon International; 
 (iii) Except as set forth on Schedule 9.01(b)(iii), there are
no Claims pending or, to Avon International’s knowledge and within the past three years, threatened in writing contesting the validity, use, ownership, registrability or enforceability of any of the NA Licensed IP Rights, except for such
threatened claims that have been resolved as of the Effective Date and, solely with regard to threatened claims, except as, individually or in the aggregate, are not and would not reasonably be expected to be material to the North America Business,
taken as a whole; 
 (iv) All of the Trademarks included in the NA Licensed IP Rights are subsisting and, to Avon
International’s knowledge (A) such Trademarks are valid and enforceable and (B) the Other IP Rights included in the NA Licensed IP Rights are valid and enforceable, and all renewals and maintenance fees in respect of the Registered
Existing North America IP which were due prior to the Effective Date have been duly paid; 

  
 35 

 (v) To Avon International’s knowledge, Avon International has not engaged in
(or omitted to perform) any act, the result of which would reasonably be expected to invalidate or render unenforceable any of the NA Licensed IP Rights (for the avoidance of doubt, the Parties acknowledge that nothing in this Section 9.01(b)
shall be interpreted as a warranty or representation that Avon International has not, or a covenant that Avon International will not continue to, engage in such acts of portfolio pruning in the ordinary course of business); 

(vi) (A) Since January 1, 2014, Avon International and its Subsidiaries have required that all Persons (including
current and former employees, contractors and consultants of Avon International or any of its Subsidiaries) who have participated in the creation, invention, modification, improvement or development of NA Licensed Rights owned by Avon International
or any of its Subsidiaries have executed and delivered to Avon International or one of its Subsidiaries a valid and enforceable agreement, or have a duty by operation of law, obliging such Person to assign to Avon International or its applicable
Subsidiary any such NA Licensed IP Rights arising out of such Person’s employment by, engagement by or contract with Avon International or any of its Subsidiaries and (B) all Persons (including current and former employees, contractors and
consultants of Avon International or any of its Subsidiaries) who have created or invented any material NA Licensed Right owned by Avon International or any of its Subsidiaries have assigned, or had at the time of such creation or invention a duty
by operation of law to assign, to Avon International or its applicable Subsidiary such NA Licensed IP Right; 
 (vii) There
are no Judgments applicable to the NA Licensed IP Rights; 
 (viii) The grant of licenses by Avon International and its
Subsidiaries to Avon NA to Existing North America IP and Trademark Extensions under this Agreement will not require Avon International or its Subsidiaries, or Avon NA or its Subsidiaries, to incur liability to or a duty to provide consideration to
any third Person; and 
 (ix) To Avon International’s knowledge, the Licensed IP Quality Standards are being met in all
material respects by the North America Business as of the Effective Date, and immediately after giving effect to the Separation and Investment Agreement and the Transaction Documents, the Avon NA Business will be capable of meeting such Licensed IP
Quality Standards. 
 SECTION 9.02. Indemnity by Avon NA. Avon NA shall indemnify and hold harmless Avon International, its
Affiliates. equity holders, and each of their Personnel (collectively, “Avon International Indemnified Parties”) and defend such Avon International Indemnified Party, from and against all Losses arising out of or resulting from
Claims by any third Person against such Avon International Indemnified Party arising out of any material breach by Avon NA of any of its representations or warranties set forth in this Article IX and Article VI (all such Claims, together with all
Claims that are the subject of the indemnity by Avon NA in Section 2.08(c), hereafter referred to as “Avon International Indemnified Claims”). 

  
 36 

 SECTION 9.03. Indemnity by Avon International. Avon International shall indemnify and hold
harmless Avon NA, its Affiliates and each of their Personnel (collectively, “Avon NA Indemnified Parties”) and defend such Avon NA Indemnified Party, from and against all Losses arising out of or resulting from Claims by any third
Person against such Avon NA Indemnified Party arising out of (i) any material breach by Avon International of any of its representations or warranties set forth in this Article IX or of the covenants set forth in Article VI, (ii) Avon
International’s exercise of the licenses granted under this Agreement to Avon International or (iii) the operation by Avon International of the Avon International Business from and after the Effective Date, including any product liability
Claims or Claims for infringement or misappropriation of any IP Rights (all such Claims, together with all Claims that are the subject of the indemnity by Avon International in Section 2.08(d), hereafter referred to as “Avon NA Indemnified
Claims”). 
 SECTION 9.04. Indemnification Procedures. 

(a) Each Avon NA Indemnified Party or Avon International Indemnified Party (each, an “Indemnified Party”) shall promptly
notify the other Party (the “Indemnifying Party”) of any Avon NA Indemnified Claims or Avon International Indemnified Claims, as applicable (each, an “Indemnified Claim”) for indemnification pursuant to this Article
IX. Failure to give prompt notice shall not reduce the Indemnifying Party’s duties of, and Indemnified Parties’ rights to, indemnification hereunder, unless, and only to the extent that, the Indemnifying Party is actually and materially
prejudiced thereby (except that the Indemnifying Party shall not be liable for any expenses incurred by an Indemnified Party during the period in which the Indemnified Party failed to give notice). 

(b) Upon receiving notice of an Indemnified Claim, the Indemnifying Party shall be entitled to participate in the defense thereof and, if it so
chooses, to assume the defense thereof with counsel selected by the Indemnifying Party and not reasonably objected to by the Indemnified Party. If the Indemnifying Party assumes such defense, the Indemnified Party shall have the right to participate
in defense thereof and to employ counsel not reasonably objected to by the Indemnifying Party, at the Indemnified Party’s sole cost and expense, separate from the counsel employed by the Indemnifying Party, it being understood that the
Indemnifying Party shall control such defense. The Indemnified Party agrees, at the Indemnifying Party’s sole cost and expense, to cooperate in the defense of any Indemnified Claim, to provide information and assistance as may be reasonably
necessary for the Indemnifying Party to defend such Indemnified Claim, and use reasonable efforts to make employees available on a mutually convenient basis to provide additional information and explanation. 

(c) The Indemnifying Party may pay, settle or compromise an Indemnified Claim without the consent of the Indemnified Party, unless such
settlement, payment or compromise includes or results in a financial obligation or other restriction on, or admission of fault of the Indemnified Party (including any restriction on any right or license granted to the Indemnified Party under this
Agreement) or does not include a full release of the Indemnified Party with respect to the subject matter of such Claim, in each which case, the Indemnified Party’s written consent is required in order for the Indemnifying Party to pay, settle
or compromise such Indemnified Claim, which consent shall not be unreasonably withheld. 

  
 37 

 (d) Notwithstanding the foregoing, the Indemnifying Party shall not be entitled to assume the
defense of any Indemnified Claim (and shall be liable for the reasonable fees and expenses of counsel incurred by the Indemnified Party in defending such Claim) if the Indemnified Claim seeks an order, injunction or other equitable relief or relief
for other than money damages against the Indemnified Party that the Indemnified Party reasonably determines, after conferring with its outside counsel, cannot be separated from any related claim for money damages. If such equitable relief or other
relief portion of the Indemnified Claim can be so separated from that for money damages, the Indemnifying Party shall be entitled to assume the defense of the portion relating to money damages. 

(e) Each Party shall cooperate with the other with respect to resolving any Claim or liability with respect to which one Party is obligated to
indemnify another Party hereunder or any Affiliate thereof, including by using commercially reasonable efforts to mitigate or resolve any such Claim or liability. In the event that a Party seeking indemnification shall fail to make such commercially
reasonable efforts to mitigate or resolve any Claim or liability, then notwithstanding anything else to the contrary contained herein, the Party against whom indemnification is being sought shall not be required to indemnify any Person for any
Losses that could reasonably be expected to have been avoided if the Party seeking indemnification had made such efforts. 
 SECTION 9.05.
Disclaimer. 
 (a) OTHER THAN AS EXPRESSLY SET FORTH IN THIS ARTICLE IX OR ANY OTHER TRANSACTION DOCUMENT, EACH PARTY EXPRESSLY
DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES RELATING TO THIS AGREEMENT AND ALL MATTERS AND THINGS PERTAINING TO IT, WHETHER WRITTEN, ORAL, EXPRESS, IMPLIED, STATUTORY OR OTHERWISE, INCLUDING ANY EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT, AND ANY WARRANTIES THAT MAY ARISE FROM COURSE OF PERFORMANCE, COURSE OF DEALING OR USAGE OF TRADE. TO THE FULLEST EXTENT PERMITTED BY LAW, AND EXCEPT IN CONNECTION WITH OBLIGATIONS UNDER SECTIONS
2.08(c), SECTION 2.08(d), 9.02 OR 9.03, NEITHER PARTY SHALL BE LIABLE TO THE OTHER PARTY OR ANY OTHER PERSON FOR ANY SPECULATIVE, SPECIAL, OR PUNITIVE, DAMAGES, ARISING FROM THIS AGREEMENT OR PERFORMANCE UNDER THIS AGREEMENT. THIS WAIVER APPLIES
REGARDLESS OF WHETHER OR NOT THE DAMAGES WERE FORESEEABLE, AND REGARDLESS OF THE THEORY OR CAUSE OF ACTION UPON WHICH THE DAMAGES MIGHT BE BASED. HOWEVER, THIS AGREEMENT DOES NOT REVOKE OR MODIFY ANY WARRANTY OR INDEMNITY CONTAINED IN ANY OTHER
TRANSACTION DOCUMENT OR OTHER AGREEMENT. 
 (b) NOTWITHSTANDING THE FOREGOING, THE WAIVERS AND INDEMNITIES IN THIS ARTICLE IX DO NOT APPLY TO
LOSS OR LIABILITY DIRECTLY CAUSED BY THE GROSS NEGLIGENCE OR INTENTIONAL MISCONDUCT OF THE INDEMNIFIED PARTY OR ANY OF ITS PERSONNEL, OR BY FRAUD, AND THE LIMITATIONS ON DAMAGES (INCLUDING THE LIMITATION SET FORTH IN 

  
 38 

 SECTION 9.05(a)) DO NOT APPLY TO ANY LOSS DIRECTLY OR INDIRECTLY CAUSED BY THE GROSS NEGLIGENCE OR INTENTIONAL
MISCONDUCT OF THE INDEMNIFYING PARTY, OR BY FRAUD. FURTHER, A PARTY HAS NO DUTY TO INDEMNIFY AN INDEMNIFIED PARTY AGAINST CLAIMS BY THE INDEMNIFIED PARTY’S PERSONNEL. 

ARTICLE X 
 Term 

SECTION 10.01. Term. This Agreement shall become effective as of the Effective Date, and the rights and licenses granted hereunder
shall continue in full force and effect in perpetuity (the “Term”). The Parties hereby acknowledge and agree that this Agreement (i) is neither of indefinite duration nor terminable at will, (ii) is irrevocable and
perpetual, and (iii) cannot be terminated, even for material breach. 
 ARTICLE XI 

General Provisions 

SECTION 11.01. Further Assurances. Each Party shall, and shall cause its respective Affiliates to, upon the reasonable request of the
other Party, promptly execute such documents (including the execution and delivery of affidavits, declarations, oaths, samples, exhibits, specimens, assignments, powers of attorney and other documentation) and, at the requesting Party’s
expense, take such further actions as may be necessary to give full effect to the terms of this Agreement and the transactions contemplated hereby. 

SECTION 11.02. Security Interests. Neither Party shall grant a Lien on, in or with respect to, any IP Rights Owned or Controlled by the
other Party, or record any such Lien against any application or registration in the United States Patent and Trademark Office or similar Governmental Entity with respect to any IP Rights Owned or Controlled by the other Party. Each Party
acknowledges that each Licensee shall be permitted to grant a Lien on this Agreement, on its respective license to IP Rights under this Agreement, and on its tangible products licensed pursuant to this Agreement in connection with a financing
transaction so long as any such Lien expressly prohibits the Person in whose favor such Lien is granted from licensing, sub-licensing, assigning, transferring, leasing or otherwise granting rights to or disposing of any such IP Rights in any manner
that the Licensee itself could not under this Agreement. In connection with such grant by Licensee, Licensor shall enter into any agreement reasonably requested by the financer and consistent with Licensee’s right to grant such Lien. 

SECTION 11.03. Force Majeure. Neither Party shall have any liability on account of any loss, damage or delay occasioned or caused by
strikes, riots, fires, insurrection, war, flood, earthquake, storm or other extreme adverse weather conditions, embargoes, any acts of God or of the public enemy, governmental order, whether or not valid, or other non-economic causes, in each case
beyond the control of the Party and only to the extent that such causes make performance without loss, damage or delay impossible; provided, however, that the obligations of the Party set forth herein shall be restored and considered in full force
and effect upon the disappearance, removal, termination, revocation, or abandonment of the force majeure so affecting such obligations. 

  
 39 

 SECTION 11.04. Severability. If any term or other provision of this Agreement is or
becomes invalid, illegal or incapable of being enforced because of any Applicable Law or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal
substance of the Agreement is not affected in any manner materially adverse to any Party hereto. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties hereto shall negotiate in good
faith to modify this Agreement so as to effect the original intent of the Parties as closely as possible in a mutually acceptable manner in order that the Agreement be given the effect originally contemplated to the greatest extent possible. 

SECTION 11.05. Notices. All notices, requests, permissions, waivers or other communications required or permitted to be given under
this Agreement shall be in writing and shall be delivered by hand or sent by facsimile or email or sent, postage prepaid, by registered, certified or express mail or overnight courier service and shall be deemed given when so delivered by hand, by
facsimile (which is confirmed), by email (which is confirmed) or if mailed, three days after mailing (one Business Day in the case of express mail or overnight courier service) to the Parties at the following addresses or facsimiles or emails (or at
such other address or facsimile or email for a Party as shall be specified by like notice): 
  

					
		 	If from Avon NA to Avon International:
		
		 	Avon Products, Inc.
		 	One Avon Place
		 	Suffern, NY 10901
		 	Attention:	  	Joan McGillycuddy, Chief IP Counsel
		 	Facsimile:	  	(845) 369-2114
		 	Email:	  	joan.mcgillycuddy@avon.com
		
		 	with a copy to (which copy alone shall not constitute notice):
		
		 	 Avon Products, Inc.
 777 Third
Avenue
 New York, NY 10017-1307

		 	Attention:	  	General Counsel
		 	Email:	  	jeff.benjamin@avon.com
			
		 	and	  	
		
		 	Cravath, Swaine & Moore LLP
		 	Worldwide Plaza
		 	825 Eighth Avenue
		 	New York, NY 10019
		 	Attention:	  	Scott A. Barshay, Esq.
		 		  	Jonathan L. Davis, Esq.
			
		 	Facsimile:	  	(212) 474-3700
			
		 	Email:	  	sbarshay@cravath.com
		 		  	jdavis@cravath.com

  
 40 

					
		 	If from Avon International to Avon NA:
		
		 	 New Avon LLC
 777 Third
Avenue

		 	New York, NY 10017
		 	Attention:	  	Karen Leu, General Counsel
		 	Facsimile:	  	(646) 829-1072
		 	Email:	  	karen.leu@avon.com
		
		 	with a copy to (which copy alone shall not constitute notice):
		
		 	Kirkland & Ellis LLP
		 	601 Lexington Avenue
		 	New York, NY 10022
		 	Attention:	  	Douglas Ryder, Esq.
		 		  	Kevin Morris, Esq.
			
		 	Facsimile:	  	(212) 446-6460
			
		 	Email:	  	Douglas.Ryder@kirkland.com
		 		  	Kevin.Morris@kirkland.com

 SECTION 11.06. Entire Agreement. This Agreement (including all schedules attached hereto which are
incorporated herein by reference) constitutes the entire agreement, and supersedes all other prior agreements, understandings, representations and warranties, both written and oral, between the Parties, with respect to the subject matter hereof.

 SECTION 11.07. Governing Law; Specific Enforcement; Submission to Jurisdiction; Waiver of Jury Trial. 

(a) This Agreement shall be governed by and construed in accordance with the internal laws of the State of New York applicable to agreements
made and to be performed entirely within such state, without regard to the conflicts of law principles of such state. 
 (b) Except as
provided in Section 3.02(c), the Parties shall attempt to resolve any dispute arising under this Agreement in good faith utilizing in the first instance each party’s manager with primary responsibility for this Agreement. If such managers
cannot resolve the dispute, then each party shall escalate such dispute to (i) in the case of Avon NA, its CEO and (ii) in the case of Avon International, its Chief Scientific Officer, in each case who shall be available to speak with
(including by telephone) his or her counterpart upon reasonable notice and at a reasonable time. 
 (c) The Parties hereto acknowledge and
agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the Parties hereto shall be
entitled to an injunction or injunctions to prevent breaches or 

  
 41 

 
threatened breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in any court of competent jurisdiction, in each case without proof of damages or
otherwise (and each Party hereto hereby waives any requirement for the securing or posting of any bond in connection with such remedy), this being in addition to any other remedy to which they are entitled at law or in equity. The Parties hereto
agree not to assert that a remedy of specific enforcement is unenforceable, invalid, contrary to law or inequitable for any reason, nor to assert that a remedy of monetary damages would provide an adequate remedy. 

(d) Each of the Parties hereto irrevocably and unconditionally submits to the exclusive jurisdiction of the Supreme Court of the State of New
York, New York County, and the United States District Court for the Southern District of New York, for the purposes of any action or other proceeding arising out of this Agreement and the rights and obligations arising hereunder, and irrevocably and
unconditionally waives any objection to the laying of venue of any such action or proceeding in any such court, and further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such action or proceeding
has been brought in an inconvenient forum. Each Party hereto agrees that service of any process, summons, notice or document by registered mail to such Party’s respective address set forth in Section 11.05 shall be effective service of
process for any such action or proceeding. 
 (e) EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY
RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY ACTION, CLAIM OR OTHER PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT. EACH PARTY HERETO (i) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER
PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, CLAIM OR OTHER PROCEEDING, SEEK TO ENFORCE THE FOREGOING WAIVER AND (ii) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN
INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 11.07. 
 SECTION 11.08.
Amendments; Waivers. This Agreement may be amended or waived if, and only if, such amendment or waiver is in writing and signed by the Party against whom such amendment or waiver shall be enforced. The failure of any Party hereto to exercise
any right, power or remedy provided under this Agreement or otherwise available in respect hereof at law or in equity, or to insist upon compliance by any other Party hereto with its obligations hereunder, shall not constitute a waiver by such Party
of its right to exercise any such other right, power or remedy or to demand such compliance. 
 SECTION 11.09. Assignment; Successors and
Assigns. Neither this Agreement nor any of the rights, interests or obligations hereunder nor any of the NA Licensed IP nor the economic interest in any of the NA Licensed IP (each, an “Assignable Asset”) may be assigned by
either Party hereto (whether by operation of Applicable Law or otherwise) without the prior written consent of the other Party. Notwithstanding the foregoing: 

  
 42 

 (a) either Party but not IPCO (the “Assigning Party”) shall, upon prior written
notice to the other Party, be permitted to assign any of its Assignable Assets without the prior written consent of the other Party to the successor in interest to the assets of the Assigning Party in any merger, business combination or other change
of control transaction of the Assigning Party (in the case of Avon NA, solely to the extent such merger, business combination or other change of control transaction is not prohibited under the LLC Agreement), 

(b) Avon NA shall, upon prior written notice to the other Party, be permitted to assign any of its Assignable Assets without the prior written
consent of the other Party to any of Avon NA’s Subsidiaries, provided that in the event of any such assignment, the Assigning Party will remain liable for all of its obligations under this Agreement, 

(c) Avon International but not IPCO shall, upon prior written notice to the other Party, be permitted to assign any of its Assignable Assets to
any of Avon International’s Subsidiaries without the prior written consent of Avon NA, provided that if such assignment would reasonably be expected to diminish or interfere with Avon NA’s rights pursuant to this Agreement, then Avon
International shall obtain Avon NA’s prior written consent, which consent shall not be unreasonably withheld or delayed, and provided further that in the event of any such assignment, Avon International will remain liable for all of its
obligations under this Agreement, and 
 (d) Avon NA shall, upon prior written notice to Avon International, be permitted to assign any
portion (but in no event all) of its rights, interests and obligations hereunder to any assignee (other than any Restricted Person) in connection with any sale of a product or service line by Avon NA to such assignee; provided that Avon NA shall in
no event exercise its rights under this Section 11.09(d) more than two (2) times (with no more than a single assignee for each of the two (2) permitted assignments under this Section 11.09(d)) while this Agreement remains in
effect. Any assignment or attempted assignment, sale, transfer, delegation or disposal of this Agreement, or any rights or obligations under this Agreement, not in compliance with this Section 11.09 shall be null and void. Subject to the
foregoing, this Agreement shall be binding upon and inure to the benefit of the Parties and their respective legal successors, permitted assigns and legal representatives. 

SECTION 11.10. Rights in Bankruptcy. 

(a) All rights and licenses granted to Avon NA and Avon International under or pursuant to this Agreement are, and will otherwise be deemed to
be, for purposes of the Title 11 of the United States Code, as amended from time to time (the “Bankruptcy Code”), licenses of rights to “intellectual property” as defined under Section 101 of the Bankruptcy Code. The
Parties agree that Avon NA and Avon International will retain and may fully exercise all of their respective rights and elections as licensees of intellectual property under the Bankruptcy Code. The Parties further agree and acknowledge that
enforcement by Avon NA or Avon International of any of their respective rights under Section 365(n) of the Bankruptcy Code in connection with this Agreement shall not violate the automatic stay of Section 362 of the Bankruptcy Code and
waive any right to object on such basis. If Avon International or Avon NA commence a case under the Bankruptcy Code after the Effective Date or otherwise become the subject of a case 

  
 43 

 
under the Bankruptcy Code commenced after the Effective Date, voluntarily or involuntarily (such Party, a “Filing Party”), in addition to and not in lieu of any other right or
remedy the other Party (the “Non-Filing Party”) may have under this Agreement or Section 365(n) of the Bankruptcy Code, the Non-Filing Party shall have the right to obtain, and the Filing Party or any trustee for the Filing
Party or its assets shall, at the Non-Filing Party’s written request to the Filing Party, deliver a copy of all embodiments held by the Filing Party of any IP Rights licensed to the Non-Filing Party under or pursuant to this Agreement,
including such embodiments necessary for the Non-Filing Party to exercise its rights hereunder. In addition, the Filing Party shall take all steps reasonably requested by the Non-Filing Party to perfect, exercise and enforce its rights hereunder,
including filings in the U.S. Copyright Office, U.S. Patent and Trademark Office or other similar Governmental Entity, and under the Uniform Commercial Code. 

(b) To the extent any license of rights under or pursuant to this Agreement does not constitute a license to “intellectual property”
as defined under Section 101 of the Bankruptcy Code, each of Avon NA and Avon International in its position of Licensor hereby acknowledges and agrees that: (i) this Agreement is a material inducement to Licensee paying Licensor the
Closing Payment pursuant to the Separation and Investment Agreement and Licensee relying on this Agreement in connection with its business and investment planning; (ii) this Agreement gives Licensor sufficient control over the quality of the
products sold by the Licensee; (iii) this Agreement is not an executory contract and does not contain any material, ongoing obligations on Licensee relevant to the standard governing executor contracts; (iv) the Parties hereby acknowledge
and agree that in the event Licensee were to lose its rights in and to the Trademarks included in the Licensed IP Rights, irreparable damage would occur to Licensee for which monetary damages alone could not provide sufficient remedy to Licensee;
accordingly, Licensor (and any debtor-in-possession or trustee of the business of Licensor) cannot and shall not attempt to reject this Agreement pursuant to Section 365 of the U.S. Bankruptcy Code or any foreign equivalent; and (v) in the
event Licensor (or any debtor-in-possession or trustee of the business of Licensor) does seek to reject this Agreement and in the event such relief is granted, (a) the rejection shall be treated merely as breach of the contract and not its
avoidance, rescission, or termination, (b) the rejection does not terminate Licensee’s right to use such license and has no effect upon the contract’s continued existence, (c) Licensee may elect rights under Section 365(n)
of the U.S. Bankruptcy Code or any foreign equivalent, and (d) Licensee shall be entitled to seek other equitable treatment relating to such rejection. 

SECTION 11.11. Migration. Subject solely to Section 11.09, Avon International shall retain the right, upon advance written notice
to Avon NA, to transfer the economic interest in any of its Intellectual Property to an Affiliate as part of a tax-advantaged asset migration. 

SECTION 11.12. Interpretation. When a reference is made in this Agreement to an Article or Section, such reference shall be to an
Article or Section of this Agreement unless otherwise indicated. The table of contents and headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. Whenever
the words “include”, “includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation”. 

  
 44 

 
The words “hereof”, “herein” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any
particular provision of this Agreement. The words “date hereof” shall refer to the date of this Agreement. The word “or” shall not be exclusive. The word “extent” in the phrase “to the extent” shall mean the
degree to which a subject or other thing extends, and shall not simply mean “if”. All references to “$” mean the lawful currency of the United States of America. The definitions contained in this Agreement are applicable to the
singular as well as the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such term. Except as specifically stated herein, any agreement, instrument or statute defined or referred to herein or in any
agreement or instrument that is referred to herein means such agreement, instrument or statute as from time to time amended, modified or supplemented, including (in the case of agreements or instruments) by waiver or consent and (in the case of
statutes) by succession of comparable successor statutes and references to all attachments thereto and instruments incorporated therein. Except as otherwise specified herein, references to a Person are also to its permitted successors and assigns.
Each of the Parties hereto has participated in the drafting and negotiation of this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement must be construed as if it is drafted by all the Parties and no presumption
or burden of proof shall arise favoring or disfavoring any Party by virtue of authorship of any of the provisions of this Agreement. 

SECTION 11.13. Counterparts and Facsimile. This Agreement may be executed in two or more identical counterparts (including by facsimile
or electronic transmission), each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument, and shall become effective when one or more counterparts have been signed by each Party
hereto and delivered (by facsimile, electronic transmission or otherwise) to the other Party. 
 SECTION 11.14. Independent
Contractors. The relationship between the Parties is that of independent contractors. Nothing contained in this Agreement shall be construed as creating any agency, partnership, joint venture or other form of joint enterprise, employment or
fiduciary relationship between the Parties, and neither Party shall have authority to contract for or bind the other Party in any manner whatsoever. 

SECTION 11.15. No Third-Party Beneficiaries. Except as expressly provided otherwise in this Agreement, this Agreement is for the sole
benefit of the Parties hereto and their permitted assigns and nothing expressed or referred to in this Agreement will be construed to give any Person, other than the Parties to this Agreement and such permitted assigns, any legal or equitable right,
remedy or claim under or with respect to this Agreement or any provision of this Agreement, whether as third party beneficiary or otherwise. 

SECTION 11.16. Costs and Expenses. Except as specifically provided otherwise in this Agreement, each Party shall bear its own costs and
expenses incurred in relation to the negotiation, preparation, execution, and performance of this Agreement. 

  
 45 

 SECTION 11.17. Parent Guaranty. Avon Products hereby guarantees irrevocably, absolutely
and unconditionally and as a primary obligation (and not as surety only) to Avon NA (the “Guaranteed Party”) all obligations of Avon International contained in this Agreement (the “Guaranteed Obligations”). If Avon
International fails or refuses to pay or perform any such Guaranteed Obligations, then Avon Products shall, without any right to notice or demand whatsoever, immediately pay, perform or cause AIO or IPCO to perform such Guaranteed Obligations, as
applicable. Avon Products hereby expressly waives (to the fullest extent permitted by Applicable Law) diligence, presentment, demand of payment, protest and, to the extent permitted by Applicable Law, all notices whatsoever (except for notices
required to be provided to Avon International pursuant to this Agreement), and any requirement that any party to this Agreement exhaust any right, power or remedy or proceed against Avon International under this Agreement. The obligations of Avon
Products hereunder shall be continuing, absolute and unconditional and such obligations shall be binding upon Avon Products, its successors and assigns and inure to the benefit of, and be enforceable by, the Guaranteed Parties and their respective
successors and permitted assigns. 
 [Signature Page Follows] 

  
 46 

 IN WITNESS WHEREOF, this Agreement has been duly executed and delivered by the parties hereto as
of the date first written above. 
  

					
	AVON PRODUCTS, INC.,
		
	By:	 	/s/ James S. Scully
		 	 Name:
 Title:
	 	 James S. Scully

Executive Vice President, Chief Operating Officer & Chief Financial Officer

 
			
	AVON INTERNATIONAL OPERATIONS, INC.,
		
	    By:	 	/s/ Ginny Edwards
		 	 Name: Ginny Edwards
 Title:
Secretary

 
					
	NEW AVON LLC,
			
		 	By:	 	 /s/ Steve Bosson

		 		 	 Name: Steve Bosson
 Title:
  Manager

 IN WITNESS WHEREOF, this letter agreement has been duly executed and delivered by the parties
hereto as of the date first written above. 
  

			
	 AVON INTERNATIONAL OPERATIONS, INC.,
  

as sole member of Avon NA IP LLC

	
	 /s/ Ginny Edwards

	 Name: Ginny Edwards
 Title:
  Secretary

 Schedule A: 

Existing North America Trademarks 
  

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	(AVON) FOUR “A” DEVICE	 	Avon Products, Inc.	 	Canada	 	Pending	 	1695889	 	29-Sep-14	 		 		 	14, 18, 25
	(Device Only)	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85776891	 	12-Nov-12	 	4837117	 	20-Oct-15	 	25
	126 CHAMBERS STREET	 	Avon Products, Inc.	 	Canada	 	Pending	 	1713486	 	2-Feb-15	 		 		 	3
	126 CHAMBERS STREET	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86521229	 	2-Feb-15	 		 		 	3
	3D RESCUE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1506063	 	1-Dec-10	 	TMA812,292	 	21-Nov-11	 	3
	4 A LOGO (Device Only)	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85776860	 	12-Nov-12	 	4672248	 	13-Jan-15	 	18
	4 A LOGO (DEVICE)	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85776839	 	12-Nov-12	 	4672247	 	13-Jan-15	 	14
	50’S GLAM	 	Avon Products, Inc.	 	Canada	 	Registered	 	1369824	 	30-Oct-07	 	TMA755913	 	22-Dec-09	 	3
	A V O N	 	Avon Products, Inc.	 	United States of America	 	Registered	 	75703776	 	12-May-99	 	3469979	 	22-Jul-08	 	35
	AVON BASICS	 	Avon Canada Inc.	 	Canada	 	Registered	 	TMA533127	 	11-Aug-97	 	0853053	 	21-Sep-00	 	3
	A.M. BODY LIPO 24	 	Avon Products, Inc.	 	Canada	 	Registered	 	1406996	 	12-Aug-08	 	TMA750934	 	22-Oct-09	 	3
	ABSOLUTE EVEN	 	Avon Products, Inc.	 	Canada	 	Registered	 	1568189	 	12-Mar-12	 	TMA846,896	 	22-Mar-13	 	3
	ABSOLUTE EVEN	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85574167	 	20-Mar-12	 	4365581	 	9-Jul-13	 	3
	ADVANCE TECHNIQUES	 	Avon Products, Inc.	 	Canada	 	Registered	 	1012271	 	19-Apr-99	 	TMA561430	 	7-May-02	 	
	ADVANCE TECHNIQUES	 	Avon Products, Inc.	 	United States of America	 	Registered	 	76225190	 	16-Mar-01	 	2623893	 	24-Sep-02	 	3
	ADVANCE TECHNIQUES 360 NOURISH WITH MOROCCAN ARGAN OIL	 	Avon Canada Inc.	 	Canada	 	Pending	 	1737722	 	16-Jul-15	 		 		 	3
	ADVANCE TECHNIQUES COLOR PROTECTION	 	Avon Products, Inc.	 	Canada	 	Registered	 	1452462	 	21-Sep-09	 	TMA771973	 	14-Jul-10	 	
	ADVANCE TECHNIQUES DAILY RESULTS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1452461	 	21-Sep-09	 	TMA771974	 	14-Jul-10	 	

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	ADVANCE TECHNIQUES DAMAGE REPAIR	 	Avon Products, Inc.	 	Canada	 	Registered	 	1452463	 	21-Sep-09	 	TMA780870	 	27-Oct-10	 	
	ADVANCE TECHNIQUES INTENSE REPAIR	 	Avon Products, Inc.	 	Canada	 	Registered	 	1307419	 	29-Jun-06	 	TMA699804	 	30-Oct-07	 	
	ADVANCE TECHNIQUES PROFESSIONAL HAIR CARE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1234370	 	20-Oct-04	 	TMA668426	 	21-Jul-06	 	
	ADVANCE TECHNIQUES PROFESSIONAL HAIR CARE FOR MEN	 	Avon Products, Inc.	 	Canada	 	Registered	 	1237336	 	16-Nov-04	 	TMA668445	 	21-Jul-06	 	
	ADVANCE TECHNIQUES PROFESSIONAL HAIR CARE STYLING	 	Avon Products, Inc.	 	Canada	 	Registered	 	1271256	 	8-Sep-05	 	TMA682,931	 	5-Mar-07	 	3
	ADVANCE TECHNIQUES PROFESSIONAL HAIR COLOR	 	Avon Products, Inc.	 	Canada	 	Registered	 	1530893	 	8-Jun-11	 	TMA825,142	 	30-May-12	 	3
	ADVANCE TECHNIQUES RECONSTRUCTION 7	 	Avon Products, Inc.	 	Canada	 	Registered	 	1656856	 	18-Dec-13	 	TMA885,304	 	5-Sep-14	 	3
	ADVANCE TECHNIQUES SALON HAIR CARE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1159019	 	19-Nov-02	 	TMA638945	 	3-May-05	 	
	ADVANCE TECHNIQUES ULTIMATE VOLUME COLLAGEN COMPLEX	 	Avon Products, Inc.	 	Canada	 	Pending	 	1,625,929	 	9-May-13	 		 		 	3
	ADVANCE TECHNIQUES VOLUME	 	Avon Products, Inc.	 	Canada	 	Registered	 	1452470	 	21-Sep-09	 	TMA778947	 	4-Oct-10	 	
	ADVANCED ALL-IN-ONE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1047230	 	21-Feb-00	 	TMA574814	 	30-Jan-03	 	
	ADVANCED ALL-IN-ONE MAX	 	Avon Products, Inc.	 	Canada	 	Registered	 	1181920	 	2-Jul-03	 	TMA642896	 	23-Jun-05	 	
	ADVANCED MIRA-CUTICLE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1041074	 	29-Dec-99	 	TMA553017	 	26-Oct-01	 	
	AERO VOLUME	 	Avon Products, Inc.	 	Canada	 	Registered	 	1617063	 	6-Mar-13	 	TMA879,061	 	29-May-14	 	3
	AERO VOLUME	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85868315	 	6-Mar-13	 	4544628	 	3-Jun-14	 	3
	A-F 33	 	Avon Products, Inc.	 	Canada	 	Registered	 	1551808	 	14-Nov-11	 	TMA846,889	 	22-Mar-13	 	3
	A-F 33	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85471458	 	14-Nov-11	 	4247262	 	20-Nov-12	 	3

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	A-F 33 COMPLEX	 	Avon Products, Inc.	 	Canada	 	Pending	 	1685686	 	17-Jul-14	 		 		 	3
	AGELESS RESULTS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1247698	 	18-Feb-05	 	TMA668333	 	20-Jul-06	 	
	AGELESS RESULTS	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77205851	 	14-Jun-07	 	3378320	 	5-Feb-08	 	3
	ALL DAY COMFORT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1169553	 	5-Mar-03	 	TMA651,151	 	24-Oct-05	 	
	AMAZONIAN TREASURES	 	Avon Products, Inc.	 	Canada	 	Pending	 	1712912	 	28-Jan-15	 		 		 	3
	ANEW	 	Avon Products, Inc.	 	Canada	 	Registered	 	0844099	 	2-May-97	 	TMA511786	 	13-May-99	 	
	ANEW	 	Avon Products, Inc.	 	Canada	 	Registered	 	1249130	 	2-Mar-05	 	TMA659355	 	20-Feb-06	 	5
	ANEW	 	Avon Products, Inc.	 	United States of America	 	Registered	 	74705178	 	24-Jul-95	 	1982608	 	25-Jun-96	 	3
	ANEW	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78382300	 	11-Mar-04	 	2936317	 	29-Mar-05	 	5
	ANEW	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78382318	 	11-Mar-04	 	3373763	 	22-Jan-08	 	3
	ANEW AHA	 	Avon Products, Inc.	 	Canada	 	Pending	 	1744372	 	2-Sep-15	 		 		 	3
	ANEW ALTERNATIVE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1251899	 	24-Mar-05	 	TMA658295	 	7-Feb-06	 	
	ANEW BEAUTY	 	Avon Products, Inc.	 	Canada	 	Registered	 	1274182	 	30-Sep-05	 	TMA724178	 	23-Sep-08	 	3
	ANEW CLEAN	 	Avon Products, Inc.	 	Canada	 	Pending	 	1703421	 	19-Nov-14	 		 		 	3
	ANEW CLEANSE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1353517	 	27-Jun-07	 	TMA733720	 	2-Feb-09	 	3
	ANEW CLINICAL	 	Avon Products, Inc.	 	Canada	 	Registered	 	1165190	 	21-Jan-03	 	TMA643813	 	7-Jul-05	 	
	ANEW CLINICAL	 	Avon Products, Inc.	 	Canada	 	Registered	 	1306905	 	27-Jun-06	 	TMA682,728	 	1-Mar-07	 	
	ANEW CLINICAL	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78205424	 	21-Jan-03	 	3016088	 	15-Nov-05	 	3
	ANEW CLINICAL CROW’S FEET CORRECTOR	 	Avon Products, Inc.	 	Canada	 	Registered	 	1394330	 	6-May-08	 	TMA737919	 	9-Apr-09	 	
	ANEW CLINICAL LASER	 	Avon Products, Inc.	 	Canada	 	Registered	 	1231709	 	27-Sep-04	 	TMA652,949	 	18-Nov-05	 	3
	ANEW CLINICAL LINE ERASER WITH RETINOL	 	Avon Canada Inc.	 	Canada	 	Pending	 	1735847	 	6-Jul-15	 		 		 	3

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	ANEW CLINICAL RESURFACING EXPERT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1519846	 	18-Mar-11	 	TMA823,336	 	3-May-12	 	3
	ANEW ESSENTIAL	 	Avon Products, Inc.	 	Canada	 	Pending	 	1711158	 	16-Jan-15	 		 		 	3
	ANEW GENICS	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85299962	 	20-Apr-11	 	4155488	 	5-Jun-12	 	3
	ANEW GENICS and Design	 	Avon Products, Inc.	 	Canada	 	Registered	 	1523905	 	15-Apr-11	 	TMA822,615	 	20-Apr-12	 	3
	ANEW MEN	 	Avon Products, Inc.	 	Canada	 	Pending	 	1697930	 	14-Oct-14	 		 		 	3
	ANEW PLATINUM	 	Avon Products, Inc.	 	Canada	 	Registered	 	1443404	 	2-Jul-09	 	TMA802,314	 	18-Jul-11	 	3
	ANEW REJUVENATE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1359211	 	9-Jul-07	 	TMA717,302	 	23-Jun-08	 	3
	ANEW REJUVENATE	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77251112	 	9-Aug-07	 	3525279	 	28-Oct-08	 	3
	ANEW REJUVENATE DAY	 	Avon Products, Inc.	 	Canada	 	Registered	 	1359641	 	14-Aug-07	 	TMA719648	 	29-Jul-08	 	3
	ANEW REJUVENATE NIGHT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1359640	 	14-Aug-07	 	TMA737922	 	9-Apr-09	 	3
	ANEW REVERSALIST COMPLETE RENEWAL	 	Avon Products, Inc.	 	Canada	 	Registered	 	1,599,528	 	24-Oct-12	 	TMA918,178	 	23-Oct-15	 	3
	ANEW REVERSALIST COMPLETE RENEWAL DAY	 	Avon Products, Inc.	 	Canada	 	Pending	 	1640140	 	20-Aug-13	 		 		 	3
	ANEW REVERSALIST COMPLETE RENEWAL NIGHT	 	Avon Products, Inc.	 	Canada	 	Pending	 	1640141	 	20-Aug-13	 		 		 	3
	ANEW SOLAR ADVANCE	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85117271	 	27-Aug-10	 	4050488	 	1-Nov-11	 	3
	ANEW SUN	 	Avon Products, Inc.	 	Canada	 	Registered	 	1483026	 	31-May-10	 	TMA799,633	 	9-Jun-11	 	3
	ANEW ULTIMATE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1103050	 	18-May-01	 	TMA612144	 	4-Jun-04	 	
	ANEW ULTIMATE	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78063121	 	11-May-01	 	2718121	 	20-May-03	 	3
	ANEW ULTIMATE 7S	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85393063	 	9-Aug-11	 	4246969	 	20-Nov-12	 	3
	ANEW ULTIMATE 7S & Design	 	Avon Products, Inc.	 	Canada	 	Registered	 	1539158	 	10-Aug-11	 	TMA829,827	 	13-Aug-12	 	3

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	ANEW ULTIMATE 7S DAY & DESIGN	 	Avon Products, Inc.	 	Canada	 	Registered	 	1539159	 	10-Aug-11	 	TMA831,522	 	7-Sep-12	 	3
	ANEW ULTIMATE 7S NIGHT & DESIGN	 	Avon Products, Inc.	 	Canada	 	Registered	 	1539163	 	10-Aug-11	 	TMA829,836	 	13-Aug-12	 	3
	ANEW ULTIMATE DAY	 	Avon Products, Inc.	 	Canada	 	Registered	 	1222682	 	6-Jul-04	 	TMA642465	 	20-Jun-05	 	
	ANEW ULTIMATE DAY	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78446104	 	6-Jul-04	 	3030676	 	13-Dec-05	 	3
	ANEW ULTIMATE DAY MULTI-PERFORMANCE	 	Avon Products, Inc.	 	Canada	 	Pending	 	1681585	 	19-Jun-14	 		 		 	3
	ANEW ULTIMATE MULTI-PERFORMANCE	 	Avon Products, Inc.	 	Canada	 	Pending	 	1681596	 	17-Jun-14	 		 		 	3
	ANEW ULTIMATE NIGHT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1222684	 	6-Jul-04	 	TMA642793	 	22-Jun-05	 	
	ANEW ULTIMATE NIGHT	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78446105	 	6-Jul-04	 	3038462	 	3-Jan-06	 	3
	ANEW ULTIMATE NIGHT MULTI-PERFORMANCE	 	Avon Products, Inc.	 	Canada	 	Pending	 	1681587	 	17-Jun-14	 		 		 	3
	ANEW ULTIMATE SUPREME	 	Avon Products, Inc.	 	Canada	 	Pending	 	1605717	 	7-Dec-12	 		 		 	3
	ANEW ULTIMATE SUPREME	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86305463	 	10-Jun-14	 		 		 	3
	ANEW ULTIMATE SUPREME ADVANCED PERFORMANCE CREME	 	Avon Products, Inc.	 	Canada	 	Pending	 	1700899	 	3-Nov-14	 		 		 	3
	ANEW VITALE	 	Avon Products, Inc.	 	Canada	 	Pending	 	1654506	 	3-Dec-13	 		 		 	3
	ANEW VITALE	 	Avon Products, Inc.	 	United States of America	 	Registered	 	86305062	 	10-Jun-14	 	4787163	 	4-Aug-15	 	3
	ANEW VITALE VITA TONE COMPLEX	 	Avon Products, Inc.	 	Canada	 	Pending	 	1677610	 	20-May-14	 		 		 	3
	ANEW VITAMIN C	 	Avon Products, Inc.	 	Canada	 	Pending	 	1744364	 	2-Sep-15	 		 		 	3
	ARIZONA HOT SANDS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1262875	 	28-Jun-05	 	TMA682699	 	1-Mar-07	 	
	AROMADISIAC	 	Avon Products, Inc.	 	Canada	 	Registered	 	1440989	 	10-Jun-09	 	TMA774866	 	18-Aug-10	 	3
	AROMADISIAC	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77495451	 	10-Jun-08	 	3835662	 	17-Aug-10	 	3
	ASTONISHING LENGTHS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1095361	 	13-Mar-01	 	TMA586253	 	30-Jul-03	 	

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	AUTO FOCUS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1095364	 	13-Mar-01	 	TMA602355	 	17-Feb-04	 	
	AVC10	 	Avon Products, Inc.	 	United States of America	 	Registered	 	75426702	 	30-Jan-98	 	2222831	 	9-Feb-99	 	3
	AVON	 	Avon Canada Inc.	 	Canada	 	Registered	 	0158869	 	30-Aug-32	 	TMDA56439	 	11-Feb-33	 	1
	AVON	 	Avon Canada Inc.	 	Canada	 	Registered	 	0350664	 	25-Feb-72	 	TMA201535	 	30-Aug-74	 	
	AVON	 	Avon Canada Inc.	 	Canada	 	Registered	 	0350665	 	25-Feb-72	 	TMA193191	 	3-Aug-73	 	
	AVON	 	Avon Canada Inc.	 	Canada	 	Registered	 	0368204	 	20-Sep-73	 	TMA209880	 	3-Oct-75	 	
	AVON	 	Avon Canada Inc.	 	Canada	 	Registered	 	0498447	 	7-Feb-83	 	TMA296122	 	12-Oct-84	 	
	AVON	 	Avon Canada Inc.	 	Canada	 	Registered	 	187795	 	23-Aug-45	 	UCA21072	 	23-Aug-45	 	14, 21
	AVON	 	Avon Canada Inc.	 	Canada	 	Registered	 	372656	 	20-Feb-1974	 	TMA206151	 	27-Mar-1975	 	16, 21
	AVON	 	Avon Products, Inc.	 	United States of America	 	Registered	 	71695678	 	3-Oct-55	 	0633318	 	21-Aug-56	 	3
	AVON	 	Avon Products, Inc.	 	United States of America	 	Registered	 	72036947	 	10-Sep-57	 	0674387	 	24-Feb-59	 	5
	AVON	 	Avon Products, Inc.	 	United States of America	 	Registered	 	72036948	 	10-Sep-57	 	0692928	 	9-Feb-60	 	3
	AVON	 	Avon Products, Inc.	 	United States of America	 	Registered	 	72036949	 	10-Sep-57	 	0663255	 	17-Jun-58	 	3
	AVON	 	Avon Products, Inc.	 	United States of America	 	Registered	 	72389361	 	16-Apr-71	 	0932585	 	18-Apr-72	 	
	AVON	 	Avon Products, Inc.	 	United States of America	 	Registered	 	72390477	 	28-Apr-71	 	0926035	 	21-Dec-71	 	35
	AVON	 	Avon Products, Inc.	 	United States of America	 	Registered	 	73150176	 	28-Nov-77	 	1122624	 	24-Jul-79	 	3, 5
	AVON	 	Avon Products, Inc.	 	United States of America	 	Registered	 	73223463	 	16-Jul-79	 	1194685	 	4-May-82	 	14
	AVON	 	Avon Products, Inc.	 	United States of America	 	Registered	 	73691207	 	22-Oct-87	 	1488521	 	17-May-88	 	21
	AVON	 	Avon Products, Inc.	 	United States of America	 	Registered	 	73691208	 	22-Oct-87	 	1491306	 	7-Jun-88	 	28
	AVON	 	Avon Products, Inc.	 	United States of America	 	Registered	 	73761314	 	1-Nov-88	 	1540022	 	23-May-89	 	4
	AVON	 	Avon Products, Inc.	 	United States of America	 	Registered	 	73761316	 	1-Nov-88	 	1555418	 	12-Sep-89	 	3

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	AVON	 	Avon Products, Inc.	 	United States of America	 	Registered	 	73761332	 	1-Nov-88	 	1538820	 	16-May-89	 	3
	AVON	 	Avon Products, Inc.	 	United States of America	 	Registered	 	75118006	 	12-Jun-96	 	2052798	 	15-Apr-97	 	25
	AVON	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86314953	 	19-Jun-14	 		 		 	18
	“AVON”	 	Avon Canada Inc.	 	Canada	 	Registered	 	0187795	 	23-Aug-45	 	UCA21072	 	23-Aug-45	 	
	AVON AQUA CLEAN SHOWER GEL	 	Avon Canada Inc.	 	Canada	 	Registered	 	0515619	 	23-Jan-84	 	TMA308944	 	6-Dec-85	 	
	AVON AROMATHERAPY	 	Avon Canada Inc.	 	Canada	 	Registered	 	1016409	 	25-May-99	 	TMA561728	 	10-May-02	 	
	AVON ATTRACTION	 	Avon Canada Inc.	 	Canada	 	Pending	 	1683374	 	2-Jul-14	 		 		 	3
	AVON ATTRACTION	 	Avon Products, Inc.	 	United States of America	 	Registered	 	86325211	 	1-Jul-14	 	4882432	 	5-Jan-2016	 	3
	AVON ATTRACTION FOR HER	 	Avon Canada Inc.	 	Canada	 	Pending	 	1726823	 	5-May-15	 		 		 	3
	AVON ATTRACTION FOR HIM	 	Avon Canada Inc.	 	Canada	 	Pending	 	1726824	 	5-May-15	 		 		 	3
	AVON BODY	 	Avon Canada Inc.	 	Canada	 	Registered	 	0879156	 	26-May-98	 	TMA546779	 	19-Jun-01	 	
	AVON BODY BEAUTY	 	Avon Canada Inc.	 	Canada	 	Registered	 	0473142	 	24-Jul-81	 	TMA279325	 	6-May-83	 	
	AVON CALLING	 	Avon Canada Inc.	 	Canada	 	Registered	 	0382748	 	7-Feb-75	 	TMA212251	 	20-Feb-76	 	
	AVON CARE	 	Avon Canada Inc.	 	Canada	 	Registered	 	1461053	 	1-Dec-09	 	TMA801,769	 	8-Jul-11	 	3
	AVON CARE 3 IN 1	 	Avon Canada Inc.	 	Canada	 	Registered	 	1498852	 	7-Oct-10	 	TMA861,676	 	1-Oct-13	 	3
	AVON CARE FAMILY	 	Avon Canada Inc.	 	Canada	 	Registered	 	1517565	 	3-Mar-11	 	TMA818,483	 	27-Feb-12	 	3
	AVON CARE SOOTHING CREAM	 	Avon Canada Inc.	 	Canada	 	Registered	 	1498853	 	7-Oct-10	 	TMA806,863	 	15-Sep-11	 	3
	AVON CLASSICS COLLECTION	 	Avon Canada Inc.	 	Canada	 	Pending	 	1753200	 	3-Nov-2015	 		 		 	3
	AVON CUSTOMER CONNECT	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85363217	 	5-Jul-11	 	4289738	 	12-Feb-13	 	35
	AVON DESIGN	 	Avon Canada Inc.	 	Canada	 	Registered	 	0331606	 	1-Apr-70	 	TMA175337	 	2-Apr-71	 	
	AVON DESIGN	 	Avon Canada Inc.	 	Canada	 	Registered	 	0528463	 	17-Sep-84	 	TMA381397	 	15-Mar-91	 	

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	AVON ELEMENTS	 	Avon Canada Inc.	 	Canada	 	Registered	 	1609318	 	10-Jan-13	 	TMA878,879	 	28-May-14	 	3
	AVON ELEMENTS	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85799716	 	11-Dec-12	 	4476071	 	28-Jan-14	 	3
	AVON ELEMENTS MOISTURE BOOST NIGHT	 	Avon Canada Inc.	 	Canada	 	Registered	 	1627488	 	21-May-13	 	TMA885,621	 	11-Sep-14	 	3
	AVON ELEMENTS MOISTURIZING CREAM CLEANSER	 	Avon Canada Inc.	 	Canada	 	Registered	 	1609315	 	10-Jan-13	 	TMA878,877	 	28-May-14	 	3
	AVON ELEMENTS NOURISHING CLEANSING MILK	 	Avon Canada Inc.	 	Canada	 	Pending	 	1631815	 	19-Jun-13	 		 		 	3
	AVON ELEMENTS PURIFYING GEL CLEANSER	 	Avon Canada Inc.	 	Canada	 	Registered	 	1609312	 	10-Jan-13	 	TMA878,881	 	28-May-14	 	3
	AVON ELEMENTS REFINING SCRUB & MASK	 	Avon Canada Inc.	 	Canada	 	Pending	 	1642680	 	9-Sep-13	 		 		 	3
	AVON ELEMENTS REFRESHING CLEANSING WIPES	 	Avon Canada Inc.	 	Canada	 	Registered	 	1609316	 	10-Jan-13	 	TMA878,878	 	28-May-14	 	3
	AVON ELEMENTS SKIN REVITALIZE NIGHT	 	Avon Canada Inc.	 	Canada	 	Registered	 	1627487	 	21-May-13	 	TMA885,620	 	11-Sep-14	 	3
	AVON ELEMENTS YOUTH RESTORING NIGHT	 	Avon Canada Inc.	 	Canada	 	Registered	 	1627483	 	21-May-13	 	TMA885,605	 	11-Sep-14	 	3
	AVON EXPLORATION	 	Avon Canada Inc.	 	Canada	 	Registered	 	1617067	 	06-Mar-13	 	TMA878870	 	28-May-14	 	3
	AVON EXPLORATION	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85868273	 	6-Mar-13	 	4649794	 	2-Dec-14	 	3
	AVON EXPRESSIONS	 	Avon Canada Inc.	 	Canada	 	Registered	 	1242754	 	6-Jan-05	 	TMA705037	 	18-Jan-08	 	
	AVON EXPRESSIONS	 	Avon Canada Inc.	 	Canada	 	Registered	 	1258996	 	26-May-05	 	TMA743820	 	21-Jul-09	 	
	AVON EYE PERFECTOR	 	Avon Canada Inc.	 	Canada	 	Registered	 	0564813	 	20-Jun-86	 	TMA357218	 	16-Jun-89	 	
	AVON FLAME FOUNDATION	 	Avon Canada Inc.	 	Canada	 	Registered	 	1029545	 	20-Sep-99	 	TMA562641	 	28-May-02	 	

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	AVON FOUNDATION FOR WOMEN, CANADA	 	Avon Canada Inc.	 	Canada	 	Registered	 	1458394	 	9-Nov-09	 	TMA850,728	 	13-May-13	 	
	AVON GEL FINISH NAIL ENAMEL	 	Avon Canada Inc.	 	Canada	 	INSTRUCTED- WTG. FOR PARTICULAR S (Pending)	 		 		 		 		 	3
	AVON HAT BOX TEDDIES	 	Avon Canada Inc.	 	Canada	 	Registered	 	1105251	 	8-Jun-01	 	TMA588187	 	26-Aug-03	 	
	AVON HEALTHY MAKEUP	 	Avon Canada Inc.	 	Canada	 	Registered	 	1464958	 	7-Jan-10	 	TMA778944	 	4-Oct-10	 	3
	AVON HEALTHY REMEDIES	 	Avon Canada Inc.	 	Canada	 	Registered	 	1149385	 	14-Aug-02	 	TMA625930	 	18-Nov-04	 	
	AVON HEALTHY REMEDIES TOTAL BODY & design	 	Avon Canada, Inc.	 	Canada	 	Registered	 	1206258	 	12-Feb-2004	 	TMA639419	 	10-May-2005	 	3
	AVON HOME	 	Avon Canada Inc.	 	Canada	 	Registered	 	1259000	 	26-May-05	 	TMA739865	 	11-May-09	 	
	AVON HOME FRAGRANCE COLLECTION	 	Avon Canada Inc.	 	Canada	 	Registered	 	1161382	 	10-Dec-02	 	TMA625440	 	15-Nov-04	 	
	AVON I © My Pet Animal Cheri De Mon ©	 	Avon Products, Inc.	 	Canada	 	Registered	 	1354884	 	9-Jul-07	 	TMA758481	 	1-Feb-10	 	
	AVON INSTINCT	 	Avon Canada Inc.	 	Canada	 	Pending	 	1637970	 	2-Aug-13	 		 		 	2, 3
	AVON INSTINCT	 	Avon Products, Inc.	 	United States of America	 	Registered	 	86027032	 	2-Aug-13	 	4594262	 	26-Aug-14	 	3
	AVON JEWELRY EVERYDAY ESSENTIALS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1308854	 	12-Jul-06	 	TMA704969	 	18-Jan-08	 	14
	AVON KEEP CLEAR	 	Avon Canada Inc.	 	Canada	 	Registered	 	0416836	 	24-Oct-77	 	TMA238118	 	7-Dec-79	 	
	AVON LA COMPAGNIE POUR LES FEMMES	 	Avon Canada Inc.	 	Canada	 	Registered	 	1127280	 	11-Jan-02	 	TMA714,795	 	21-May-08	 	
	AVON LIFE	 	Avon Canada Inc.	 	Canada	 	Pending	 	1748755	 	2-Oct-15	 		 		 	3
	AVON LIFE	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86775664	 	1-Oct-15	 		 		 	3
	AVON LIVING	 	Avon Canada Inc.	 	Canada	 	Pending	 	1743651	 	27-Aug-15	 		 		 	35
	AVON LIVING	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86738894	 	27-Aug-15	 		 		 	35

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	AVON LONGEST LASHES EVER	 	Avon Canada Inc.	 	Canada	 	Registered	 	1350099	 	4-Jun-07	 	TMA713,770	 	7-May-08	 	3
	AVON LUCK	 	Avon Canada Inc.	 	Canada	 	Pending	 	1638508	 	7-Aug-13	 		 		 	3
	AVON LUCK	 	Avon Products, Inc.	 	United States of America	 	Registered	 	86031660	 	7-Aug-13	 	4717251	 	7-Apr-15	 	3
	AVON MMM...CANDY!	 	Avon Products, Inc.	 	Canada	 	Pending	 	1723152	 	10-Apr-15	 		 		 	3
	AVON MMM...CANDY!	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86592567	 	9-Apr-15	 		 		 	3
	AVON MOISTURE SHIELD	 	Avon Canada Inc.	 	Canada	 	Registered	 	1137047	 	16-Apr-02	 	TMA581056	 	8-May-03	 	
	AVON MOISTURE THERAPY	 	Avon Canada Inc.	 	Canada	 	Registered	 	0492924	 	4-Oct-82	 	TMA289654	 	6-Apr-84	 	
	AVON MOISTURE THERAPY	 	Avon Products, Inc.	 	United States of America	 	Registered	 	73687024	 	28-Sep-87	 	1492828	 	21-Jun-88	 	3
	AVON MOISTURE THERAPY CALMING RELIEF	 	Avon Products, Inc.	 	Canada	 	Registered	 	1540160	 	18-Aug-11	 	TMA822,941	 	26-Apr-12	 	3
	AVON MOISTURE THERAPY DAILY SKIN DEFENSE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1540162	 	18-Aug-11	 	TMA822,942	 	26-Apr-12	 	3
	AVON MOISTURE THERAPY INTENSIVE HEALING & REPAIR	 	Avon Canada Inc.	 	Canada	 	Registered	 	1537878	 	1-Aug-11	 	TMA822,936	 	26-Apr-12	 	3
	AVON MUSK STORM	 	Avon Canada Inc.	 	Canada	 	Pending	 	1730962	 	2-Jun-15	 		 		 	3
	AVON MUSK STORM	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86630097	 	14-May-15	 		 		 	3
	AVON NATURALS	 	Avon Canada Inc.	 	Canada	 	Registered	 	0434098	 	29-Dec-78	 	TMA249590	 	15-Aug-80	 	
	AVON NATURALS	 	Avon Products, Inc.	 	United States of America	 	Registered	 	76618066	 	28-Oct-04	 	3089185	 	9-May-06	 	3
	AVON NATURALS	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78936964	 	25-Jul-06	 	3187478	 	19-Dec-06	 	3
	AVON NATURALS ANTIBACTERIAL	 	Avon Canada Inc.	 	Canada	 	Registered	 	1164481	 	14-Jan-03	 	TMA639943	 	16-May-05	 	

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	AVON NATURALS KIDS	 	Avon Canada Inc.	 	Canada	 	Registered	 	1522660	 	7-Apr-11	 	TMA822,862	 	25-Apr-12	 	3
	AVON NUTRAEFFECTS	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86691420	 	13-Jul-15	 		 		 	5
	AVON NUTRAEFFECTS	 	Avon Canada Inc.	 	Canada	 	Pending	 	1737142	 	13-Jul-15	 		 		 	5
	AVON PASSION	 	Avon Canada Inc.	 	Canada	 	Registered	 	1643676	 	16-Sep-13	 	TMA903,728	 	14-May-15	 	3
	AVON PASSION	 	Avon Products, Inc.	 	United States of America	 	Registered	 	86061861	 	11-Sep-13	 	4594343	 	26-Aug-14	 	3
	AVON PAVIELLE	 	Avon Canada Inc.	 	Canada	 	Registered	 	0492921	 	4-Oct-82	 	TMA305747	 	9-Aug-85	 	
	AVON PEARLS & LACE	 	Avon Canada Inc.	 	Canada	 	Registered	 	0501047	 	29-Mar-83	 	TMA315696	 	27-Jun-86	 	
	AVON PRIMA	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86808212	 	3-Nov-15	 		 		 	3
	AVON PRIMA	 	Avon Canada Inc.	 	Canada	 	Pending	 	1753199	 	3-Nov-15	 		 		 	3
	AVON RENEWABLE COLOUR LIPSTICK	 	Avon Canada Inc.	 	Canada	 	Registered	 	0654415	 	29-Mar-90	 	TMA388356	 	30-Aug-91	 	
	AVON SENSES	 	Avon Canada Inc.	 	Canada	 	Registered	 	1226692	 	11-Aug-04	 	TMA651,371	 	25-Oct-05	 	
	AVON SENSES BODY CARE	 	Avon Canada Inc.	 	Canada	 	Pending	 	1732038	 	9-Jun-15	 		 		 	3
	AVON SKIN CARE LABORATORIES	 	Avon Canada Inc.	 	Canada	 	Registered	 	0876062	 	22-Apr-98	 	TMA517175	 	28-Sep-99	 	
	AVON SMILE	 	Avon Canada Inc.	 	Canada	 	Registered	 	1174257	 	22-Apr-03	 	TMA639554	 	11-May-05	 	
	AVON SOLUTIONS	 	Avon Canada Inc.	 	Canada	 	Registered	 	1130371	 	12-Feb-02	 	TMA581167	 	9-May-03	 	
	AVON SOLUTIONS COMPLETELY CLEAN	 	Avon Canada Inc.	 	Canada	 	Registered	 	1325796	 	27-Nov-06	 	TMA706017	 	29-Jan-08	 	3
	AVON SOLUTIONS MAXIMUM MOISTURE	 	Avon Canada Inc.	 	Canada	 	Registered	 	1267809	 	9-Aug-05	 	TMA687997	 	18-May-07	 	3
	AVON STYLE	 	Avon Canada Inc.	 	Canada	 	Registered	 	1022168	 	14-Jul-99	 	TMA553086	 	29-Oct-01	 	
	AVON SUN	 	Avon Canada Inc.	 	Canada	 	Registered	 	0881239	 	16-Jun-98	 	TMA557497	 	7-Feb-02	 	
	 AVON SUPERMAGNIFY
	 	 Avon Canada Inc.
	 	 Canada
	 	 Registered
	 	1448426	 	 17-Aug-09
	 	 TMA778950
	 	 4-Oct-10
	 	3
	AVON THE COMPANY FOR WOMEN & DESIGN	 	Avon Canada Inc.	 	Canada	 	Registered	 	1024210	 	30-Jul-99	 	TMA668728	 	26-Jul-06	 	
	 AVON TRUE
	 	 Avon Products, Inc.
	 	 Canada
	 	 Pending
	 	1730954	 	 2-Jun-15
	 		 		 	3

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	AVON TRUE	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86648370	 	2-Jun-15	 		 		 	3
	AVON TRUE color and Design	 	Avon Canada Inc.	 	Canada	 	Pending	 	1752583	 	29-Oct-15	 		 		 	3
	AVON WOMEN OF INSPIRATION AWARDS	 	Avon Canada Inc.	 	Canada	 	Registered	 	1154050	 	2-Oct-02	 	TMA616515	 	10-Aug-04	 	
	BAISER D’ADIEU AU CANCER DU SEIN	 	Avon Products, Inc.	 	Canada	 	Registered	 	1122710	 	26-Nov-01	 	TMA625740	 	17-Nov-04	 	
	BE...TEMPTING	 	Avon Products, Inc.	 	Canada	 	Registered	 	1304900	 	9-Jun-06	 	TMA694606	 	22-Aug-07	 	3
	BEAUTIFUL MORNING	 	Avon Products, Inc.	 	Canada	 	Registered	 	1112668	 	20-Aug-01	 	TMA616158	 	3-Aug-04	 	
	BEAUTIFUL PROMISES KEPT	 	Avon Products, Inc.	 	Canada	 	Pending	 	1768017	 	16-Feb-16	 		 		 	35
	BEAUTIFUL PROMISES KEPT	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86782172	 	8-Oct-15	 		 		 	35
	BEAUTIFULLY BRIGHT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1184819	 	1-Aug-03	 	TMA642614	 	21-Jun-05	 	
	BERRY GRAND	 	Avon Products, Inc.	 	Canada	 	Registered	 	1368604	 	23-Oct-07	 	TMA778946	 	4-Oct-10	 	3
	BEYOND COLOR	 	Avon Products, Inc.	 	Canada	 	Registered	 	1038910	 	10-Dec-99	 	TMA553213	 	1-Nov-01	 	
	BEYOND COLOR	 	Avon Products, Inc.	 	United States of America	 	Registered	 	74708819	 	31-Jul-95	 	2049866	 	1-Apr-97	 	3
	BEYOND COLOR LIP RECOVERY CREAM	 	Avon Products, Inc.	 	Canada	 	Registered	 	1228957	 	1-Sep-04	 	TMA652,477	 	8-Nov-05	 	
	BIG & DARING	 	Avon Products, Inc.	 	Canada	 	Pending	 	1636982	 	26-Jul-13	 		 		 	3
	BIG & DARING	 	Avon Products, Inc.	 	United States of America	 	Registered	 	86019461	 	25-Jul-13	 	4717220	 	7-Apr-15	 	3
	BIG & FALSE EFFECT	 	Avon Products, Inc.	 	Canada	 	Pending	 	1663814	 	13-Feb-14	 		 		 	3
	BIG & FALSE EFFECT	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86193095	 	13-Feb-14	 		 		 	3
	BIG & FALSE LASH	 	Avon Products, Inc.	 	Canada	 	Registered	 	1676956	 	14-May-14	 	TMA927836	 	1-Feb-2016	 	3
	BIG & FALSE LASH	 	Avon Products, Inc.	 	United States of America	 	Registered	 	86322371	 	27-Jun-14	 	4882427	 	5-Jan-2016	 	3
	BIG & MULTIPLIED	 	Avon Products, Inc.	 	Canada	 	Pending	 	1721301	 	27-Mar-15	 		 		 	3
	BIG & MULTIPLIED	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86578441	 	27-Mar-15	 		 		 	3

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	BIO 6	 	Avon Products, Inc.	 	Canada	 	Registered	 	1137045	 	16-Apr-02	 	TMA638644	 	28-Apr-05	 	
	BIOSEED COMPLEX	 	Avon Products, Inc.	 	Canada	 	Registered	 	1235193	 	27-Oct-04	 	TMA653638	 	25-Nov-05	 	
	BLACK SUEDE	 	Avon Products, Inc.	 	Canada	 	Registered	 	0462806	 	11-Dec-80	 	TMA280318	 	10-Jun-83	 	
	BLACK SUEDE	 	Avon Products, Inc.	 	United States of America	 	Registered	 	73224632	 	24-Jul-79	 	1150754	 	14-Apr-81	 	3
	BLACK SUEDE LEATHER	 	Avon Products, Inc.	 	Canada	 	Registered	 	1408857	 	28-Aug-08	 	TMA804,854	 	19-Aug-11	 	3
	BLISSFULLY NOURISHING	 	Avon Products, Inc.	 	Canada	 	Pending	 	1712500	 	26-Jan-15	 		 		 	3
	BLUE RUSH	 	Avon Products, Inc.	 	Canada	 	Registered	 	1226687	 	11-Aug-04	 	TMA661199	 	22-Mar-06	 	
	BODY ILLUSIONS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1528215	 	18-May-11	 	TMA890,744	 	25-Nov-14	 	25
	BODY ILLUSIONS	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85330618	 	26-May-11	 	4246804	 	20-Nov-12	 	25
	BOHISTA	 	Avon Products, Inc.	 	Canada	 	Registered	 	1298018	 	18-Apr-06	 	689443	 	8-Jun-07	 	
	BOHYLUROX	 	Avon Products, Inc.	 	Canada	 	Registered	 	1231897	 	28-Sep-04	 	TMA650902	 	20-Oct-2005	 	3
	BOTANISOURCE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1047231	 	21-Feb-00	 	TMA574813	 	30-Jan-2003	 	3
	BUG GUARD	 	Avon Products, Inc.	 	United States of America	 	Registered	 	75102151	 	10-May-96	 	2100341	 	23-Sep-97	 	5
	BUG GUARD PLUS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1449196	 	24-Aug-09	 	TMA829,769	 	10-Aug-12	 	
	BUST SCULPT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1216720	 	13-May-04	 	TMA689014	 	5-Jun-07	 	
	CANDID	 	Avon Canada Inc.	 	Canada	 	Registered	 	0392495	 	11-Dec-75	 	TMA218608	 	28-Jan-77	 	
	CARE DEEPLY	 	Avon Products, Inc.	 	Canada	 	Registered	 	0357296	 	25-Sep-72	 	TMA198966	 	10-May-74	 	
	CARE DEEPLY	 	Avon Products, Inc.	 	United States of America	 	Registered	 	76345810	 	7-Dec-01	 	2615287	 	3-Sep-02	 	3
	CÉLÈBRE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1041070	 	29-Dec-99	 	TMA561498	 	7-May-02	 	
	CELLU-SCULPT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1147822	 	29-Jul-02	 	TMA640406	 	25-May-05	 	
	CELLU-SCULPT BODY	 	Avon Products, Inc.	 	Canada	 	Registered	 	1185696	 	7-Aug-03	 	TMA642890	 	23-Jun-05	 	
	CELLU-SCULPT LEG PERFECTOR	 	Avon Products, Inc.	 	Canada	 	Registered	 	1229891	 	10-Sep-04	 	TMA651,103	 	21-Oct-05	 	
	CHIC IN BLACK	 	Avon Products, Inc.	 	Canada	 	Registered	 	1403507	 	16-Jul-08	 	TMA753771	 	24-Nov-09	 	3
	CHIC IN BLACK	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77669431	 	12-Feb-09	 	3658037	 	21-Jul-09	 	3

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	CHIC IN WHITE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1403516	 	16-Jul-08	 	TMA766549	 	12-May-10	 	3
	CHIC IN WHITE	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77669439	 	12-Feb-09	 	3796926	 	1-Jun-10	 	3
	CHINESE CHARACTERS DESIGN	 	Avon Products, Inc.	 	Canada	 	Registered	 	1143118	 	10-Jun-02	 	TMA625306	 	12-Nov-04	 	
	CLEAR SKIN	 	Avon Canada Inc.	 	Canada	 	Registered	 	0428279	 	4-Aug-78	 	TMA248634	 	25-Jul-80	 	
	CLEARING TREND	 	Avon Products, Inc.	 	Canada	 	Registered	 	1168194	 	21-Feb-03	 	669313	 	4-Aug-06	 	
	CLEARSKIN	 	Avon Canada Inc.	 	Canada	 	Registered	 	1410361	 	11-Sep-08	 	TMA756,315	 	4-Jan-10	 	3
	CLEARSKIN	 	Avon Products, Inc.	 	United States of America	 	Registered	 	74515428	 	22-Apr-94	 	1975701	 	28-May-96	 	5
	CLEARSKIN	 	Avon Products, Inc.	 	United States of America	 	Registered	 	74687583	 	12-Jun-95	 	1976573	 	28-May-96	 	3
	CLEARSKIN BLACKHEAD ELIMINATING	 	Avon Canada Inc.	 	Canada	 	Registered	 	1438055	 	13-May-09	 	TMA767,910	 	27-May-10	 	3
	CLEARSKIN BLEMISH CLEARING	 	Avon Canada Inc.	 	Canada	 	Registered	 	1438057	 	13-May-09	 	TMA767,545	 	20-May-10	 	3
	CLEARSKIN PORE PENETRATING	 	Avon Canada Inc.	 	Canada	 	Registered	 	1438060	 	13-May-09	 	TMA786517	 	5-Jan-11	 	3
	CLEARSKIN PROFESSIONAL	 	Avon Canada Inc.	 	Canada	 	Registered	 	1373011	 	21-Nov-07	 	TMA734299	 	11-Feb-09	 	3
	COLOR TREND	 	Avon Products, Inc.	 	Canada	 	Registered	 	0882579	 	29-Jun-98	 	TMA563859	 	20-Jun-02	 	
	COLOR TREND	 	Avon Products, Inc.	 	United States of America	 	Registered	 	75337165	 	7-Aug-97	 	2265523	 	27-Jul-99	 	3
	COOL CONFIDENCE	 	Avon Products, Inc.	 	Canada	 	Registered	 	0552001	 	4-Nov-85	 	TMA327405	 	8-May-87	 	
	COTILLION	 	Avon Canada Inc.	 	Canada	 	Registered	 	0166759	 	20-Aug-35	 	UCA5130	 	20-Aug-35	 	
	CRYSTAL AURA	 	Avon Products, Inc.	 	Canada	 	Registered	 	1281960	 	5-Dec-05	 	TMA727365	 	29-Oct-08	 	3
	CRYSTAL SHIMMER	 	Avon Products, Inc.	 	Canada	 	Registered	 	1168246	 	21-Feb-03	 	TMA669035	 	31-Jul-06	 	
	C-THRU	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77568955	 	12-Sep-08	 	3704308	 	3-Nov-2009	 	3
	C-THRU-U	 	Avon Products, Inc.	 	Canada	 	Registered	 	1168172	 	20-Feb-03	 	669257	 	3-Aug-06	 	

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	CUCINA DONNA	 	Avon Products, Inc.	 	Canada	 	Pending	 	1654963	 	5-Dec-13	 		 		 	21
	CUCINA DONNA	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86134615	 	4-Dec-13	 		 		 	21
	CURL GODDESS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1225211	 	28-Jul-04	 	TMA668948	 	28-Jul-06	 	
	CURL GODDESS	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78457921	 	28-Jul-04	 	3094185	 	16-May-06	 	3
	CURL-ASCIOUS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1085774	 	18-Dec-00	 	TMA600221	 	22-Jan-04	 	
	CUSHION WALK	 	Avon Products, Inc.	 	Canada	 	Registered	 	1221978	 	28-Jun-04	 	TMA691456	 	6-Jul-07	 	
	CUSHION WALK	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78441590	 	25-Jun-04	 	3094100	 	16-May-06	 	25
	DAILY RESULTS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1155017	 	11-Oct-02	 	TMA638616	 	28-Apr-05	 	
	DARING CURVES	 	Avon Products, Inc.	 	Canada	 	Registered	 	1231209	 	21-Sep-04	 	TMA651,209	 	21-Oct-05	 	
	DARING DEFINITION	 	Avon Products, Inc.	 	Canada	 	Registered	 	1258353	 	20-May-05	 	TMA716812	 	18-Jun-08	 	3
	DAY FORCE	 	Avon Products, Inc.	 	Canada	 	Registered	 	0881240	 	16-Jun-98	 	TMA547963	 	11-Jul-01	 	
	DERMA-3X TECHNOLOGY	 	Avon Products, Inc.	 	Canada	 	Registered	 	1174255	 	22-Apr-03	 	TMA642851	 	23-Jun-05	 	
	DERMA-FULL	 	Avon Products, Inc.	 	Canada	 	Registered	 	1445804	 	23-Jul-09	 	TMA770244	 	21-Jun-10	 	3
	DERMA-REFINE TECHNOLOGY	 	Avon Products, Inc.	 	Canada	 	Registered	 	1265256	 	18-Jul-05	 	TMA682609	 	28-Feb-07	 	
	DERMASHADE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1308697	 	11-Jul-06	 	TMA743244	 	10-Jul-09	 	
	DEW KISS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1154794	 	9-Oct-02	 	TMA638239	 	25-Apr-05	 	
	DEW KISS	 	Avon Products, Inc.	 	United States of America	 	Registered	 	76420696	 	14-Jun-02	 	2713293	 	6-May-03	 	3
	DIAMONEX	 	Avon Products, Inc.	 	Canada	 	Registered	 	1038171	 	6-Dec-99	 	TMA571346	 	27-Nov-02	 	
	DREAMLIFE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1110758	 	30-Jul-01	 	TMA616471	 	9-Aug-04	 	
	DREAMLIFE BOUQUET	 	Avon Products, Inc.	 	Canada	 	Registered	 	1216718	 	13-May-04	 	TMA651,022	 	20-Oct-05	 	
	DRIVEN	 	Avon Products, Inc.	 	Canada	 	Registered	 	1295961	 	30-Mar-06	 	TMA736008	 	10-Mar-09	 	
	DRIVEN	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78498273	 	12-Oct-04	 	3319613	 	23-Oct-2007	 	
	DRIVEN BLACK	 	Avon Products, Inc.	 	Canada	 	Registered	 	1333079	 	29-Jan-07	 	TMA756266	 	31-Dec-09	 	

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	ELECTRIFY ME	 	Avon Products, Inc.	 	Canada	 	Registered	 	1375533	 	11-Dec-07	 	TMA786808	 	10-Jan-11	 	3
	ELECTRIFY ME	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77351966	 	14-Dec-07	 	3758164	 	9-Mar-10	 	3
	ELECTRO-LIGHTS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1168238	 	21-Feb-03	 	TMA668151	 	18-Jul-06	 	
	ETERNAL MAGIC	 	Avon Products, Inc.	 	Canada	 	Registered	 	1410171	 	10-Sep-08	 	TMA770849	 	29-Jun-10	 	3
	ETERNAL MAGIC	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77567513	 	11-Sep-08	 	3873954	 	9-Nov-10	 	3
	ETERNAL MAGIC ENCHANTED	 	Avon Products, Inc.	 	Canada	 	Registered	 	1499461	 	13-Oct-10	 	TMA810,714	 	1-Nov-11	 	3
	EXPLORATION	 	Avon Products, Inc.	 	Canada	 	Registered	 	1617067	 	6-Mar-13	 	TMA878,870	 	28-May-14	 	3
	EXTRALASTING	 	Avon Products, Inc.	 	Canada	 	Registered	 	1484129	 	8-Jun-10	 	TMA799,107	 	1-Jun-11	 	3
	EXTRALASTING	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85054709	 	4-Jun-10	 	3907636	 	18-Jan-11	 	3
	EYE BE GOOD	 	Avon Products, Inc.	 	Canada	 	Registered	 	1213274	 	14-Apr-04	 	669711	 	11-Aug-06	 	
	EYE PERFECTOR	 	Avon Products, Inc.	 	United States of America	 	Registered	 	73604489	 	16-Jun-86	 	1449166	 	28-Jul-87	 	3
	FAR AWAY BELLA SUNSET	 	Avon Products, Inc.	 	Canada	 	Pending	 	1650949	 	6-Nov-13	 		 		 	3
	FAR AWAY INFINITY	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86592517	 	9-Apr-15	 		 		 	3
	FARAWAY	 	Avon Products, Inc.	 	Canada	 	Registered	 	0750551	 	29-Mar-94	 	TMA474742	 	15-Apr-97	 	
	FARAWAY	 	Avon Products, Inc.	 	United States of America	 	Registered	 	74508521	 	4-Apr-94	 	1986071	 	9-Jul-96	 	3
	FARAWAY EXOTIC	 	Avon Products, Inc.	 	Canada	 	Registered	 	1491203	 	5-Aug-10	 	TMA855952	 	23-Jul-13	 	3
	FEELIN’ FRESH	 	Avon Canada Inc.	 	Canada	 	Registered	 	0849601	 	4-Jul-97	 	TMA505956	 	29-Dec-98	 	
	FEELIN’ FRESH	 	Avon Canada Inc.	 	Canada	 	Registered	 	0849602	 	4-Jul-97	 	TMA505957	 	29-Dec-98	 	
	FEELIN’ FRESH	 	Avon Products, Inc.	 	United States of America	 	Registered	 	73326070	 	31-Aug-81	 	1224783	 	25-Jan-83	 	3
	FEELIN’ FRESH AND Device	 	Avon Canada Inc.	 	Canada	 	Registered	 	1012785	 	22-Apr-99	 	TMA545548	 	24-May-01	 	
	FIBER FULL	 	Avon Products, Inc.	 	Canada	 	Pending	 	1768004	 	16-Feb-16	 		 		 	3
	FIBER FULL	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86918521	 	24-Feb-16	 		 		 	3

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	FIRE ME UP	 	Avon Products, Inc.	 	Canada	 	Registered	 	1361400	 	28-Aug-07	 	TMA755974	 	23-Dec-09	 	3
	FLAVOR SAVERS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1161189	 	9-Dec-02	 	TMA625167	 	10-Nov-04	 	
	FLEXI-SHIELD	 	Avon Products, Inc.	 	Canada	 	Registered	 	1103052	 	18-May-01	 	TMA586418	 	1-Aug-03	 	
	FLIP FOR IT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1316660	 	15-Sep-06	 	TMA747538	 	14-Sep-09	 	
	FLOR VIOLETA	 	Avon Products, Inc.	 	Canada	 	Registered	 	1,583,387	 	22-Jun-12	 	TMA906174	 	11-June-2015	 	3
	FLORAL PRINTS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1198510	 	4-Dec-03	 	TMA640446	 	25-May-05	 	
	FLORAL PRINTS LAVENDER	 	Avon Products, Inc.	 	Canada	 	Registered	 	1248802	 	28-Feb-05	 	TMA683856	 	16-Mar-07	 	
	FONDATION AVON POUR LES FEMMES, CANADA	 	Avon Canada Inc.	 	Canada	 	Registered	 	1458395	 	9-Nov-09	 	TMA850,730	 	13-Jun-13	 	
	FOOT WORKS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1032247	 	13-Oct-99	 	TMA569302	 	22-Oct-02	 	
	FOOT WORKS	 	Avon Products, Inc.	 	United States of America	 	Registered	 	75407077	 	17-Dec-97	 	2293987	 	23-Nov-99	 	3
	FOOTWORKS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1032247(01)	 	29-Jan-03	 	TMA569302	 	22-Jun-05	 	
	FOOTWORKS BEAUTIFUL & DESIGN	 	Avon Products, Inc.	 	Canada	 	Registered	 	1530720	 	7-Jun-11	 	TMA826,334	 	14-Jun-12	 	3
	FOOTWORKS HEALTHY & DESIGN	 	Avon Products, Inc.	 	Canada	 	Registered	 	1530721	 	7-Jun-11	 	TMA826,333	 	14-Jun-12	 	3
	FOR GOODNESS FACE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1362208	 	4-Sep-07	 	TMA719190	 	24-Jul-08	 	3
	FRESH & SMOOTH	 	Avon Products, Inc.	 	Canada	 	Registered	 	1147961	 	30-Jul-02	 	TMA638392	 	27-Apr-05	 	
	FRESH & SMOOTH	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78147565	 	25-Jul-02	 	2830800	 	6-Apr-04	 	3
	FRESH & SMOOTH MOISTURIZING +MEADOWFOAM	 	Avon Products, Inc.	 	Canada	 	Registered	 	1550296	 	2-Nov-11	 	TMA888,448	 	21-Oct-14	 	3
	FRESH & SMOOTH SENSITIVE SKIN +MEADOWFOAM	 	Avon Products, Inc.	 	Canada	 	Registered	 	1550297	 	2-Nov-11	 	TMA888,449	 	21-Oct-14	 	3
	FRESH KISS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1153610	 	27-Sep-02	 	TMA668271	 	19-Jul-06	 	3
	friktion	 	Avon Products, Inc.	 	Canada	 	Registered	 	1016410	 	25-May-99	 	TMA560834	 	25-Apr-02	 	

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	friktion	 	Avon Products, Inc.	 	Canada	 	Registered	 	1138634	 	30-Apr-02	 	TMA625281	 	10-Nov-04	 	
	GLAZEWEAR	 	Avon Products, Inc.	 	Canada	 	Registered	 	1016432	 	26-May-99	 	TMA553227	 	1-Nov-01	 	
	GLAZEWEAR	 	Avon Products, Inc.	 	United States of America	 	Registered	 	75671832	 	31-Mar-99	 	2384206	 	5-Sep-00	 	3
	GLAZEWEAR DAZZLERS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1186519	 	13-Aug-03	 	TMA625270	 	10-Nov-04	 	
	GLAZEWEAR INTENSE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1424172	 	12-Jan-09	 	TMA817,611	 	14-Feb-12	 	3
	GLAZEWEAR SHINE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1424175	 	12-Jan-09	 	TMA817,599	 	14-Feb-12	 	3
	GLAZEWEAR SPARKLE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1424173	 	12-Jan-09	 	TMA817,598	 	14-Feb-12	 	3
	GLEAMSTICK	 	Avon Products, Inc.	 	Canada	 	Registered	 	1290219	 	16-Feb-06	 	TMA682,849	 	5-Mar-07	 	
	GLIMMERSTICKS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1002666	 	21-Jan-99	 	TMA531738	 	24-Aug-00	 	
	GLIMMERSTICKS	 	Avon Products, Inc.	 	United States of America	 	Registered	 	74513761	 	18-Apr-94	 	1881791	 	7-Mar-95	 	3
	GLIMMERSTICKS DIAMONDS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1433163	 	1-Apr-09	 	TMA820990	 	28-Mar-12	 	3
	GLOSSBLOSSOM	 	Avon Products, Inc.	 	Canada	 	Registered	 	1193680	 	22-Oct-03	 	TMA667606	 	13-Jul-06	 	
	GLOW BABY GLOW	 	Avon Products, Inc.	 	Canada	 	Registered	 	1168210	 	21-Feb-03	 	TMA667875	 	17-Jul-06	 	
	GO WITH THE GRAIN	 	Avon Products, Inc.	 	Canada	 	Registered	 	1362215	 	4-Sep-07	 	TMA755076	 	10-Dec-09	 	3
	GODDESS BY AVON	 	Avon Canada Inc.	 	Canada	 	Registered	 	1194943	 	31-Oct-03	 	TMA643932	 	8-Jul-05	 	
	GOLD MESH TECHNOLOGY	 	Avon Products, Inc.	 	Canada	 	Registered	 	1224225	 	20-Jul-04	 	TMA651,450	 	26-Oct-05	 	
	GOOD GLOWING	 	Avon Products, Inc.	 	Canada	 	Registered	 	1168211	 	21-Feb-03	 	TMA667866	 	17-Jul-06	 	
	GOOD GLOWING	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78214965	 	14-Feb-03	 	3018439	 	22-Nov-05	 	3
	HAIKU	 	Avon Products, Inc.	 	Canada	 	Registered	 	1141970	 	31-May-02	 	TMA625187	 	10-Nov-04	 	
	HAIKU	 	Avon Products, Inc.	 	United States of America	 	Registered	 	75839924	 	5-Nov-99	 	2698122	 	18-Mar-03	 	3
	HAIKU	 	Avon Products, Inc.	 	United States of America	 	Registered	 	76416499	 	31-May-02	 	2720999	 	3-Jun-03	 	3
	HAIKU AWAKENINGS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1142578	 	11-Jun-02	 	TMA625341	 	12-Nov-04	 	
	HELLO TOMORROW	 	Avon Products, Inc.	 	Canada	 	Registered	 	1308693	 	11-Jul-06	 	TMA689938	 	15-Jun-07	 	

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	HELLO TOMORROW	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78926562	 	11-Jul-06	 	3332761	 	6-Nov-07	 	35
	HERE’S MY HEART	 	Avon Products, Inc.	 	Canada	 	Registered	 	0258177	 	2-Aug-60	 	TMA121130	 	10-Feb-61	 	
	HOOK UP	 	Avon Products, Inc.	 	Canada	 	Registered	 	1168244	 	21-Feb-03	 	TMA668152	 	18-Jul-06	 	
	HOOK UP	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78215125	 	14-Feb-03	 	3340778	 	20-Nov-07	 	3
	HYDROFIRMING BIO 6	 	Avon Products, Inc.	 	Canada	 	Registered	 	1138164	 	25-Apr-02	 	TMA633203	 	18-Feb-05	 	
	I MARK	 	Avon Products, Inc.	 	Canada	 	Registered	 	1168216	 	21-Feb-03	 	TMA667906	 	17-Jul-06	 	
	I MARK	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78214972	 	14-Feb-03	 	2990289	 	30-Aug-05	 	3
	I USE AVON & DESIGN	 	Avon Canada Inc.	 	Canada	 	Registered	 	1634453	 	9-Jul-13	 	TMA913,138	 	4-Sep-15	 	35
	ICE SHEERS	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77666450	 	9-Feb-09	 	3838687	 	24-Aug-10	 	3
	IDEAL FLAWLESS	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85124648	 	8-Sep-10	 	4053928	 	8-Nov-11	 	3
	IDEAL FLAWLESS INVISIBLE COVERAGE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1495856	 	14-Sep-10	 	TMA855,182	 	20-Aug-13	 	3
	IDEAL SHADE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1349436	 	30-May-07	 	TMA755075	 	10-Dec-09	 	3
	ILLUMINATING RADIANCE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1070348	 	10-Aug-00	 	TMA568565	 	4-Oct-02	 	
	IMARI	 	Avon Products, Inc.	 	Canada	 	Registered	 	0529209	 	1-Oct-84	 	TMA335529	 	24-Dec-87	 	
	IMARI	 	Avon Products, Inc.	 	United States of America	 	Registered	 	73499898	 	17-Sep-84	 	1339942	 	11-Jun-85	 	3
	IMARI BLOSSOM	 	Avon Products, Inc.	 	Canada	 	Registered	 	1552106	 	15-Nov-11	 	TMA853,807	 	20-Jun-13	 	3
	IMARI ELIXIR	 	Avon Products, Inc.	 	Canada	 	Pending	 	1670745	 	1-Apr-14	 		 		 	3
	IMARI ELIXIR	 	Avon Products, Inc.	 	United States of America	 	Registered	 	86237536	 	31-Mar-14	 	4863892	 	1-Dec-2015	 	3
	I’MPERFECT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1201297	 	9-Dec-03	 	TMA639323	 	6-May-2005	 	3
	INCANDESSENCE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1059456	 	18-May-00	 	TMA559664	 	25-Mar-02	 	
	INCREDIBLE FINISH	 	Avon Products, Inc.	 	Canada	 	Registered	 	1059450	 	18-May-00	 	TMA569233	 	22-Oct-02	 	
	INDIVIDUAL BLUE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1081718	 	6-Nov-00	 	TMA596686	 	5-Dec-03	 	

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	INFINITE LIFT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1623457	 	18-Apr-13	 	TMA883,496	 	6-Aug-14	 	3
	INFINITE LIFT	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85907774	 	18-Apr-13	 	4539931	 	27-May-14	 	3
	INFINITE MOMENT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1528611	 	20-May-11	 	TMA825,839	 	7-Jun-12	 	3
	INFINITE MOMENT	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85330078	 	25-May-11	 	4144189	 	15-May-12	 	3
	IRRESISTIBLY SEXY	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85492596	 	12-Dec-11	 	4343360	 	28-May-13	 	3
	JET FEMME	 	Avon Products, Inc.	 	Canada	 	Registered	 	1384365	 	21-Feb-08	 	TMA744909	 	7-Aug-09	 	3
	JET HOMME	 	Avon Products, Inc.	 	Canada	 	Registered	 	1384364	 	21-Feb-08	 	TMA744531	 	4-Aug-09	 	3
	JUST PLAY	 	Avon Products, Inc.	 	Canada	 	Registered	 	1392753	 	24-Apr-08	 	TMA743616	 	16-Jul-09	 	3
	KARMALA	 	Avon Products, Inc.	 	Canada	 	Registered	 	1235696	 	1-Nov-04	 	TMA684528	 	23-Mar-07	 	
	KISS DRY GOODBYE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1362210	 	4-Sep-07	 	TMA719182	 	24-Jul-08	 	3
	KISS GOODBYE TO BREAST CANCER	 	Avon Products, Inc.	 	Canada	 	Registered	 	1122709	 	26-Nov-01	 	TMA625571	 	16-Nov-04	 	
	KISS GOODBYE TO BREAST CANCER	 	Avon Products, Inc.	 	Canada	 	Registered	 	1145370	 	5-Jul-02	 	TMA625749	 	17-Nov-04	 	
	KISS RESIST	 	Avon Products, Inc.	 	Canada	 	Registered	 	1221940	 	28-Jun-04	 	TMA651,221	 	24-Oct-05	 	
	KISS THERAPY	 	Avon Products, Inc.	 	Canada	 	Registered	 	1184274	 	25-Jul-03	 	TMA667955	 	17-Jul-06	 	
	KISSINK	 	Avon Products, Inc.	 	Canada	 	Registered	 	1198484	 	4-Dec-03	 	TMA678816	 	2-Jan-07	 	
	KISSINK	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78334995	 	2-Dec-03	 	2979631	 	26-Jul-05	 	3
	LA COMPAGNIE POUR LES FEMMES	 	Avon Canada Inc.	 	Canada	 	Registered	 	1127279	 	11-Jan-02	 	TMA714281	 	13-May-08	 	
	LASH DESIGNER	 	Avon Products, Inc.	 	Canada	 	Registered	 	1137042	 	16-Apr-02	 	TMA625464	 	16-Nov-04	 	
	LAUGH OFTEN	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85060326	 	11-Jun-10	 	4003695	 	26-Jul-11	 	3
	LET’S TALK	 	Avon Products, Inc.	 	Canada	 	Registered	 	1041643	 	6-Jan-00	 	TMA565242	 	25-Jul-02	 	
	LIFESTYLE SOLUTIONS	 	Avon Products, Inc.	 	United States of America	 	Registered	 	74525322	 	16-May-94	 	1975306	 	21-May-96	 	42
	LIFT & TUCK	 	Avon Products, Inc.	 	Canada	 	Registered	 	1238421	 	24-Nov-04	 	TMA659852	 	1-Mar-06	 	

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	LIGHTEN UP PLUS	 	Avon Canada Inc.	 	Canada	 	Registered	 	1104210	 	30-May-01	 	TMA654038	 	30-Nov-05	 	
	LIIV BOTANICALS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1349437	 	30-May-07	 	TMA755080	 	10-Dec-2009	 	3
	LIP MARK-IT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1168219	 	21-Feb-03	 	669240	 	3-Aug-06	 	
	LITTLE BLACK DRESS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1059452	 	18-May-00	 	TMA571241	 	25-Nov-02	 	
	LITTLE BLACK DRESS	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86181527	 	31-Jan-14	 		 		 	3
	LITTLE BLOSSOM	 	Avon Products, Inc.	 	Canada	 	Registered	 	1084643	 	7-Dec-00	 	TMA572780	 	23-Dec-02	 	
	LITTLE LACE DRESS	 	Avon Products, Inc.	 	Canada	 	Pending	 	1721267	 	27-Mar-15	 		 		 	3
	LITTLE LACE DRESS	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86577712	 	26-Mar-15	 		 		 	3
	LIVE WITHOUT REGRETS	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85060333	 	11-Jun-10	 	4099739	 	14-Feb-12	 	3
	LOTUS SHIELD	 	Avon Products, Inc.	 	Canada	 	Registered	 	1478787	 	28-Apr-10	 	TMA796113	 	26-Apr-11	 	3
	LOTUS SHIELD	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85022904	 	26-Apr-10	 	3895632	 	21-Dec-10	 	3
	LOVE TO THE FULLEST	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85060360	 	11-Jun-10	 	4003696	 	26-Jul-11	 	3
	LUMINOSITY	 	Avon Products, Inc.	 	Canada	 	Registered	 	0885155	 	24-Jul-98	 	TMA548914	 	30-Jul-01	 	
	LUMINOSITY	 	Avon Products, Inc.	 	United States of America	 	Registered	 	75509486	 	26-Jun-98	 	2350822	 	16-May-00	 	3
	MAGIX	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77344697	 	5-Dec-07	 	3555031	 	30-Dec-08	 	3
	MAGIX and Design	 	Avon Products, Inc.	 	Canada	 	Registered	 	1374938	 	6-Dec-07	 	TMA730425	 	9-Dec-08	 	3
	MAKE ME WONDER	 	Avon Products, Inc.	 	Canada	 	Registered	 	1368880	 	24-Oct-07	 	TMA756058	 	29-Dec-09	 	3
	MARK	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85505413	 	29-Dec-11	 	4256479	 	11-Dec-12	 	14
	MARK	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85505458	 	29-Dec-11	 	4256480	 	11-Dec-12	 	3
	MARK	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85505472	 	29-Dec-11	 	4256481	 	11-Dec-12	 	18
	MARK	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85505495	 	29-Dec-11	 	4197643	 	28-Aug-12	 	5

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	MARK, SET, SHINE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1168221	 	21-Feb-03	 	669312	 	4-Aug-06	 	
	MARK. & Design	 	Avon Products, Inc.	 	United States of America	 	INSTRUCTED- WTG. FOR PARTICULAR S	 		 		 		 		 	3
	MARK. & Design	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85/505486	 	29-Dec-2011	 	4252873	 	4-Dec-2012	 	25
	MARK. & Design	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85/505520	 	29-Dec-11	 	4256483	 	11-Dec-2012	 	35
	MARK. & Design	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85/505536	 	29-Dec-11	 	4201461	 	4-Sep-2012	 	21
	MARK. SELF SANCTUARY	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77711407	 	10-Apr-09	 	3701535	 	27-Oct-09	 	3
	MARK.AVON	 	Avon Canada Inc.	 	Canada	 	Registered	 	1153098	 	24-Sep-02	 	TMA685636	 	5-Apr-07	 	
	MARK.AVON	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78166023	 	19-Sep-02	 	3046726	 	17-Jan-06	 	35
	MARK.THE BOLD	 	Avon Products, Inc.	 	Canada	 	Pending	 	1768015	 	16-Feb-16	 		 		 	3,14, 18,25
	MARK.THE BOLD	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86918222	 	24-Feb-16	 		 		 	3
	MARK.CELEBRATE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1601630	 	8-Nov-12	 	TMA864,352	 	5-Nov-13	 	3
	MARK.CELEBRATE	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77886082	 	4-Dec-09	 	3901824	 	4-Jan-11	 	3
	MARK.CHEEK MAGNET	 	Avon Products, Inc.	 	Canada	 	Pending	 	1768005	 	16-Feb-16	 		 		 	3
	MARK.CHEEK MAGNET	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86918263	 	24-Feb-16	 		 		 	3
	MARK. DESIGN	 	Avon Products, Inc.	 	Canada	 	Pending	 	1759003	 	10-Dec-15	 		 		 	3
	MARK.EARTH	 	Avon Products, Inc.	 	Canada	 	Registered	 	1371232	 	8-Nov-07	 	TMA756,629	 	7-Jan-10	 	3
	MARK.EYE CONTACT	 	Avon Products, Inc.	 	Canada	 	Pending	 	1768007	 	16-Feb-16	 		 		 	3
	MARK.EYE CONTACT	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86918317	 	24-Feb-16	 		 		 	3
	MARK.GLOW TOGETHER	 	Avon Products, Inc.	 	Canada	 	Pending	 	1768009	 	16-Feb-16	 		 		 	3
	MARK.GLOW TOGETHER	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86918297	 	24-Feb-16	 		 		 	3

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	MARK.JEWEL	 	Avon Products, Inc.	 	Canada	 	Registered	 	1325295	 	22-Nov-06	 	TMA734,582	 	17-Feb-09	 	
	MARK.JEWEL	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77052818	 	29-Nov-06	 	3445832	 	10-Jun-08	 	3
	MARK.NUDE MATTE	 	Avon Products, Inc.	 	Canada	 	Pending	 	1768011	 	16-Feb-16	 		 		 	3
	MARK.NUDE MATTE	 	Avon Products, Inc.	 	United States of America	 	Pending	 	86918339	 	24-Feb-16	 		 		 	3
	MARK.PURE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1335618	 	15-Feb-07	 	TMA756,624	 	7-Jan-10	 	3
	MARK.REBEL ROSE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1378166	 	7-Jan-08	 	TMA756167	 	30-Dec-09	 	
	MATTE-NIFICENT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1168224	 	21-Feb-03	 	TMA669045	 	31-Jul-06	 	
	MATTE-NIFICENT	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78215047	 	14-Feb-03	 	3002557	 	27-Sep-05	 	3
	MEADOW DEW	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77549481	 	18-Aug-08	 	3677666	 	1-Sep-09	 	3
	MEET MARK	 	Avon Products, Inc.	 	Canada	 	Registered	 	1153093	 	24-Sep-02	 	TMA675107	 	17-Oct-06	 	
	MEET MARK	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78166138	 	20-Sep-02	 	2972813	 	19-Jul-05	 	35
	MEGA EFFECTS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1667134	 	10-Mar-14	 	TMA902,982	 	6-May-15	 	3
	MEGA EFFECTS	 	Avon Products, Inc.	 	United States of America	 	Registered	 	86110542	 	5-Nov-13	 	4533711	 	20-May-14	 	3
	MEGA EFFECTS 5D	 	Avon Products, Inc.	 	Canada	 	Pending	 	1617066	 	6-Mar-2013	 		 		 	3
	MEGA VOLUME	 	Avon Products, Inc.	 	Canada	 	Registered	 	1290908	 	22-Feb-06	 	TMA698729	 	17-Oct-07	 	
	MEMORABLE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1059457	 	18-May-00	 	TMA582744	 	29-May-03	 	
	MESMERIZE	 	Avon Products, Inc.	 	Canada	 	Registered	 	0701873	 	30-Mar-92	 	TMA442464	 	5-May-95	 	
	MESMERIZE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1239972	 	8-Dec-04	 	TMA659290	 	17-Feb-06	 	
	MESMERIZE	 	Avon Products, Inc.	 	United States of America	 	Registered	 	74185140	 	15-Jul-91	 	1749185	 	26-Jan-93	 	3
	MESMERIZE	 	Avon Products, Inc.	 	United States of America	 	Registered	 	75764649	 	29-Jul-99	 	2905393	 	30-Nov-04	 	3
	MESMERIZE FOR MEN	 	Avon Products, Inc.	 	Canada	 	Registered	 	1213943	 	20-Apr-04	 	TMA635139	 	14-Mar-05	 	
	MINI MARK-IT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1350100	 	4-Jun-07	 	TMA755973	 	23-Dec-09	 	3

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	MIRROR SHINE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1117036	 	3-Oct-01	 	TMA623188	 	21-Oct-04	 	
	MIRROR SHINE	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77657163	 	27-Jan-09	 	3845971	 	7-Sep-10	 	3
	MIST OPPORTUNITY	 	Avon Products, Inc.	 	Canada	 	Registered	 	1362206	 	4-Sep-07	 	TMA726,292	 	17-Oct-08	 	3
	MOISTURE 24	 	Avon Products, Inc.	 	Canada	 	Registered	 	1099064	 	12-Apr-01	 	TMA586364	 	31-Jul-03	 	
	MOISTURE REPLENISH	 	Avon Products, Inc.	 	Canada	 	Registered	 	1501415	 	27-Oct-10	 	TMA873,103	 	11-Mar-14	 	3
	MOISTURE THERAPY	 	Avon Products, Inc.	 	United States of America	 	Registered	 	74168185	 	20-May-91	 	1680036	 	24-Mar-92	 	3
	MOISTURE THERAPY DERMA RESTORING	 	Avon Products, Inc.	 	Canada	 	Pending	 	1639063	 	12-Aug-13	 		 		 	3
	MOISTURE THERAPY DERMA SOOTHING	 	Avon Products, Inc.	 	Canada	 	Pending	 	1,664,236	 	18-Feb-14	 		 		 	3
	MOMMY TILLIA	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77959246	 	15-Mar-10	 	4026789	 	13-Sep-11	 	3
	MOMMY TILLIA	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77959271	 	15-Mar-10	 	4026790	 	13-Sep-11	 	5
	MRS. ALBEE	 	Avon Canada Inc.	 	Canada	 	Registered	 	0837497	 	25-Feb-97	 	TMA521898	 	20-Jan-00	 	
	MUSK FIRE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1475923	 	7-Apr-10	 	TMA845,571	 	8-Mar-13	 	3
	MUSK MARINE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1475921	 	7-Apr-10	 	TMA799,648	 	9-Jun-11	 	3
	MUSK WOOD	 	Avon Products, Inc.	 	Canada	 	Registered	 	1475924	 	7-Apr-10	 	TMA846,573	 	19-Mar-13	 	3
	MY LIP MIRACLE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1235538	 	29-Oct-04	 	TMA648140	 	15-Sep-05	 	
	NAIL EXPERTS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1110108	 	24-Jul-01	 	TMA578545	 	31-Mar-03	 	
	NAIL EXPERTS	 	Avon Products, Inc.	 	United States of America	 	Registered	 	76186426	 	26-Dec-00	 	2620101	 	17-Sep-02	 	3
	NAILWEAR	 	Avon Products, Inc.	 	Canada	 	Registered	 	1106027	 	18-Jun-01	 	TMA585408	 	16-Jul-03	 	
	NAILWEAR DAZZLERS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1186518	 	13-Aug-03	 	TMA639311	 	6-May-05	 	
	NATURAL MATCH	 	Avon Products, Inc.	 	Canada	 	Registered	 	1137043	 	16-Apr-02	 	TMA625423	 	15-Nov-04	 	
	NEED A SHRINK?	 	Avon Products, Inc.	 	Canada	 	Registered	 	1362209	 	4-Sep-07	 	TMA719183	 	24-Jul-08	 	3
	NIGHT DEW	 	Avon Products, Inc.	 	Canada	 	Registered	 	1225203	 	28-Jul-04	 	TMA643123	 	28-Jun-05	 	
	NIGHT FORCE	 	Avon Canada Inc.	 	Canada	 	Registered	 	0863945	 	11-Dec-97	 	TMA539037	 	28-Dec-00	 	

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	NIGHT MAGIC	 	Avon Products, Inc.	 	Canada	 	Registered	 	0564816	 	20-Jun-86	 	TMA333915	 	6-Nov-87	 	
	NIGHT MAGIC	 	Avon Products, Inc.	 	United States of America	 	Registered	 	73590488	 	28-Mar-86	 	1432638	 	17-Mar-87	 	3
	NURTURA	 	Avon Canada Inc.	 	Canada	 	Registered	 	0434101	 	29-Dec-78	 	TMA249592	 	15-Aug-80	 	
	NURTURA	 	Avon Products, Inc.	 	United States of America	 	Registered	 	72371329	 	22-Sep-70	 	0925969	 	21-Dec-71	 	
	NUTRALUSH	 	Avon Products, Inc.	 	Canada	 	Registered	 	1059459	 	18-May-00	 	TMA565886	 	15-Aug-02	 	
	ODYSSEY	 	Avon Canada Inc.	 	Canada	 	Registered	 	0466593	 	10-Mar-81	 	TMA268366	 	23-Apr-82	 	
	ODYSSEY	 	Avon Products, Inc.	 	United States of America	 	Registered	 	71672442	 	30-Aug-54	 	0611883	 	6-Sep-55	 	
	ODYSSEY	 	Avon Products, Inc.	 	United States of America	 	Registered	 	73724887	 	27-Apr-88	 	1515090	 	6-Dec-88	 	3
	ON DUTY	 	Avon Products, Inc.	 	Canada	 	Registered	 	0314308	 	26-Jun-68	 	TMA168142	 	13-Mar-70	 	
	ON DUTY	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78838499	 	16-Mar-06	 	3187386	 	19-Dec-06	 	3
	ON DUTY 24	 	Avon Products, Inc.	 	Canada	 	Registered	 	0386614	 	9-Jun-75	 	TMA214671	 	9-Jul-76	 	
	ON DUTY 24	 	Avon Products, Inc.	 	United States of America	 	Registered	 	76559208	 	12-Nov-03	 	2903040	 	16-Nov-04	 	3
	ON DUTY 24 HOURS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1316012	 	11-Sep-06	 	TMA748,003	 	17-Sep-09	 	
	ON THE EDGE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1168227	 	21-Feb-03	 	TMA668153	 	18-Jul-06	 	
	ON THE EDGE	 	Avon Products, Inc.	 	United States of America	 	Registered	 	78215055	 	14-Feb-03	 	3002558	 	27-Sep-05	 	3
	OUTSPOKEN	 	Avon Products, Inc.	 	Canada	 	Registered	 	1466115	 	18-Jan-10	 	TMA790736	 	15-Feb-11	 	3
	OUTSPOKEN	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77814357	 	27-Aug-09	 	3881179	 	23-Nov-10	 	3
	OUTSPOKEN INTENSE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1500242	 	19-Oct-10	 	TMA862,868	 	18-Oct-13	 	3
	OUTSPOKEN PARTY!	 	Avon Products, Inc.	 	Canada	 	Pending	 	1678037	 	22-May-14	 		 		 	3
	PARADIGM	 	Avon Products, Inc.	 	Canada	 	Registered	 	1131430	 	21-Feb-02	 	TMA625455	 	16-Nov-04	 	
	PAXILLIUM TECHNOLOGY	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77942871	 	23-Feb-10	 	4060652	 	22-Nov-11	 	3
	PERCEIVE	 	Avon Products, Inc.	 	Canada	 	Pending	 	1700431	 	30-Oct-14	 		 		 	3

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	PERCEIVE	 	Avon Products, Inc.	 	United States of America	 	Registered	 	75316567	 	30-Jun-97	 	2400424	 	31-Oct-00	 	3
	PERFECT STRENGTH	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85158740	 	22-Oct-10	 	4218449	 	2-Oct-12	 	3
	PERFECT WEAR	 	Avon Products, Inc.	 	United States of America	 	Registered	 	74515426	 	22-Apr-94	 	1886868	 	4-Apr-95	 	3
	PERFECT WEAR	 	Avon Products, Inc.	 	United States of America	 	Registered	 	75577502	 	27-Oct-98	 	2288011	 	19-Oct-99	 	3
	PERFECT WEAR EXTRALASTING	 	Avon Products, Inc.	 	Canada	 	Registered	 	1270385	 	30-Aug-05	 	TMA686729	 	27-Apr-07	 	3
	PERFECTLY PURIFYING	 	Avon Products, Inc.	 	Canada	 	Pending	 	1712501	 	26-Jan-15	 		 		 	3
	PERSIAN WOOD	 	Avon Canada, Inc.	 	Canada	 	Registered	 	0236903	 	1-Aug-56	 	TMA106139	 	22-Mar-57	 	
	PERSONAL MATCH	 	Avon Products, Inc.	 	Canada	 	Registered	 	1202979	 	8-Jan-14	 	1202979	 	6-May-05	 	3
	PINK SUEDE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1117043	 	3-Oct-01	 	TMA623392	 	25-Oct-04	 	
	PLANET SPA	 	Avon Products, Inc.	 	Canada	 	Registered	 	1139002	 	2-May-02	 	TMA638218	 	25-Apr-05	 	
	PLANET SPA	 	Avon Products, Inc.	 	United States of America	 	Registered	 	86214683	 	7-Mar-14	 	4,725,139	 	21-Apr-15	 	3
	PORE-FECTION	 	Avon Products, Inc.	 	Canada	 	Registered	 	1084642	 	7-Dec-00	 	TMA602279	 	16-Feb-04	 	
	POSITIVITY	 	Avon Products, Inc.	 	Canada	 	Registered	 	1057706	 	5-May-00	 	TMA560931	 	26-Apr-02	 	
	PRO EXTREME	 	Avon Products, Inc.	 	Canada	 	Registered	 	1223287	 	13-Jul-04	 	TMA642885	 	23-Jun-05	 	
	PRO SPORT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1223289	 	13-Jul-04	 	TMA642646	 	21-Jun-05	 	
	PROSPECT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1148257	 	2-Aug-02	 	TMA625016	 	9-Nov-04	 	
	PRO-TO-GO	 	Avon Products, Inc.	 	Canada	 	Registered	 	1353077	 	25-Jun-07	 	TMA724936	 	1-Oct-08	 	3
	PROVIBE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1224227	 	20-Jul-04	 	TMA652,853	 	16-Nov-05	 	
	PUR BLANCA	 	Avon Products, Inc.	 	Canada	 	Registered	 	1038914	 	10-Dec-99	 	TMA571298	 	26-Nov-02	 	
	PUR BLANCA	 	Avon Products, Inc.	 	United States of America	 	Registered	 	75839922	 	5-Nov-99	 	2550701	 	19-Mar-02	 	3
	PUR BLANCA	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77546737	 	14-Aug-08	 	3815114	 	6-Jul-10	 	3
	PUR BLANCA BLOSSOM	 	Avon Products, Inc.	 	Canada	 	Registered	 	1406661	 	8-Aug-08	 	TMA770800	 	28-Jun-10	 	3
	QUICK PEN	 	Avon Products, Inc.	 	Canada	 	Registered	 	1095367	 	13-Mar-01	 	TMA602354	 	17-Feb-04	 	

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	R.P.M.	 	Avon Products, Inc.	 	Canada	 	Registered	 	1188772	 	10-Sep-03	 	TMA639049	 	4-May-05	 	
	R.P.M.	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	78297956	 	9-Sep-03	 	2990429	 	30-Aug-05	 	3
	RADIANT SILVER	 	Avon Products, Inc.	 	Canada	 	Registered	 	1155015	 	11-Oct-02	 	TMA639016	 	3-May-05	 	
	RARE GOLD	 	Avon Canada Inc.	 	Canada	 	Registered	 	0777022	 	6-Mar-95	 	TMA491623	 	19-Mar-98	 	
	RARE GOLD	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	74622005	 	17-Jan-95	 	1987685	 	16-Jul-96	 	3
	RARE PEARLS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1066563	 	11-Jul-00	 	TMA586327	 	31-Jul-03	 	
	RARE PEARLS	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	76056643	 	25-May-00	 	2628960	 	1-Oct-02	 	3
	RARE RUBIES	 	Avon Products, Inc.	 	Canada	 	Registered	 	0863947	 	11-Dec-97	 	TMA539130	 	4-Jan-01	 	
	REFRESHING BLUE	 	Avon Products, Inc.	 	Canada	 	Pending	 	1730947	 	2-Jun-15	 		 		 	3
	REFRESHING BLUE	 	Avon Products, Inc.	 	 United States
 of America
	 	Pending	 	86648573	 	2-Jun-15	 		 		 	3
	RELIEF EFFORT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1446715	 	31-Jul-09	 	TMA778951	 	4-Oct-10	 	3
	REPAIRSHIELD	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	85117289	 	27-Aug-10	 	4061198	 	22-Nov-11	 	3
	RETINEX PLUMPING COMPLEX	 	Avon Products, Inc.	 	Canada	 	Registered	 	1184820	 	1-Aug-03	 	TMA659027	 	15-Feb-06	 	
	RETROACTIVE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1059458	 	18-May-00	 	TMA560330	 	17-Apr-02	 	
	RETROACTIVE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1133534	 	13-Mar-02	 	TMA633207	 	18-Feb-05	 	
	REVERSALIST	 	Avon Products, Inc.	 	Canada	 	Registered	 	1422312	 	18-Dec-08	 	TMA764,551	 	20-Apr-10	 	3
	REVERSALIST	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	77635816	 	18-Dec-08	 	3800463	 	8-Jun-10	 	3
	REVERSALIST DAY	 	Avon Products, Inc.	 	Canada	 	Registered	 	1449706	 	27-Aug-09	 	TMA786,862	 	10-Jan-11	 	3
	REVERSALIST NIGHT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1449708	 	27-Aug-09	 	TMA786,867	 	10-Jan-11	 	3
	SALON STRAIGHT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1290916	 	22-Feb-06	 	TMA684148	 	20-Mar-07	 	
	SAVED BY THE GEL	 	Avon Products, Inc.	 	Canada	 	Pending	 	1759011	 	10-Dec-15	 		 		 	3
	SCANDA-LASH	 	Avon Products, Inc.	 	Canada	 	Registered	 	1168240	 	21-Feb-03	 	TMA668154	 	18-Jul-06	 	
	SCANDA-LASH	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	78215089	 	14-Feb-03	 	2990290	 	30-Aug-05	 	3

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	SCENTINI	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	77877167	 	20-Nov-09	 	4091476	 	24-Jan-12	 	3
	SECRETS OF INDIA	 	Avon Products, Inc.	 	Canada	 	Registered	 	1184280	 	25-Jul-03	 	TMA638295	 	26-Apr-05	 	
	SEE THINGS CLEARLY	 	Avon Products, Inc.	 	Canada	 	Registered	 	1362205	 	4-Sep-07	 	TMA756059	 	29-Dec-09	 	3
	SELF SANCTUARY	 	Avon Products, Inc.	 	Canada	 	Registered	 	1186517	 	13-Aug-03	 	TMA667946	 	17-Jul-06	 	
	SELF SANCTUARY SPA SEA WATER	 	Avon Products, Inc.	 	Canada	 	Registered	 	1237334	 	16-Nov-04	 	TMA668145	 	18-Jul-06	 	
	SELF SANCTUARY SPA THERMAL WATER	 	Avon Products, Inc.	 	Canada	 	Registered	 	1290907	 	22-Feb-06	 	TMA684673	 	27-Mar-07	 	
	SENSUAL EMBRACE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1106361	 	21-Jun-01	 	TMA616242	 	4-Aug-04	 	
	SENSUALITY BY LIIV BOTANICALS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1351409	 	13-Jun-07	 	TMA776586	 	8-Sep-10	 	3
	SHEER NOURISHMENT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1099345	 	19-Apr-01	 	TMA609728	 	7-May-04	 	
	SHINE ATTRACT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1530155	 	2-Jun-11	 	TMA824,347	 	17-May-12	 	3
	SHINE ATTRACT	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	85330680	 	26-May-11	 	4191728	 	14-Aug-12	 	3
	SHINE DIVINE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1139005	 	2-May-02	 	TMA625305	 	12-Nov-04	 	
	SIGNATURE SILK	 	Avon Products, Inc.	 	Canada	 	Registered	 	1406662	 	8-Aug-08	 	TMA755074	 	10-Dec-09	 	3
	SIGNATURE SILK	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	77546726	 	14-Aug-08	 	3710021	 	10-Nov-09	 	3
	 SIGNATURE
 COLLECTION and design
	 	Avon Products, Inc.	 	 United States
 of America
	 	Pending	 	1758973	 	10-Dec-15	 		 		 	18, 25
	 SIGNATURE WEEKEND

and design
	 	Avon Products, Inc.	 	Canada	 	Pending	 	1758990	 	10-Dec-15	 		 		 	18, 25
	 SILICONE GLOVE
	 	 Avon Canada Inc.
	 	 Canada
	 	 Registered
	 	0262224	 	 7-Apr-61
	 	 TMA128542
	 	 26-Oct-62
	 	
	 SILICONE GLOVE
	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	77871997	 	13-Nov-09	 	3810753	 	29-Jun-10	 	3
	 SIMPLE ELEMENTS
	 	 Avon Products, Inc.
	 	 Canada
	 	 Registered
	 	1407226	 	 14-Aug-08
	 	 TMA754370
	 	 2-Dec-09
	 	3
	 SIMPLE ELEMENTS
	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	77546731	 	14-Aug-08	 	3782005	 	27-Apr-10	 	3
	 SIMPLY BECAUSE
	 	 Avon Products, Inc.
	 	 Canada
	 	 Registered
	 	1458396	 	 9-Nov-09
	 	 TMA802,944
	 	 26-Jul-11
	 	3
	 SIMPLY BECAUSE
	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	77865939	 	5-Nov-09	 	3982202	 	21-Jun-11	 	3

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	SIMPLY COMPLETE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1152467	 	17-Sep-02	 	TMA638904	 	3-May-05	 	
	 SKIN SO SOFT AROMA
 THERAPY CALMING
	 	Avon Canada Inc.	 	Canada	 	Registered	 	1609319	 	10-Jan-13	 	TMA885,591	 	11-Sep-14	 	3
	SKIN SO SOFT AROMA+THERAPY ENERGIZING	 	Avon Canada Inc.	 	Canada	 	Registered	 	1609323	 	10-Jan-13	 	TMA882,108	 	14-Jul-14	 	3
	SKIN SO SOFT MINERAL GEMS GLAMOROUS GOLD & DESIGN	 	Avon Canada Inc.	 	Canada	 	Registered	 	1438325	 	15-May-09	 	TMA775596	 	26-Aug-10	 	3
	 SKIN SO SOFT MINERAL GEMS LUMINOUS
 PEARLS
& DESIGN
	 	Avon Canada Inc.	 	Canada	 	Registered	 	1438320	 	15-May-09	 	TMA775597	 	26-Aug-10	 	3
	 SKIN SO SOFT SUPREME
 NOURISHMENT
	 	Avon Canada Inc.	 	Canada	 	Pending	 	1753005	 	2-Nov-15	 		 		 	3
	SKINDISIAC +PASSIONFRUIT	 	Avon Products, Inc.	 	Canada	 	Registered	 	1,567,562	 	9-Mar-12	 	TMA898,442	 	11-Mar-15	 	3
	SKIN-SO-SOFT	 	Avon Canada Inc.	 	Canada	 	Registered	 	0258043	 	22-Jul-60	 	TMA121666	 	24-Mar-61	 	
	SKIN-SO-SOFT	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	72158130	 	29-Nov-62	 	0780479	 	17-Nov-64	 	3
	 SKIN-SO-SOFT
	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	74286231	 	19-Jun-92	 	1748065	 	26-Jan-93	 	3
	 SKIN-SO-SOFT
	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	75543607	 	27-Aug-98	 	2267373	 	3-Aug-99	 	3
	 SKIN-SO-SOFT
	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	75545042	 	27-Aug-98	 	2272317	 	24-Aug-99	 	5
	 SKIN-SO-SOFT
	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	75545043	 	27-Aug-98	 	2318318	 	15-Feb-00	 	3
	 SLEEPTHERAPY
	 	 Avon Products, Inc.
	 	 Canada
	 	 Registered
	 	1083369	 	 24-Nov-00
	 	 TMA597883
	 	 17-Dec-03
	 	
	 SMARTREPAIR
	 	 Avon Products, Inc.
	 	 Canada
	 	 Registered
	 	1603133	 	 20-Nov-12
	 	 TMA875,614
	 	 14-Apr-14
	 	3
	 SMOOTH MINERALS
	 	 Avon Products, Inc.
	 	 Canada
	 	 Registered
	 	1407934	 	 20-Aug-08
	 	 TMA750935
	 	 22-Oct-09
	 	3
	 SMOOTH MINERALS
	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	77550551	 	19-Aug-08	 	3710041	 	10-Nov-09	 	3
	 SNAP TO IT
	 	 Avon Products, Inc.
	 	 Canada
	 	 Registered
	 	1299266	 	 26-Apr-06
	 	 TMA700372
	 	 6-Nov-07
	 	

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	SNAP TO IT	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	78868984	 	25-Apr-06	 	3332517	 	6-Nov-07	 	3
	SOCIAL BEAUTY	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	78166141	 	20-Sep-02	 	3002511	 	27-Sep-05	 	35
	SOFT MUSK	 	Avon Canada Inc.	 	Canada	 	Registered	 	0479044	 	1-Dec-81	 	TMA286145	 	23-Dec-83	 	
	SOFT MUSK	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	73328697	 	18-Sep-81	 	1232450	 	29-Mar-83	 	3
	SOFT & SENSUAL	 	Avon Products, Inc.	 	Canada	 	Registered	 	1007420	 	5-Mar-99	 	TMA559583	 	21-Mar-02	 	3, 8
	SOLE SUPPORT	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	86259001	 	22-Apr-14	 	4767040	 	7-Jul-15	 	3
	SOLUTIONS AM AGELESS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1421269	 	10-Dec-08	 	TMA759,676	 	16-Feb-10	 	3
	SOLUTIONS AM TOTAL RADIANCE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1421272	 	10-Dec-08	 	TMA759,668	 	16-Feb-10	 	3
	SOLUTIONS CLEANSE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1447840	 	11-Aug-09	 	TMA778934	 	4-Oct-10	 	3
	SOLUTIONS NECK + CHEST PERFECTOR	 	Avon Products, Inc.	 	Canada	 	Registered	 	1465140	 	8-Jan-10	 	TMA779,139	 	6-Oct-10	 	3
	SOLUTIONS PM AGELESS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1421266	 	10-Dec-08	 	TMA759,667	 	16-Feb-10	 	3
	SOLUTIONS PM TOTAL RADIANCE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1421273	 	10-Dec-08	 	TMA759,669	 	16-Feb-10	 	3
	SOLUTIONS VIBES	 	Avon Products, Inc.	 	Canada	 	Registered	 	1468733	 	8-Feb-10	 	TMA786115	 	30-Dec-10	 	3
	SOMEWHERE	 	Avon Canada Inc.	 	Canada	 	Registered	 	0262069	 	29-Mar-61	 	TMA123350	 	25-Aug-61	 	
	 SPEAK OUT AGAINST

DOMESTIC VIOLENCE

AVON FOUNDATIO
	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	76649985	 	8-Nov-05	 	3514530	 	14-Oct-08	 	36
	 SPECTRACOLOR
	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	77653211	 	21-Jan-09	 	3791050	 	18-May-10	 	3
	 STEP INTO SEXY
	 	 Avon Products, Inc.
	 	 Canada
	 	 Registered
	 	1456504	 	 23-Oct-09
	 	 TMA825,824
	 	 7-Jun-12
	 	3
	 STEP INTO SEXY
	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	77856135	 	23-Oct-09	 	4080531	 	3-Jan-12	 	3
	 SUMMER WHITE
	 	 Avon Products, Inc.
	 	 Canada
	 	 Registered
	 	1222008	 	 28-Jun-04
	 	 TMA651,340
	 	 25-Oct-05
	 	
	 SUN SEEKERS
	 	 Avon Canada Inc.
	 	 Canada
	 	 Registered
	 	337575	 	 3-Nov-70
	 	 TMA178836
	 	 8-Oct-71
	 	3
	 SUPER DRAMA
	 	 Avon Products, Inc.
	 	 Canada
	 	 Registered
	 	1524876	 	 26-Apr-11
	 	 TMA874,270
	 	 26-Mar-14
	 	3

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	SUPER DRAMA	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	85301146	 	21-Apr-11	 	4250791	 	27-Nov-12	 	3
	SUPER SHAPE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1287529	 	26-Jan-06	 	TMA710946	 	3-Apr-08	 	
	SUPERCURLACIOUS	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	77676079	 	23-Feb-09	 	3769011	 	30-Mar-10	 	3
	SUPEREXTEND	 	Avon Products, Inc.	 	Canada	 	Registered	 	1415439	 	22-Oct-08	 	TMA801,151	 	30-Jun-11	 	3
	SUPEREXTEND and Design	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	77916726	 	21-Jan-10	 	3955608	 	3-May-11	 	3
	SUPEREXTEND EXTREME	 	Avon Products, Inc.	 	Canada	 	Registered	 	1508492	 	20-Dec-10	 	TMA867,183	 	11-Dec-13	 	3
	 SUPEREXTEND EYE
 ACCENTS MASCARA
	 	Avon Products, Inc.	 	Canada	 	Registered	 	1500554	 	21-Oct-10	 	TMA809698	 	20-Oct-11	 	4
	SUPERFULL	 	Avon Products, Inc.	 	Canada	 	Registered	 	1289019	 	7-Feb-06	 	TMA700370	 	6-Nov-07	 	
	SUPERFULL	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	78808151	 	6-Feb-06	 	3862167	 	12-Oct-10	 	3
	SUPERSHOCK	 	Avon Products, Inc.	 	Canada	 	Registered	 	1345332	 	27-Apr-07	 	TMA755029	 	10-Dec-09	 	3
	SUPERSHOCK	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	77166663	 	26-Apr-07	 	3481656	 	5-Aug-08	 	3
	 SUPREME
 NOURISHMENT
	 	Avon Products, Inc.	 	Canada	 	Pending	 	1,656,224	 	13-Dec-13	 		 		 	3
	 SUPREME
 NOURISHMENT
	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	86143243	 	13-Dec-13	 	4660926	 	23-Dec-14	 	3
	SURREAL	 	Avon Products, Inc.	 	Canada	 	Registered	 	1225866	 	4-Aug-04	 	TMA661518	 	28-Mar-06	 	
	SWEET FINISH	 	Avon Products, Inc.	 	Canada	 	Registered	 	1139003	 	2-May-02	 	TMA633292	 	21-Feb-05	 	
	SWEET HONESTY	 	Avon Products, Inc.	 	Canada	 	Registered	 	0357305	 	25-Sep-72	 	TMA198723	 	11-Apr-74	 	
	 SWEET HONESTY
	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	74431987	 	3-Sep-93	 	1867915	 	20-Dec-94	 	3
	 TENACILS
	 	 Avon Products, Inc.
	 	 Canada
	 	 Registered
	 	1116841	 	 2-Oct-01
	 	 TMA603050
	 	 24-Feb-04
	 	
	 THAT’S DEEP
	 	 Avon Products, Inc.
	 	 Canada
	 	 Registered
	 	1362204	 	 4-Sep-07
	 	724162	 	 23-Sep-08
	 	3
	 THE COMPANY FOR

WOMEN
	 	 Avon Canada Inc.
	 	 Canada
	 	 Registered
	 	1084627	 	 6-Dec-00
	 	 TMA683670
	 	 14-Mar-07
	 	
	 THE COMPANY FOR
 WOMEN
	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	75590121	 	17-Nov-98	 	2625444	 	24-Sep-02	 	35

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	THE MORE OF US WHO WALK THE MORE OF US SURVIVE	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	85743441	 	2-Oct-12	 	4467523	 	14-Jan-14	 	35, 36
	THERMAFIRM	 	Avon Products, Inc.	 	Canada	 	Registered	 	1276846	 	24-Oct-05	 	TMA675203	 	18-Oct-06	 	
	THERMAFIRM	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	78740650	 	26-Oct-05	 	3295251	 	18-Sep-07	 	3
	TIME OF YOUR LIFE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1084155	 	30-Nov-00	 	TMA597536	 	15-Dec-03	 	
	TIMELESS	 	Avon Canada Inc.	 	Canada	 	Registered	 	0384557	 	7-Apr-75	 	TMA213015	 	26-Mar-76	 	
	TIMELESS	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	73724891	 	27-Apr-88	 	1514261	 	29-Nov-88	 	3
	TINY TILLIA	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	77959041	 	15-Mar-10	 	4029512	 	20-Sep-11	 	3
	TINY TILLIA	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	77959182	 	15-Mar-10	 	4026787	 	13-Sep-11	 	5
	TINY TILLIA	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	77959207	 	15-Mar-10	 	4026788	 	13-Sep-11	 	25
	TINY TILLIA	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	78928806	 	13-Jul-06	 	3348476	 	4-Dec-07	 	3
	TODAY TOMORROW ALWAYS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1190378	 	25-Sep-03	 	TMA651,122	 	21-Oct-05	 	
	TODAY TOMORROW ALWAYS	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	76633431	 	16-Mar-05	 	3846851	 	14-Sep-10	 	3
	TODAY TOMORROW ALWAYS FOREVER	 	Avon Products, Inc.	 	Canada	 	Registered	 	1492556	 	17-Aug-10	 	TMA824,148	 	15-May-12	 	3
	TOPAZE	 	Avon Canada Inc.	 	Canada	 	Registered	 	166764	 	20-Aug-35	 	UCA05132	 	20-Aug-35	 	
	TOTALLY KISSABLE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1573723	 	18-Apr-12	 	TMA845,058	 	1-Mar-13	 	3
	TOTALLY KISSABLE	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	85598497	 	16-Apr-12	 	4505975	 	1-Apr-14	 	3
	 TRANQUIL MOMENTS
	 	 Avon Products, Inc.
	 	 Canada
	 	 Registered
	 	0554697	 	 24-Dec-85
	 	 TMA339740
	 	 29-Apr-88
	 	
	 TRI-ELASTINEX
	 	 Avon Products, Inc.
	 	 Canada
	 	 Pending
	 	1639775	 	 16-Aug-13
	 		 		 	3
	TRIPLE SONIC TECHNOLOGY	 	Avon Products, Inc.	 	Canada	 	Registered	 	1289313	 	9-Feb-06	 	TMA682,822	 	5-Mar-07	 	
	TRIPLE SONIC TECHNOLOGY	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	78810691	 	9-Feb-06	 	3304368	 	2-Oct-07	 	3

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	TRM3	 	Avon Products, Inc.	 	Canada	 	Registered	 	1086628	 	22-Dec-00	 	TMA599581	 	15-Jan-04	 	
	TRUE FORCE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1424318	 	13-Jan-09	 	TMA814,744	 	29-Dec-11	 	3
	TRUE FORCE	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	77649032	 	14-Jan-09	 	3832642	 	10-Aug-10	 	3
	TRUE GLOW	 	Avon Products, Inc.	 	Canada	 	Registered	 	1312078	 	8-Aug-06	 	TMA715915	 	4-Jun-08	 	3
	TRUE PORE-FECTION	 	Avon Products, Inc.	 	Canada	 	Registered	 	1195823	 	12-Nov-03	 	TMA642183	 	16-Jun-05	 	
	ULTIMAT-E	 	Avon Products, Inc.	 	Canada	 	Registered	 	1146148	 	11-Jul-02	 	TMA638987	 	3-May-05	 	
	ULTIMATE FUSION COMPLEX	 	Avon Products, Inc.	 	Canada	 	Registered	 	1122985	 	28-Nov-01	 	TMA627944	 	8-Dec-04	 	
	ULTRA COLOR ABSOLUTE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1618890	 	19-Mar-13	 	TMA879,062	 	29-May-14	 	3
	ULTRA COLOR INDULGENCE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1672187	 	10-Apr-14	 	TMA917,654	 	20-Oct-15	 	3
	ULTRA COLOR RICH BRILLIANCE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1536419	 	20-Jul-11	 	TMA840,053	 	14-Jan-13	 	3
	ULTRA COLOR RICH BRILLIANCE	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	85375708	 	20-Jul-11	 	4242986	 	13-Nov-12	 	3
	ULTRA GLAZEWEAR ABSOLUTE LIPGLOSS	 	Avon Products, Inc.	 	Canada	 	Pending	 	1621561	 	8-Apr-13	 		 		 	3
	ULTRA SEXY	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	86001797	 	3-Jul-13	 	4582979	 	12-Aug-14	 	3
	ULTRA SEXY HEART	 	Avon Canada Inc.	 	Canada	 	Pending	 	1730949	 	2-Jun-15	 		 		 	
	 ULTRA SEXY HEART
	 	Avon Products, Inc.	 	 United States
 of America
	 	Pending	 	86648717	 	2-Jun-15	 		 		 	
	 ULTRA SEXY LACE
	 	 Avon Products, Inc.
	 	 Canada
	 	 Registered
	 	1590953	 	 21-Aug-12
	 	 TMA860,584
	 	 18-Sep-13
	 	3
	 ULTRA SEXY LACE
	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	85709616	 	22-Aug-12	 	4475819	 	28-Jan-14	 	3
	 ULTRA SEXY PINK
	 	 Avon Products, Inc.
	 	 Canada
	 	 Pending
	 	1652621	 	 19-Nov-13
	 		 		 	3
	 ULTRA SEXY PINK
	 	Avon Products, Inc.	 	 United States
 of America
	 	Registered	 	86129570	 	26-Nov-13	 	4761098	 	23-Jun-15	 	3
	UN TEMPS NOUVEAU (HELLO TOMORROW)	 	Avon Products, Inc.	 	Canada	 	Registered	 	1339454	 	15-Mar-07	 		 	4-Mar-08	 	
	 UNPLUGGED
	 	 Avon Products, Inc.
	 	 Canada
	 	 Registered
	 	1176322	 	 7-Apr-05
	 	 TMA638,746
	 	 29-Apr-05
	 	

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	UNPLUGGED	 	Avon Products, Inc.	 	Canada	 	Registered	 	1546589	 	5-Oct-11	 	TMA886,342	 	22-Sep-14	 	3
	UNPLUGGED	 	Avon Products, Inc.	 	United States of America	 	Pending	 	85439396	 	5-Oct-11	 		 		 	3
	UNSCRIPTED	 	Avon Products, Inc.	 	Canada	 	Registered	 	1385254	 	28-Feb-08	 	TMA737625	 	7-Apr-09	 	3
	UNSCRIPTED	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77409551	 	29-Feb-08	 	3706133	 	3-Nov-09	 	3
	UNTOUCHABLE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1534465	 	6-Jul-11	 	TMA880,256	 	17-Jun-14	 	3
	UNTOUCHABLE	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85363843	 	6-Jul-11	 	4407524	 	24-Sep-13	 	3
	UNTOUCHABLE STRENGTH	 	Avon Products, Inc.	 	Canada	 	Pending	 	1636765	 	25-Jul-13	 		 		 	3
	UNTOUCHABLE STRENGTH	 	Avon Products, Inc.	 	United States of America	 	Registered	 	86023537	 	30-Jul-13	 	4717230	 	7-Apr-15	 	3
	UOMO 1886 & DESIGN	 	Avon Products, Inc.	 	Canada	 	Registered	 	1041072	 	29-Dec-99	 	TMA571254	 	26-Nov-02	 	
	URBAN FLOWERS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1418796	 	19-Nov-08	 	TMA768991	 	8-Jun-10	 	3
	URBAN FLOWERS	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77618789	 	20-Nov-08	 	3758859	 	9-Mar-10	 	3
	VISUAL PERFECTION	 	Avon Products, Inc.	 	Canada	 	Registered	 	1219368	 	7-Jun-04	 	TMA683953	 	16-Mar-07	 	
	VITA MOIST	 	Avon Products, Inc.	 	Canada	 	Registered	 	1059467	 	18-May-00	 	TMA582285	 	23-May-03	 	
	VITA-MOIST	 	Avon Products, Inc.	 	United States of America	 	Registered	 	72063921	 	9-Dec-58	 	0695807	 	5-Apr-60	 	
	VITADVANCE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1162169	 	17-Dec-02	 	TMA624071	 	29-Oct-04	 	5
	VITALITY BY LIIV BOTANICALS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1351540	 	13-Jun-07	 	TMA756163	 	30-Dec-09	 	3
	WEEKEND	 	Avon Canada Inc.	 	Canada	 	Registered	 	0426119	 	14-Jun-78	 	TMA250381	 	12-Sep-80	 	
	WHITE GRAPE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1141001	 	21-May-02	 	TMA640467	 	25-May-05	 	
	WILD COUNTRY	 	Avon Products, Inc.	 	Canada	 	Registered	 	0299375	 	1-Sep-66	 	TMA150644	 	5-May-67	 	
	WILD COUNTRY	 	Avon Products, Inc.	 	United States of America	 	Registered	 	72248959	 	27-Jun-66	 	0833473	 	8-Aug-67	 	
	WILD COUNTRY FOR HER	 	Avon Products, Inc.	 	Canada	 	Registered	 	1153613	 	27-Sep-02	 	TMA624946	 	8-Nov-04	 	
	WILD COUNTRY OUTBACK	 	Avon Products, Inc.	 	Canada	 	Registered	 	1106924	 	27-Jun-01	 	TMA616260	 	4-Aug-04	 	

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	WINDSCAPE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1421951	 	16-Dec-08	 	TMA802,897	 	25-Jul-11	 	3
	WINDSCAPE	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77621303	 	25-Nov-08	 	3796755	 	1-Jun-10	 	3
	WINGED OUT	 	Avon Products, Inc.	 	Canada	 	Pending	 	1,668,003	 	14-Mar-13	 		 		 	3
	WINGED OUT	 	Avon Products, Inc.	 	United States of America	 	Registered	 	86221101	 	14-Mar-14	 	4749820	 	2-Jun-15	 	3
	WINK	 	Avon Products, Inc.	 	Canada	 	Registered	 	1177685	 	21-May-03	 	TMA639079	 	4-May-05	 	
	WINKINK	 	Avon Products, Inc.	 	Canada	 	Registered	 	1297949	 	18-Apr-06	 	TMA684668	 	27-Mar-07	 	
	WINTERSOFT	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77166050	 	26-Apr-07	 	3359367	 	25-Dec-07	 	3
	WINTERSOFT WITH HYDROSEAL COMPLEX and design	 	Avon Products, Inc.	 	Canada	 	Registered	 	1310117	 	21-Jul-06	 	TMA741527	 	05-Jun-2009	 	3
	WISH OF HAPPINESS	 	Avon Products, Inc.	 	Canada	 	Registered	 	1347285	 	14-May-07	 	TMA768978	 	8-Jun-10	 	3
	WISH OF HOPE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1375532	 	11-Dec-07	 	TMA786094	 	30-Dec-10	 	3
	WISH OF HOPE	 	Avon Products, Inc.	 	United States of America	 	Registered	 	77351964	 	14-Dec-07	 	3726086	 	15-Dec-09	 	3
	WISH OF LOVE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1347280	 	14-May-07	 	TMA768971	 	8-Jun-10	 	3
	WISH OF PEACE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1347283	 	15-May-07	 	TMA768970	 	8-Jun-10	 	3
	WOMEN OF EARTH	 	Avon Products, Inc.	 	Canada	 	Registered	 	850941	 	16-Jul-97	 	TMA531718	 	24-Aug-00	 	3
	WOMEN OF INSPIRATION	 	Avon Canada Inc.	 	Canada	 	Registered	 	1154020	 	1-Oct-02	 	TMA605363	 	16-Mar-04	 	
	X-SERIES	 	Avon Products, Inc.	 	Canada	 	Registered	 	1512701	 	26-Jan-11	 	TMA868728	 	10-Jan-2014	 	3
	X-SERIES FLASH	 	Avon Products, Inc.	 	Canada	 	Registered	 	1527806	 	13-May-11	 	TMA876599	 	28-Apr-14	 	3
	X-SERIES FORCE	 	Avon Products, Inc.	 	Canada	 	Pending	 	1637966	 	2-Aug-13	 		 		 	3
	X-SERIES QUAKE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1527808	 	13-May-11	 	TMA876600	 	28-Apr-14	 	3
	X-SERIES RECHARGE	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85792790	 	3-Dec-12	 	4580937	 	5-Aug-14	 	3
	X-SERIES RECHARGE	 	Avon Products, Inc.	 	Canada	 	Registered	 	1604778	 	3-Dec-12	 	TMA869868	 	24-Jan-14	 	3
	X-SERIES RUSH	 	Avon Products, Inc.	 	Canada	 	Registered	 	1527804	 	13-May-11	 	TMA876598	 	28-Apr-14	 	3

																	
	 Trademark
	 	 Owner
	 	 Jurisdiction
	 	 Status
	 	 Application
Number
	 	 Application
Date
	 	 Registration
Number
	 	 Registration
Date
	 	 Class

	YESSAMIN	 	Avon Products, Inc.	 	Canada	 	Registered	 	1117044	 	3-Oct-01	 	TMA586290	 	31-Jul-03	 	
	YOU MAKE IT BEAUTIFUL	 	Avon Products, Inc.	 	Canada	 	Pending	 	1655353	 	9-Dec-13	 		 		 	35
	YOU MAKE IT BEAUTIFUL	 	Avon Products, Inc.	 	United States of America	 	Registered	 	86196583	 	18-Feb-14	 	4683833	 	10-Feb-15	 	35
	YOUTHGEN TECHNOLOGY	 	Avon Products, Inc.	 	Canada	 	Registered	 	1526216	 	4-May-11	 	TMA822,622	 	20-Apr-12	 	3
	YOUTHGEN TECHNOLOGY	 	Avon Products, Inc.	 	United States of America	 	Registered	 	85311876	 	4-May-11	 	4184159	 	31-Jul-12	 	3

 Schedule B: 

Existing North America Domain Names 

126chambersstreet.ca 
 126chambersstreet.us 

advancetechniques.us 
 anew.us 

avon.com 
 avon.us 

avoncalling.us 
 avoncollectibles.us 

avoncosmetics.us 
 avon-cosmetics.us 

avongirl.us 
 avonhome.us 

avonlady.us 
 avonleadershipmastercard.us 

avonleadershipvisa.us 
 avonmark.us 

avonpersonalbeauty.us 
 avon-products.us 

avontest.us 
 avon-usocares.us 

avonwellness.us 
 avonwoman.us 

babytillia.us 
 beautyforapurpose.us 

blacksuede.us 
 clearskin.us 

derekjeterbyavon.com 
 derekjeterdriven.com 

derek-jeter-driven.com 
 extralasting.us 

footworks.us 
 imari.us 

insideavon.com 
 markavon.us 

meetmark.us 
 myavon.us 

skinsosoft.us 
 skin-so-soft.us 

thecompanyforwomen.us 
 timeless.ca 

timeless.us 
 tinytillia.us 

wildcountry.ca 
 wrinklediagnosis.us 

xn-labeaupourlabont-htbk.ca 

 Schedule C: 

Existing North America Patents 
  

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Composition and Method for Under Eye Skin Lightening	 	Avon Products, Inc.	 	United States of America	 	Granted	 	08/602,004	 	15-Feb-1996	 	5,643,587
							
	Oxa Diacids and Related Compounds for Treating Skin Conditions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	08/636,540	 	25-Apr-1996	 	5,834,513
							
	Lip Treatment Containing Live Yeast Cell Derivatives	 	Avon Products, Inc.	 	United States of America	 	Granted	 	08/705,779	 	30-Aug-1996	 	5,776,441
							
	Multiple Layered Article Having a Bright Copper Layer	 	Avon Products, Inc.	 	United States of America	 	Granted	 	08/733,865	 	18-Oct-1996	 	5,792,565
							
	Oxa Diacids and Related Compounds for Treating Skin Conditions	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,251,146	 	25-Apr-1997	 	2,251,746
							
	Oxa Diacids and Related Compounds for Treating Skin Conditions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	08/850,333	 	02-May-1997	 	5,932,229
							
	Nail Bleach	 	Avon Products, Inc.	 	United States of America	 	Granted	 	08/954,837	 	21-Oct-1997	 	5,888,483
							
	Supersaturated Ascorbic Acid Solutions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	08/982,821	 	2-Dec-1997	 	6,020,367
							
	Wear Resistant Cosmetics	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,284,628	 	12-Mar-1998	 	2,284,628
							
	Wear Resistant Cosmetics	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/162,052	 	28-Sep-1998	 	6,083,516

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Cosmetic Composition for Imparting Wear Resistance and Shine	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/465,474	 	16-Dec-1999	 	6,303,105
							
	Cosmetic Composition Containing Fluorosilane Coated Particulates	 	Avon Products, Inc.	 	United States of America	 	Opposition	 	09/467,442	 	20-Dec-1999	 	6,315,990 C1
							
	Cosmetic Composition Containing Fluorosilane Coated Particulates	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/467,442	 	20-Dec-1999	 	6,315,990
							
	Extended Duration Insect Repellent Composition and Method of Application to the Skin	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/724,160	 	28-Nov-2000	 	6,719,959
							
	Improved Corrosion Resistant Aerosol Cosmetic Formulations	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/741490	 	19-Dec-2000	 	6,913,711
							
	Extended Duration Insect Repellent Composition and Method of Application to the Skin	 	Avon Products, Inc.	 	United States of America	 	Granted	 	10/203,839	 	27-Nov-2001	 	7,150,878
							
	Lightening Compositions And Methods Of Use	 	Avon Products, Inc.	 	United States of America	 	Granted	 	10/319,781	 	13-Dec-2002	 	7,014,844
							
	Non-Foaming Hair Care Composition for Cleansing and Conditioning	 	Avon Products, Inc.	 	United States of America	 	Granted	 	10/320,305	 	16-Dec-2002	 	7,087,559
							
	 si-RNA-Mediated Gene Silencing
 Technology To
Inhibit Tyrosinase
 And Reduce Pigmentation
	 	Avon Products, Inc.	 	United States of America	 	Granted	 	10/738,413	 	17-Dec-2003	 	7,504,385
							
	Segmented Composition And a Method And a System for Making Same	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/124,502	 	6-May-2005	 	7,208,168
							
	Cosmetic Compositions Having Extracts of Amomum Melegueta(aka Grains of Paradise) and Methods of Treating Skin	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,541,936	 	10-Jun-2006	 	2541936

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	 Cosmetic Compositions Having

Extracts of Amomum
 Melegueta(aka Grains of Paradise)

and Methods of Treating Skin
	 	 Avon Products, Inc.
	 	 United States of America
	 	 Granted
	 	 11/880,201
	 	 23-Jul-2007
	 	 7,842,316

	 	 	 	 	 	 
	 	 	 	 	 	 
	 	 	 	 	 	 
							
	 Hair And Scalp Composition With
 A
Crosslinked Silicone Elastomer
 And Method Of Using Same
	 	 Avon Products, Inc.
	 	 United States of America
	 	 Granted
	 	 11/862,689
	 	 27-Sep-2007
	 	 7,491,382

	 	 	 	 	 	 
	 	 	 	 	 	 
							
	Cosmetic Applicator	 	Avon Products, Inc.	 	United States of America	 	Granted	 	29/326,182	 	14-Oct-2008	 	D603093
							
	 si-RNA-Mediated Gene Silencing

Technology To Inhibit Tyrosinase
 And Reduce Pigmentation
	 	 Avon Products, Inc.
	 	 United States of America
	 	 Granted
	 	 12/361,576
	 	 29-Jan-2009
	 	 8,119,791

	 	 	 	 	 	 
	 	 	 	 	 	 
							
	Capless Cosmetic Applicator	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/514,506	 	12-May-2009	 	8,303,204
							
	Cosmetic Applicator	 	Avon Products, Inc.	 	United States of America	 	Granted	 	29/345,783	 	22-Oct-2009	 	D625992
							
	Topical Compositions Comprising Non-Proteogenic Amino Acids and Methods of Treating Skin	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,707,768	 	2-Jun-2010	 	2,707,768
							
	Cosmetic Compositions For Imparting Superhydrophobic Films	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,707,942	 	3-Jun-2010	 	2,707,942
							
	Cosmetic Compositions For Imparting Superhydrophobic Films	 	Avon Products, Inc.	 	United States of America	 	Published	 	12/747,430	 	10-Jun-2010	 	
							
	Topical Compositions Comprising Non-Proteogenic Amino Acids and Methods of Treating Skin	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/747,272	 	10-Jun-2010	 	8,168,212
							
	Use of Tiliacora Triandra in Cosmetics and Compositions Thereof	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/813,732	 	11-Jun-2010	 	9,084,744

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Use of Tiliacora Triandra in Cosmetics and Compositions Thereof	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/827,001	 	30-Jun-2010	 	8,771,758
							
	Stabilized Wax Composition and Uses Thereof	 	Avon Products, Inc.	 	United States of America	 	Published	 	12/839,692	 	20-Jul-2010	 	
							
	Cosmetic Compositions For Imparting Superhydrophobic Films	 	Avon Products, Inc.	 	Canada	 	Published	 	2,717,017	 	27-Aug-2010	 	
							
	Cosmetic Compositions For Imparting Superhydrophobic Films	 	Avon Products, Inc.	 	United States of America	 	Published	 	12/920,506	 	1-Sep-2010	 	
							
	Topical Lightening Composition and Uses Thereof	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/975,415	 	22-Dec-2010	 	8,329,149
							
	Method of Treating Skin with microRNA Modulators	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/979,695	 	28-Dec-2010	 	8,455,518
							
	Use of Glutamide Stabilizers	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/979,539	 	28-Dec-2010	 	8,591,871
							
	Partially Extendable Hair Brush	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/152,324	 	3-Jun-2011	 	9,055,804
							
	Cosmetic Applicator	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/152,324	 	3-Jun-2011	 	9,055,804
							
	Partially Extendable Hair Brush	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/152,379	 	3-Jun-2011	 	8,920,058
							
	Cosmetic Applicator	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/152,379	 	3-Jun-2011	 	8,920,058

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Collagen and Elastin Stimulating Compositions and Uses Thereof	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/216,626	 	24-Aug-2011	 	
							
	Cosmetic Use of Substituted Amino Heterocylic Carbamoyl Analogs and Related Compounds	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/217,870	 	25-Aug-2011	 	8,686,013
							
	Cosmetic Liquid Extractor Comprising Nonionic Polymers	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/222,370	 	31-Aug-2011	 	8,673,279
							
	Method for Enhancing the Growth and Fullness of Hair	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/231,329	 	13-Sep-2011	 	8,568,797
							
	Compositions and Methods for Stimulating Collagen Synthesis in the Skin	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/279,605	 	24-Oct-2011	 	
							
	Cosmetic Use of N-Heteroarylbisamide Analogs and Related Compounds	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/285,458	 	31-Oct-2011	 	9,044,408
							
	Hair Care Compositions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/311,685	 	6-Dec-2011	 	8,592,376
							
	Wash Resistant Compositions Containing Aminosilicone	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/313,463	 	7-Dec-2011	 	8,597,670
							
	Modulation of Thymosin Beta-4 in Skin	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/324,150	 	13-Dec-2011	 	8,632,827
							
	Use of Starfruit Extract as a CPT-1 Modulator and Compositions Thereof	 	Avon Products, Inc.	 	United States of America	 	Pending	 	61/604,870	 	29-Feb-2012	 	
							
	Transfer Resistant Cosmetic	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/395,330	 	9-Mar-2012	 	9,050,474

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Sol-Gel Compositions and Cosmetic Methods of Use Thereof	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/463,154	 	3-May-2012	 	
							
	Self-Leveling Cosmetic	 	Avon Products, Inc.	 	Canada	 	Published	 	2,781,033	 	15-May-2012	 	
							
	Dickkopf-1 Expression Modulating Compositions and Uses Thereof	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/599,631	 	30-Aug-2012	 	9,023,327
							
	Capless Cosmetic Applicator	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/632,619	 	1-Oct-2012	 	8,690,465
							
	Use of Tiliacora Triandra in Cosmetics and Compositions Thereof	 	Avon Products, Inc.	 	Canada	 	Published	 	2,799,083	 	9-Nov-2012	 	
							
	Use of Adipose Septa Protein Modulators and Compositions Thereof	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/710,536	 	11-Dec-2012	 	
							
	Modulation of Thymosin Beta-4 in Skin	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/710,585	 	11-Dec-2012	 	8,709,507
							
	Methods and Compositions to Impart Memory Effects onto Biosurfaces	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/711,713	 	12-Dec-2012	 	
							
	Enhanced Substantivity of Cosmetic Ingredients on Keratinous Substrate	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/717,920	 	18-Dec-2012	 	
							
	Collagen Stimulators and Their Use in the Treatment of Skin	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/721,509	 	20-Dec-2012	 	8,865,700
							
	Collagen Stimulators and Their Use in the Treatment of Skin	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/721,491	 	20-Dec-2012	 	8,901,122

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	PLOD-2 Stimulators and Their Use in the Treatment of Skin	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/721,758	 	20-Dec-2012	 	
							
	PLOD-2 Modulators and Their Use in the Treatment of Skin	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/721,687	 	20-Dec-2012	 	
							
	Use of Melicope Extracts to Improve Conditions Caused by Excess Lipids	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/808,280	 	4-Jan-2013	 	
							
	Modulation of Thymosin Beta-4 in Skin	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/735,659	 	7-Jan-2013	 	
							
	PLOD-2 Stimulators and Their Use in the Treatment of Skin	 	Avon Products, Inc.	 	Canada	 	Published	 	2,803,591	 	22-Jan-2013	 	
							
	Medemia Nobilis Extracts and Methods of Use	 	Avon Products, Inc.	 	Canada	 	Published	 	2,803,590	 	22-Jan-2013	 	
							
	Callistephus Chinensis Extracts and Methods of Use	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/813,336	 	30-Jan-2013	 	
							
	Hoya Carnosa Extracts and Methods of Use	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/814,422	 	5-Feb-2013	 	
							
	Serissa Japonica Extracts and Methods of Use	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/814,383	 	5-Feb-2013	 	8,999,403
							
	Stephanotis Jasminoides Extracts and Methods of Use	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/814,672	 	6-Feb-2013	 	9,186,316
							
	Use of CPT-1 Modulators and Compositions Thereof	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/777,288	 	26-Feb-2013	 	
							
	Hoya Carnosa Extracts and Methods of Use	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/793,177	 	11-Mar-2013	 	8,865,231

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Serissa Japonica Extracts and Methods of Use	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/793,109	 	11-Mar-2013	 	9,034,396
							
	Method of Treating Skin with microRNA Modulators	 	Avon Products, Inc.	 	Canada	 	Published	 	2,817,395	 	8-May-2013	 	
							
	Method of Treating Skin with microRNA Modulators	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/905,708	 	30-May-2013	 	8,865,740
							
	Use of Glutamide Stabilizers	 	Avon Products, Inc.	 	Canada	 	Published	 	2,822,325	 	19-Jun-2013	 	
							
	Method for Enhancing the Growth and Fullness of Hair	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/036,455	 	25-Sep-2013	 	
							
	Method of Improving Aging Appearance of Skin by Modulation of WIPI-1	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/055,037	 	16-Oct-2013	 	
							
	Wash Resistant Compositions Containing Aminosilicone	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/058,638	 	21-Oct-2013	 	
							
	Use of Glutamide Stabilizers	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/059,881	 	22-Oct-2013	 	
							
	Hair Care Compositions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	14/064,260	 	28-Oct-2013	 	9,017,651
							
	Use of Nesprin-2 Expression Modulators and Compositions Thereof	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/066,862	 	30-Oct-2013	 	
							
	Modulation of Thymosin Beta-4 in Skin	 	Avon Products, Inc.	 	United States of America	 	Granted	 	14/100,514	 	9-Dec-2013	 	9,114,089
							
	Cosmetic Liquid Extractor Comprising Nonionic Polymers	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/167,211	 	29-Jan-2014	 	

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Method for Enhancing the Growth and Fullness of Hair	 	Avon Products, Inc.	 	Canada	 	Published	 	2,844,142	 	4-Feb-2014	 	
							
	Cosmetic Use of Substituted Amino Heterocylic Carbamoyl Analogs and Related Compounds	 	Avon Products, Inc.	 	United States of America	 	Granted	 	14/174,455	 	6-Feb-2014	 	9,056,842
							
	Hair Care Compositions	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,852,663	 	16-Apr-2014	 	2,852,663
							
	Compositions and Methods for Treating Damaged Hair	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/354,827	 	28-Apr-2014	 	
							
	Modulation of Thymosin Beta-4 in Skin	 	Avon Products, Inc.	 	Canada	 	Published	 	2,854,979	 	7-May-2014	 	
							
	Wash Resistant Compositions Containing Aminosilicone	 	Avon Products, Inc.	 	Canada	 	Published	 	2,854,801	 	7-May-2014	 	
							
	Laponite Clay in Color Cosmetics and Personal Care Products	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/282,311	 	20-May-2014	 	
							
	Laponite Clay in Cosmetic and Personal Care Products	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/282,392	 	20-May-2014	 	
							
	Methods and Compositions to Impart Memory Effects onto Biosurfaces	 	Avon Products, Inc.	 	Canada	 	Published	 	2,856,556	 	21-May-2014	 	
							
	Use of Tiliacora Triandra in Cosmetics and Compositions Thereof	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/284,869	 	22-May-2014	 	
							
	Use of Starfruit Extract as a CPT-1 Modulator and Compositions Thereof	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/372,651	 	16-Jul-2014	 	
							
	Use of CPT-1 Modulators and Compositions Thereof	 	Avon Products, Inc.	 	Canada	 	Published	 	2,863,710	 	1-Aug-2014	 	
							
	Use of Starfruit Extract as a CPT-1 Modulator and Compositions Thereof	 	Avon Products, Inc.	 	Canada	 	Published	 	2,863,591	 	1-Aug-2014	 	

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Antidesma bunius Extracts and Methods of Use	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/379,544	 	19-Aug-2014	 	
							
	A Topical Lightening Composition and Methods of Use Thereof	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/379,520	 	19-Aug-2014	 	
							
	Melanin Binding Agents for Targeted Topical Delivery	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/379,795	 	20-Aug-2014	 	
							
	Functional Dynamic Cosmetic Package	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/488,776	 	17-Sep-2014	 	
							
	Collagen Stimulators and Their Use in the Treatment of Skin	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/521,972	 	23-Oct-2014	 	
							
	Topical Compositions and Methods of Use Thereof	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/529,383	 	31-Oct-2014	 	
							
	Cosmetic Use of Salicylic Acid Derivatives	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/408,114	 	15-Dec-2014	 	
							
	Cosmetic Use of Salicylic Acid Derivatives	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/408,645	 	17-Dec-2014	 	
							
	Cosmetic Use of Salicylic Acid Derivatives	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/408,676	 	17-Dec-2014	 	
							
	Cosmetic Use of Salicylic Acid Derivatives	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/408,735	 	17-Dec-2014	 	
							
	Topical Compositions and Methods for Skin Lightening	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/408,809	 	17-Dec-2014	 	

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Dickkopf-1 Expression Modulating Compositions and Uses Thereof	 	Avon Products, Inc.	 	Canada	 	Published	 	2,877,084	 	17-Dec-2014	 	
							
	Topical Compositions and Methods for Skin Lightening	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/409,607	 	19-Dec-2014	 	
							
	Cosmetic Compositions for Improving The Appearance of Skin	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/409,506	 	19-Dec-2014	 	
							
	Tyrosinase Inhibitors	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/412,032	 	30-Dec-2014	 	
							
	Tyrosinase Inhibitors	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/586,856	 	30-Dec-2014	 	
							
	Tyrosinase Inhibitors	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/412,185	 	30-Dec-2014	 	
							
	Tyrosinase Inhibitors	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/586,883	 	30-Dec-2014	 	
							
	Tyrosinase Inhibitors	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/412,194	 	30-Dec-2014	 	
							
	Methods and Compositions to Impart Memory Effects onto Biosurfaces	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/627,600	 	20-Feb-2015	 	
							
	Method of Improving Aging Appearance of Skin by Modulation of WIPI-1	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/661,061	 	18-Mar-2015	 	
							
	Method of Improving Aging Appearance of Skin by Modulation of WIPI-1	 	Avon Products, Inc.	 	Canada	 	Published	 	2,886,506	 	26-Mar-2015	 	

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	CGRP Compositions and Uses Thereof	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/669,545	 	26-Mar-2015	 	
							
	Ergonomic Cosmetic Applicator	 	Avon Products, Inc.	 	Canada	 	Published	 	2,888,672	 	17-Apr-2015	 	
							
	Cosmetic Use of N-Heteroarylbisamide Analogs and Related Compounds	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/700,661	 	30-Apr-2015	 	
							
	Topical Lightening Composition and Methods of Use Thereof	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/722,427	 	27-May-2015	 	
							
	Peptides and Their Use in the Treatment of Skin	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/742,060	 	17-Jun-2015	 	
							
	Modulation of Thymosin Beta-4 in Skin	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/745,542	 	22-Jun-2015	 	
							
	Screening Method for Identifying Active Agents	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/800,847	 	16-Jul-2015	 	
							
	System and Method for Measuring Skin Firmness	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/804,822	 	21-Jul-2015	 	
							
	A Topical Lightening Composition and Methods of Use Thereof	 	Avon Products, Inc.	 	Canada	 	Published	 	2,899,611	 	26-Jul-2015	 	
							
	Basella alba Extracts And Methods Of Use	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/763,710	 	27-Jul-2015	 	
							
	Compositions and Methods for Treating Damaged Hair	 	Avon Products, Inc.	 	Canada	 	Published	 	2,899,426	 	27-Jul-2015	 	
							
	Phyllanthus acidus Extracts And Methods Of Use	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/763,992	 	28-Jul-2015	 	

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Glochidium wallichianum Extracts And Methods Of Use	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/764,379	 	29-Jul-2015	 	
							
	Calotropis gigantea Extracts And Methods Of Use	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/764,330	 	29-Jul-2015	 	
							
	Allamanda cathartica Extracts And Methods Of Use	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/764,258	 	29-Jul-2015	 	
							
	Sesbania aculeata Extracts And Methods Of Use	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/764,191	 	29-Jul-2015	 	
							
	Vernonia cinerea Extracts And Methods Of Use	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/764,791	 	30-Jul-2015	 	
							
	Plumeria acuminata Extracts And Methods Of Use	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/764,620	 	30-Jul-2015	 	
							
	Peptides and Their Use in the Treatment of Skin	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/766,006	 	5-Aug-2015	 	
							
	Eurya groffii Extracts And Methods Of Use	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/766,886	 	10-Aug-2015	 	
							
	Hedyotis hedyotidea Extracts And Methods Of Use	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/766,843	 	10-Aug-2015	 	
							
	Tetracera asiatica Extracts And Methods Of Use	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/766,799	 	10-Aug-2015	 	
							
	Compositions Containing Peptides and Method of Use	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/767,451	 	12-Aug-2015	 	

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Compositions Containing Peptides and Method of Use	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/767,805	 	13-Aug-2015	 	
							
	Abutilon indicum Extracts And Methods Of Use	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/767,609	 	13-Aug-2015	 	
							
	Sargassum muticum Extracts And Methods Of Use	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/767,638	 	13-Aug-2015	 	
							
	Gracilaria textorii Extracts And Methods Of Use	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/767,705	 	13-Aug-2015	 	
							
	Genetic Assay for Skin Pigmentation	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/843,279	 	2-Sep-2015	 	
							
	Peptides and Their Use in the Treatment of Skin	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/844,095	 	3-Sep-2015	 	
							
	Paxillin Stimulating Compositions and Cosmetic Uses Thereof	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/675,891	 	01-Apr-2015	 	
							
	Volumizing Mascara Compositions	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/675,818	 	01-Apr-2015	 	
							
	Cosmetic Compositions for Imparting Superhydrophobic Films	 	Avon Products, Inc.	 	United States of America	 	Published	 	12/920,506	 	01-Sep-2010	 	
							
	Oxa Acids and Related Compounds for Treating Skin Conditions	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,256,582	 	02-Jun-1997	 	2,256,582
							
	Oxa Acids and Related Compounds for Treating Skin Conditions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	08/863,502	 	02-Jun-1997	 	6,069,169
							
	Gel-Based Lipstick Having Improved Rheology	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,671,363	 	02-Jun-2009	 	2,671,363

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Dispensing Mechanism Assembly	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/287,464	 	02-Nov-2011	 	8,545,121
							
	Powder Cosmetic Composition	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/949,240	 	03-Dec-2007	 	9,050,259
							
	Cosmetic Compositions for Imparting Superhydrophobic Films	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,707,942	 	03-Jun-2010	 	2,707,942
							
	Container	 	Avon Products, Inc.	 	Canada	 	Granted	 	132047	 	03-Sep-2009	 	132047
							
	Multi-Unit Cosmetic Applicator	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,677,298	 	04-Aug-2009	 	2,677,298
							
	Cosmetic Uses of Modified Stressed Yeast Extracts and Related Compositions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/850,193	 	04-Aug-2010	 	8,575,106
							
	Nail Strips Having a Crosslinked Polymer Top Coat	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/884,996	 	04-Dec-2008	 	8,586,164
							
	Cosmetic Compositions Having Improved Transfer Resistance	 	Avon Products, Inc.	 	Canada	 	Published	 	2,687,901	 	04-Dec-2009	 	
							
	Methods and Compositions for Preventing or Reducing Frizzy Appearance of Hair	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/560,602	 	04-Dec-2014	 	
							
	Oxa Acids and Related Compounds for Treating Skin Conditions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	08/658,089	 	04-Jun-1996	 	5,847,003
							
	Method Of Treating Skin Conditions	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,397,183	 	04-Sep-2002	 	2,397,183
							
	Paxillin Stimulating Compositions and Cosmetic Uses Thereof	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/602,557	 	04-Sep-2012	 	9,066,896
							
	Clear or Translucent Composition	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/080,034	 	05-Apr-2011	 	

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Cosmetic Compositions Having Improved Transfer Resistance	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/543,004	 	05-Jul-2012	 	
							
	Self-Leveling Cosmetic	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/513,980	 	05-Jun-2012	 	
							
	Brush for Applying a Cosmetic Product	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,601,255	 	05-Nov-2001	 	2,601,255
							
	Skin Treatment Using a New Retinoid	 	Avon Products, Inc.	 	United States of America	 	Granted	 	10/288,603	 	05-Nov-2002	 	7,074,420
							
	Method for Improving Color Retention in Artificially Colored Hair	 	Avon Products, Inc.	 	United States of America	 	Published	 	12/940,805	 	05-Nov-2010	 	
							
	Cosmetic Compositions Having Improved Transfer Resistance	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/810,559	 	06-Jun-2007	 	8,277,791
							
	Brush for Applying a Cosmetic Product	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/124,484	 	06-May-2005	 	1,909,043
							
	Topical Lightening Compositions and Methods of Use	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,411,222	 	06-Nov-2002	 	2,411,222
							
	Container	 	Avon Products, Inc.	 	Canada	 	Granted	 	137430	 	06-Oct-2010	 	137430
							
	Ergonomic Mascara Applicator	 	Avon Products, Inc.	 	Canada	 	Published	 	2,739,839	 	07-Apr-2011	 	
							
	Method Of Treating Skin Conditions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/521,442	 	07-Mar-2000	 	7,736,661
							
	Ergonomic Mascara Applicator	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/062,592	 	07-Mar-2011	 	

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Face Mask	 	Avon Products, Inc.	 	United States of America	 	Granted	 	29/317,803	 	07-May-2008	 	D608500
							
	Press-On Cosmetic Applicator System	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/290,616	 	07-Nov-2011	 	8,864,398
							
	Gel-Based Lipstick Having Improved Rheology	 	Avon Products, Inc.	 	United States of America	 	Granted	 	14/047,480	 	07-Oct-2013	 	9,205,039
							
	Post-Application Expanding Cosmetic Composition And Method Employing Same	 	Avon Products, Inc.	 	United States of America	 	Granted	 	10/502,061	 	08-Apr-2005	 	7,837,985
							
	Method for Lengthening Keratin Fibers	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/634,658	 	08-Dec-2006	 	8,821,846
							
	Shaper	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/562,870	 	08-Dec-2014	 	
							
	Nanoparticle Compositions Providing Enhanced Color for Cosmetic Formulations	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/970,882	 	08-Jan-2008	 	9,056,053
							
	Gel Technology Suitable for Use in Cosmetic Compositions	 	Avon Products, Inc.	 	Canada	 	Allowed	 	2,708,543	 	08-Jun-2010	 	
							
	Coupling Emulsions for Use With Ultrasound Devices	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/514,794	 	08-Jun-2012	 	
							
	Oxa Acids and Related Compounds for Treating Skin Conditions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/566,556	 	08-May-2000	 	6,333,356
							
	Cosmetic Composition with Encapsulated Pigments and a Method for Using	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,629,233	 	08-May-2008	 	2,629,233

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Multi-Unit Cosmetic Applicator	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/169,933	 	09-Jul-2008	 	8,662,776
							
	Ascorbyl - Phosphoryl - Cholesterol (AVC-10)	 	Avon Products, Inc.	 	United States of America	 	Granted	 	08/853,271	 	09-May-1997	 	5,951,990
							
	Cosmetic Compositions Containing Smectite Gels	 	Avon Products, Inc.	 	United States of America	 	Granted	 	08/853,992	 	09-May-1997	 	5,882,662
							
	Ascorbyl - Phosphoryl - Cholesterol (AVC-10)	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/189,368	 	09-Nov-1998	 	6,162,450
							
	Skin Treatment Using a New Retinoid	 	Avon Products, Inc.	 	United States of America	 	Granted	 	10/039,745	 	09-Nov-2001	 	6,641,824
							
	Compositions and Methods for Stimulation MAGP-1 to Improve the Appearance of Skin	 	Avon Products, Inc.	 	Canada	 	Published	 	2,799,223	 	09-Nov-2012	 	
							
	Cosmetic Compact with Pivoting Tray	 	Avon Products, Inc.	 	United States of America	 	Published	 	12556100	 	09-Sep-2009	 	
							
	Compositions and Methods for Stimulation MAGP-1 to Improve the Appearance of Skin	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/848,443	 	09-Sep-2015	 	
							
	Composition and Method for Under Eye Skin Lightening	 	Avon Products, Inc.	 	United States of America	 	Granted	 	08/631,815	 	10-Apr-1996	 	5,676,956
							
	Topical Compositions Containing Desthiobiotin and its Derivatives and a Method of Treating Skin	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/747,364	 	10-Jun-2010	 	8,450,353
							
	Cosmetic Compositions for Imparting Superhydrophobic Films	 	Avon Products, Inc.	 	United States of America	 	Published	 	12/747,430	 	10-Jun-2010	 	

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Gel Technology Suitable for Use in Cosmetic Compositions	 	Avon Products, Inc.	 	United States of America	 	Published	 	12/747,469	 	10-Jun-2010	 	
							
	Applicator Brush	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,300,665	 	10-Mar-2000	 	2,300,665
							
	Stable Ascorbic Acid Preparation for Topical Use	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/150,806	 	10-Sep-1998	 	6,299,889
							
	Shaper	 	Avon Products, Inc.	 	Canada	 	Allowed	 	2,680,749	 	10-Sep-2009	 	
							
	Ascorbyl - Phosphoryl - Cholesterol (AVC-10)	 	Avon Products, Inc.	 	United States of America	 	Granted	 	08/837,282	 	11-Apr-1997	 	5,866,147
							
	Non-Pressurized Post-Application Expanding Composition	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,502,048	 	11-Apr-2005	 	2,502,048
							
	Methods and Compositions for Preventing or Reducing Frizzy Appearance of Hair	 	Avon Products, Inc.	 	Canada	 	Published	 	2,777,378	 	11-Apr-2012	 	
							
	Methods and Compositions for Preventing or Reducing Frizzy Appearance of Hair	 	Avon Products, Inc.	 	Canada	 	Published	 	2,777,375	 	11-Apr-2012	 	
							
	Multistep Cosmetic Compositions	 	Avon Products, Inc.	 	United States of America	 	Published	 	11/953,915	 	11-Dec-2007	 	
							
	Optical Blurring Pigment Composition Suitable for Use in Cosmetics	 	Avon Products, Inc.	 	Canada	 	Published	 	2,709,097	 	11-Jun-2010	 	
							
	Cosmetic Container for Lipstick	 	Avon Products, Inc.	 	United States of America	 	Granted	 	29/259638	 	11-May-2006	 	D542978
							
	Cosmetic Compact	 	Avon Products, Inc.	 	United States of America	 	Granted	 	29/286,583	 	11-May-2007	 	D564133

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Self Emulsified Compositions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/294,562	 	11-Nov-2011	 	8,580,238
							
	Self Emulsified Compositions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/294,665	 	11-Nov-2011	 	9,066,862
							
	Cosmetic Compositions of Reactively Blended Copolymers	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/294,562	 	11-Nov-2011	 	8,580,238
							
	Cosmetic Compositions of Reactively Blended Copolymers	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/294,665	 	11-Nov-2011	 	9,066,862
							
	Compositions Containing A Vitamin C Component and Pigment	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/659,223	 	11-Sep-2000	 	6,576,248
							
	Compositions Containing Peptides with Non-Natural Amino Acids and Methods of Use	 	Avon Products, Inc.	 	Canada	 	Published	 	2,642,191	 	12-Aug-2008	 	
							
	Applicator Brush	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/267,959	 	12-Mar-1999	 	6,016,815
							
	Cosmetic Adhesive Composition	 	Avon Products, Inc.	 	Canada	 	Published	 	2,811,296	 	12-Mar-2013	 	
							
	Biofunctional Anchored Extended-Wear Cosmetics	 	Avon Products, Inc.	 	Canada	 	Published	 	2,811,274	 	12-Mar-2013	 	
							
	Compositions for Imparting Superhydrophobicity	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/945,003	 	12-Nov-2010	 	9,005,591
							
	Cosmetic Compositions and Methods for Using Same to Improve the Aesthetic Appearance of Skin	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/584,136	 	13-Aug-2012	 	8,808,765

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Cosmetic Composition with Encapsulated Pigments and a Method for Using	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/301,421	 	13-Dec-2005	 	8,277,785
							
	Paxillin Stimulating Compositions and Cosmetic Uses Thereof	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/966,098	 	13-Dec-2010	 	8,394,427
							
	Multi-Unit Cosmetic Applicator	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/818,027	 	13-Jun-2007	 	8,579,529
							
	Compositions and Methods for Stimulation MAGP-1 to Improve the Appearance of Skin	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/158,947	 	13-Jun-2011	 	9,132,294
							
	Compositions Having a Plurality of Discrete Emulsions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/129,184	 	13-May-2011	 	8,613,911
							
	Wear Resistant Cosmetic Compositions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/461,447	 	14-Dec-1999	 	6,309,629
							
	Photostable Sunscreen Compositions And Methods of Stabilizing	 	Avon Products, Inc.	 	United States of America	 	Granted	 	10/020,642	 	14-Dec-2001	 	6,440,402
							
	Multi-Unit Cosmetic Applicator	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,728,080	 	14-Dec-2010	 	2,728,080
							
	Long-Lasting Easy Wash-Off Cosmetic Compositions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/325,670	 	14-Dec-2011	 	8,771,656
							
	Long Wearing Powder-Based Cosmetic Compositions	 	Avon Products, Inc.	 	Canada	 	Published	 	2,821,938	 	14-Jun-2013	 	
							
	Long-Lasting Easy Wash-Off Cosmetic Compositions	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/826,724	 	14-Mar-2013	 	
							
	Cosmetic Applicator	 	Avon Products, Inc.	 	Canada	 	Published	 	2,848,866	 	14-Mar-2014	 	

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Long Wearing Powder-Based Cosmetic Compositions	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/295,299	 	14-Nov-2011	 	
							
	Gel Technology Suitable for Use in Cosmetic Compositions	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/882,540	 	14-Oct-2015	 	
							
	Oxa Acids and Related Compounds for Treating Skin Conditions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/152,574	 	14-Sep-1998	 	6,071,962
							
	Use of Eclipta Prostrata and other PPAR-Gamma Inhibitors in Cosmetics and Compositions Thereof	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,793,423	 	14-Sep-2012	 	2,793,423
							
	Cosmetic Powder Compositions for Delivering Actives	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/379,175	 	15-Aug-2014	 	
							
	Stabilized Glycerin-in-Oil Emulsions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/968,356	 	15-Dec-2010	 	8,302,774
							
	False Eyelash Holder	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/408,067	 	15-Dec-2014	 	
							
	Transparent Topical Cosmetic Gel Having Colored Fibers and Method of Using	 	Avon Products, Inc.	 	United States of America	 	Granted	 	10/891,843	 	15-Jul-2004	 	7,682,621
							
	Cosmetic Use of N-Substituted Sulfonyloxybenzylamines and Related Compounds	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/331,638	 	15-Jul-2014	 	
							
	Clear or Translucent Composition	 	Avon Products, Inc.	 	Canada	 	Published	 	2,784,733	 	15-Jun-2012	 	
							
	Compositions for Imparting Superhydrophobicity	 	Avon Products, Inc.	 	Canada	 	Published	 	2,721,225	 	15-Nov-2010	 	
							
	Compositions for Imparting Superhydrophobicity	 	Avon Products, Inc.	 	Canada	 	Published	 	2,724,392	 	15-Nov-2010	 	

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Compositions for Imparting Superhydrophobicity	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/992,729	 	15-Nov-2010	 	8,999,307
							
	Web Community Pre-Population Method and System	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/857,064	 	16-Aug-2010	 	8,868,651
							
	Mascara Composition	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/970,441	 	16-Dec-2010	 	8,128,918
							
	Shaving Preparation and Method for Shaving	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,633,384	 	16-Jun-2008	 	2,633,384
							
	Method and Composition for Reducing Appearance of Wrinkles	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,588,131	 	16-May-2007	 	2,588,131
							
	Compositions and Methods of Their Use for Improving the Condition and Appearance of Skin	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,588,128	 	16-May-2007	 	2,588,128
							
	Applicator Brush	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/441,355	 	16-Nov-1999	 	6,450,177
							
	Hair Care Compositions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/448,564	 	17-Apr-2012	 	8,980,237
							
	Nail Enamel Composition Having Fluorosilane Coated Particulates	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/465,606	 	17-Dec-1999	 	6,471,950
							
	Use of Active Extracts To Lighten Skin, Lips, Hair And/Or Nails	 	Avon Products, Inc.	 	United States of America	 	Granted	 	10/321,706	 	17-Dec-2002	 	7,189,419
							
	Glycerin-in-Oil Emulsion	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/108,835	 	17-Dec-2013	 	
							
	Compositions for Keratin Fibers	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/408,855	 	17-Dec-2014	 	

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Multi-Unit Cosmetic Applicator	 	Avon Products, Inc.	 	Canada	 	Published	 	2,875,082	 	17-Dec-2014	 	
							
	Multi-Unit Cosmetic Applicator	 	Avon Products, Inc.	 	Canada	 	Published	 	2,875,023	 	17-Dec-2014	 	
							
	Cosmetic Compact with Pivoting Tray	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,681,202	 	17-Sep-2009	 	2,681,202
							
	Cosmetic Formulation Incorporating a UV-Triggered Self-Healing Material	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/379,398	 	18-Aug-2014	 	
							
	Long-Wearing Transfer Resistant Film-Forming Ingredient	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/409/009	 	18-Dec-2014	 	
							
	Multi-layer Cosmetic Films	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/408,985	 	18-Dec-2014	 	
							
	Cosmetic Uses of Modified Stressed Yeast Extracts and Related Compositions	 	Avon Products, Inc.	 	Canada	 	Published	 	2,768,653	 	18-Jan-2012	 	
							
	Ergonomic Cosmetic Applicator	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/144,684	 	18-Jan-2013	 	
							
	Colored Cosmetic Compositions with Pearlescent and Color Pigment Blends	 	Avon Products, Inc.	 	United States of America	 	Granted	 	10/622,299	 	18-Jul-2003	 	7,628,998
							
	Novel Hair Treatment Compositions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/097,932	 	18-Jun-2008	 	8,846,016
							
	Paxillin Stimulating Compositions and Cosmetic Uses Thereof	 	Avon Products, Inc.	 	Canada	 	Published	 	2,784,895	 	18-Jun-2012	 	
							
	Cosmetic Compositions Comprising Fibrous Pigments	 	Avon Products, Inc.	 	Canada	 	Published	 	2,784,863	 	18-Jun-2012	 	
							
	Clear or Translucent Composition	 	Avon Products, Inc.	 	Canada	 	Published	 	2,785,977	 	18-Jun-2012	 	

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Multiphase Compositions	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/743,079	 	18-Jun-2015	 	
							
	Use of Thermoplastic Elastomers in a Composition and Compositions Thereof	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,633,619	 	18-May-2008	 	2,633,619
							
	Powder Cosmetic Composition	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,706,107	 	18-May-2010	 	2,706,107
							
	Styrene Maleic Anhydride Polymers in Cosmetics and Personal Care Products	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/133,851	 	19-Dec-2013	 	
							
	Biofunctional Anchored Extended-Wear Cosmetics	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/817,570	 	19-Feb-2013	 	
							
	Colored Cosmetic Compositions with Pearlescent and Color Pigment Blends	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,493,332	 	19-Jan-2005	 	2,493,332
							
	Compositions Containing Peptides with Non-Natural Amino Acids and Methods of Use	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/158,188	 	19-Jun-2008	 	8,551,956
							
	Modulation of Dynein in Skin	 	Avon Products, Inc.	 	Canada	 	Published	 	2,822,328	 	19-Jun-2013	 	
							
	Extended Release Fragrance Compositions	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/547,439	 	19-Nov-2014	 	
							
	Non-Pressurized Post-Application Expanding Composition	 	Avon Products, Inc.	 	United States of America	 	Granted	 	10/532,361	 	20-Apr-2005	 	7,846,424
							
	Mascara Composition	 	Avon Products, Inc.	 	United States of America	 	Granted	 	10/644,321	 	20-Aug-2003	 	7,431,919
							
	Cosmetic Compositions and Methods for Using Same to Improve the Aesthetic Appearance of Skin	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/141,383**	 	20-Dec-2000	 	6,562,321

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	High Gloss Gel-Based Lipstick	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/642,348	 	20-Dec-2006	 	7,989,002
							
	Gel-Based Lipstick Having Improved Rheology	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/642,403	 	20-Dec-2006	 	8,580,283
							
	Cosmetic Applicator and Method of Making	 	Avon Products, Inc.	 	Canada	 	Published	 	2,693,598	 	20-Jan-2010	 	
							
	Novel Hair Treatment Compositions	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,634,685	 	20-Jun-2008	 	2,634,685
							
	Container	 	Avon Products, Inc.	 	United States of America	 	Granted	 	29/328,193	 	20-Nov-2008	 	D640569
							
	Novel Hair Treatment Compositions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/314,889	 	21-Dec-2005	 	8,815,224
							
	Use of Thermoplastic Elastomers in a Composition and Compositions Thereof	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/314,634	 	21-Dec-2005	 	7,750,073
							
	Cosmetic Composition Containing Novel Fractal Particle Based Gels Having Improved Optical Properties	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/643,573	 	21-Dec-2006	 	8,603,505
							
	Cosmetic Composition Containing Novel Fractal Particle-Based Gels	 	Avon Products, Inc.	 	United States of America	 	Allowed	 	11/643,583	 	21-Dec-2006	 	
							
	Cosmetic Powder Bead Compositions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/974,688	 	21-Dec-2010	 	8,658,187
							
	Skin Care Composition that Mediates Cell to Cell Communication	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/040,534	 	21-Jan-2005	 	7,960,437
							
	Cosmetic Use of 1-Aroyl-N-(2-oxo-3-piperidinyl)-2-Piperazine Carboxamides and Related Compounds	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/164,873	 	21-Jun-2011	 	8,207,171

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Cosmetic Use of 1-Aroyl-N-(2-oxo-3-piperidinyl)-2-Piperazine Carboxamides and Related Compounds	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/164,915	 	21-Jun-2011	 	8,168,640
							
	Color Cosmetic with High Coverage and Naturalness	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/497,439	 	21-Mar-2012	 	
							
	Optical Blurring Pigment Composition Suitable for Use in Cosmetics	 	Avon Products, Inc.	 	United States of America	 	Published	 	12/744,061	 	21-May-2010	 	
							
	Long-Lasting Easy Wash-Off Cosmetic Compositions	 	Avon Products, Inc.	 	Canada	 	Published	 	2,856,564	 	21-May-2014	 	
							
	Oxa Acids and Related Compounds for Treating Skin Conditions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/957,923	 	21-Sep-2001	 	6,534,543
							
	Mascara Composition	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,561,127	 	21-Sep-2006	 	2,561,127
							
	Cosmetic Use of N-Substituted Sulfonyloxybenzylamines and Related Compounds	 	Avon Products, Inc.	 	Canada	 	Published	 	2,794,129	 	21-Sep-2012	 	
							
	The Use of Plant Extracts to Prevent and/or Reduce the Signs of Subjective Discomfort and/or Irritation in the Topical Application of Cosmetic Products	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/021,024	 	22-Dec-2004	 	8,221,766
							
	Use of Natural Plant Extracts in Cosmetic Compositions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/021,047	 	22-Dec-2004	 	7,618,662
							
	Use of Alisma Orientale Plant Extracts in Cosmetics and Compositions Thereof	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/021,023	 	22-Dec-2004	 	7,410,658

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Compositions and Methods of Their Use for Improving the Condition and Appearance of Skin	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/021,073	 	22-Dec-2004	 	7,514,092
							
	Cosmetic Compositions Comprising Fibrous Pigments	 	Avon Products, Inc.	 	United States of America	 	Published	 	12/645,067	 	22-Dec-2009	 	
							
	Printable Nail Strips	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/337,515	 	22-Jul-2014	 	
							
	Use Of Purslane To Treat Facial Wrinkles	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,485,403	 	22-Jun-2004	 	2,485,403
							
	Topical Compositions Containing CIS-6-Nonenol and its Derivatives and Methods for Treating Skin	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/165,876	 	22-Jun-2011	 	8,128,914
							
	Topical Compositions Containing Melicope Hayesii and a Method of Treating Skin	 	Avon Products, Inc.	 	Canada	 	Published	 	2,748,312	 	22-Jun-2011	 	
							
	Cosmetic Package	 	Avon Products, Inc.	 	Canada	 	Granted	 	156815	 	22-May-2014	 	156815
							
	Cosmetic Package	 	Avon Products, Inc.	 	Canada	 	Granted	 	156816	 	22-May-2014	 	156816
							
	Long-Lasting Easy Wash-Off Cosmetic Compositions	 	Avon Products, Inc.	 	Canada	 	Published	 	2,885,484	 	22-May-2014	 	
							
	Long-Lasting Easy Wash-Off Cosmetic Compositions	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/284,757	 	22-May-2014	 	
							
	Hair Care Compositions	 	Avon Products, Inc.	 	Canada	 	Allowed	 	2,722,399	 	22-Oct-2010	 	
							
	Method and Composition for Reducing Appearance of Wrinkles	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/789,017	 	23-Apr-2007	 	9,149,665
							
	Cosmetic Package	 	Avon Products, Inc.	 	Canada	 	Granted	 	150810	 	23-Apr-2013	 	150810    

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Cosmetic Package	 	Avon Products, Inc.	 	Canada	 	Granted	 	150809	 	23-Apr-2013	 	150809
							
	Topical Compositions Containing CIS-6-Nonenol and its Derivatives and Methods for Treating Skin	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/342,197	 	23-Dec-2008	 	7,993,629
							
	Cosmetic Use of 1-Aroyl-N-(2-oxo-3-piperidinyl)-2-Piperazine Carboxamides and Related Compounds	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/645,622	 	23-Dec-2009	 	7,993,663
							
	A Block Copolymer and Ester-Terminated Polyesteramide Composition and Uses Thereof	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/645,919	 	23-Dec-2009	 	8,545,860
							
	Anhydrous Mascara Compositions with Enhanced Depth of Color and Flexibility	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/410,770	 	23-Dec-2014	 	
							
	Shaper	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/442,417	 	23-Mar-2009	 	8,939,667
							
	Cosmetic Compositions and Methods for Using Same to Improve the Aesthetic Appearance of Skin	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,429,935	 	23-May-2003	 	2,429,935
							
	Ergonomic Cosmetic Applicator	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/658,397	 	23-Oct-2012	 	
							
	Ergonomic Applicator	 	Avon Products, Inc.	 	United States of America	 	Granted	 	29/435,321	 	23-Oct-2012	 	D700439
							
	Ergonomic Applicator	 	Avon Products, Inc.	 	United States of America	 	Pending	 	29/435,327	 	23-Oct-2012	 	
							
	Ergonomic Applicator	 	Avon Products, Inc.	 	United States of America	 	Granted	 	29/435,330	 	23-Oct-2012	 	D704,450

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Ergonomic Applicator	 	Avon Products, Inc.	 	United States of America	 	Granted	 	29/435,337	 	23-Oct-2012	 	D725,914
							
	Ergonomic Applicator	 	Avon Products, Inc.	 	United States of America	 	Granted	 	29/435,340	 	23-Oct-2012	 	D731,797
							
	Ergonomic Applicator	 	Avon Products, Inc.	 	United States of America	 	Granted	 	29/435,348	 	23-Oct-2012	 	D726,012
							
	Ergonomic Applicator	 	Avon Products, Inc.	 	United States of America	 	Granted	 	29/435,353	 	23-Oct-2012	 	D708064
							
	Sunscreen Compositions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	14/260,775	 	24-Apr-2014	 	9,173,830
							
	Self Emulsified Compositions	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/695,487	 	24-Apr-2015	 	
							
	Cosmetic Compositions of Reactively Blended Copolymers	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/695,487	 	24-Apr-2015	 	
							
	Anhydrous Mascara Compositions with Enhanced Depth of Color and Flexibility	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/411,175	 	24-Dec-2014	 	
							
	Compositions Containing Titanate Silicone Networks	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/411,119	 	24-Dec-2014	 	
							
	Compositions Containing Titanate Silicone Networks	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/411,147	 	24-Dec-2014	 	
							
	A Water Based Clear Sunscreen and Insect Repellent Composition	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,661,626	 	24-Feb-2009	 	2,661,626
							
	Web Community Pre-Population Method and System	 	Avon Products, Inc.	 	Canada	 	Published	 	2,806,518	 	24-Jan-2013	 	

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Compositions Having a Plurality of Discrete Emulsions	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/061,940	 	24-Oct-2013	 	
							
	Container for Personal Care	 	Avon Products, Inc.	 	United States of America	 	Granted	 	29/467,801	 	24-Sep-2013	 	D716147
							
	Container for Personal Care	 	Avon Products, Inc.	 	United States of America	 	Granted	 	29/467,821	 	24-Sep-2013	 	D743,261
							
	Container for Personal Care	 	Avon Products, Inc.	 	United States of America	 	Granted	 	29/467,826	 	24-Sep-2013	 	D719,450
							
	Container for Personal Care	 	Avon Products, Inc.	 	United States of America	 	Granted	 	14/034,728	 	24-Sep-2013	 	9,079,696
							
	A Water Based Clear Sunscreen and Insect Repellent Composition	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/510,304	 	25-Aug-2006	 	7,744,911
							
	Shaper	 	Avon Products, Inc.	 	Canada	 	Published	 	2,883,021	 	25-Feb-2015	 	
							
	Methods for Improving the Aesthetic Appearance of Skin (Mangostin)	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,471,657	 	25-Jun-2004	 	2,471,657
							
	Post-Application Expanding Cosmetic Composition And Method Employing Same	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,471,165	 	25-Jun-2004	 	2,471,165
							
	High Gloss Gel-Based Lipstick	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,670,529	 	25-May-2009	 	2,670,529
							
	Use of Eclipta Prostrata and other PPAR-Gamma Inhibitors in Cosmetics and Compositions Thereof	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/115,395	 	25-May-2011	 	8,802,167
							
	Coupling Emulsions for Use With Ultrasound Devices	 	Avon Products, Inc.	 	Canada	 	Published	 	2,781,904	 	25-May-2012	 	

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Cosmetic Package	 	Avon Products, Inc.	 	United States of America	 	Granted	 	29/435,540	 	25-Oct-2012	 	D694,019
							
	Topical Compositions Containing CIS-6-Nonenol and its Derivatives and Methods for Treating Skin	 	Avon Products, Inc.	 	Canada	 	Published	 	2,741,671	 	26-Apr-2011	 	
							
	Method for Improving Color Retention in Artificially Colored Hair	 	Avon Products, Inc.	 	Canada	 	Published	 	2,809,688	 	26-Feb-2013	 	
							
	Cosmetic Sampler Sheet	 	Avon Products, Inc.	 	Canada	 	Published	 	2,809,680	 	26-Feb-2013	 	
							
	Matte Cosmetic Compositions	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/632,093	 	26-Feb-2015	 	
							
	Cosmetic Container for Lipstick	 	Avon Products, Inc.	 	Canada	 	Granted	 	117568	 	26-Sep-2006	 	117568
							
	Cosmetic Compositions for Imparting Superhydrophobic Films	 	Avon Products, Inc.	 	Canada	 	Published	 	2,717,017	 	27-Aug-2010	 	
							
	Post-Application Expanding Cosmetic Composition And Method Employing Same	 	Avon Products, Inc.	 	United States of America	 	Granted	 	10/331,069	 	27-Dec-2002	 	7,837,984
							
	Cosmetic Films	 	Avon Products, Inc.	 	Canada	 	Published	 	2,809,885	 	27-Feb-2013	 	
							
	Cosmetic Use of 1-Aroyl-N-(2-oxo-3-piperidinyl)-2-Piperazine Carboxamides and Related Compounds	 	Avon Products, Inc.	 	Canada	 	Published	 	2,750,145	 	27-Jun-2011	 	
							
	Methods and Compositions for Preventing or Reducing Frizzy Appearance of Hair	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/912,859	 	27-Oct-2010	 	8,932,569
							
	Methods and Compositions for Preventing or Reducing Frizzy Appearance of Hair	 	Avon Products, Inc.	 	United States of America	 	Published	 	12/912,816	 	27-Oct-2010	 	

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Extended Release Fragrance Compositions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	14/165,687	 	28-Jan-2014	 	8,921,303
							
	Long-Wearing Glossy Lipcolor	 	Avon Products, Inc.	 	Canada	 	Published	 	2,899,608	 	28-Jul-2015	 	
							
	Aerosol Insect Repellent Composition Having Low VOC Content and Method of Applying Same to the Skin	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/724,313	 	28-Nov-2000	 	6,969,521
							
	Cosmetic Applicator	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/283,921	 	28-Oct-2011	 	8,448,650
							
	Multi-Unit Cosmetic Applicator	 	Avon Products, Inc.	 	United States of America	 	Granted	 	14/064,514	 	28-Oct-2013	 	8,950,963
							
	Compositions and Methods of Their Use for Improving the Condition and Appearance of Skin	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/647,648	 	29-Dec-2006	 	7,642,062
							
	Cosmetic Use of 1-Aroyl-N-(2-oxo-3-piperidinyl)-2-Piperazine Carboxamides and Related Compounds	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/344,868	 	29-Dec-2008	 	7,994,175
							
	Topical Compositions Containing Melicope Hayesii and a Method of Treating Skin	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/344,787	 	29-Dec-2008	 	7,592,024
							
	Cosmetic Composition	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/980,815	 	29-Dec-2010	 	8,802,063
							
	Photostable Sunscreen Compositions And Methods of Stabilizing	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/093,217	 	29-Mar-2005	 	7,186,404
							
	Cosmetic Composition Containing Novel Fractal Particle Based Gels Having Improved Optical Properties	 	Avon Products, Inc.	 	Canada	 	Allowed	 	2,671,277	 	29-May-2009	 	

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Cosmetic Composition Containing Novel Fractal Particle-Based Gels	 	Avon Products, Inc.	 	Canada	 	Allowed	 	2,671,245	 	29-May-2009	 	
							
	Cosmetic Powder Bead Compositions	 	Avon Products, Inc.	 	Canada	 	Published	 	2,782,368	 	29-May-2012	 	
							
	Modulation of Dynein in Skin	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/305,779	 	29-Nov-2011	 	
							
	Transparent Topical Cosmetic Gel Having Colored Fibers and Method of Using	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,561,783	 	29-Sep-2006	 	2,561,783
							
	Hair Care Compositions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/112,447	 	30-Apr-2008	 	8,178,080
							
	Stable Ascorbic Acid Preparation for Topical Use	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,309,195	 	30-Aug-1999	 	2,309,195
							
	Methods for Improving the Aesthetic Appearance of Skin (Mangostin)	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/026,198	 	30-Dec-2004	 	7,825,157
							
	Long Wearing Cosmetic Compositions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/323,711	 	30-Dec-2005	 	8,377,425
							
	Long Wear Color Cosmetic Composition	 	Avon Products, Inc.	 	United States of America	 	Granted	 	13/361,041	 	30-Jan-2012	 	8,808,673
							
	Ascorbyl - Phosphoryl - Cholesterol (AVC-10)	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/126,191	 	30-Jul-1998	 	5,922,335
							
	Cosmetic Use of N-Substituted Sulfonyloxybenzylamines and Related Compounds	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/826,864	 	30-Jun-2010	 	8,815,265
							
	Cosmetic Compositions and Methods for Using Same to Improve the Aesthetic Appearance of Skin	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/319,661	 	30-Jun-2014	 	

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Color Cosmetic with High Coverage and Naturalness	 	Avon Products, Inc.	 	Canada	 	Published	 	2,776,338	 	30-Mar-2012	 	
							
	Stabilized Glycerin-in-Oil Emulsions	 	Avon Products, Inc.	 	Canada	 	Published	 	2,776,337	 	30-Mar-2012	 	
							
	A Block Copolymer and Ester-Terminated Polyesteramide Composition and Uses Thereof	 	Avon Products, Inc.	 	Canada	 	Published	 	2,776,311	 	30-Mar-2012	 	
							
	Compositions Having a Plurality of Discrete Emulsions	 	Avon Products, Inc.	 	Canada	 	Published	 	2,745,143	 	30-May-2011	 	
							
	Long-Wearing Glossy Lipcolor	 	Avon Products, Inc.	 	United States of America	 	Published	 	14/361,765	 	30-May-2014	 	
							
	Cosmetic Adhesive Composition	 	Avon Products, Inc.	 	United States of America	 	Published	 	13/301,121	 	30-Nov-2011	 	
							
	Sunscreen Compositions	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/870,279	 	30-Sep-2015	 	
							
	Cosmetic Compositions and Methods for Using Same to Improve the Aesthetic Appearance of Skin	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,477,748	 	31-Aug-2004	 	2,477,748
							
	Topical Lightening Compositions and Methods of Use	 	Avon Products, Inc.	 	United States of America	 	Granted	 	11/215,814	 	31-Aug-2005	 	1,544,351
							
	Compositions And Methods Of Delivery For The Treatment Of Wrinkles, Fine Lines And Hyperhidrosis	 	Avon Products, Inc.	 	United States of America	 	Granted	 	10/334,887	 	31-Dec-2002	 	6,866,856
							
	Use Of Purslane To Treat Facial Wrinkles	 	Avon Products, Inc.	 	United States of America	 	Granted	 	10/334,886	 	31-Dec-2002	 	7,060,303
							
	Cosmetic Applicator and Method of Making	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,695,219	 	31-Jul-2008	 	2,695,219

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Cosmetic Applicator and Method of Making	 	Avon Products, Inc.	 	United States of America	 	Published	 	12/222,037	 	31-Jul-2008	 	
							
	Cosmetic Applicator and Method of Making	 	Avon Products, Inc.	 	United States of America	 	Granted	 	12/183,136	 	31-Jul-2008	 	9,113,692
							
	Skin Treatment Using a New Retinoid	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,411,058	 	31-Oct-2002	 	2,411,058
							
	Use of CPT-1 Modulators and Compositions Thereof	 	Avon Products, Inc.	 	United States of America	 	Unfiled	 	TBD-con of 13/777,2888	 		 	
							
	Gel Technology Suitable for Use in Cosmetic Compositions	 	Avon Products, Inc.	 	Canada	 	Unfiled	 	TBD-DIV of 2,708,543	 		 	
							
	Shaving Preparation and Method for Shaving	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/955,232	 	1-Dec-2015	 	
							
	Cosmetic Composition Containing Novel Fractal Particle-Based Gels	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/933,188	 	5-Nov-2015	 	
							
	Gel-Based Lipstick Having Improved Rheology	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/931,386	 	3-Nov-2015	 	
							
	Methods for Treating Skin	 	Avon Products, Inc.	 	United States of America	 	Pending	 	62/128,647	 	5-Mar-2015	 	
							
	Matte Cosmetic Compositions	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/718,529	 	21-May-2015	 	
							
	Volumizing Mascara Compositions	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/675,818	 	1-Apr-2015	 	
							
	Compositions of Melicope Elleryana	 	Avon Products, Inc.	 	United States of America	 	Pending	 	14/335,467	 	18-Jul-2014	 	

													
	 Title
	 	 Owner
	 	 Country
	 	 Application

Status
	 	 Application
Number
	 	 Filing

Date
	 	 Patent

Number

							
	Compositions and Methods for Enhancing Eyelashes	 	Avon Products, Inc.	 	United States of America	 	Pending	 	12/895,936	 	1-Oct-2010	 	
							
	Anhydrous Insect Repellent Composition	 	Avon Products, Inc.	 	United States of America	 	Granted	 	10/343,385	 	2-Jun-2003	 	7,037,515
							
	Cosmetic Composition and Methods of Use	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/461,448	 	14-Dec-1999	 	6,521,668
							
	Insect Repellent Composition	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/045,088	 	20-Mar-1998	 	6,355,264
							
	Wear Resistant Cosmetic Compositions	 	Avon Products, Inc.	 	United States of America	 	Granted	 	09/461,447	 	14-Dec-1999	 	6,309,629
							
	Cosmetic Liquid Extractor Comprising Nonionic Polymers	 	Avon Products, Inc.	 	Canada	 	Pending	 	2,843,721	 	2-Jul-2012	 	
							
	Clear or Translucent Composition	 	Avon Products, Inc.	 	Canada	 	Pending	 	2,784,733	 	4-Oct-2010	 	
							
	Compositions and Methods for Enhancing Eyelashes	 	Avon Products, Inc.	 	Canada	 	Pending	 	2,778,346	 	1-Oct-2010	 	
							
	Compositions for Imparting Superhydrophobicity	 	Avon Products, Inc.	 	Canada	 	Pending	 	2,724,392	 	14-Apr-2009	 	2,724,392
							
	Composition and Method for Dry Application of Mascara	 	Avon Products, Inc.	 	Canada	 	Granted	 	2,705,756	 	17-Nov-2008	 	2,705,756
							
	Compositions Containing Peptides with Non-Natural Amino Acids and Methods of Use	 	Avon Products, Inc.	 	Canada	 	Pending	 	2,642,197	 	28-Feb-2007	 	

 Schedule D 

Existing North America Copyrights 
  

											
	 Title
	  	 Type of Work
	  	 Claimant
	  	 Registration
Number
	  	 Registration

Date
	  	 Date of

Creation

	Artwork of Hawaiian characters.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VAu001020444	  	9-Apr-10	  	2009
	Artwork of three characters.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VAu001020445	  	9-Apr-10	  	2008
	Austin elephant	  		  	Avon Products, Inc.	  	VA 1 718 495	  	15-Apr-10	  	9-Apr-10
	[Avon American fashion thimble (1890)]	  	Visual Material	  	Avon Products, Inc.	  	VA0000148811	  	21-Mar-84	  	approx. 1981
	[Avon American fashion thimble (1900)]	  	Visual Material	  	Avon Products, Inc.	  	VA0000148812	  	21-Mar-84	  	approx. 1981
	[Avon American fashion thimble (1923)]	  	Visual Material	  	Avon Products, Inc.	  	VA0000148809	  	21-Mar-84	  	approx. 1981
	[Avon American fashion thimble (1927)]	  	Visual Material	  	Avon Products, Inc.	  	VA0000148806	  	21-Mar-84	  	approx. 1982
	[Avon American fashion thimble (1928)]	  	Visual Material	  	Avon Products, Inc.	  	VA0000148807	  	21-Mar-84	  	approx. 1982
	[Avon American fashion thimble (1938)]	  	Visual Material	  	Avon Products, Inc.	  	VA0000148808	  	21-Mar-84	  	approx. 1982
	[Avon American fashion thimble (1942)]	  	Visual Material	  	Avon Products, Inc.	  	VA0000148810	  	21-Mar-84	  	approx. 1982
	Avon (Beauty) : 30 sec. / composer, Garry Bell.	  	Music	  	Avon Products, Inc.	  	PAu000753224	  	19-Aug-85	  	1985
	Avon—Face of the eighties : 45 [sec.]	  	Music	  	Avon Products, Inc.	  	PAu000586087	  	19-Dec-83	  	1983
	Avon gave me a new world of friends.	  	Visual Material	  	Avon Products, Inc.	  	VA0000018385	  	21-Dec-78	  	1978
	Avon/Ideals present The Active woman’s cookbook : great tasting, time saving, money saving recipes!.	  	Text	  	Ideals Publishing Corporation & Avon Products, Inc.	  	TX0000657273	  	23-Mar-81	  	1980
	Avon leadership representative guidelines : a guide to building and developing your unit.	  	Text	  	Avon Products, Inc.	  	TX0003365241	  	28-Jul-91	  	1991
	Avon leadership representative guidelines : reference material.	  	Text	  	Avon Products, Inc.	  	TX0003360311	  	27-Jul-92	  	1991
	Avon leadership success training : building and developing your unit.	  	Motion Picture	  	Avon Products, Inc.	  	VA0000522903	  	27-Jul-92	  	1991
	Avon—looking good.	  	Music	  	Avon Products, Inc.	  	PAu000081908	  	2-Feb-79	  	1978
	[Avon. Making the holiday season just right for you]	  	Visual Material	  	Avon Products, Inc.	  	VA0000038584	  	23-Nov-79	  	1979
	Avon representative manual for success.	  	Kit	  	© · on text, recording; Avon Products, Inc.	  	SR0000143643	  	27-Jul-92	  	1991

											
	 Title
	  	 Type of Work
	  	 Claimant
	  	 Registration
Number
	  	 Registration

Date
	  	 Date of

Creation

	Avon—“Special woman.”	  	Music	  	Avon Products, Inc.	  	PAu000231789	  	11-Sep-80	  	1980
	Avon. The biggest collection of colors for black women.	  	Visual Material	  	Avon Products, Inc.	  	VA0000009824	  	28-Jul-78	  	1978
	Avon. The biggest collection of colors for black women.	  	Visual Material	  	Avon Products, Inc.	  	VA0000012160	  	10-Aug-78	  	1978
	Avon. The biggest collection of foundation and colors that are just right for you.	  	Visual Material	  	Avon Products, Inc.	  	VA0000030306	  	30-Jul-79	  	1978
	Avon. The biggest collection of foundation and colors that are just right for you.	  	Visual Material	  	Avon Products, Inc.	  	VA0000046834	  	7-Jun-79	  	1979
	Avon, the smartest opportunity in town!	  	Motion Picture	  	Avon Products, Inc.	  	VA0000522900	  	27-Jul-92	  	1991
	Avon, the world’s leading entrepreneurial company.	  	Text	  	Avon Products, Inc.	  	TX0003367275	  	29-Jul-92	  	1991
	The Best winter fun guide / Avon Products, Inc.	  	Text	  	Meredith Corporation	  	TX0000742651	  	14-Nov-80	  	1980
	Bird and Dog / by Tiffany Lerman, Michael Matthews.	  	Visual Material	  	Avon Products, Inc.	  	VAu000757366	  	20-Aug-10	  	
	Blueberry the Pig.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469214	  	4-Oct-99	  	1999
	[Bullhead]	  	Visual Material	  	Avon Products, Inc.	  	VA0000038219	  	7-Dec-79	  	1978
	[Butterfly]	  	Visual Material	  	Avon Products, Inc.	  	VA0000038220	  	7-Dec-79	  	1978
	Candy Poodle	  	Visual Material	  	Avon Products, Inc.	  	VA00017184489	  	15-Apr-10	  	2009
	Cheesecake the Mouse.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469199	  	4-Oct-99	  	1999
	Chester style guide collection 2003-2005	  	Recorded Document	  		  	VA 1-356-451	  	23-Sep-05	  	2005
	Chloe Mouse.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VA0001718249	  	15-Apr-10	  	2005
	Chrysanthemum porcelain ginger jar.	  	Visual Material	  	Avon Products, Inc.	  	VA0000209273	  	18-Dec-85	  	1983
	Clara the Cow.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469203	  	4-Oct-99	  	1999
	Color never looked so good : Avon.	  	Visual Material	  	Avon Products, Inc.	  	VA0000032038	  	13-Jun-79	  	1979
	Drawing of Bird and Dog Characters.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VAu001028040	  	18-May-10	  	2005
	David the Penguin	  	Visual Material	  	Avon Products, Inc.	  	VAu 1 020 445	  	9-Apr-10	  	
	Dilly Pig	  	Visual Material	  	Avon Products, Inc.	  	VA 1 718 512	  	15-Apr-10	  	
	Duncan Dog	  	Visual Material	  	Avon Products, Inc.	  	VA 1 718 503	  	15-Apr-06	  	
	Egyptian style bracelet.	  	Visual Material	  	Avon Products, Inc.	  	VA0000821027	  	15-Oct-96	  	 1993

											
	 Title
	  	 Type of Work
	  	 Claimant
	  	 Registration
Number
	  	 Registration

Date
	  	 Date of

Creation

	The Exceptional manager : prepared for Avon Products, Inc. / prepared by The Forum Corporation.	  	Text	  	The Forum Corporation of North America	  	TX0001244265	  	15-Sep-83	  	1973
	Feathers the Bird.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469196	  	4-Oct-99	  	1999
	Fine Home by Avon	  		  	Avon Products, Inc.	  	53883	  	22-Aug-06	  	NOTE: PR design registration
	Gary Reindeer.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VAu001020470	  	9-Apr-10	  	2005
	Geese spoons with stand.	  	Visual Material	  	Avon Products, Inc.	  	VA0000226651	  	3-Jul-86	  	1985
	Gill the Goldfish.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469215	  	4-Oct-99	  	1999
	Gumdrop the Koala.	  	Visual Material	  	Avon Products, Inc.	  	VAu000475085	  	4-Oct-99	  	1999
	Hilda the Hippo.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469195	  	4-Oct-99	  	1999
	Indy the Sheep	  	Visual Material	  	Avon Products, Inc.	  	VA 1 718 507	  	15-Apr-10	  	
	Jac Jac Cat.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VA0001725660	  	21-Jun-10	  	2005
	Jewelry in the nature of a pin with gingerbread man design.	  	Visual Material	  	Avon Products, Inc.	  	VA0000010999	  	31-Jul-78	  	1972
	Jordy Bug.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VA0001725661	  	21-Jun-10	  	2005
	June Bug.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469200	  	4-Oct-99	  	1999
	Katie Koala	  	Visual Material	  	Avon Products, Inc.	  	VA 1-718-510	  	15-Apr-10	  	
	Liiv Brand Book and Style Guidelines.	  	Text	  	Avon Products, Inc., Transfer: Assignment.	  	TXu001605228	  	29-May-09	  	2006
	Liiv Layout Tutorial.	  	Text	  	Avon Products, Inc., Transfer: Assignment.	  	TXu001605224	  	29-May-09	  	2006
	Little Blueberry.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469205	  	4-Oct-99	  	1999
	Little Cheesecake.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469210	  	4-Oct-99	  	1999
	Little Clara.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469202	  	4-Oct-99	  	1999
	Little Feathers.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469208	  	4-Oct-99	  	1999
	Little Gill.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469206	  	4-Oct-99	  	1999
	Little Gumdrop.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469194	  	4-Oct-99	  	1999
	Little Hilda.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469209	  	4-Oct-99	  	1999
	Little June Bug.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469211	  	4-Oct-99	  	1999

											
	 Title
	  	 Type of Work
	  	 Claimant
	  	 Registration
Number
	  	 Registration

Date
	  	 Date of

Creation

	Little MacDougal.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469204	  	4-Oct-99	  	1999
	Little Paddles.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469212	  	4-Oct-99	  	1999
	Little Purrdy.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469201	  	4-Oct-99	  	1999
	Little Rembrandt.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469207	  	4-Oct-99	  	1999
	Live in it, laugh in it, love in it, Tempo.	  	Visual Material	  	Avon Products, Inc.	  	VA0000020179	  	23-Oct-78	  	1978
	Looking good.	  	Motion Picture	  	Avon Products	  	PA0000055504	  	7-Nov-79	  	1979
	Looking good, feeling beautiful : the Avon book of beauty / art direction & design by John Staiano ; photos. by Charles Tracy ; [ill. by David Croland].	  	Text	  	Avon Products, Inc.	  	TX0000719845	  	18-May-81	  	1980
	MacDougal the Scottie dog	  	Visual Material	  	Avon Products, Inc.	  	VAu000469213	  	4-Oct-99	  	1999
	Most colors / produced by UniWorld Group, Inc.	  	Motion Picture	  	Avon Products, Inc.	  	PA0000015809	  	8-Jun-78	  	1978
	[Mother’s Day bangle bracelet]	  	Visual Material	  	Avon Products, Inc.	  	VA0000751557	  	21-May-96	  	1995
	Mother’s love ceramic planter.	  	Visual Material	  	Avon Products, Inc.	  	VAu000055852	  	13-Feb-84	  	1983
	[No title on deposit.]	  	Text	  	Avon Products, Inc., Transfer: Assignment.	  	TXu001605231	  	29-May-09	  	2005
	Oscar (Oki) Owl	  	Visual Material	  	Avon Products, Inc.	  	VA 1-718-485	  	15-Apr-10	  	
	Paddles the Duck.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469198	  	4-Oct-99	  	1999
	Pavielle : TV, 29 sec.	  	Music	  	Avon Products, Inc.	  	PAu000538172	  	22-Aug-83	  	1983
	Pavielle : TV, 44 sec.	  	Music	  	Avon Products, Inc.	  	PAu000538167	  	22-Aug-83	  	1983
	Purrdy the Lion.	  	Visual Material	  	Avon Products, Inc.	  	VAu000475084	  	4-Oct-99	  	1999
	Rembrandt the Bear.	  	Visual Material	  	Avon Products, Inc.	  	VAu000469197	  	4-Oct-99	  	1999
	[Rope pin]	  	Visual Material	  	Avon Products, Inc.	  	VA0000698347	  	25-Jan-95	  	1988
	Rorsie Lion.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VA0001718263	  	15-Apr-10	  	2005
	[Selling Avon is a beautiful experience (Jeanette Fabio)]	  	Visual Material	  	Avon Products, Inc.	  	VA0000035770	  	14-Sep-78	  	1978
	[Sunny Bunny]	  	Visual Material	  	Avon Products, Inc.	  	VA0000150008	  	6-Apr-84	  	1981
	TC Frog.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VA0001718260	  	15-Apr-10	  	2008
	Trace Frog	  	Visual Material	  	Avon Products, Inc.	  	VA 1 718 514	  	15-Apr-10	  	
	Thanks, America.	  	Music	  	Avon Products, Inc.	  	PAu000129103	  	13-Aug-79	  	1978

											
	 Title
	  	 Type of Work
	  	 Claimant
	  	 Registration
Number
	  	 Registration

Date
	  	 Date of

Creation

	[Thanks America for making us number one]	  	Visual Material	  	Avon Products	  	VA0000035771	  	14-Sep-78	  	1979
	Tiny Tilla – 18 characters	  	Visual Material	  	Avon Products, Inc.	  	VAu 1-020-440	  	9-Apr-2010	  	
	Tiny Tilla Signature Berry Blossom Hair Detangler.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VA0001718489	  	15-Apr-10	  	2008
	Tiny Tillia - 18 Characters - 2010.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VAu001020440	  	9-Apr-10	  	2010
	Tiny Tillia Bath Book.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VA0001718519	  	15-Apr-10	  	2005
	The Tiny Tillia Bedtime Book.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VAu001045701	  	15-Apr-10	  	2009
	Tiny Tillia Cherry Blossom Hair Detangler.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VA0001718507	  	15-Apr-10	  	2005
	Tiny Tillia Citrus Sorbet Bubble Bath.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VA0001718506	  	15-Apr-10	  	2005
	Tiny Tillia Colds & Stuffy Noses Bath Powder.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VA0001718510	  	15-Apr-10	  	2005
	Tiny Tillia Cucumber Mango Head to Toe Foamy Wash.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VA0001718512	  	15-Apr-10	  	2005
	Tiny Tillia Lavender Chamomile All Over Moisture Spray.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VA0001718503	  	15-Apr-10	  	2005
	The Tiny Tillia Munch Book.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VAu001044824	  	15-Apr-10	  	2009
	The Tiny Tillia Playtime Book.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VAu001044821	  	15-Apr-10	  	2009
	Tiny Tillia Sleepytime Bath Powder.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VA0001718485	  	15-Apr-10	  	2005
	Tiny Tillia Sun Stick SPF30.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VA0001718514	  	15-Apr-10	  	2005
	Tiny Tillia Tea Tree Lime Hand Sanitizing Gel.	  	Visual Material	  	Avon Products, Inc., Transfer: By written agreement.	  	VA0001718495	  	15-Apr-10	  	2005
	[Tomahawk]	  	Visual Material	  	Avon Products, Inc.	  	VA0000038218	  	7-Dec-79	  	1978
	TT Cow	  	Visual Material	  	Avon Products, Inc.	  	VA 1 718 506	  	15-Apr-10	  	

											
	 Title
	  	 Type of Work
	  	 Claimant
	  	 Registration
Number
	  	 Registration

Date
	  	 Date of

Creation

	The Undeniable fragrance case : National Black MBA Association 13th annual national conference & exposition.	  	Text	  	Avon Products, Inc.	  	TX0003232361	  	31-Jan-92	  	1991
	We’re gonna make you feel beautiful : 10-24-80 : vocal / arr. Gerald Alters	  	Music	  	Avon Products, Inc.	  	PAu000283517	  	2-Apr-81	  	 1981

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}]]